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Abstract 
Background 
Public health interventions need to both improve health and reduce health 
inequalities, whilst using limited health care resources efficiently. Well-
established ethnic differences in cardiovascular disease (CVD) raise the 
possibility that CVD prevention policies may not work equally well across ethnic 
groups. The aim of this thesis was to explore whether there are ethnic 
differences in the potential impact of two CVD prevention policy choices – the 
choice between mass and targeted screening for high cardiovascular risk, 
including the use of area deprivation measures to target screening, and the 
choice between population and high-risk approaches. 
Methods 
Cross-sectional data from the Health Survey for England 2003 and 2004 were 
used. Three sets of analyses were carried out – first, calculation of ethnic 
differences in the utility of area deprivation measures to identify individual 
socioeconomic deprivation; second, investigation of ethnic differences in the 
cost-effectiveness of mass and targeted screening for high cardiovascular risk; 
third, analysis of ethnic differences in the potential impact of population and 
high-risk approaches to CVD prevention. 
Results 
Area deprivation measures worked relatively effectively and efficiently at 
identifying individual socioeconomic deprivation in ethnic minority groups 
compared to the white group. In ethnic groups at high risk of CVD, cardiovascular 
risk screening programmes were a relatively cost-effective option, screening 
programmes targeted at deprived areas were particularly cost-effective, and 
population approaches were found to be an effective and equitable way of 
preventing CVD despite potential underestimation of their impact. 
Discussion 
This thesis found that ethnic minority groups in the UK are unlikely to be 
systematically disadvantaged by a range of CVD prevention policies that have 
been proposed, or implemented, for the general population. Additional CVD 
prevention policies, in particular those based on the population approach, should 
be implemented.
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1 Chapter 1: Introduction 
Health policy makers face continual decisions regarding how best to prevent 
disease and promote population health. Against a background of limited health 
resources and increasing demand and need for health services (1, 2), decision 
makers must assess the relative merits of public health interventions. The first 
aim of any public health intervention must be to improve health. Second, public 
health interventions should reduce, or at least not widen, health inequalities. In 
addition, the financial, resource and opportunity costs of interventions must be 
considered, to ensure that they offer good value for money and do not take up 
resources that could be better used elsewhere (3).  
It can be difficult to ensure that these aims can and will be achieved in practice. 
Making this assessment requires detailed evaluation and evidence gathering 
regarding the effectiveness, cost and equity impact of potential and existing 
interventions. Evidence needs to be gathered both for the population as a whole 
and for population subgroups (4). This is because it is possible that public health 
interventions could work less effectively or efficiently in subgroups of the 
population, a difference that could create or exacerbate health inequalities or 
waste resources (5). 
This thesis aims to explore this issue from the perspective of an important 
disease (cardiovascular disease) and important axis of health inequality 
(ethnicity). Cardiovascular disease (CVD) is the leading cause of premature 
mortality in the United Kingdom (UK) and, crucially, may be preventable through 
the modification of cardiovascular risk factors (6, 7). There is a well-established, 
though complex, association between CVD and ethnicity, with evidence of ethnic 
differences in CVD and many important determinants and causes of CVD (8-11). 
In particular, some of the largest ethnic minority groups in the UK experience a 
higher risk of CVD than the majority white population (12).  
A number of high-profile decisions regarding CVD prevention policy have been 
made in recent years. In England, decision makers opted to implement a 
nationwide cardiovascular risk screening programme for all middle-aged adults 
(13), whilst in Scotland decision makers chose to target screening at 
socioeconomically deprived populations (14). The approach used by the English 
government to encourage healthy behaviours, and therefore reduce 
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cardiovascular risk factors, across the population has been controversial and 
continues to be debated (15-17), whilst national recommendations have been 
made for population wide measures to prevent CVD (18). 
Alongside these developments in CVD prevention policy, the UK is becoming 
more ethnically diverse (19). This raises the increasingly important question of 
whether CVD prevention policies designed for the general population work 
equally well in different ethnic groups. If these policies worked less effectively 
or efficiently in these groups existing ethnic inequalities in CVD could be 
worsened and resources, which could be used elsewhere, wasted. Therefore, the 
purpose of this thesis is to explore whether there are ethnic differences in the 
potential effectiveness, cost and equity impact of a range of CVD prevention 
policy options designed for the general population.  
1.1 Thesis structure 
In addition to this introductory chapter (chapter 1) this thesis is made up of 6 
further chapters (chapters 2-7). Chapters 2 and 3 form the literature review; the 
first of these review chapters provides a broad overview of the literature on CVD 
prevention including the various approaches available, whilst the second of 
these chapters reviews the association between ethnicity and CVD and the 
implications of ethnicity for CVD prevention approaches. Following these 
literature review chapters, there are three chapters which each address 
separate, but linked, research questions (Chapters 4, 5 and 6). These questions 
relate to two policy choices in CVD prevention – the choice between mass and 
targeted screening for high cardiovascular risk, including the use of area 
deprivation measures to target screening, and the choice between population 
and high-risk approaches to CVD prevention. The specific research questions 
addressed are: 
Are there ethnic differences in the utility of area deprivation measures to 
target socioeconomically deprived individuals? (Chapter 4) 
Are there ethnic differences in the cost-effectiveness of targeted and 
mass screening for high cardiovascular risk? (Chapter 5) 
Are there ethnic differences in the potential impact of population and 
high-risk approaches to CVD prevention? (Chapter 6) 
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Chapters 4, 5 and 6 each contain a brief introduction, plus methods, results and 
discussion sections. Finally, Chapter 7 provides a general discussion of the 
findings and their implications for CVD prevention policy makers.
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2 Chapter 2: Cardiovascular disease prevention 
2.1 Overview 
This chapter forms the first part of the literature review and focuses on CVD 
prevention. This thesis is principally concerned with primary prevention of CVD – 
that is prevention in people who do not yet have a diagnosis of CVD. Therefore, 
this chapter focuses on the potential impact of primary prevention of CVD, 
alongside various methods of categorising preventative interventions, including 
population and high-risk approaches. The evidence for commonly used primary 
prevention interventions is reviewed. The chapter finishes by reviewing evidence 
of the potential impact of public health interventions on health inequalities, 
another core theme in this thesis. 
2.2 Definition of cardiovascular disease 
CVD is a term that encompasses a range of diseases affecting the heart and 
circulatory system (20). Whilst this can include diseases such as peripheral 
arterial disease and heart failure, this thesis is principally concerned with two of 
the most important diseases within this definition – ischaemic heart disease 
(IHD) (also known as coronary heart disease) and stroke. The main cause of CVD 
is atherosclerosis, a build up of fatty deposits (atheroma) in arteries (21). 
Atheroma in coronary arteries can result in partial blockages leading to angina 
or, if a clot (thrombosis) also forms, complete blockage leading to myocardial 
infarction (20); stroke can result from atheroma and thrombosis causing blocked 
arteries to the brain (ischaemic stroke), or from bleeding in the brain 
(haemorrhagic stroke) (22).  
The Framingham study, a pivotal cohort study from North America, clearly 
demonstrated the importance of risk factors to the development of CVD (23), 
changing our understanding of CVD and how it could be prevented (24). These 
risk factors have subsequently been found to apply in different populations 
across the world, in both men and women and at all ages (7, 25). Cardiovascular 
risk factors can be unmodifiable or modifiable. Increased age and being male are 
important unmodifiable risk factors. Modifiable risk factors include health 
behaviours, such as smoking, and biological markers, such as high cholesterol 
concentrations (see Figure 2-1), risk factors that can be altered through lifestyle 
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changes and pharmacological interventions. Yusuf et al calculated a population 
attributable risk for first myocardial infarction of 90.4% associated with a 
combination of nine modifiable risk factors (smoking, fruit and vegetable 
consumption, physical activity, alcohol consumption, psychosocial factors, 
hypertension, dyslipidaemia, obesity and diabetes) (7). Population attributable 
risk is a statistic used in epidemiology to indicate the proportion of disease that 
could be prevented by eliminating exposure to risk factor(s) (26). When 
interpreting this value of 90.4% it is important to note that population 
attributable risks for multiple risk factors can exceed 100%, and that this value 
does not suggest that other risk factors can only account for 9.6% of disease 
(27). Despite this, Yusuf et al’s finding indicates that a very high proportion of 
CVD could be prevented if these risk factors were eliminated and, therefore, the 
enormous potential that exists for prevention of CVD.  
In addition, broader determinants of health exist that influence the 
development of these individual risk factors and provide additional opportunities 
for CVD prevention (see Figure 2-1). Of particular relevance to this thesis is the 
well-established association between socioeconomic position and CVD, whereby 
lower socioeconomic position is associated with increased risk of CVD (28, 29). 
Socioeconomic position has been described as the social and economic factors 
that determine a person or group’s position within society, which may in turn 
influence health, either positively or negatively (30); this definition indicates 
that socioeconomic position is a relative concept that will vary depending on the 
society considered. Socioeconomic position may act as an upstream determinant 
of health that influences the development of other cardiovascular risk factors or 
as an independent risk factor in itself (31, 32). The important role of 
socioeconomic position as a determinant of CVD and cardiovascular risk factors, 
and in CVD prevention, will be discussed further in this, and subsequent, 
chapters.
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Broad 
determinants of 
health 
 Lifestyle / health 
behaviours 
  
  Smoking   
  Diet   
Socioeconomic 
conditions 
 Physical activity 
Alcohol 
  
  Psychosocial factors   
     
Culture 
   Cardiovascular 
disease 
  Biological risk 
factors 
  
  Age   
  Sex   
Environment  Hypertension   
  Dyslipidaemia   
  Obesity   
  Diabetes   
Figure 2-1: Main determinants and causes of cardiovascular disease (derived 
from (33)) 
2.3 Epidemiology of cardiovascular disease 
CVD is the leading cause of death worldwide, as well as a major cause of 
disability (34, 35). It is the largest cause of premature mortality in the UK (6), 
where it is estimated that over 3 million people have CVD, with significant 
health service and societal costs amounting to around £30 billion per year and 
21% of the NHS’s overall expenditure (21, 36). The UK’s record on CVD does not 
compare favourably with other high-income countries, with evidence that the 
age-standardised rate of years of life lost due to IHD is significantly higher in the 
UK than the mean rate in these countries (6).  
The burden of CVD is changing around the world. The Global Burden of Disease 
project found that between 1990 and 2010 IHD and stroke moved from being the 
4th and 5th leading causes of disease globally to being the 1st and 3rd, respectively 
(34). This change reflects the epidemiological transition, where non-
communicable diseases, such as CVD, are becoming more prevalent whilst 
communicable diseases are declining. The burden of CVD is increasing in 
countries in the earlier stages of this transition (37), in contrast to the UK and 
other developed countries which are in the later stages of the transition and 
have reached a point where CVD is now declining (38-40). Compared to other 
Western European countries, whilst IHD mortality rates in the UK have been 
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high, the percentage reduction in mortality rates seen in the UK has been 
comparatively large (41). There is evidence that the decline in CVD is due to 
falling incidence, mortality and case fatality (38, 40), although there is 
uncertainty over the extent to which each of these contribute to the decline 
(38, 39, 42).  
Falling rates of CVD may be partially accounted for by falls in cardiovascular risk 
factors, alongside better treatment (41, 43-45). A number of studies have 
attempted to identify the separate contributions made by treatment and risk 
factor changes to declines in CVD, although this is a difficult process considering 
recent favourable trends in both of these factors (46). The results vary but in 
general show that risk factor changes and treatment contributed similar 
proportions to the decline, with the contribution from risk factor changes 
ranging from approximately one-third to one-half depending on the country 
studied (47-52). In the UK it has been estimated that 46% of the reduction was 
due to risk factor changes, whilst a proportion of the decline in CVD remained 
unexplained (53). A number of these studies used the IMPACT model (47-50, 52), 
a mathematical model that uses local data on IHD mortality, risk factors and 
treatment. Whilst this model does not include nonfatal cases, and classifies 
prevention in people after a cardiovascular event (secondary prevention) as 
treatment, the results from different countries are largely consistent. However, 
it is possible that the contribution of risk factor changes may have been 
underestimated, as risk reductions due to risk factor changes may be more 
difficult to estimate accurately than those from treatment. This is because 
evidence of the effects of risk factor changes is more likely to come from 
observational studies, which are more likely to underestimate associations 
between exposures and risk factors than randomised controlled trials from which 
estimates of treatment effects are obtained. These important risk factor 
reductions are due to falls in blood pressure, cholesterol and smoking that have 
occurred across many developed countries. However, there is still room for 
improvement, with modelling studies suggesting that further, achievable risk 
factor reductions could halve the number of predicted IHD deaths in the UK and 
the USA (46, 54). However, evidence suggests that increases in the prevalence of 
obesity and diabetes may offset some of these recent gains and lead to rising 
levels of cardiovascular risk in younger age groups, with unknown consequences 
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as these groups get older (39, 41, 55-57). Therefore, it is crucial that recent 
declines in CVD are not taken for granted.   
In addition to differences in the burden of CVD between countries, there are 
also differences within populations themselves. Differences in disease between 
populations and individuals can be described as health inequalities (58). Health 
inequalities can be both avoidable (e.g. due to lifestyle differences) or 
unavoidable (e.g. due to genetic differences) (58). Furthermore, some health 
inequalities may be viewed as being unfair, in which case they could be 
described as health inequities, a term that incorporates concepts of justice (59). 
However, this judgement is not necessary for the definition of health 
inequalities (58).This thesis uses the term health inequalities, however some of 
the differences described could also be considered health inequities depending 
on their cause and potential for reduction. Health inequalities can be measured 
in relative or absolute terms, complementary approaches that offer different 
information on the nature of or changes in inequalities (60). For instance, 
absolute measures provide evidence of the scale of differences in health 
between population groups, information that is particularly important to public 
health professionals (60). Socio-economic, geographic and ethnic inequalities in 
CVD are well established in the UK and other countries (21, 32, 61, 62). In fact, 
inequalities in CVD and cardiovascular risk factors are key drivers of overall 
socioeconomic health inequalities (61, 63). Although tackling health inequalities 
is a key aim of health and social policy, evidence suggests that despite falling 
prevalence of cardiovascular risk factors and declining mortality from CVD in the 
UK, relative and absolute inequalities may have widened or, at least, not 
improved (47, 61, 64-66). The issue of inequalities in CVD will be discussed 
further later in this chapter.   
In summary, epidemiological evidence highlights that CVD carries a significant 
but changing burden, which affects population sub-groups unequally.  
Additionally, and crucially for this thesis, individual and population risk of CVD 
can be reduced through the modification of risk factors. 
2.4 CVD prevention 
The importance of CVD prevention is widely accepted (67, 68). International 
guidelines highlight its potential, efficacy and the future gains that can be made 
(69). Effective preventative interventions can help to control escalating health-
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care costs and promote the sustainability of health care services if they reduce 
overall resource use and demand (24, 67, 70-72). However, the argument for 
prevention is not entirely straightforward. As well as practical issues of 
implementation and evaluation (73, 74), there is a potential conflict between 
prevention and treatments used to cure disease or reduce symptoms in clinical 
medicine (75). A number of disadvantages of prevention have been described, 
including that it can create anxiety in otherwise healthy people, and that 
preventative interventions can be potentially harmful (75, 76). The opportunity 
costs of implementing preventative interventions must be considered, especially 
if they divert limited healthcare resources away from treatment. In fact, it has 
been argued that prevention should not be prioritised over providing basic 
medical care (75, 76). Despite these criticisms, it is important to note that 
clinical care can also be associated with disadvantages (side effects, 
polypharmacy, reduced quality of life, cost and so on) and it is hard to ignore 
the large potential health gains that prevention can bring.  
Preventative interventions, like all health interventions, also need to ensure 
that they do not worsen health inequalities. This means that it is important to 
choose preventative approaches carefully and with consideration for the 
population involved. The next sections in the chapter will outline various 
approaches to CVD prevention and give examples of the types of interventions 
that can be used.  
2.5 Primary prevention of CVD 
CVD can be prevented in a number of ways, depending on who the prevention is 
aimed at, which intervention is used and which risk factor is targeted. The four 
levels of prevention - primary, secondary, tertiary and primordial - provide a 
way of categorising preventative approaches (see Table 2-1) (77). Use of these 
levels is well established in public health practice although they have been 
criticised for a number of reasons. The levels divide preventative interventions 
according to whether an individual has developed the disease or not, but the 
progression of most diseases is unclear and cannot be divided neatly into groups 
(77, 78), and regardless of the categorisation used the actual interventions 
adopted may be similar (78). This is certainly the case for CVD, where 
atherosclerosis gradually progresses into disease (77), it is now possible to 
identify people with asymptomatic but established disease (68), and there is an 
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overlap in the interventions that are recommended for primary and secondary 
prevention (78). 
Table 2-1: Four levels of disease prevention (77, 79) 
 Level of 
prevention 
Primordial 
prevention 
Primary 
prevention 
Secondary 
prevention 
Tertiary 
prevention 
Definition Prevention of 
risk factors 
before they 
occur in a 
population 
Prevention of 
the onset of 
symptomatic 
disease 
Prevention of 
recurrence or 
worsening of 
the disease 
after its initial 
occurrence 
Reduction of 
the negative 
consequences 
of an 
incurable 
disease  
Example 
from CVD 
prevention 
Measures to 
prevent 
children being 
exposed to 
tobacco 
smoke 
Use of 
cholesterol-
lowering 
medication in 
a patient who 
has not 
developed 
symptomatic 
CVD 
Prescription of 
lifelong 
aspirin in a 
patient who 
has had a 
heart attack 
Management 
of heart 
failure in a 
patient with 
severe IHD 
CVD cardiovascular disease, IHD ischaemic heart disease 
Primary prevention has significant potential to reduce CVD (80). Evidence 
obtained from applying the IMPACT model suggests that primary prevention may 
account for 2 to 4 times more of the mortality reduction associated with 
reductions in risk factors seen in recent years than secondary prevention (52, 81, 
82). In addition, Gemmell et al estimated that meeting government targets for 
cardiovascular risk factors through primary prevention could prevent more 
events than increasing treatment levels in secondary prevention (83). In 
contrast, data from the USA indicate that downward trends in age-standardised 
mortality and rates of hospital admission with recurrent myocardial infarction 
were not matched by reductions in incidence of admission, suggesting that 
recent declines in CVD may be due to treatment and secondary prevention 
rather than primary prevention (84). However, others have highlighted that it 
can be difficult to separate primary and secondary prevention in this way as 
better primary prevention may impact on mortality and recurrence indirectly 
through less severe presentations of disease (85).  
Despite the potential effectiveness of primary prevention it is often underused, 
at both an individual and population level, and underfunded compared to 
secondary prevention (52, 72, 82). This could be because it is more challenging 
to implement effective primary preventative interventions. In primary 
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prevention it can be difficult to identify individuals who could benefit from 
interventions (86), and even in those who are positively identified there is 
evidence of poorer control of risk factors compared to secondary prevention 
patients (87, 88). Adherence to primary prevention medication was found to be 
only around 50% in a meta-analysis, a lower proportion than in secondary 
prevention (89). This contrasts with secondary prevention where it is easier to 
identify people who have the disease, the patients involved will be at high 
individual risk and therefore have greater potential to benefit from 
interventions, and there is a good range of evidence on the efficacy of 
preventative interventions in this group of patients (73). This is not to say that 
we have achieved all we can from secondary prevention, in fact uptake of 
secondary prevention drugs is far from complete (90). However, given the 
potential impact of primary prevention and evidence of its underuse it is an 
important area that needs further development.  
2.6 Population and high-risk approaches 
The previous section described the four levels of disease prevention, with a 
focus on primary prevention. This section discusses another way of categorising 
approaches to prevention – population and high-risk approaches. Whilst the focus 
of this literature review remains on primary prevention, population and high-risk 
approaches can also include the other levels of disease prevention.  
Geoffrey Rose compared two alternative approaches for disease prevention - a 
population approach in which risk across a whole population is reduced, and a 
high-risk approach where preventative action is focused on high-risk individuals 
(see Box 2-1 for examples of population and high-risk interventions) (91). This 
distinction was based on the premise that the causes of individual cases of 
disease may be different to the causes of incidence of disease at a population 
level, therefore requiring different interventions (92).  
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Box 2-1: Examples of high-risk and population interventions in cardiovascular 
disease prevention 
High risk A screening programme that identifies people who are at high 
risk of developing CVD and offers them interventions, such as 
statins and lifestyle advice, to reduce their risk; smoking 
cessation for individuals. 
Population Legislation to reduce salt content of processed food at a national 
level; comprehensive tobacco control measures, including 
legislation, taxation and restriction. 
CVD cardiovascular disease 
Rose described a risk distribution that may exist for certain exposures in the 
population, where risk gradually increases as exposure to a normally distributed 
risk factor increases (see Figure 2-2 (a)) (91). Of note, he also highlighted that 
other exposure to risk relationships may exist that follow a different 
distribution. For instance, a J-shaped curve in which risk is also increased at low 
levels of exposure, such as that observed for alcohol and mortality (93). 
However, the risk distribution illustrated in Figure 2-2 (a) corresponds with many 
cardiovascular risk factors, such as cholesterol concentration and blood 
pressure. Within this distribution two key observations can be made - first, there 
are only a small number of people at the higher, more risky end of the 
distribution; and second, the majority of people lie in the middle of the 
distribution with a moderate risk.  
Rose defined high-risk based on thresholds of single risk factors, such as 
cholesterol concentration or blood pressure. In the high-risk approach, 
individuals on the right-hand side of the distribution, above a predetermined 
threshold, would be targeted with risk reducing interventions (see Figure 2-2 
(b)). The rest of the population would be unaffected. Rose outlined a number of 
advantages and disadvantages to the high-risk approach (see Table 2-2). One of 
these disadvantages - the difficulty of identifying high-risk individuals - is a key 
issue in this thesis. 
The alternative to this approach is to prevent disease at a population level by 
shifting the whole risk distribution to the left, i.e. to a lower overall level of risk 
for the whole population (see Figure 2-2 (c)) (91). This type of approach would 
be suitable for widespread diseases in which the risk is distributed throughout 
the population. Looking again at the risk distribution, it can be seen that most 
people lie in the middle of the distribution (see Figure 2-2). Rose described that 
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even though these individuals are not at high-risk most cases of disease will arise 
from this group. This group of people would not be identified, and therefore not 
benefit, from a high risk approach, so a more widespread intervention may be 
more appropriate. As with the high-risk approach, this approach has both 
advantages and disadvantages (see Table 2-2). The disadvantages include a key 
concept in disease prevention - the prevention paradox. This is the idea that 
while a population approach to disease prevention may offer a large benefit for 
the population, the benefit experienced by each individual may be small 
because most people are not at high risk of developing the disease. 
Table 2-2: Strengths and weaknesses of population and high-risk approaches 
(based on (92) with additional points) 
 Strengths Weaknesses 
High-risk 
approach 
• Potentially large risk 
reduction for the individual 
• Intervention tailored to 
individual 
• Low risk individuals 
unaffected 
• Potentially cost-effective 
as target resources at high-
risk individuals 
• Preferable benefit to risk 
ratio 
• Potential for greater 
motivation from patient 
and clinician 
• Easier to evaluate efficacy 
in clinical trials 
• Medicalisation of otherwise 
healthy individuals 
• Risk reducing effect may 
not be sustainable in long-
term 
• Difficulties identifying 
high-risk individuals and 
predicting their future risk 
• May only lead to small 
reductions in disease 
burden 
Population 
approach 
• Potential to effect change 
in underlying causes of 
disease, e.g. 
socioeconomic deprivation 
• May lead to large 
reductions in disease 
burden 
• Long-term and sustainable 
approach 
• May be a more efficient 
use of resources 
• Prevention paradox 
• Small risk reduction for the 
individual 
• Sometimes unacceptable at 
an individual level 
• Difficult to implement 
• Poor benefit to risk ratio 
• Implementation may be 
influenced by non-health 
related priorities, e.g. 
from industry 
• More difficult to evaluate 
effectiveness, as evidence 
may need to come from 
e.g. natural experiments 
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(a) Relationship between risk and exposure 
 
(b) High-risk approach 
 
(c) Population approach 
 
Figure 2-2: Population and high-risk approaches (based on (91)) 
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Geoffrey Rose’s ideas have been widely explored and debated. Rose advocated 
use of the population approach but Charlton criticised the lack of evidence on 
the relationship between risk and disease, and expressed concern over the 
potential for population interventions to lead to greater government control 
over people's lives (92, 94). Others have highlighted that developments in 
techniques to identify people at high risk of disease, for example cardiovascular 
risk calculators (see section 2.8.1), and the availability of safer and more 
effective interventions to reduce risk at an individual level may mean that the 
high-risk approach is a more favourable option than when Rose wrote his original 
work (95-97). However, the large potential gains that can be achieved from a 
population approach, evidence of its favourable cost effectiveness compared to 
high-risk options (98), and the long-term sustainability of this type of 
intervention, mean that it is an approach that is widely supported (97, 99, 100). 
In addition to the theoretical debate on the relative merits of population and 
high-risk approaches, a variety of studies exist which quantify their impact on 
CVD. Many of these support the potential impact of population approaches (101, 
102). Of particular interest is evidence from real-life populations, where 
significant changes in cardiovascular risk factors have occurred, associated with 
reductions in disease. The North Karelia project in Finland, in which a 
community wide programme of CVD prevention was introduced in response to 
high levels of CVD, led to a downward shift in the cholesterol levels of the 
population, in a similar way to that predicted by Rose (103). A comparable 
finding has also been made in Mauritius (104). Whilst evidence also exists of the 
potential effectiveness of high-risk approaches in real-life settings, largely from 
screening programmes, the scale of the changes achieved does not match those 
of the population approach (105, 106).  
Other studies have directly compared the potential impact of population and 
high-risk approaches using modelling. Murray et al compared the costs and 
effects of population and high-risk approaches across a range of geographical 
regions (107). They found that population approaches were potentially very cost-
effective; in contrast, individual interventions could prevent more disease but 
were less cost-effective. Cooney et al and Emberson et al both calculated the 
number of cardiovascular events that could be prevented using population versus 
high-risk approaches (108, 109). Their methods differ in terms of statistical 
techniques and populations studied, but both found that population 
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interventions could prevent more cardiovascular events than high-risk 
approaches. A particular strength of Emberson et al's study is that they 
corrected for regression dilution bias, an inaccuracy in physical measurements 
that can occur when they are only taken once, not allowing for in person 
variability (108-110). In contrast to these findings, Manuel et al and Zulman et al 
found that high-risk approaches might be a more effective and efficient way to 
prevent CVD than population approaches (111, 112). The discrepancy in these 
studies’ findings could be explained by methodological differences, including the 
populations studied, assumptions made about potential risk reductions and the 
age ranges included. For example, Manuel et al modelled an arguably 
conservative 2% reduction in cholesterol for the population approach (113), 
compared to 1-20% reductions by Cooney et al. However, Manuel et al argued 
that the high-risk approach may be more effective because, unlike previously 
thought, cardiovascular risk is not widely distributed in the population but is 
instead concentrated in certain individuals, who can now be more easily 
identified (111). This change in understanding may have arisen because recently 
developed cardiovascular risk calculators, which incorporate multiple risk 
factors (see section 2.8.1), allow more accurate prediction of risk, in contrast to 
Rose’s consideration of single risk factors (114). Given this mix of evidence on 
the relative benefits of population and high-risk approaches, alongside the 
advantages and disadvantages of both approaches, it is not surprising that the 
general consensus is that a combination of both is needed. In the future, 
however, the boundary between population and high-risk approaches may 
become increasingly blurred through widespread use of individual level 
interventions, for example through use of fixed dose combination drugs 
(“Polypills”) or personalised Smart health technology.  
2.7 Primary prevention interventions 
A number of interventions can be used in the primary prevention of CVD (see 
Table 2-3). These include pharmacological and lifestyle interventions, acting at 
a population or individual level. Evidence in support of the effectiveness of 
pharmacological interventions appears more robust, although this may be 
because interventions of this type are easier to investigate using randomised 
controlled trials, whereas evaluating the effectiveness of population 
interventions, for example to improve diet, is more difficult. 
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Table 2-3: Summary of interventions for primary prevention of CVD 
Intervention Evidence of effectiveness Nationally 
recommended in 
UK? 
Comments Population 
or high-
risk  
Statins Two meta-analyses found significant reductions 
in CVD, but another found no benefit on all-
cause mortality (115-117). 
Yes Cheap and generally well 
tolerated (96). 
Long-term adherence poor 
(118, 119). 
High-risk 
Treatment of 
high blood 
pressure 
Recent systematic review and meta-analysis 
found significant reductions in CVD (120). 
Yes Choice of medication depends 
on age, ethnicity and 
comorbidity (121, 122). 
High-risk 
Smoking 
cessation 
Evidence suggests 15% quitters abstinent after 1 
year (123). 
Nicotine Replacement Therapy increases chance 
of quitting by 50% to 70% (124). 
Yes UK has a well-developed 
smoking cessation service 
(125). 
High-risk 
Tobacco 
control 
measures 
Systematic review evidence suggests that bans 
on smoking in public places can reduce exposure 
to second-hand smoke and improve health 
outcomes (126, 127). 
Taxation a particularly effective way of reducing 
smoking (128, 129). 
Yes Various measures available, 
including taxation, sales and 
marketing restrictions, and 
bans on smoking in public 
places. 
Population 
Dietary salt 
reduction 
Associated with reductions in blood pressure and 
cardiovascular events (130, 131). 
Evidence from UK of approximate 15% decrease 
in salt intake associated with salt reduction 
policy (132). 
Yes UK’s Food Standard Agency 
previously ran a successful salt 
reduction programme, although 
this has been replaced by a new 
policy (133).  
Population 
Ban on trans 
fatty acids 
Consumption associated with increased risk of 
CVD, with no nutritional benefit (134). 
Yes Bans in place in Denmark and 
New York (135). 
Population 
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Table 2-3 continued…    
Individual 
dietary 
changes 
One systematic review found that dietary advice 
improved cardiovascular risk factors (136).  
Another systematic review found limited 
evidence of a beneficial effect (137). Individual 
interventions to reduce dietary salt intake may 
lead to small reductions in blood pressure (138). 
Mediterranean diet associated with 28-30% 
reduction in rate of cardiovascular events in a 
randomised controlled trial (139). 
Yes Evidence on best way of 
promoting healthy diets 
remains unclear. 
Size of relative risk reduction 
observed with a Mediterranean 
diet could exceed that from 
statins (117, 139). 
Both 
Promotion of 
physical 
activity 
A systematic review of community wide 
interventions found no clear evidence that 
interventions were effective (140). Another 
systematic review found that individual 
interventions had moderate effects on exercise 
levels and fitness (141). 
Yes Limited evidence of the 
effectiveness of interventions 
for individuals. 
Both 
Aspirin Associated with a significant, but small, 
reduction in cardiovascular events. However, 
this may be offset by an increase in 
gastrointestinal and extracranial bleeding (142). 
Previously 
recommended, 
but unlicensed in 
UK (143, 144). 
Unfavourable balance of risks 
and benefits illustrates Rose’s 
discussion of the benefit to risk 
ratio. 
High-risk 
Multiple 
lifestyle 
interventions 
Unhealthy behaviours have been found to cluster 
together (145). A systematic review of 
interventions did not find significant reductions 
in coronary heart disease mortality (146). 
Found to be the least cost-effective of a range 
of primary prevention strategies (98). 
No Limited evidence of 
effectiveness. 
High-risk 
“Polypill” Recent Cochrane systematic review and meta-
analysis found unclear evidence of effectiveness 
and concluded that further evidence is needed 
(147). 
No Proposal that all individuals >55 
years should be offered a single 
pill, containing a statin, blood 
pressure lowering medication, 
aspirin and folic acid (148). 
Both 
CVD cardiovascular disease 
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2.8 Identification of high-risk individuals 
Earlier in this chapter one of the key challenges of the high-risk approach was 
highlighted – how to accurately identify high-risk people who will go on to 
develop disease. Two steps are required in this process - a screening test needs 
to be available which accurately distinguishes between low and high-risk 
individuals; and a strategy is needed to identify who should be invited for 
screening. The first of these steps relates to the use of cardiovascular risk 
calculators, the second to the screening strategy that is adopted. 
2.8.1 Cardiovascular0risk0calculators0
The Framingham cohort study led to the development of the Framingham 
equation - a multivariable cardiovascular risk calculator (149). This equation 
allowed information on an individual’s risk factors, such as age, sex, cholesterol, 
blood pressure and smoking status, to be used to estimate the likelihood of them 
developing CVD in the future. This increased the accuracy of risk prediction 
compared to the use of single risk factors, such as high cholesterol or blood 
pressure, improving the identification of high-risk individuals and allowing 
interventions to be targeted appropriately (150, 151).  
Use of the Framingham equation became widespread, and other cardiovascular 
risk equations were developed. In the UK, national guidelines recommend the 
use of cardiovascular risk calculators for the identification of high-risk 
individuals (121, 144). These guidelines set a threshold of risk - an individual 
with a risk score of ≥ 20% in 10 years (i.e. a 20% or greater chance of 
experiencing a cardiovascular event in the next 10 years) is classed as high-risk 
(121). 
Despite this widespread use, cardiovascular risk calculators have a number of 
limitations. There is little evidence that the use of these risk scores actually 
improves clinical outcomes (152), and because age is such a powerful factor in 
these calculations they may perform less well in younger and older individuals 
(150). The accuracy of cardiovascular risk calculators is a key concern as any 
inaccuracy would mean that people who have potential to benefit from risk 
reducing interventions might be missed and others inappropriately targeted 
(151). When a cardiovascular risk calculator is used in a different population 
from the one in which it was developed it may be less accurate, a particular 
  
31 
issue relating to the use of the Framingham equation in the UK (150). The 
Framingham equation was derived from a now historical, largely white and 
affluent cohort in North America that had high rates of CVD (151). This limits its 
applicability to the UK population, which is more ethnically diverse, has greater 
variation in socioeconomic position and now experiences lower levels of CVD. 
Efforts have been made to improve the accuracy of cardiovascular risk 
prediction by recalibrating the original Framingham equations to different 
populations, adding new risk factors, and creating new UK specific calculators 
(153). Cardiovascular risk calculation will be discussed further in the next 
chapter in relation to ethnicity. 
2.8.2 Screening0strategies070mass0and0targeted0screening0
Any CVD prevention programme seeking to identify high-risk individuals needs a 
strategy that specifies who will be screened. One approach is to offer screening 
to all members of the population (mass screening), another is to target 
screening at certain groups deemed to be at greatest potential risk (targeted 
screening). There is no consensus as to which of these two approaches is best, as 
illustrated by the national policy differences that exist in the UK – England has 
adopted a mass screening approach through the NHS Health Check programme, 
whereas Scotland’s Keep Well programme targets screening at the most 
socioeconomically deprived areas. 
2.8.2.1 Mass(screening(
Evidence on the effectiveness of mass health check strategies is mixed. In a 
Cochrane systematic review, Krogsboll et al found no evidence that general 
health checks improved health and concluded that programmes that 
systematically offered them to the general population should be avoided (154). 
Similarly, in a randomised controlled trial of mass screening and lifestyle 
interventions, Jorgensen et al found no significant difference in the incidence of 
cardiovascular events between the intervention and control groups (155). 
Likewise, recent evidence from a cluster-randomised trial of diabetes screening 
found no significant reduction in the relative risk of all-cause or cardiovascular 
mortality in the screened group compared to the control (156).This differs from 
Schuetz et al who modelled the cost effectiveness of health checks for CVD in 
Europe and found they had the potential to reduce incidence of CVD whilst being 
a cost-effective measure (157). Considering the strength of evidence arising 
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from these differing study designs – trial and systematic review evidence 
compared to evidence from modelling, which relies on assumptions of 
effectiveness – suggests that mass screening may not be an effective way to 
prevent CVD. However, a number of factors limit how generalisable some of this 
evidence may be to current high-risk CVD prevention programmes. For instance, 
Krogsboll et al’s review has been criticised for including older studies, where 
current drug prescribing guidelines would not have been followed, and 
considering general health checks as opposed to CVD checks (158). Similarly, 
Jorgensen et al’s study did not include use of preventative medications, such as 
statins. This means that it may not be appropriate to generalise these findings to 
programmes that use both pharmaceutical and lifestyle interventions. 
Despite this mixed evidence, a mass screening programme involving health 
checks has been launched in England (159). Initial assessment suggested that this 
programme could prevent 9,500 heart attacks and strokes each year and would 
be highly cost-effective (159, 160). In the programme all 40 to 74-year-old 
adults without pre-existing CVD, chronic kidney disease, or diabetes, and who 
are not taking statins or antihypertensive medication, are invited for a health 
check every 5 years, where they are assessed for high cardiovascular risk and 
followed up as appropriate (159). Whilst the programme was developed centrally 
it is implemented locally (13). The programme is still in its early stages and 
awaits full evaluation, but evidence has started to emerge regarding its 
coverage (a measure of how many eligible people receive a health check), 
uptake (a measure of how many people who are invited for a health check 
subsequently attend), delivery and potential impact on CVD. Coverage of the 
programme has been found to vary widely, ranging in one study from 0% to 29.8% 
between primary care trusts (161). In a deprived area of London uptake in the 
first year of the programme was 44.8% (162). Early evidence suggests wide 
variation in how the programme is implemented across England (163, 164), an 
issue which has been cited as a key weakness of the programme (165). It would 
be particularly interesting to know whether a programme of this type can result 
in demonstrable reductions in cardiovascular risk. Two studies investigated this 
question by assessing changes in cardiovascular risk following health checks, 
with their findings suggesting small reductions in cardiovascular risk (166, 167). 
However, the studies did not have true control groups and did not account for 
secular reductions in risk. The Department of Health’s initial impact assessment 
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has been criticised for providing an overly optimistic view of what could be 
achieved by the programme, for example they modelled uptake of 75% (159, 
168). So far the evidence suggests that the programme is not meeting these 
levels, although further evidence is expected. 
Mass screening programmes have the advantage of being able to offer 
assessment to all individuals in the population, without intentionally excluding 
any individuals or groups. However, mass screening has been criticised because 
it may not offer good value for money and may be an inefficient way to identify 
high-risk individuals (169); targeted screening of individuals who are likely to be 
at higher risk of CVD may be a more efficient and cost-effective alternative 
(168, 170).  
2.8.2.2 Targeted(screening(
A variety of potential targeted screening approaches have been suggested. 
These include strategies in which an individual's cardiovascular risk is estimated 
prior to screening (pre-stratification) and strategies that target deprived areas.  
2.8.2.2.1 Pre7stratification0
Pre-stratification involves using existing individual patient information to 
determine who should be invited for screening, based on an assessment of 
whether that individual may be at high cardiovascular risk. Chamnan et al used 
prospective cohort data to model a variety of screening strategies including mass 
screening and pre-stratification, based on risk factors such as age, body mass 
index and estimated risk of diabetes (171). This study had a particular advantage 
of containing prospective data so providing information on actual, rather than 
estimated, cardiovascular events. They found that pre-stratification could 
prevent a similar number of events as mass screening but with fewer people 
needing to be screened. Similarly, with regards to diabetes screening, Harding 
et al found that pre-stratification by age, family history, physical activity and 
body mass index could provide an effective and efficient alternative to mass 
screening (172). Marshall and Rouse also found that pre-stratification could 
increase the efficiency of cardiovascular screening, although the treatments 
they modelled are now slightly dated (173).  
  
34 
2.8.2.2.2 Targeting0deprived0areas0
An alternative way of targeting cardiovascular screening is to use an area-based 
approach focusing on deprived areas. Before describing evidence of this 
approach in CVD prevention, it is worth considering what area deprivation is, 
how it can be measured and why it might be useful for this purpose. 
Socioeconomic deprivation refers to a state in which individuals or groups do not 
have the resources necessary to achieve a normal standard of living, relative to 
the society they are living in (174). Socioeconomic deprivation overlaps with 
measures of poverty or low socioeconomic position, and can occur at an 
individual and area level. Area deprivation offers a potentially useful way of 
targeting CVD prevention interventions because socioeconomic deprivation is a 
risk factor for CVD and deprived areas have higher rates of CVD than less 
deprived areas (61, 64).  
Area deprivation can be measured using indices that capture information on 
socioeconomic deprivation gathered at small area levels. A variety of these 
indices have been created, including the English Index of Multiple deprivation 
(IMD) and its Scottish counterpart (SIMD), Townsend scores and the Carstairs 
index. Each index differs in terms of how it was developed and the information 
it is based on. These indices incorporate multiple aggregate indicators, on which 
data are gathered and then combined, rather than relying on a single measure of 
deprivation such as income (60). Take for example the IMD (175). This contains 
seven domains (income, employment, health and disability, education skills and 
training, housing and service barriers, living environment and crime) with a 
variety of indicators in each domain. Data in each of these domains is combined 
into a single score for each super output area in England (small areas with 
approximately 1,500 residents). These areas are then ranked so that areas can 
be compared in terms of their relative deprivation. This can then be used for 
targeting by, for example, selecting the most deprived 20% of areas. A particular 
advantage of area deprivation measures is that they can be used as practical and 
accessible proxies for individual socioeconomic position (176, 177), on which 
data may not be available or may be too resource intensive to collect.  
Macintyre et al described three mechanisms by which area may be related to 
health - through its composition (the individuals who live in an area), its context 
(the environment itself) and its collective characteristics (the social and cultural 
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nature of the community) (178). These categories can be used to highlight the 
potential advantages of using area deprivation measures to target public health 
interventions. First, given the association between socioeconomic deprivation 
and CVD, deprived areas may have higher rates of CVD because there are 
relatively high numbers of socioeconomically deprived people living there, who 
are at increased risk of CVD. This concentration of socioeconomically deprived 
individuals occurs because the UK population is partially segregated by 
socioeconomic position, with distinct deprived and affluent areas (179). Indeed, 
individual socioeconomic position can influence a person’s area of residence 
(177), for example because low income can restrict housing choices (180). Area 
deprivation measures could therefore be used to identify areas with high 
concentrations of individuals known to be at increased risk of CVD (181), 
allowing limited healthcare resources to be targeted at these individuals (182).  
Second, targeting interventions at deprived areas could allow modifiable area 
characteristics that have a detrimental effect on health to be improved (177, 
182, 183). Studies have identified independent effects of individual and area 
level deprivation on health (and more specifically CVD), with poorer health in 
deprived areas over and above the individual socioeconomic characteristics of 
the population (31, 184, 185). For instance, Davey Smith et al analysed cohort 
data from Scotland and found that area deprivation and individual social class 
were independently associated with cardiovascular risk factors and all cause 
mortality (31). It has therefore been suggested that physical and social 
environmental characteristics, such as access to healthy food in shops or 
opportunities to exercise in good quality parks, may influence health, with these 
positive characteristics being less prevalent in deprived areas (177, 183). In 
addition, if unhealthy behaviours, such as smoking, are more common in 
deprived communities this could influence individual health behaviour and 
potentially worsen health (178). 
Neither composition, context, nor collective characteristics completely explain 
the association between area and health (186), and these mechanisms for the 
association between area and health are likely to be inter-related (177, 183). 
Indeed, if an individual’s socioeconomic circumstances influence their choice of 
where to live then area characteristics may lie on the causal pathway between 
individual socioeconomic position and health (and CVD) (177, 186). A further 
complication arises from the potentially long temporal association between area 
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and health that could occur if the effect of area or socioeconomic deprivation 
occurs intergenerationally, as suggested by Barker (178, 187); a long frame could 
also impact on the ability to influence this association in the short-term. Despite 
this complexity, from the practical perspective of designing public health 
interventions, this evidence suggests that area deprivation can be used as a 
means of identifying and targeting socioeconomically deprived individuals who 
are at increased risk of CVD, as well as providing an opportunity to create 
interventions that improve health related area characteristics.  
There are a number of disadvantages in using area deprivation measures to 
target public health interventions. Choosing which areas to target, based on 
which measure of area deprivation, is a difficult and politically contentious issue 
(181). Evidence of the effectiveness of area-based programmes is limited (188, 
189). For instance, evaluation of Health Action Zones, an area based programme 
involving the development of multi-agency working, found that the programme 
only had a small impact on health, although it has been suggested that the short 
time frame and complexity of the programme may have influenced this finding 
(188). Additionally, and crucially, most deprived people do not live in deprived 
areas and would be missed by an area deprivation based intervention (181). This 
potential for misclassification relates to the “ecological fallacy”. Macintyre et al 
described this as the issue of using area level information to make conclusions at 
an individual level, although individual or area level analysis could produce 
different results (178). Regarding the use of area deprivation measures to target 
socioeconomic deprivation, this could mean that information collated on a group 
of individuals may not accurately reflect the characteristics of all the individuals 
in that group. Tunstall and Lupton tested the accuracy of the IMD 2000 to 
correctly target deprived individuals (182). They found that area based 
initiatives had the potential to identify the majority of deprived individuals 
(defined by unemployment benefit receipt) but were not efficient at doing so, 
i.e. a large proportion of people living in target areas were not deprived by their 
definition. In addition, the role of area deprivation measures as a proxy for 
individual socioeconomic position has been tested by calculating agreement 
between these measures. Both Demissie et al and Hanley et al found low 
agreement and correlation between area and individual socioeconomic measures 
(190, 191), although the measures used in these Canadian studies may not be 
comparable to area deprivation measures used in the UK. This potential for 
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inaccuracy and misclassification is an important issue in the performance of area 
deprivation measures for targeting public health interventions, and will be 
explored further in Chapter 4.  
Area deprivation measures have been used to target cardiovascular risk 
screening in Scotland’s Keep Well programme, although the scope of the 
programme has since increased to include other population groups and targeting 
approaches (14). In Keep Well, general practices in some of the most deprived 
areas in Scotland offer health checks to their patients. Evaluation has found that 
individuals involved in the programme are generally supportive of this area 
deprivation based approach and that it may be an effective way of targeting 
people at high risk of CVD (14). However a lack of data has limited evaluation of 
the programme’s effectiveness (14).  
The use of area-based targeting for cardiovascular screening has also been 
assessed through modelling. Lawson et al used cross-sectional data from 
Scotland to model the cost effectiveness of targeted screening strategies based 
on area deprivation and family history compared to mass screening (192). They 
found that targeting the 20% most deprived areas would involve screening 15% of 
the population but identifying 25% of high-risk individuals. It has been 
highlighted that mass screening has been found to be cost-effective in 
comparison to no screening, but not when compared with targeted screening 
(193). Lawson et al used an incremental analysis to compare the cost 
effectiveness of screening strategies with each other rather than with no 
screening, and found that targeted screening was more cost-effective than mass 
screening (192). The implementation of Keep Well, alongside Lawson et al’s 
findings, demonstrate that targeting CVD prevention programmes at deprived 
areas as a means of identifying high-risk individuals is feasible and a potentially 
cost-effective alternative to mass screening. This is an important theme in this 
thesis and will be considered further in Chapter 5.  
2.8.3 Section0summary0
Mass and targeted screening have both been used in the UK and provide two 
alternative ways of identifying high-risk individuals. Each of these approaches 
has its own merits, such as the equal provision that comes from mass screening 
or increased efficiency from a targeted approach. The use of area deprivation 
  
38 
measures for targeting is an interesting, though complex, option that will be 
discussed further in the next chapter in relation to ethnicity. 
2.9 Public health interventions and health inequalities 
Previous sections provided an overview of CVD prevention, including the types of 
preventative interventions and approaches that are available. A key issue that 
has not yet been discussed is the potential impact of these interventions on 
health inequalities. As highlighted in the introductory chapter, public health 
interventions share the dual goals of improving health whilst also tackling health 
inequalities. These aims are central to health policy and public health 
interventions, including Keep Well and the NHS Health Check programme (14, 
159, 194-196). 
Improving inequalities in CVD is particularly important because, whilst rates of 
CVD have declined in recent years, there is evidence that inequalities have 
increased. For instance, Asaria et al analysed routine, area level data from 
England and found that absolute inequalities decreased between the most to 
least deprived areas from the 1980s and 2000s but relative inequalities increased 
(61). Bajekal et al made a similar finding using a modelling approach, despite 
evidence that the uptake of treatment was equitable across socio-economic 
groups (47).  
Although most public health interventions have these dual goals of improving 
health and reducing health inequalities, there can be a conflict between them 
(197). An intervention that makes positive health gains may increase inequalities 
in health, perhaps inadvertently. White et al suggested a range of potential 
sources of inequalities in public health interventions, ranging from low survey 
response rates impacting on assessment of need, to variations in the uptake of 
interventions and subsequent compliance with them (4). Similarly, Tugwell 
proposed that a “staircase effect” could occur whereby combined disadvantage 
from, for example, reduced access, lower screening rates, poorer diagnosis and 
lower adherence, in already disadvantaged populations could lead to greater 
health inequalities (198). The "inverse equity hypothesis" provides another way 
of considering how preventative interventions could lead to inequalities, by 
highlighting that new interventions tend to reach more socioeconomically 
affluent people first, thereby initially widening inequalities, before they narrow 
as lower socioeconomic groups catch up with the intervention (199). All of these 
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frameworks are relevant to CVD prevention where it is fairly easy to imagine the 
inverse equity hypothesis applying after the launch of the NHS Health Check 
programme with the “worried well” benefitting first. 
There is an ongoing debate regarding the impact population and high-risk 
approaches may have on health inequalities. It has been suggested that 
population approaches may be less likely to increase health inequalities than 
high-risk approaches (5). Indeed, Kivimaki et al demonstrated, using modelling, 
that it is possible to greatly reduce absolute and relative socioeconomic 
inequalities in CVD if substantial cardiovascular risk factor reductions can be 
made equally across the population (200). However, population approaches may 
increase inequalities if some people benefit more from the shift in exposure 
than others. For instance, Frohlich and Potvin suggested that population 
interventions could increase inequalities if there are subgroups of the population 
who are both at higher baseline risk than the general population and less able to 
benefit from the intervention (201). Further, differences in the prevalence of 
the risk factor being addressed by a population intervention between population 
groups could influence health inequalities. For instance, inequalities in 
unhealthy behaviours, such as diet and salt intake, could mean that a population 
intervention that altered these risk factors could produce differential effects 
across the population (202, 203).  
Evidence also suggests that the choice of population intervention used may 
influence its effect on health inequalities. Lorenc et al systematically reviewed 
the evidence for the impact of various population interventions on health 
inequalities and found evidence that mass media campaigns may increase 
inequalities whereas interventions based on price may reduce them (204). 
Similarly, Thomas et al found that fiscal measures may be a particularly 
effective way of reducing inequalities in smoking between social groups (205). 
This fits with Macintyre’s conclusion that structural, upstream interventions may 
be more beneficial for health inequalities than downstream ones (206).  
High-risk approaches, which tend to rely on individual behaviour and change, 
may exacerbate health inequalities more than population approaches (207). This 
could be because some population groups are less able to access and benefit 
from the types of preventative services and advice that are typically offered in 
high-risk interventions, such as health checks and lifestyle advice (206). Indeed, 
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there is evidence that the uptake of health checks varies according to 
demographic characteristics and is lower in people with greater clinical need 
(208). There is also evidence of inequalities in the use of preventative 
interventions, such as statins and cholesterol screening, in Europe and the UK 
(209-211), and in the effectiveness of interventions in population subgroups, 
including by socioeconomic position and ethnicity (for ethnicity see sections 
3.7.7.2 and 3.7.7.3) (212). However, the use of incentive based approaches in 
UK general practice may have reduced these types of inequalities, and there is 
evidence that smoking cessation services have the potential to reduce 
inequalities in smoking (213, 214). 
There are two notable themes that emerge from the literature in this final 
section. First, it is crucial that the impact of public health interventions on 
inequalities is considered, and not just socioeconomic inequalities but other 
axes as well (4, 5, 207, 215). The type of intervention used, and the way it is 
implemented, will be key to whether it increases or decreases inequalities. 
Second, despite the importance of this issue there is a lack of evidence on the 
impact of interventions on health inequalities (205, 206, 216). Inequalities in 
CVD can arise from differences in socioeconomic position, lifestyle, geography, 
age and ethnicity (217). Whilst most of the research reviewed in this section 
considered socioeconomic inequalities, this thesis focuses on ethnic health 
inequalities.  
2.10 Chapter summary 
This chapter outlined a number of key issues relevant to CVD prevention, 
including the various approaches available, and the types of interventions that 
could be used. Prevention has significant potential to reduce the burden of CVD 
and therefore improve health overall. However, it is important that the 
preventative approach used does not worsen health inequalities and instead 
reduces them. This thesis seeks to explore whether there are ethnic differences 
in the potential impact of a number of the CVD prevention interventions 
described in this chapter. Therefore, the next chapter builds on the topics 
reviewed in this chapter by focusing on ethnicity.
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3 Chapter 3: Ethnicity and cardiovascular disease 
The purpose of this chapter is to provide a review of the association between 
ethnicity and CVD, and to outline how ethnicity may relate to the various 
aspects of CVD prevention discussed in the previous chapter. The chapter starts 
by discussing the definition of ethnicity and moves on to describe ethnic 
inequalities in health and CVD. A number of potential explanations for these 
inequalities are then reviewed, including the role of socioeconomic position, 
CVD prevention policies and interventions, and area.  
3.1 Ethnicity as an epidemiological variable 
Ethnicity is a widely used, but complex, epidemiological variable with no single, 
straightforward definition (218). It is generally considered to be a complex, 
multifaceted, context-dependent social construct (219-222), that represents a 
variety of characteristics, including ancestry, religion, culture, language, socio-
economic position, biology, geography and race (218, 219, 221, 223, 224). These 
characteristics can either be shared, providing a common identity, or used as 
markers of distinction from other groups of the population (225). Karlsen 
suggested that ethnicity involves both internal and external forces, arising from 
the individual and from their context in society, which act to distinguish one 
individual or group from another (225). Ford and Harawa describe a similar view, 
highlighting the importance of the relationship between the individual or group 
and their society in determining ethnicity (223). 
Despite its complexity, ethnicity is considered to be an important 
epidemiological variable because it can identify differences in disease and 
disease risk factors between populations, help improve understanding of the 
causes of disease, and potentially improve provision of healthcare and 
preventative services (222, 224). Indeed, Senior and Bhopal highlighted that 
good epidemiological variables should be accurate measures that can be used for 
these purposes (222). However, the use of ethnicity as an epidemiological 
variable has been criticised because it has a number of limitations, which could 
result in the misclassification of individuals and populations (223). First, it is 
difficult to measure accurately (222). A number of methods have previously 
been used to categorise populations in ways comparable to using ethnic group, 
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including race, nationality or country of birth. Race refers to a longstanding 
method of classifying people based largely on physical appearance or 
geographical origins (226). It is an arguably unsound construct with significant 
negative connotations (226), and it is important to differentiate it from ethnicity 
(222). Race was thought to be linked to biological and genetic differences, often 
based on skin colour, but has subsequently been shown to have little scientific 
basis (226). Race is still used as an epidemiological variable in some settings, 
especially the USA (227), where it is used to provide information on 
socioeconomic position and discrimination (223). Interestingly, routine data in 
the USA divides the population into both racial and ethnic groups, with ethnicity 
based on Hispanic or non-Hispanic origin (228), highlighting the different uses 
and interpretations of these terms that still exist (see Figure 3-3). Nationality or 
country of birth can be useful in certain settings, for example in studies of 
migration or as adjuncts to measurement of ethnicity, but are limited in the 
aspects of ethnicity that they can measure. For example, knowing that a person 
was born in India does not provide potentially significant information on their 
religion, language or cultural background; a broader measure of ethnic group 
may be better able to incorporate this information. Second, there is significant 
heterogeneity within ethnic groups, although research often makes the 
assumption of similarity between people in the same group (222). One particular 
example is South Asian populations, which are often grouped together and 
considered as one ethnic group for research purposes, but which represent 
populations that can be vastly different in terms of culture, language, religion 
and geographical origins (222). Third, because it is widely accepted that 
ethnicity should be self-reported, it is possible for a person to change their 
ethnic group during their life, affecting the consistency of the measure (219). 
This could be seen as a limitation of self-reported ethnicity, but the practical 
implications of this are unclear given that ethnicity by definition represents an 
individual’s own perception of their identity. However, longitudinal data 
suggests fairly good consistency in self-reported ethnicity, although this may 
vary between ethnic groups (229). !
Collection of data on ethnicity has increased in recent decades in the UK 
because of legislative requirements and the introduction of a question on 
ethnicity to the Census (221). This Census question, which was first added in 
1991, measures self-reported ethnicity using tick boxes and free text responses 
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(230). The question has been developed and expanded upon in 2001 and 2011, 
with the addition of further categories, including mixed ethnicity options (see 
Box 3-1) (230). Aspinall has highlighted that this nationwide measure of ethnicity 
has helped improve our knowledge of the relationship between ethnicity and 
health (231). However, he has also questioned the continuing use of skin colour 
in the definitions used, and the limited range of white and Asian categories 
available (230). This approach of measuring ethnicity appears to have been 
accepted as reasonable and pragmatic (perhaps in the absence of alternative 
options) and has been used in other surveys and research, despite the fact that 
it was developed for administrative rather than research purposes (221). In 
addition, qualitative evidence suggests that individuals from ethnic minority 
groups consider recording of ethnicity to be important and acceptable in 
healthcare, as long as it is done for clearly explained reasons (232).  
Box 3-1: Ethnic categories in the 2001 Census of England and Wales (233) 
Note: Categories from the 2001 Census are shown because they are most relevant to 
this thesis. The 2011 Census included similar categories with the addition of tick boxes 
for Gypsy or Irish Traveller and Arab.!
Senior and Bhopal described a number of ways in which the use of ethnicity as 
an epidemiological variable could be improved, including acknowledgement of 
its complexity and limitations, clear statement of how it is defined in the 
research, and acknowledgement that its changeable nature may limit 
generalisability across time and populations (222). In addition to these 
suggestions, ways of improving the broader issue of research into ethnicity and 
• White 
! White British 
! Irish 
! Other white background 
• Mixed 
! White and black Caribbean 
! White and black African 
! White and Asian 
! Other mixed background 
• Asian or Asian British 
! Indian 
! Pakistani 
! Bangladeshi 
! Other Asian background 
• Black or black British 
! African 
! Caribbean 
! Other black background 
• Chinese or other ethnic group 
! Chinese 
! Other 
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health have also being considered. In an exercise that involved gaining consensus 
from a group of researchers in this field, it was agreed that it was important to 
include ethnicity in research on health inequalities, that researchers should seek 
to reduce disadvantage and discrimination experienced by ethnic minority 
groups, that it was important to be transparent about how ethnicity is defined 
and to recognise the diversity that exists within groups, that ways of 
categorising ethnicity need to be meaningful, and that it is important to 
acknowledge social context (234). 
3.2 Ethnic groups in the UK 
The UK is becoming increasingly ethnically diverse (19). The white British 
population is still very much in the majority in the UK, but the proportional size 
of this group has decreased (from 87.5% in 2001 to 80.5% in 2011) (19). 
Currently, the largest ethnic minority groups are other white, Indian and 
Pakistani (see Figure 3-1).  
The size and composition of the ethnic minority population varies 
geographically, with the highest ethnic diversity in London (see Figure 3-2) (19). 
For instance, whilst the overall size of the Indian population is 2.5%, this ranges 
from 0.0% to 28.3% by local authority (19).  
Two studies that calculated population projections by ethnicity in the UK found 
that the relative size of the white population is likely to fall in subsequent 
decades, alongside significant increases in the size of ethnic minority groups 
(235, 236). One of these studies projected that the white British population will 
decline to 56% in 2056 with increases in all ethnic minority groups (236). This 
ongoing trend of increasing ethnic diversity means that measurement of 
ethnicity and research into ethnicity and health has become, and will become, 
increasingly important (231). 
The ethnic make-up of the UK contrasts with that of other countries, where 
different historical contexts and migration patterns have resulted in the 
formation of different ethnic minority groups. A number of studies in this review 
are based on populations in the USA and Holland so these countries have been 
selected to illustrate the differences in the ethnic make-up of populations in 
other countries (see Figure 3-3 and Figure 3-4). 
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Figure 3-1: Proportion of population in ethnic minority groups in England and 
Wales, 2011 (19) 
 
 
 
Figure 3-2: Ethnic groups in selected areas of high and low ethnic diversity in 
England, 2011 (19)   
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(a) Ethnic groups 
!
 
 
 
(b) Racial groups 
 
 
Figure 3-3: Racial and ethnic groups in the USA (228)
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Figure 3-4: Ethnic groups by origin in Holland (237) 
Note: Dutch routine statistics are based on country of birth 
3.3 Ethnic inequalities in health 
Examining the association between ethnicity and health reveals a range of 
ethnic inequalities. There is evidence of ethnic inequalities in mortality and 
morbidity from a variety of conditions, including CVD (238). However, these 
inequalities vary by ethnic group and context.  
Early studies from the UK used country of birth to explore health inequalities, 
likely driven by data availability. Wild and McKeigue analysed routine death and 
census data from 1970-92 and found inequalities in mortality by country of birth 
(239). They found that all-cause mortality was higher in all immigrant groups 
than in the general population, except in immigrants from the Caribbean. 
Marmot et al and Harding and Maxwell also studied mortality according to 
country of birth and identified significant inequalities (240, 241). Whilst these 
studies identified and drew attention to important inequalities between 
immigrant groups, country of birth does not fully measure ethnicity according to 
the definition we understand today. However, subsequent research that used a 
broader measure of ethnicity has also identified inequalities in health. Using 
self-reported ethnicity data from the 1991 census, Harding and Balarajan found 
that the relative risk of limiting long-term illness was significantly higher in all 
ethnic minority groups than in the white group, with the exception of the 
Chinese group (242). Becares also used census data on limiting long-term illness 
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and reported similar findings, with higher prevalence of illness in Irish and black 
Caribbean men, and Pakistani and Bangladeshi women (243). Cooper analysed 
cross-sectional data from the Health Survey for England and identified poorer 
self-reported health in black Caribbean, Indian and Pakistani women (244). In 
addition to evidence on general health outcomes, ethnic inequalities in infant 
mortality and cancer have also been observed (9, 245). 
Ethnic inequalities in health are seen around the world. A range of ethnic 
inequalities have been documented in the USA (246). For example, in the USA 
black and American Indian people are generally seen to have poorer health than 
white people (246). In Europe, a systematic review found an association 
between poorer self-reported health and most ethnic minority groups; however, 
many of the studies reviewed were from Sweden, limiting the applicability of 
the findings to other countries (247). Similar to Wild and McKeigue’s findings in 
England and Wales, ethnic inequalities in mortality have been identified in the 
Netherlands from classifying people by country of birth (248). In New Zealand 
there are well-established ethnic inequalities in health, largely related to the 
indigenous Maori population (249), which has a very different historical 
background to ethnic minority populations in Europe.  
3.4 Ethnic inequalities in cardiovascular disease 
In addition to the health outcomes described above, there are also well-
established ethnic inequalities in CVD. Evidence of these inequalities comes 
from a variety of ethnic groups, countries and sources. In England and Wales 
Wild et al found notable ethnic differences in mortality from both IHD and 
stroke (239). For instance, between 1989 and 1992 they found that the 
standardised mortality ratio was higher in men born in South Asia and Ireland 
compared to the general male population (146 and 124, respectively), whereas it 
was lower in men born in the Caribbean (standardised mortality ratio 46). The 
standardised mortality ratio for stroke was higher in all immigrant groups than 
the general population - in South Asian men it was 155, in Caribbean men 168 
and in Irish men 138. In a similar follow-up study, using more recent data, these 
ethnic inequalities were again noted (250). IHD mortality was significantly higher 
in men born in Ireland, Bangladesh, India and Pakistan compared to the general 
male population, and was significantly lower in men born in China and the West 
Indies. A similar pattern was noted for women. Stroke mortality was significantly 
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higher in men born in Ireland, the West Indies, Bangladesh, India, Pakistan, 
China, Eastern Europe and Scotland. These two studies indicate inequalities in 
cardiovascular mortality, including differences in the inequalities observed in 
IHD and stroke. However, the measure of ethnicity used was country of birth, 
which the authors note, may be an unreliable measure of ethnicity in younger 
people who are less likely to be migrants. This potential for misclassification 
means that these results may not fully reflect ethnic inequalities in CVD.  
Despite this limitation, Wild et al’s findings are consistent with evidence from a 
range of other sources. First, evidence suggests that the risk of developing IHD 
varies by ethnicity. Some ethnic groups, in particular South Asian groups, have 
been found to be at higher risk than others, such as the black Caribbean and 
Chinese groups. Forouhi et al used prospective data from primary care patients 
in London to analyse inequalities in mortality between South Asian and European 
people, using a broader measure of ethnicity than country of birth (12). After 
adjusting for age they found that IHD mortality was 60% higher in South Asian 
people than European people, a difference that remained after adjustment for 
socioeconomic position and cardiovascular risk factors. Data linkage work from 
Scotland has also identified inequalities in IHD incidence between South Asian 
ethnic groups and the majority white population (251, 252). Ethnicity data from 
the Census 2001 were added to routine hospital admission and mortality data. 
Indian and Pakistani people were found to have higher rate ratios of chest pain 
and angina compared to white Scottish people, and there was a significantly 
increased incidence rate ratio of acute myocardial infarction in South Asian 
compared to non-South Asian people (251, 252). This approach demonstrates 
that data linkage may be a potentially useful way of adding ethnicity data to 
routine sources that lack it, although the lack of primary care data in this 
analysis limits the conclusions that can be drawn about less severe presentations 
of IHD. In addition to a higher risk of IHD, there is evidence that Asian people 
develop the disease at a younger age and may present with different symptoms 
(253, 254). However, South Asian ethnic groups may experience a better 
prognosis than white individuals, with evidence of better survival after acute 
myocardial infarction (251, 255). In contrast, mortality rates from IHD are lower 
in black men and women compared to white and South Asian people in England 
and Wales, consistent with Wild et al’s findings (239, 256). There is also 
evidence of ethnic inequalities in IHD from other countries. In the USA, mortality 
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rates from IHD have been found to be higher in black people than white people, 
although hospital admissions for myocardial infarction were highest in white 
individuals (257). In Canada, higher prevalence of IHD has been identified in 
South Asian people compared to European and Chinese people (258). 
There are also ethnic inequalities in the epidemiology of stroke, although these 
are not entirely consistent with those observed for IHD. For instance, the risk of 
stroke has been found to be higher in Caribbean and Chinese populations 
compared to the general population, despite the lower risk of IHD in these 
groups (250). A range of studies has identified ethnic inequalities in stroke 
incidence, prevalence and mortality. In London, using data from a stroke 
register, higher age-adjusted incidence of stroke has been found in black African 
and black Caribbean people compared to white people (259, 260). Analysis of 
linked data from Scotland, as described above, found that the risk ratio for 
hospitalisation and mortality from stroke was significantly higher in African men 
than white Scottish men (261), although this study did not report results for 
black Caribbean people. Ethnic inequalities in stroke between black and white 
individuals have also been identified in the USA, and demonstrated higher 
incidence of and mortality from stroke in black people compared to white (262). 
Similarly to IHD, stroke has been found to occur at an earlier age in higher risk 
ethnic groups, with differences in presentation and survival. For instance, black 
stroke patients in London were found to be significantly younger than white 
patients, with ethnic differences noted in the types of stroke occurring, and 
evidence of better survival in black compared to white patients (263, 264). 
3.5 Ethnic differences in cardiovascular risk factors 
The vast majority of cases of CVD can be accounted for by a group of modifiable 
risk factors, as described in the previous chapter (see section 2.2). The 
Framingham study demonstrated the importance of cardiovascular risk factors to 
the development of CVD (23), and subsequent research indicates that these 
traditional risk factors are also relevant across ethnic groups and in explaining 
ethnic differences in CVD (265, 266). This section outlines evidence of ethnic 
differences in the prevalence of important cardiovascular risk factors and 
considers whether there may be ethnic differences in the risk associated with 
these risk factors.  
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3.5.1 Cholesterol0
A number of studies have found ethnic differences in cholesterol concentrations 
and lipid profiles. It has been suggested that South Asian people may have a 
higher risk lipid profile than white individuals (267), whilst individuals of African 
descent may have a lower risk profile (268). However, a systematic review of 
ethnic differences in cardiovascular risk factors found that evidence of ethnic 
differences in cholesterol was inconsistent (10). In a cross-sectional study, 
Bhopal et al found that South Asian people living in Newcastle had a lower HDL 
concentration, higher triglycerides, and a higher total cholesterol:HDL ratio than 
European people (269). Likewise, in an analysis of UK civil servants, Whitty et al 
found that South Asian people may have a more adverse lipid profile than white 
people (270). In contrast, age-adjusted prevalence of raised total cholesterol 
concentration was found to be highest in white people in an analysis of 
cardiovascular risk factors in London (271). There is evidence that African 
Caribbean people have a more favourable lipid profile than white people, with 
lower total cholesterol, lower triglycerides and higher HDL observed in a 
prospective study from London (272). In contrast, a different type of analysis, 
using cross-sectional data from the Health Survey for England 1999, found that 
cholesterol concentrations were similar between black Caribbean people and the 
general population (273). 
3.5.2 Blood0pressure0
Raised blood pressure is the most important modifiable risk factor for stroke 
(274). Black people have a relatively increased risk of stroke, and evidence 
suggests that black populations may have higher levels of blood pressure and 
hypertension than white populations. Higher blood pressure and higher 
prevalence of hypertension in black populations has been observed in the UK and 
the USA (10, 267, 270, 275). For instance, age-adjusted prevalence of 
hypertension was found to be highest in individuals of African origin in a sample 
of general practice patients from London in the 1990s, with a prevalence ratio of 
2.6 compared to the white group (271). In the USA, the prevalence of 
hypertension and risk of developing hypertension has been found to be higher in 
black compared to white populations (276, 277). Risk of stroke is also relatively 
high in Chinese populations. Prevalence of hypertension in Chinese adults in the 
UK has been found to be similar to the general population (11, 256), a finding 
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that contrasts with evidence from North America of increased risk and 
prevalence of hypertension in Chinese compared to White individuals (258, 277). 
Studies of South Asian populations suggest that they may have similar or lower 
blood pressure and prevalence of hypertension than white populations, although 
the evidence is mixed. On the one hand, Lyratzopoulos et al found that South 
Asian people had significantly lower blood pressure than white people, in a study 
that excluded people with known hypertension (278). Similarly, Bhopal et al 
found that hypertension was less common in South Asian people than European 
people in an analysis of cross-sectional survey data from Newcastle (269). In 
contrast, two studies carried out in London found increased prevalence of 
hypertension in South Asian people compared to white and European people 
(271, 279), and Whitty et al found that whilst South Asian men had lower mean 
systolic blood pressure, South Asian people had higher prevalence of 
hypertension than white people (270). These differences could be explained by 
variations in the populations studied and inclusion criteria used. In addition, a 
number of these studies are limited by the age of the data used, for example 
based on cohorts from the 1980s and 1990s (270, 279), and so may not reflect 
recent trends in blood pressure across ethnic groups. 
3.5.3 Smoking0
Smoking is a very important cardiovascular risk factor that carries a population 
attributable risk of over 35% for myocardial infarction (7). Prevalence of smoking 
is lower in many ethnic minority groups than in the white population in the UK, 
although this varies by gender. Smoking was found to be less common among 
black Caribbean, black African and South Asian individuals compared to white 
individuals in two studies from London (271, 272). Analysis of the Health Survey 
for England indicated that the prevalence of current smoking is highest in 
Bangladeshi men (43.5%), Irish men (38.0%) and Irish women (31.7%) (11). Bhopal 
et al also found a higher prevalence of smoking among Bangladeshi men 
compared to Indian, Pakistani and white men (269). In contrast, low levels of 
smoking have been observed in Pakistani (4.5%) and Bangladeshi (2.4%) women 
(11). However, it should be noted these very low levels of smoking in 
Bangladeshi women may conceal a higher proportion who consume tobacco in 
different ways, such as chewing it (256). Another analysis of the Health Survey 
for England reported similar findings, with higher prevalence of current smoking 
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in black Caribbean and Bangladeshi men compared to white men, and lower 
prevalence of current smoking in Pakistani, black African and Indian men (280). 
In this study, very low smoking levels were observed in Indian, Pakistani, 
Bangladeshi, black African and Chinese women. However, these findings were 
found to be largely influenced by socioeconomic position with reductions in 
ethnic differences after adjusting for area deprivation (280). Ethnic differences 
in smoking have also been noted in the USA, with consistently lower levels in 
Mexican-American people but conflicting results in comparisons of smoking in 
black versus white populations (10). 
3.5.4 Diet0
Eating an unhealthy diet is an important risk factor for CVD; indeed, evidence 
from the Global Burden of Disease study suggests that the proportion of 
disability-adjusted life-years from IHD attributable to poor diet may exceed 
those attributable to tobacco smoking, alcohol or physical inactivity (281). 
Dietary risk factors that would lead to lower levels of CVD, according to this 
study, include high consumption of nuts and seeds, fruit and vegetables, whole 
grains and fibre, and low consumption of trans fatty acids, sodium and processed 
meat (281). Evidence suggests that people from ethnic minority groups in the UK 
may consume more fruit and vegetables than the general population (256), a 
potentially positive lifestyle behaviour. For example, Bhopal et al found that 
Pakistani and Indian men consumed more fruit and vegetables each day than 
Bangladeshi and white men (269). In contrast, however, the InterHeart case-
control study found that intake of fruit and vegetables was lower in South Asian 
cases and controls compared to individuals from other countries (254). However, 
this finding was based on South Asian individuals living in South Asian countries, 
rather than those who have migrated to other parts of the world. In addition to 
ethnic differences in fruit and vegetable consumption, there may also be ethnic 
differences in consumption of salt and trans fatty acids, two dietary behaviours 
that are particularly relevant to population CVD prevention policies (see section 
3.7.7.3 for further details).  
3.5.5 Physical0activity0
Physical inactivity is another important lifestyle risk factor for CVD. Similar to 
diet, there is evidence of ethnic differences in physical activity levels in the UK 
although this evidence generally suggests lower physical activity levels in ethnic 
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minority groups (282). Data from two separate analyses of the Health Survey for 
England indicated that South Asian individuals had the lowest levels of physical 
activity compared to other ethnic groups (11, 282). For instance, Williams et al 
found that higher proportions of Indian, Pakistani and Bangladeshi individuals 
reported taking no physical activity each week compared to white individuals 
(31.7% among Indian, 56.7% among Pakistani and Bangladeshi, and 28.1% among 
white people) (282). This is consistent with evidence from other countries, 
where for example InterHeart found a lower prevalence of physical activity in 
South Asian cases and controls (254), and lower levels of physical activity have 
been noted in Mexican-American women and black men and women in the USA 
(10). 
3.5.6 Obesity0
Prevalence of obesity has been found to vary between ethnic groups, with 
evidence of differences using a variety of measures including body mass index 
and waist to hip ratio. Prevalence of having a high waist to hip ratio was found 
to be higher in Indian, Pakistani and Bangladeshi men compared to white men 
(269). Cappuccio et al found the highest age-adjusted prevalence of obesity in 
African women and the lowest in South Asian men in London in the 1990s (271). 
Analysis of the Health Survey for England showed the highest prevalence of 
obesity in black Caribbean men and women, Pakistani women and Irish men (11). 
Evidence from a cohort study in London showed higher mean waist 
circumference in Afro-Caribbean women than in European women (272), and in a 
separate analysis higher waist circumference and higher waist:hip ratios in South 
Asian people compared to the European group (279). Whilst there is evidence 
that black and Mexican-American populations in the USA may have higher body 
mass index than white populations, other studies have found no difference 
between these groups (10, 283). Ethnic differences in adiposity and the related 
cardiovascular risk factor of metabolic syndrome are discussed further in section 
3.7.6.3. 
3.5.7 Diabetes0mellitus0
This important risk factor for CVD varies notably by ethnicity (10). Indeed, 
increased risk of insulin resistance in South Asian and African Caribbean groups 
has been suggested as a potentially important cause of ethnic inequalities in CVD 
(62). Higher prevalence of insulin resistance and diabetes has been found in 
  
55 
African and South Asian ethnic groups (12, 279). Similarly, black Caribbean, 
Indian, Pakistani, Bangladeshi and Chinese men have been found to be at 
increased risk of diabetes than the general population (11). Indeed, Bhopal et al 
found that the prevalence of diabetes was five times higher in South Asian 
groups than in white individuals (269), and Cappuccio et al observed the highest 
prevalence of diabetes in South Asian people, followed by African and then 
white individuals in London (271). 
3.5.8 The0association0between0ethnicity0and0cardiovascular0risk0factors0
The evidence outlined above illustrates that ethnic differences in cardiovascular 
risk factors are not straightforward, and vary by risk factor, ethnic group and 
context. Ethnic differences in cardiovascular risk factors mean studies that seek 
to investigate ethnic inequalities in CVD often attempt to control for these 
factors, in order to explore the role of cardiovascular risk factors in explaining 
ethnic differences in CVD. For instance, Howard et al found that classic 
cardiovascular risk factors accounted for around 40% of the excess risk of stroke 
in black compared to white people in the USA (284). In contrast, other studies 
have found that adjusting for risk factors made little difference to ethnic 
inequalities in CVD (272), or conversely that it eliminated all observed ethnic 
differences (285). Despite these discrepancies, it appears that ethnic differences 
in cardiovascular risk factors are important in understanding ethnic inequalities 
in CVD, although these differences cannot be fully explained by classic risk 
factors (286). 
Three additional considerations arise from examining the relationship between 
ethnicity and cardiovascular risk factors. First, it is important to consider overall 
risk profiles as well as prevalence of individual risk factors, i.e. whether 
individuals have multiple cardiovascular risk factors. A conclusion from some 
studies is that, for example, South Asian ethnic groups have a more adverse risk 
profile than white individuals (269). However, other studies have drawn a 
different conclusion. For instance, Lyratzopoulos et al concluded that South 
Asian people did not exhibit an adverse risk profile compared with white people 
(278). These differences may be due to differences in study design and inclusion 
criteria. For example, the latter study did not include people with hypertension 
and diabetes. In the USA, black people have been found to have a higher total 
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number of cardiovascular risk factors compared to white and Mexican-American 
people, a factor that is associated with a higher risk of developing CVD (287).  
Second, the association between cardiovascular risk factors and disease may 
itself vary by ethnicity. A difference of this kind has also been suggested for 
other epidemiological variables, such as sex and socioeconomic position (288, 
289). Forouhi et al found that diabetes is associated with a higher risk of 
mortality in South Asian than in European people (12). Similarly, Bellary et al 
found that South Asian people with diabetes were more likely to develop 
premature CVD, with higher incidence rates of cardiovascular events at younger 
ages compared to white people, although there were few events in the follow-up 
period of this study (290). In a longitudinal cohort analysis from the USA, Howard 
et al found that the increased risk of stroke associated with increasing systolic 
blood pressure varied between black and white people - a 10 mmHg increase was 
associated with an 8% increased risk of stroke in white people and 24% in black 
people (291). Indeed, it has been suggested that some cardiovascular risk factors 
may be associated with greater risk in ethnic minority individuals (292), and that 
different thresholds for common risk factors, such as cholesterol and body mass 
index, may be needed in higher risk ethnic groups (292, 293). For instance, a 
recent study using data from the UK Biobank found that the risk of diabetes 
mellitus was higher in non-white than white individuals at lower body mass index 
values (294). The National Institute for Health and Care Excellence (NICE) has 
previously considered lowering the thresholds for defining overweight and 
obesity in black and Asian populations in the UK, however a lack of evidence 
meant that the thresholds were not changed (293).  
In contrast, other evidence suggests that the relationship between risk factors 
and disease are similar across ethnic groups. Forouhi et al found that the hazard 
ratios for IHD mortality associated with smoking, blood pressure and cholesterol 
were similar in South Asian and European people, despite ethnic differences in 
the hazard ratio associated with diabetes (12). An international cohort study of 
middle-aged men found that there was little evidence of differences in the 
strength of association between cardiovascular risk factors and coronary 
mortality across countries and populations (295). Likewise, InterHeart found that 
the odds ratios for various cardiovascular risk factors were similar by country, 
including between South Asian and other countries (254), and by ethnicity (7). It 
therefore remains unclear whether there are ethnic differences in the 
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association between cardiovascular risk factors and disease. Differences may 
depend on context, other risk factors or confounders. Evidence from prospective 
cohort studies that include large samples of ethnic minority individuals would 
help to address this question, but this would be a significant undertaking. 
Third, another interesting conclusion from the InterHeart study is that the 
impact of risk factors on population levels of disease, as measured by population 
attributable risk, may vary (7, 254). These differences would be driven, at least 
partially, by variations in the prevalence of risk factors and would be important 
from a public health perspective. For instance, Joshi et al found that South 
Asian populations had a higher population attributable risk associated with high 
waist to hip ratio, but lower population attributable risk associated with 
hypertension and stress (254). However, despite these differences Yusuf et al 
found that the nine main risk factors together still accounted for a similar 
proportion of the population attributable risk in each ethnic group (86% 
European, 90% Chinese, 92% South Asian, 92% black African) (7). 
3.6 Trends in ethnic inequalities in health 
Ethnic inequalities in health and CVD have persisted and may be widening (239, 
243, 296-298). With regards to general health, Becares found persistent ethnic 
differences in rates of limiting long-term illness between 1991 and 2011 in 
England and Wales (243). In New Zealand, Blakely et al analysed routine data 
and found that relative and absolute inequalities in mortality between Maori and 
non-Maori people increased between 1981 and 1999 (296). Evidence also 
suggests that whilst CVD is declining, the rate of decline may be different in 
some ethnic groups. In Birmingham, admissions for stroke declined between 
1997 and 2005 but the fall was smaller in South Asian individuals (299). Overall 
falls in stroke incidence seen in London were not observed in black men, 
although the relative inequality between black and white men and women 
reduced (260). Similarly, in the USA mortality rates from CVD have not declined 
as much in black compared to white populations (257, 262).  
It has been recommended that steps should be taken to tackle ethnic health 
inequalities at a national level in the UK whilst public organisations have a legal 
obligation to tackle racial discrimination and promote equality (300, 301). 
However, recent work on health inequalities has been criticised for its lack of 
attention to ethnic health inequalities (302). This is concerning given evidence 
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that ethnic minority groups are accounting for an increasing proportion of the 
population and ethnic inequalities in health may be widening. 
3.7 Explanations for ethnic inequalities in health 
The next section of this review considers a range of explanations for ethnic 
inequalities in health. These explanations include artefact, socioeconomic 
position, migration, racism, cultural and behaviour, biology, healthcare access 
and effectiveness, and area effects (9, 238, 303).  
Explanations for ethnic inequalities in health do not operate in isolation but are 
linked by complex and changing relationships (see Figure 3-5). For example, 
socioeconomic position may change following migration (304); racism may 
influence socioeconomic position, perhaps through widespread structural 
discrimination (305); language may influence ability to access healthcare 
services and education; religion and culture may affect health behaviour and 
attitudes towards education and employment; where a person lives may 
influence their employment and educational opportunities, and so on.  
These complex relationships make interpreting causes of ethnic inequalities in 
health complicated and mean that interventions to reduce these inequalities are 
unlikely to be straightforward.  
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Figure 3-5: Illustration of the complex inter-relationships between 
explanations for ethnic inequalities in health (idea based on (306)) 
3.7.1 Artefact0
Ethnic inequalities in health could be due to artefact, arising from inaccuracies 
or bias in the data analysed (238). For instance, Davey Smith et al highlight that 
artefactual differences in health could arise if there are ethnic differences in 
how individuals respond to questions on self-reported health (9). Given the 
complex definition of ethnicity and variety of methods used to measure it, 
artefact should be considered when interpreting evidence of ethnic inequalities 
in health.  
3.7.2 Socioeconomic0position0
There is a well-established relationship between ethnicity, socioeconomic 
position and health. However, this complex relationship can depend on context, 
and has been interpreted and measured in different ways (307). There are two 
key reasons to suppose that socioeconomic position is important in the 
relationship between ethnicity and health. First, there are differences in the 
socioeconomic position of different ethnic groups. Second, evidence suggests 
that at least some of the observed ethnic differences in health can be accounted 
for by socioeconomic position. However, the measurement of socioeconomic 
Migration 
Socioeconomic 
status 
Racism 
Culture 
Religion Healthcare 
use and 
access 
Geography Lifestyle 
 Ethnicity 
  
60 
position in different ethnic groups can be problematic and may affect the results 
of research in this area. 
In the UK, socioeconomic deprivation is more common in ethnic minority groups 
than in the majority white population (308). Higher proportions of the ethnic 
minority population live in deprived areas (308), although this varies between 
ethnic groups and geographical areas (309). For instance, Pakistani and 
Bangladeshi groups are particularly concentrated in deprived areas, although a 
slightly smaller proportion of the Pakistani group live in the most deprived areas 
in London (309). In contrast, the Chinese and Irish groups are less likely to live in 
the most deprived areas, and the white British group are more likely to live in 
less deprived areas (309). Wages have been found to be lower in Bangladeshi and 
Pakistani men compared to Chinese men (310). Household wealth is lower in 
Bangladeshi and Pakistani groups compared to Indian and white groups - £15,000 
and £97,000 for Bangladeshi and Pakistani respectively, compared to £200,000 or 
more for Indian and white (310). There are ethnic differences in educational 
achievement, with greater achievement in many ethnic minority groups 
compared to the white majority (308). In Scotland, socio-economic deprivation 
is also more prevalent in ethnic minority groups, although there are some 
differences compared to England such as the Indian group having lower levels of 
poverty in Scotland (311).  
As well as this evidence of increased socioeconomic disadvantage in ethnic 
minority groups, it is important to note the variation that exists within ethnic 
groups. For instance, there are large income inequalities within the Chinese 
group compared to low inequalities within the Bangladeshi group (312). 
Socioeconomic disadvantage associated with being a member of an ethnic 
minority group also exists in other countries, such as the USA and New Zealand. 
In the USA, black and Hispanic populations have been found to have poorer 
socioeconomic position than the white group (313, 314). In New Zealand the 
Maori population are socioeconomically disadvantaged compared to the non-
Maori population (296).  
A number of studies have found that socioeconomic position is an important 
explanation for ethnic inequalities in general health and all-cause mortality. 
Early studies in this area, examining mortality by country of birth, found no 
socioeconomic gradient for immigrants from the Indian subcontinent and a 
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possible reverse gradient in people from the Caribbean (241). However, further 
research has suggested that this is no longer the case. For instance, Nazroo 
found socioeconomic gradients in self-reported health within ethnic groups with 
poorer general health associated with lower socioeconomic position and has 
suggested that socioeconomic factors are a "fundamental cause" of ethnic 
inequalities in health (p.277) (315). This discrepancy between earlier and later 
studies could be accounted for by a cohort effect of the largely immigrant 
populations studied in the 1970s compared to more recent studies in which 
ethnic minority people are more likely to have been born in the UK and to have 
had different socioeconomic experiences (316, 317). In fact, longitudinal 
evidence from 1971 to 1981 suggests the emergence of clearer socioeconomic 
gradients in mortality among immigrants to the UK, with socioeconomic 
circumstances improving for these groups (317). In the USA, increased life 
expectancy is associated with higher income in both white and black groups, 
despite being lower overall in black people (318). In the Netherlands, absolute 
and relative socioeconomic inequalities in mortality were identified within 
ethnic groups, but varied in size and direction according to the cause of death 
(319). 
Socioeconomic inequalities in CVD within ethnic groups have been identified, 
and found to be changing. Scottish data showed an association between 
cardiovascular risk and various measures of socioeconomic position in most 
ethnic groups, although there was variation in the strength of association (320). 
In the UK, Harding analysed deaths by country of birth and identified 
socioeconomic gradients in IHD mortality among South Asian immigrants, 
although these gradients were less consistent in Pakistani and Bangladeshi 
compared to Indian immigrants (321). This finding is perhaps consistent with 
Bhopal et al’s finding that the European pattern of socioeconomic gradients in 
CVD (higher levels of risk and disease in lower socioeconomic groups) is 
developing in Indian populations, and perhaps also amongst Pakistani and 
Bangladeshi people in the UK (8). There is also evidence of socioeconomic 
gradients in CVD within ethnic minority groups in other countries. For instance, 
in the Netherlands, Agyemang et al analysed national routine data and found a 
higher incidence of myocardial infarction in the lowest income tertile in each 
ethnic group studied (322). Analysis of cross-sectional survey data from the USA 
showed inverse socioeconomic gradients in IHD risk in most ethnic groups studied 
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(323). In addition, cardiovascular mortality in the USA has been found to be 
associated with socioeconomic position in both black and white people, with 
particularly high mortality in blue-collar black men (313). Changing patterns in 
socioeconomic gradients have also been observed in India, where individuals 
from urban and non-urban areas exhibit differences in the association between 
socioeconomic position and CVD, with an inverse relationship seen in men from 
urban areas in contrast to a positive relationship in non-urban areas (324).  
The causes of changes in socioeconomic gradients in ethnic minority groups are 
likely to be complex, but could be related to changing socioeconomic position or 
acculturation leading to lifestyle changes. The diffusion theory suggests that the 
CVD epidemic affects individuals in higher socioeconomic groups first as they can 
afford to adopt unhealthy behaviours such as smoking and high saturated fat 
consumption (28). As the epidemic progresses high levels of CVD then start to 
affect lower socioeconomic groups as they also adopt unhealthy behaviours. 
Disease rates then decline in higher socioeconomic groups, as they are the first 
to adopt healthier behaviours, leading to an inverse socioeconomic gradient 
(28). This theory could explain the changing socioeconomic gradients in CVD 
seen in ethnic minority groups, with different groups at different stages in the 
process. 
Studies have shown that adjusting for socioeconomic position attenuates the 
observed relationship between ethnicity and health (325). In the UK, Chandola 
analysed cross-sectional data for an association between ethnicity, health and 
socioeconomic position (316). Although, the socioeconomic gradient observed in 
Pakistani and Bangladeshi people was weaker than that in Indian and white 
people, ethnic differences in self-reported health became non-significant after 
adjusting for a range of socioeconomic factors. Similarly, Davey Smith et al 
found a reduction in the increased relative risk of all-cause mortality in black 
compared to white men in the USA after adjusting for an area based income 
measure (326). Another study from the USA, which benefited from large samples 
of black and white individuals, found that adjusting for income reduced the 
hazard ratio for cardiovascular deaths in black compared to white people (from 
1.35 to 1.09) (327). These findings emphasise the importance of considering 
socioeconomic position when studying ethnic differences in health. However, 
this approach has often led to the potentially incorrect conclusion that after 
adjusting for socioeconomic position any remaining differences in health must be 
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due to factors inherent to the ethnic groups themselves, such as genetics or 
culture (307). 
Examining the relationship between ethnicity, socioeconomic position and health 
is problematic for a number of reasons. First, socioeconomic measures may not 
be equally applicable to different ethnic groups and may not fully reflect 
socioeconomic disadvantage within ethnic minority groups (307). Take for 
instance common socioeconomic measures such as income, education, 
occupation and housing tenure. Income has been found to be lower in ethnic 
minority individuals in the same occupational class as white people in the UK 
(303), and similarly in the USA median income in black and Hispanic people has 
been found to be lower than in white people with the same educational level 
(318). Educational achievement may be higher in many ethnic minority groups in 
the UK, but this may translate into poorer long-term socioeconomic outcomes 
than in the majority population (307, 308). Occupational status may be 
adversely affected by migration and people from ethnic minority groups may be 
exposed to more work-related hazards and poorer quality employment (307, 
308). There are ethnic differences in housing tenure, with high levels of home 
ownership in Indian and Pakistani groups (308). This may appear to be a positive 
socioeconomic circumstance but may not reflect differences in housing quality, 
such as overcrowding or lack of modernisation (307). This could mean that 
ethnic minority individuals are more likely to be misclassified socioeconomically, 
and the real effects of socioeconomic deprivation will not be fully accounted 
for. This could mean that residual ethnic differences in health after adjustment 
socioeconomic position could be due to socioeconomic differences that have not 
been measured rather than being due to ethnicity itself (307).  
The choice of measure of socioeconomic position can influence the observed 
association between socioeconomic deprivation and health (328, 329). 
Furthermore, it may influence the observed association between ethnicity and 
health. Kelaher et al found that the size of ethnic differences in health varied 
depending on which socioeconomic measure was adjusted for (330). Similarly, 
Fischbacher et al analysed linked routine data from Scotland, with various 
measures of socioeconomic position, including education, occupation, area 
deprivation, housing tenure and car access (320). They found that the 
association between socioeconomic position and incident CVD within ethnic 
groups varied according to which measure of socioeconomic position was used. 
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The association between ethnicity and CVD changed slightly after adjustment for 
the various measures of socioeconomic position, with the largest change seen 
after adjustment for education. It has therefore been suggested that multiple 
rather than single measures of socioeconomic position should be used (303, 320).  
Second, given the complex relationship between ethnicity and socioeconomic 
position, controlling for the latter may lose some of the explanation of ethnic 
inequalities in health (303). Socioeconomic position is likely to moderate the 
effect of ethnicity on health, illustrated by the fact that ethnic inequalities in 
health vary according to socioeconomic position (326), although this would also 
be true for confounding factors. Brancati et al used cross-sectional survey data 
from the USA to analyse the relationship between diabetes, ethnicity and 
socioeconomic position (331). Although they used data from the 1970s, which is 
somewhat dated, they found that the association between ethnicity and 
diabetes differed by socioeconomic position, with a stronger association seen in 
lower socioeconomic groups. Again from the USA, local mortality data showed 
that older black men living in poor neighbourhoods had a higher rate of 
cardiovascular mortality than older white men also living in poor 
neighbourhoods, whereas cardiovascular mortality was similar in black and white 
individuals living in more affluent areas (332). Likewise, Huxley et al found that 
ethnic differences in stroke rates between black and white adults in the USA 
were smaller at higher income levels (333). Conversely, analysis of different 
data from the USA has shown that ethnic differences in cardiovascular mortality 
did not differ according to income (327). However, this range of evidence 
suggests that treating socioeconomic position as a confounding factor may not 
be appropriate. It is also possible that socioeconomic position acts as a 
mediating factor on the causal pathway between ethnicity and health, another 
reason why controlling for it may not be appropriate.  
Third, standard socioeconomic measures may not reflect life course 
circumstances. Whilst this issue applies to use of these measures in the general 
population as well, it may be particularly relevant to people from ethnic 
minority groups who have experienced events such as migration (315). Evidence 
suggests that life course socioeconomic position affects CVD in both black and 
white individuals, although adult socioeconomic position may have a greater 
effect on ethnic differences in stroke risk than childhood socioeconomic position 
(334). In the UK, Tillin et al found that both child and adulthood socioeconomic 
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position was associated with cardiovascular mortality in South Asian men (335). 
Their analysis, which was based on migrants, also showed that for many men 
good childhood socioeconomic circumstances still led to manual occupations, 
suggesting that migration may be associated with negative effects on 
socioeconomic trajectory (335).  
These three reasons mean that caution is required when interpreting evidence 
on the relationship between ethnicity, socioeconomic position and health. 
However, any research in this area must consider socioeconomic differences and 
the complex relationship with ethnicity. 
3.7.3 Migration0
Migration gives people exposure to at least two different environments (the 
place(s) of origin and destination(s)) plus the experience of migration itself, all 
of which could influence health (9). Evidence suggests that the effect of 
migration on CVD can vary according to a person's origin and destination, and 
may be driven by acculturation or changes in socioeconomic position. The 
evidence reviewed in this section relates to migration between countries, 
however migration within countries, such as between rural and urban areas, may 
also affect health. For instance, in India there is evidence that the prevalence of 
stroke is higher in urban compared to rural areas (336). 
Researching the association between migration and health can be challenging 
because of complex relationships between ethnicity, migration, CVD, and 
adaptation to new and different environments (337). In addition, selection bias 
can influence interpretation of the effect of migration on health. This is because 
migrant populations may be selected on the basis of health, with healthier 
people being more likely to migrate, destination countries imposing varying 
health requirements for migrants, and the possibility that unhealthy people may 
return to their home country (9). For example, a retrospective analysis of health 
insurance data in Canada indicated that the new migrants had a hazard ratio for 
acute stroke of 0.69 compared to long-term residents after adjusting for 
potential confounders, suggesting a potential healthy migrant effect (338). 
Furthermore, migration patterns around the world are changing (339). This 
means that the composition of ethnic minority populations within countries may 
change significantly, as existing communities become more established and new 
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communities arrive, creating a particular challenge for research and timely 
provision of appropriate health services.  
CVD mortality can vary within migrant groups depending on the destination 
country. A European analysis of cardiovascular deaths by country of birth showed 
differences in mortality rates depended both on country of origin and 
destination (340). Gray et al investigated cardiovascular mortality differences by 
country of birth using routine data in Australia (337). They found that 
cardiovascular mortality decreased with increased duration of residence in 
Australia in some migrant groups, whereas in others mortality increased. 
Interestingly, they found that CVD mortality was lower than the national average 
in migrants from India and Sri Lanka. This contrasts with findings from England 
and Wales where all-cause and cardiovascular mortality of migrants from the 
Indian subcontinent increased with increasing duration of residence (341), 
although results of a similar study on Caribbean migrants did not show such 
mortality changes (342). It is possible that changes in socioeconomic position 
could explain some of these findings, however these studies report similar 
results before and after controlling for socioeconomic position (337, 341, 342).  
Acculturation, leading to changes in health behaviours and cardiovascular risk 
factors, could be a mechanism by which migration influences CVD. Moran et al 
found that people born outside the USA had a lower prevalence of hypertension 
than people born in the USA, and that living in the USA for longer was associated 
with a higher prevalence of hypertension, although their sample was 
unrepresentative with regards to ethnicity (343). Using the Health Survey for 
England, with the sample divided into people born overseas or in the UK, Smith 
et al found that the risk of obesity in most ethnic minority groups converged 
with that of the white population (344). For instance, Chinese and Indian people 
born in the UK were more likely to be obese than those born overseas after 
controlling for demographic factors. Indeed, there is evidence that migrants to 
the UK may have worse cardiovascular risk factor profiles than those who have 
not migrated. Smeeton et al found that Barbadian stroke patients had a 
generally more favourable risk factor profile than black Caribbean stroke 
patients in London (345), and Patel et al reported a similar finding when 
comparing community samples of the Gujarati community in the West Midlands 
and India (346). These findings are consistent with evidence that mortality rates 
in some migrants are converging with mortality rates of people born in England 
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and Wales (347). Whilst acculturation could explain changes in cardiovascular 
risk factors in childhood and adulthood, this explanation contrasts with Barker’s 
hypothesis that fetal undernutrition can lead to increased risk of CVD (348). If 
this were the case, risk of developing CVD could be at least partially determined 
before migration takes place, and would be increased in individuals from 
countries where maternal undernutrition is more prevalent. 
3.7.4 Racism0and0psychosocial0experiences0
Racism, racial discrimination and harassment may have a negative impact on 
health. Racism could affect health through direct physical or psychological 
consequences, or indirectly through the creation of socioeconomic disadvantage 
(349). It can occur at an individual or institutional level (349), in fact it has been 
suggested that health services may be institutionally racist (350). Karlsen and 
Nazroo examined cross-sectional survey data and found a statistically significant 
association between poor self-reported health and experiencing racism (349). 
Becares et al also used cross-sectional data, from a more recent survey, to 
assess the association between racism and health and found an association with 
limiting long-term illness (351). In an adolescent population racism has been 
found to be associated with poorer psychological well-being (352). These 
findings are important because they suggest that racism, which is widespread 
(315), can have a negative impact on general health. However, a challenge for 
studies of this type is how to accurately measure racism and its impact on an 
individual (349). 
More specifically, there is evidence of an association between racism and 
cardiovascular risk factors. Cozier et al asked black women in the USA about 
their experiences of racism and discrimination, alongside their self-reported 
weight and height (353). They found an association between incidence of obesity 
and experience of racism, which was stronger in the women who had 
experienced racism over a longer period of time. Although they acknowledge 
that their sample was not representative and they used self-reported weight and 
height, this suggests a potential relationship between racism and cardiovascular 
risk factors.  
In addition, evidence suggests that there may be ethnic differences in the 
association between negative psychosocial experiences and CVD. For instance, 
Williams et al used a validated measure of hostility in a sample of South Asian 
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and white adults receiving cardiovascular screening in London (354). They found 
significantly higher levels of hostility in South Asian people compared to white 
people, with ethnic differences in the association between hostility and various 
cardiovascular risk factors. Negative psychosocial experiences could impact 
health if they lie on the causal pathway between socioeconomic position or 
racism and health or CVD. For instance, in a prospective cohort study of African 
American adults in the USA, the association between socioeconomic position and 
hypertension and diabetes reduced after adjustment for stress (355). 
3.7.5 Culture0and0behaviour0
Ethnic differences in health may arise from variations in cultural practices, 
religion and health behaviours (9). The previous section on cardiovascular risk 
factors described ethnic differences in various health behaviours (see sections 
3.5.3, 3.5.4 and 3.5.5).  
The nature and definition of ethnicity means that it is integrally related to a 
person’s culture, a factor that is likely to influence health behaviour. The 
mechanisms by which ethnicity influences health behaviour are likely to be 
complex and relate to factors such as socioeconomic circumstances and religion. 
For instance, qualitative research with South Asian individuals in focus groups in 
Edinburgh suggested that ethnicity may impact on lifestyle choices because of 
ethnic differences and ethnic specific barriers in social norms, working 
practices, food choices, and perceptions of health (356).  
Despite descriptive evidence of ethnic differences in health behaviour, 
interpreting these differences and forming health policy based upon them can be 
problematic. In particular, attributing ethnic inequalities in health to cultural 
and behavioural differences requires caution because of the risk of stereotyping 
heterogeneous groups and making assumptions that certain cultural behaviours 
are responsible for poor health (9). 
3.7.6 Biological0
It has been suggested that ethnic inequalities in health could be due to 
biological differences. A number of potential biological mechanisms for ethnic 
inequalities in CVD have been suggested. These include vascular, metabolic and 
genetic differences, as described below. In considering the role of physical 
differences as a cause of ethnic health inequalities it is important to remember 
the inter-relationships that exist between genetics, biological traits and the 
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social and physical environment - the relationship between socioeconomic 
position, low birthweight and chronic disease is one example of this (9). 
3.7.6.1 Genetic(
Genetics may play a role in explaining ethnic inequalities in health, although its 
role may have been overstated in the past (218). Indeed, it has been suggested 
that environmental and social exposures are more important determinants of 
CVD (357). Whilst there are a small number of conditions, predominately specific 
inherited genetic diseases, that are associated with certain ethnic groups, these 
would have a very limited impact on broader ethnic health inequalities (9). In 
addition, genetic variation between ethnic groups is smaller than that seen 
within groups (9, 218).  
Development of CVD and certain risk factors, such as diabetes, is associated with 
the presence of certain genetic traits, the prevalence of which can vary 
between ethnic groups (358). The thrifty gene hypothesis is one potential 
explanation for the origin of genetic differences; this hypothesis suggests that 
being predisposed to insulin resistance may protect individuals during periods of 
food restriction, and may have developed in populations such as those in South 
Asia and Africa (358, 359). Indeed, it has been suggested that this genotype is 
common in African populations but its expression may be driven by exposure to 
Westernised lifestyles, i.e. an epigenetic phenomenon (359). However, the 
origin of this genotype has been questioned as areas such as South Asia are 
agriculturally productive and capable of supporting large numbers of people 
(360). 
3.7.6.2 Vascular(
There may be ethnic differences in the development and presentation of 
atherosclerosis. Budoff et al found a significantly lower prevalence of coronary 
artery calcification, a sign of atherosclerosis, in black and Hispanic patients in 
the USA, with Asian people having a similar prevalence to white people (361). 
This finding was based on scans performed on patients undergoing coronary 
angiography, a potential source of selection bias. However, a prospective study 
from Canada also identified ethnic differences in atherosclerosis, with the 
highest levels seen in European people followed by Chinese and then South Asian 
people, although the South Asian group still had higher rates of CVD (258). 
Furthermore, there is evidence of ethnic differences in the distribution of 
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atherosclerosis (362), illustrated by Chaturvedi et al’s finding that South Asian 
men have less peripheral (i.e. lower limb) atherosclerosis than European men 
within categories of similar coronary artery atherosclerosis (363). Additionally, 
differences in renin activity may lead to ethnic differences in hypertension 
(364). Renin activity has been found to be lower in black compared to white 
people, potentially accounting for ethnic differences in hypertension between 
these groups (364). 
3.7.6.3 Metabolic.
Ethnic differences in metabolic syndrome have been suggested as a potentially 
important driver of ethnic inequalities in CVD (62). Metabolic syndrome is 
characterised by the presence of abdominal obesity, insulin resistance, 
hypertension and raised triglyceride:HDL ratio (365), and is associated with an 
increased risk of CVD (366). Prevalence of metabolic syndrome has been found 
to be higher and increasing in South Asian people (267, 365), and has been 
suggested as a potential cause of increased levels of CVD in this group (366). The 
African Caribbean group has also been found to have higher levels of insulin 
resistance, but have atypical associations with lipids and obesity compared to 
other ethnic groups (62). In addition, there are ethnic differences in fat 
deposition and distribution, with high levels of abdominal adiposity seen in South 
Asian groups, including evidence of ethnic differences in adiposity from infancy 
(367), and evidence of ethnic differences in visceral deposition of fat, a type of 
fat that may be underestimated by body mass index measurements (368). It has 
been suggested that current thresholds used to define metabolic syndrome may 
underestimate the prevalence of the condition in South Asian people and may 
need to be adapted with ethnic specific cut-offs, for example in body mass 
index, waist circumference and glucose measurement (also see section 3.5.8) 
(365). 
3.7.7 Prevention,and,health,care,access,and,availability,
Ethnic inequalities in health could arise from differences in the impact of 
healthcare policies and interventions. There are many potential sources of these 
differences but for the purposes of this review four key areas, which are 
particularly relevant to ethnic inequalities in CVD, have been identified. These 
are ethnic inequalities in access to prevention and healthcare, in the 
effectiveness of preventative interventions and more specifically the 
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effectiveness of population approaches, plus ethnic differences in the 
performance of cardiovascular risk calculators. The previous chapter described 
that public health interventions can lead to health inequalities if they do not 
work equally well in population subgroups and particularly if disadvantage 
accumulates through various stages of the intervention (see section 2.9). This 
mechanism is potentially relevant for this section, where it is possible that 
ethnic differences in the impact of the healthcare policies and interventions 
described could combine in such a way. 
3.7.7.1 Ethnicity(and(access(to(prevention(and(healthcare(
Ethnic inequalities in health could arise from differences in access to 
healthcare, including to CVD prevention interventions. Access is a broad concept 
that includes service availability, timely uptake, and quality (369); alongside 
this, access should also be based on health needs and aim to ensure equity (369, 
370). This section includes examples from across this broad definition of access, 
although much of the evidence relates to uptake.  
There is strong evidence of ethnic inequalities in access to health care (370). 
Ethnic inequalities have been identified in access to health care generally, and 
to preventative interventions, including those for CVD specifically. However, 
evidence regarding the nature and direction of these ethnic differences is mixed 
and depends on the intervention, ethnic group and context studied.  
Mixed evidence of ethnic differences in uptake of preventative interventions has 
been identified. For instance, Bansal et al found that women from many ethnic 
minority groups in Scotland, including Pakistani, African and Indian women, had 
a higher risk of non-attendance for breast cancer screening than white Scottish 
women, including after adjustment for socioeconomic position (371). In 
contrast, uptake of childhood vaccinations has been found to be highest in Asian 
children and lowest in black Caribbean children, with intermediate uptake in 
white children, in a study from Birmingham (372). Additionally, a study from the 
USA on uptake of preventative health services found that black individuals were 
equally or more likely to receive these services than white or Hispanic people 
(373), although this telephone survey evidence may have been subject to 
selection bias owing to potential differences in telephone access or availability 
for interview.  
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Uptake of preventative lifestyle interventions, such as smoking cessation, may 
also vary by ethnic group. Whilst ethnic minority individuals are no less willing to 
quit smoking than the rest of the population fewer attempt to quit using 
professional services (374). An evaluation of the NHS stop smoking services in 
England found that between 2001 and 2011 the proportion of people attending 
the service who were from an ethnic minority group increased from 4 to 7% 
(125). This figure is likely to underrepresent the proportion of the population 
who come from an ethnic minority group, and therefore may indicate lower 
uptake in these populations although ethnic differences in smoking will also be 
relevant. 
There is also evidence of ethnic differences in the uptake of cardiovascular 
screening programmes, including England's NHS Health Check programme. In 
contrast to the evidence cited above on cancer screening, evidence suggests 
that there may be higher uptake of cardiovascular risk screening in ethnic 
minority groups than in the white population. For instance, both Artac et al and 
Dalton et al found higher uptake of NHS Health Check appointments among 
South Asian and black individuals (162, 163). However, these studies were based 
on uptake in the earliest years of the programme, which may not reflect ongoing 
attendance (162, 163). Uptake of cardiovascular screening has also been found 
to be higher in South Asian and black groups in local screening programmes in 
Birmingham (375, 376). Whilst the generalisability of these findings may be 
limited because of the specific design of the programmes, these findings 
demonstrate the potential to achieve good uptake of cardiovascular risk 
screening among ethnic minority individuals. Ethnic differences in the uptake of 
cardiovascular risk factor screening have also been found in the USA, where self-
reported uptake of cholesterol screening was initially found to be lower among 
Hispanic individuals compared to white non-Hispanic (377). However, 
adjustment for confounding factors including health insurance and 
socioeconomic position reversed this finding. 
Ethnic differences in the diagnosis and treatment of health conditions would be 
another potential source of health inequalities. However, Nazroo et al analysed 
cross-sectional data from the Health Survey for England and found little 
evidence to suggest that chronic conditions, such as hypertension or high 
cholesterol, were less well treated or diagnosed in ethnic minority groups (378). 
Indeed, evidence from the UK suggested that uptake of cardiac investigations 
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was higher in South Asian than white civil servants after adjustment for 
differences in need (379). Ben-Schlomo et al investigated the healthcare seeking 
behaviour of South Asian and white patients admitted to hospital with acute 
coronary syndrome, and found that whilst there were ethnic differences in how 
patients arrived at the hospital and whether they received thrombolysis, this did 
not equate with inequitable care for South Asian patients (380).  
The use of preventative medications may vary across ethnic groups. An 
ecological study from the UK found that in areas with a high South Asian 
population primary care patients were less likely to be prescribed lipid-lowering 
medications (381). Similarly, Ashworth et al found that prescribing of statins was 
lower in areas with high proportions of African Caribbean or South Asian people, 
although the size of the association was small (382). Aspirin use was found to be 
lower in African-American and Hispanic individuals in the USA compared to white 
individuals, although this study made no adjustment for health insurance status 
(383). Adherence to medication has also been found to vary by ethnicity. In a 
systematic review and meta-analysis, Lewey et al compared adherence to 
statins in non-white and white individuals in the USA (384). They found a crude 
odds ratio of non-adherence in non-white compared to white people of 1.53, 
with higher odds of non-adherence also observed in studies that controlled for 
socio-economic and health insurance status. In contrast, willingness to take 
antihypertensive medication has been found to be similar in South Asian and 
white individuals in the UK (385), whilst reported use of statins has been found 
to be higher in South Asian compared to white people (386). Studies that have 
assessed uptake of medication for the secondary prevention of CVD in South 
Asian people have found it to be higher than in white individuals (379, 387), but 
lower in black patients (387). These differences between the USA and UK could 
reflect variations in availability, funding or routine recommendations. In 
addition, adherence to and uptake of medication can be difficult to measure as 
it often relies on self-report or prescription data that may not reflect actual 
intake.  
Szczepura has postulated that ethnic differences in access to health care could 
arise from individual factors, such as culture, healthcare seeking behaviour and 
language, or organisational factors, such as staff training or location of services 
(370). For instance, Nazroo et al explored ethnic differences in primary care and 
hospital attendance in England (378), indicators of healthcare seeking behaviour 
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as well as need. They found that black Caribbean, Indian, Pakistani and 
Bangladeshi adults were significantly more likely to have visited their general 
practitioner, but that Pakistani, Bangladeshi and Chinese adults were 
significantly less likely to have attended hospital than white adults. These 
differences remained after adjusting for self-reported health, although this 
measure may not fully capture ethnic differences in health need.  
There is evidence of ethnic differences in the awareness of the presence of high 
cardiovascular risk factors, a factor that could reduce uptake of recommended 
risk reducing interventions. Analysis of general practice data from the UK 
suggests that patients in areas with a high ethnic minority population may be 
less likely to have variables such as blood pressure and cholesterol recorded, 
suggesting possible variations in the quality of primary care services (388). In the 
USA, awareness and treatment of hypertension was found to be significantly 
lower in Mexican American people than in non-Hispanic white people after 
adjustment for confounding factors, including health insurance status (389); 
awareness and treatment of dyslipidaemia was also been found to be 
significantly lower in African-American compared to white people (390).  
Qualitative research has been used to identify specific barriers that could affect 
adoption of healthy behaviours and access to health interventions in ethnic 
minority communities. For example, Horne et al found a number of similarities 
between older South Asian and white individuals in their attitudes towards 
physical activity, but also identified a number of issues specifically affecting 
South Asian people (391). These included language barriers, religious 
requirements for fasting, and attitudes towards modesty and gender 
segregation; issues that could have implications for provision of health 
promoting activities. In another qualitative study, Grace et al carried out focus 
groups with the Bangladeshi community in Tower Hamlets to explore attitudes 
towards diabetes prevention (392). They also found concerns related to gender 
segregation and language barriers, in addition to the important role of 
hospitality in influencing food choices. This qualitative evidence highlights a 
number of potential explanations for ethnic differences in access to healthcare, 
although these findings may be relevant only to the particular populations 
studied. Stereotyping by health professionals has also been identified as a 
barrier to accessing CVD prevention interventions (393), and it is important to 
remember the heterogeneity that exists within and between ethnic groups.  
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In addition to the ethnic differences outlined in this section, access to 
healthcare has also been found to vary by gender, age and socioeconomic 
position (208). Given that demographic characteristics and socioeconomic 
position are known to vary by ethnicity these factors may also contribute to 
ethnic inequalities in access.  
3.7.7.2 Ethnicity(and(effectiveness(of(cardiovascular(disease(prevention(interventions(
Ethnic differences in the response to CVD prevention interventions could lead to 
ethnic inequalities in CVD. This could arise from ethnic differences in the 
response to commonly used medications or lifestyle interventions. Evidence for 
these ethnic differences is mixed and much of it comes from comparisons 
between black and white individuals in the USA.  
Ethnicity may impact on drug response, for example to antihypertensive or lipid-
lowering medication (394). Evidence for ethnic differences in drug response 
comes from a range of study types, including large randomised controlled trials, 
although the availability of evidence is limited by lack of reporting of ethnicity 
in some trials (395, 396). The outcomes reported vary - some studies report 
changes in risk factor levels following medication whilst others also report 
cardiovascular events, a more clinically relevant outcome. A key example is the 
difference between black and white individuals in response to antihypertensive 
medication. A number of studies have evaluated the efficacy of different types 
of antihypertensive medication in black and white individuals. A general finding 
is that calcium channel blockers and diuretics are more effective in black 
individuals, whilst beta-blockers and ACE inhibitors are more effective in white 
individuals (397-400). In the UK, Gupta et al compared blood pressure changes 
from a beta-blocker (atenolol) and calcium channel blocker (amlodipine) in 
European, black and South Asian hypertensive patients (398). They identified no 
ethnic differences in blood pressure reductions from taking amlodipine, but 
blood pressure did not fall with atenolol in black participants while it decreased 
in white and South Asian people. In a separate analysis of a large 
antihypertensive medication trial (ALLHAT) the impact of ACE inhibitors and 
calcium channel blockers on blood pressure and cardiovascular outcomes were 
compared in black and non-black participants (399). The calcium channel 
blocker was found to lower blood pressure more in black individuals than the 
ACE inhibitor, a difference that was not observed in non-black individuals. 
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However, despite these differences in blood pressure the relative risk of 
cardiovascular outcomes was broadly similar between black and non-black 
individuals. In contrast, a systematic review and meta-analysis of randomised 
controlled trials of antihypertensive medication in white and African-American 
women found that the use of these medications resulted in a greater risk 
reduction for cardiovascular events in African-American compared to white 
women (401). However, in this systematic review most of the evidence from 
African-American women came from a single trial, limiting its generalisability 
(401). Given the increased risk of hypertension and stroke in black individuals 
effective treatment of hypertension is particularly important in this group. 
However, it has been highlighted that there is a lack of evidence regarding 
cardiovascular outcomes in this area (397). 
Whilst much of the literature focuses on differences between black and white 
people in response to antihypertensive medication (364), there may also be 
differences between other ethnic groups. Although it has been suggested that 
response to antihypertensive medication is similar in South Asian and white 
people (402), there is also evidence of potential ethnic differences. The 
PROGRESS trial, a randomised controlled trial of the ACE inhibitor perindopril in 
patients with cerebrovascular disease in Asian (Chinese and Japanese) and 
Western locations, found larger reductions in blood pressure in Asian compared 
to Western patients (403). This trial observed a 38% reduction in major 
cardiovascular events in Asian participants compared to a 20% reduction in 
Western participants, although the confidence intervals for these risk reductions 
overlapped and the difference could partially be explained by differences in the 
prescribed dose by bodyweight (403). 
There may be ethnic differences in response to statins, although the evidence is 
less clear than for antihypertensive medication. A randomised controlled trial of 
rosuvastatin found ethnic differences in lipid profile changes with the 
medication, for instance a smaller relative reduction in LDL-cholesterol in non-
white individuals (404). However, the hazard ratios for cardiovascular events 
were similar in white and non-white individuals, although small numbers of 
ethnic minority individuals limited the ability to undertake further subgroup 
analyses (404). In contrast, a randomised controlled trial that included the use 
of atorvastatin found no statistically significant differences in the effect of the 
medication on the lipid profile of white, black and South Asian individuals (405). 
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In a different type of study, in this case a retrospective cohort study of diabetic 
patients, Brunner et al found that statin prescription was associated with similar 
benefits in all cause mortality across South Asian, Chinese and white groups 
(406). Whilst there is evidence that the effectiveness of statins may be similar 
across ethnic groups, it has been suggested that Asian individuals may achieve 
these benefits at a lower dose than Western individuals (407). A prospective 
cohort study from Japan in which patients with high cholesterol were prescribed 
low-dose simvastatin identified changes in cholesterol concentrations 
comparable to Western studies that used higher doses of medication (408). 
Many of the explanations suggested for these ethnic differences in drug response 
relate to biological or genetic differences. Differences between black and white 
people in renin activity and nephron mass, which affect the pathophysiology of 
hypertension, have been identified (364, 402). Renin activity has been found to 
be lower in black hypertensive people compared to white, a factor that could 
influence the relative efficacy of different types of antihypertensive medication 
(364). Genetic differences may also play a role if they influence the response to 
or metabolism of medication (394, 407). A number of potential genetic 
differences have been identified (394), although there is also evidence that the 
pharmacokinetics of statins may be similar in white, Asian, black and Hispanic 
individuals (409). 
Ethnic differences in drug response may influence prescribing practices and drug 
development. Indeed, UK guidelines for the prescription of antihypertensive 
medication advise different medications for black individuals (122). In the USA, 
a drug for heart failure, BiDil, has been developed only for use in African-
American individuals (410). However, the complex relationship between 
ethnicity, biological differences and social determinants of health is an 
important consideration in determining the appropriateness of this type of 
approach. Whilst ethnicity will reflect some biological and genetic differences 
between populations, it is a largely social construct, and may therefore be a 
poor predictor of biological determinants of drug response (410). Ethnic 
differences in drug response could arise from other differences for which 
ethnicity as a marker, such as environmental or lifestyle differences, which 
could potentially impact on biological response to medication. Genetic 
characteristics may directly influence response to medication, but if not all 
members of an ethnic group have those characteristics, ethnically determined 
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use of medication may be less effective or appropriate for certain individuals 
(227). In fact, Sehgal found a notable overlap in the response to 
antihypertensive medications in black and white individuals, suggesting that this 
indicated similarity rather than difference between the ethnic groups and 
highlighting that ethnic differences in drug response are often smaller and less 
significant than differences observed within ethnic groups themselves (400). 
Perhaps related to ethnic differences in drug response is the common 
observation that control of cardiovascular risk factors varies by ethnicity. In the 
UK, black general practice patients known to have hypertension have been found 
to be less likely to have a blood pressure at or below recommended treatment 
targets than white or South Asian patients (411), although there is evidence that 
this difference may have improved following changes to primary care contracts 
(412). Likewise, Schofield et al analysed primary care data from London and 
found that black patients were significantly less likely to have controlled 
hypertension than Asian and white patients (413). In contrast, Nazroo et al 
found that black Caribbean adults had similar levels of blood pressure control as 
white adults, and Indian, Pakistani and Bangladeshi adults were less likely to 
have uncontrolled cholesterol levels than white adults (378). These differences 
could reflect variations in study design and data used, including the use of self-
reported information in Nazroo et al’s study and primary care data in Schofield 
et al’s, both of which will be subject to their own limitations. In the USA, black 
and Mexican-American hypertensive patients have been found to be less likely to 
have their hypertension controlled than white patients (276, 277, 389), and 
African-American people less likely to have lipid concentrations controlled (390). 
There are likely to be multiple explanations for these differences in control. 
Whilst differences in drug response are a possible explanation, they could also 
be due to differences in prescribing, uptake, adherence and availability of 
medication.  
The impact of lifestyle interventions, including smoking cessation and diet, may 
also vary by ethnicity. Smoking cessation is associated with a sizeable reduction 
in the risk of CVD and evidence suggests that this benefit may be similar across 
ethnic groups. Analysis of a USA cohort study, which benefitted from a large 
sample size, found that the cardiovascular risk reduction associated with 
smoking cessation was similar in African-American and white people (414). 
Routine data from England’s stop smoking services indicates that the proportion 
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of smokers who set a quit date and then successfully quit (at 4 weeks) is similar 
across most ethnic groups, but lower in black Caribbeans (51% of white smokers, 
compared to 52% of Asian smokers and 44% of black Caribbean smokers) (415). 
Another method of reducing smoking rates is the use of health warning labels on 
cigarette packaging. A web based experimental study from the USA tested the 
impact of text and pictorial warnings on white, African-American and Hispanic 
smokers and found that all ethnic groups responded more to pictures rather than 
text warnings, and that Hispanic and African-American smokers had greater 
responses to both types of warning than white smokers (416). Ethnically adapted 
smoking cessation interventions have been developed and may have a role in 
ensuring good and equitable outcomes, although evidence of their added benefit 
in terms of effectiveness is limited (417). 
There is mixed evidence of ethnic differences in response to dietary 
interventions. He et al carried out a study in the USA in which 71 white and 33 
black patients with hypertension were put onto short-term high and low sodium 
diets and had their blood pressure monitored (418). Blood pressure levels fell 
more following the switch from high to low sodium intake in black participants, 
who also had a smaller change in renin activity, than in white participants. 
Adjustment for changes in renin activity eliminated the ethnic differences in 
blood pressure response, suggesting that this was an important driver of the 
observed differences. This suggests that dietary interventions based on reduced 
salt intake could have differential effects across ethnic groups.  Dietary salt 
reduction may also lead to ethnic differences in other physiological markers, 
such as urinary albumin (419). Weight loss is also an important way to reduce 
cardiovascular risk and prevalence of overweight and obesity is known to vary by 
ethnicity. Analysis of a USA prospective cohort study examined whether there 
were differences between African-American and white individuals in the impact 
of weight loss on hypertension (420). No clear ethnic differences were observed, 
with weight loss leading to similar reductions in levels of hypertension in both 
groups. Although this study had the benefit of observing the impact of weight 
loss in a large sample outside of an interventional setting, the analysis did not 
account for any differences in co-morbidity or physical activity. 
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3.7.7.3 Ethnicity(and(effectiveness(of(population(approaches(to(CVD(prevention(
Ethnic differences in the effectiveness of population approaches to CVD 
prevention could impact ethnic health inequalities. It has been suggested that 
population approaches may be more beneficial for health inequalities than high-
risk approaches (5), however there is mixed and limited evidence for the effect 
of population approaches on ethnic health inequalities (421, 422).  
One source of evidence is studies on the impact of folic acid interventions in the 
USA. Dowd et al found that folic acid fortification reduced absolute inequalities 
but increased relative inequalities in folate levels between black and white 
individuals (421). A systematic review of the effect of increasing folic acid 
intake found mixed evidence of the impact of population and high-risk 
approaches on ethnic inequalities, although the review suggested that 
population approaches may be more likely to reduce inequalities (422). 
Ethnic differences in the impact of population approaches could arise from 
differences in the baseline exposure being targeted or in response to the policy. 
Two examples of exposures that could be addressed with population approaches 
are salt intake and dietary fat intake (18), both of which may vary between 
ethnic groups. Millett et al analysed data from the Health Survey for England 
and found ethnic differences in the addition of salt to food (423). Indeed, it has 
been suggested that South Asian and black individuals may get a higher 
proportion of their salt intake from cooking and table added salt, compared to 
the general population who get a higher proportion as hidden salt in processed 
food (424). Therefore a population intervention to reduce overall salt intake by 
reducing the amount of hidden salt in processed food could lead to ethnic 
differences in overall salt consumption. Similarly, there may be ethnic 
differences in the consumption of harmful dietary fats such as trans fats that 
could lead to differential impact of eliminating them from the food chain (425). 
There are sources of artificial ghee available in northern India that contain 50% 
trans fats; in the UK high levels of trans fats have been found in takeaway food, 
which may be consumed more frequently by people from ethnic minority groups 
(135). Therefore, ethnic minority groups could potentially benefit more from the 
elimination of trans fats from takeaway food. 
Ethnic differences could also arise from variations in the response to population 
approaches. For instance, evidence suggests ethnic differences in blood pressure 
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response following salt reduction (426). As described previously larger blood 
pressure falls in response to a low sodium diet had been found in black 
compared to white individuals (418). Bibbins-Domingo et al modelled the impact 
of salt reduction in black and white individuals in the USA and found larger 
reductions in CVD in black people (131). Their model included a larger blood 
pressure reduction in black individuals but they highlighted that even without 
this difference there would still be a greater percentage reduction in CVD 
incidence from salt reduction in black individuals because of a higher baseline 
prevalence of hypertension. Conversely, a recent Cochrane systematic review 
and meta-analysis found that blood pressure falls after modest salt reduction 
were similar in white, black and Asian individuals (427). The relevance of these 
findings to the question of ethnic differences in the impact of population 
approaches may be limited as this evidence is based on response to individual 
dietary interventions. One exception to this is a study by Millett et al who 
investigated differences in salt intake between 2003 and 2007, when a 
population salt reduction strategy was being implemented in the UK (423). They 
did not identify ethnic differences in the absolute decrease in salt intake during 
this period, with higher intake among ethnic minority individuals remaining. 
The implementation of smoke-free legislation in many countries in recent years 
has enabled investigation of ethnic differences in response to this population 
intervention. In the USA, there is evidence that smoke-free legislation may be 
associated with smaller falls in current smoking and cotinine concentrations in 
ethnic minority groups, with more research needed to understand this difference 
(428). Indeed, the prevalence of exposure to second-hand smoke was found to 
be higher in non-Hispanic black people than non-Hispanic white and Mexican 
American people in a cross-sectional study from the USA (429), although this 
study did not specifically compare ethnic differences in secondhand smoke 
exposure between areas with and without smoke-free legislation. Qualitative 
research from the UK suggests that ethnic minority individuals may have 
responded differently to the introduction of smoke-free legislation. Lock et al 
interviewed Turkish, Somali and white smokers before and after the introduction 
of legislation in England (430). They found ethnic differences in the impact of 
the legislation on smoking habits at home. For instance, Somali women found 
that they had to hide their smoking or smoke at home rather than in public 
following the legislation. In another qualitative study, Highet et al interviewed 
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and carried out focus groups with Bangladeshi smokers (431). The participants 
discussed the importance of respecting elders in their community, the use of 
different types of tobacco, and the impact of working environments on smoking 
practices, factors which are likely to vary by ethnicity. 
In summary, these examples suggest potential mechanisms by which population 
approaches could perform differently across ethnic groups. The evidence is 
mixed, with no suggestion that commonly proposed population approaches would 
perform systematically worse or better in ethnic minority groups. Rather, any 
ethnic differences that did occur are likely to be variable in nature and 
direction, and would depend on other factors such as socioeconomic position and 
environment. 
3.7.7.4 Ethnicity(and(cardiovascular(risk(calculation(
The performance of cardiovascular risk calculators can be impaired if they are 
used in different populations from the one in which they were derived, 
particularly if the background incidence of CVD is different in that population or 
has changed over time since the original study that derived the risk calculator 
(432). Given that rates of CVD vary between ethnic groups, and cardiovascular 
risk calculators incorporate populations’ baseline cardiovascular risk, it is 
unsurprising that the performance of cardiovascular risk calculators has been 
found to vary by ethnicity (433). D’Agostino et al analysed the performance of 
the Framingham equation in an ethnically diverse range of cohort studies and 
found that discrimination (the ability of the equation to distinguish between 
those who will and will not develop CVD) was similar by ethnicity but calibration 
(a measure of the agreement between actual and predicted outcomes) varied 
(434). Discrimination is a measure that is particularly relevant to this thesis as it 
relates to questions of whether the individuals at highest cardiovascular risk are 
accurately identified. In this study, observed and predicted rates of IHD events 
were similar in black and white individuals but Framingham overestimated the 
risk of IHD events amongst Japanese and Hispanic men. Quirke et al compared 
risk predictions from the Framingham equation with published mortality data 
across ethnic groups in England (266). They found that the pattern and direction 
of ethnic differences in IHD risk was consistent with those seen in mortality 
data, but that the Framingham equation underestimated cardiovascular risk in 
higher risk ethnic groups and overestimated it in lower risk groups. This scenario 
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was also observed in New Zealand where the Framingham equation was found to 
underestimate cardiovascular risk in a combined group of Maori, Pacific and 
Indian individuals, and overestimate risk in lower risk European individuals, 
although data limitations prevented analysis of individual ethnic groups (435). 
Likewise, in Australia, the Framingham equation was found to significantly 
underestimate CHD risk amongst an Aboriginal community where the risk of CVD 
is known to be particularly high (436). This evidence suggests that the 
Framingham equation underestimates risk in high-risk ethnic groups and 
overestimates it in low-risk ethnic groups (266). Systematic inaccuracies in 
cardiovascular risk calculation across ethnic groups such as this could reduce the 
cost effectiveness of cardiovascular screening (437), lead to ineffective 
allocation of health care resources (438), and worsen existing health inequalities 
by reducing access to preventative interventions in higher risk groups when 
treatment decisions are made using cardiovascular risk thresholds (437, 439). 
This could have a significant impact on public health if ethnic groups with a 
higher risk of CVD form a large proportion of the population (151). 
Ethnic differences in the association between cardiovascular risk factors and 
outcomes could affect the performance of cardiovascular risk calculators (432). 
There is mixed evidence as to whether this type of difference occurs (see 
section 3.5.8), however studies that have explored the performance of 
Framingham risk factors suggest that the associations are consistent across 
populations. Hurley et al used cross-sectional data from the USA, with follow-up 
for mortality outcomes, to assess whether there were ethnic differences in the 
association between cardiovascular risk factors and mortality (265). They found 
that the relative risk associated with Framingham risk factors was consistent 
across ethnic groups and that these risk factors were able to produce accurately 
calibrated models in different ethnic groups. In addition, consistency between 
estimated cardiovascular risk scores and mortality rates, despite issues of 
relative over or underestimation, indicates that traditional cardiovascular risk 
factors play a role in ethnic differences in CVD (266).  
Inaccuracies in cardiovascular risk calculation in deprived socioeconomic groups 
may be particularly relevant to ethnic minority groups. The Framingham 
equation does not include any measure of socioeconomic position, although this 
is a recognised risk factor for CVD. It has been suggested that this could lead to 
a systematic underestimation of cardiovascular risk in deprived individuals (440, 
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441), and therefore in ethnic minority groups in which socioeconomic 
deprivation is over-represented. Two studies from the UK have assessed the 
performance of the Framingham equation in different socioeconomic groups. 
Brindle et al compared observed cardiovascular mortality rates with those 
estimated by the Framingham equation across socioeconomic groups in a 
relatively deprived sample of the Scottish population (440). They found that the 
Framingham equation consistently under predicted the risk of cardiovascular 
death, and more so in more deprived individuals. Whilst Ramsay et al also found 
that the Framingham equation underestimated the risk score in deprived 
individuals compared to affluent ones, overall they found that Framingham 
overestimated cardiovascular risk in their study of British men (441). This 
difference could be accounted for by differences in the baseline incidence of 
CVD between the studies. In these studies the social gradient in observed CVD 
was greater than that predicted by the Framingham equation (441, 442). Given 
the use of a single threshold of cardiovascular risk in determining treatment 
decisions, this means that affluent individuals may be more likely to receive CVD 
prevention interventions than deprived individuals, potentially exacerbating 
socioeconomic health inequalities (442). One response to this issue has been the 
development of the ASSIGN risk score in Scotland (443). ASSIGN incorporates 
area deprivation in its risk calculation, and whilst its overall performance has 
been found to be very similar to that of the Framingham equation, including in 
black populations in the UK (444), it may perform more equitably (443). Given 
higher levels of socioeconomic deprivation in ethnic minority groups any 
systematic inaccuracy by socioeconomic position, in addition to that from 
ethnicity, would add to the potential for cardiovascular risk calculation to 
perform poorly in deprived ethnic minority individuals.  
A number of approaches have been used to improve the accuracy of 
cardiovascular risk estimation in different ethnic groups, including recalibration 
of existing equations, simple adjustment approaches, and the creation of new 
equations that include ethnicity. Recalibration can occur by updating the 
baseline incidence rates on which the equation is based along with prevalence of 
cardiovascular risk factors. In the UK, Brindle et al adopted a pragmatic 
approach to recalibrate the Framingham equation to ethnic minority groups 
(445). Prospective data from ethnic minority groups containing incidence rates 
of CVD were not available so they used cross-sectional data instead, substituting 
  
85 
prevalence for incidence. This resulted in the creation of an updated, though 
unvalidated, equation that allowed the calculation of cardiovascular risk by 
ethnic groups – “Ethrisk”. Barzi et al recalibrated the Framingham equation to a 
Chinese population and found that this improved the accuracy of risk prediction, 
so much so that they concluded that there was no need to develop a new 
equation for this Asian population (432). A number of simple adjustment 
approaches have also been suggested that do not require the more complicated 
recalibration process. National UK guidelines have previously suggested that the 
Framingham score in South Asian men should be multiplied by 1.4 (121, 144). 
However, this straightforward adjustment does not account for differences in 
risk in women or other ethnic minority groups. Aarabi and Jackson suggested 
that the age of South Asian individuals should be increased by 10 years when 
calculating cardiovascular risk, although this solution was suggested at a time 
when paper-based tools were more commonly used and a simple adjustment 
process was needed (446). Cappuccio et al suggested that lower thresholds 
should to be used to define high-risk individuals in high-risk ethnic groups (447). 
This particular conclusion was made at a time when it was more common to 
estimate risk of CHD and then multiply it in order to calculate CVD risk. Given 
that the risk of stroke varies by ethnicity this approach could underestimate risk 
of CVD in some ethnic groups, however it is now recommended practice to 
calculate CVD rather than CHD risk. 
An arguably more significant step to improving the accuracy of cardiovascular 
risk calculation in ethnic minority groups is the creation of new calculators that 
include ethnicity. Indeed, it has been suggested that models that incorporate 
ethnicity may be necessary in ethnically diverse populations in order to 
accurately discriminate between people who will or will not develop CVD (151). 
One key example of this in the UK is the QRISK2 calculator (438). This updated 
version of QRISK contains both ethnicity and socioeconomic deprivation as 
independent risk factors of CVD. It was derived from a prospective cohort of 
primary care patients in England and Wales, taken from a large electronic 
database. Independent validation of this score found that it performs better 
than Framingham in a general UK population, with better accuracy, 
discrimination and calibration (448, 449). However, a limitation of QRISK2 is that 
the original dataset contained a large proportion of missing data. In particular, 
ethnicity was recorded in only 27.1% of women and 23.8% of men with the 
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remaining individuals assumed to be white (438). This assumption may have led 
to an underrepresentation of ethnic minority individuals in the cohort (438). Two 
recent studies have assessed the performance of QRISK2 among ethnic minority 
groups in the UK. Tillin et al compared the performance of QRISK2 and 
Framingham in an ethnically diverse London cohort (450). They found that 
calibration of the scores varied by ethnicity and gender; for instance they found 
that both QRISK2 and Framingham under predicted cardiovascular risk in South 
Asian women whilst both scores were fairly accurate in South Asian and 
European men. Correct classification of individuals as high or low risk was poor 
in African Caribbeans and classification by QRISK2 was also poor in South Asian 
women. The authors concluded that there was no evidence that either QRISK2 or 
Framingham performed better than the other score. However, the baseline data 
on which their risk calculations were based were over 20 years old and may not 
reflect individual changes in incidence and prevalence of cardiovascular risk 
factors. Schofield et al also used data from an ethnically diverse area of London 
to compare the performance of a variety of cardiovascular risk scores in the 
black population, including QRISK2 and Framingham (444). QRISK2 was the only 
equation that did not appear to over predict cardiovascular risk when compared 
with national data. The authors concluded that QRISK2 might provide the most 
accurate estimation of cardiovascular risk in black individuals in the UK (444). 
3.7.7.5 Section(summary(
This section has outlined how a variety of interventions used in CVD prevention 
could impact on ethnic health inequalities. Whilst evidence for ethnic 
differences in access to healthcare, or the performance of individual and 
population interventions is at times mixed or limited, there is stronger evidence 
that cardiovascular risk calculators need to consider ethnicity.  
3.8 Ethnicity and area of residence 
The previous section of this chapter reviewed the evidence for a variety of 
potential explanations for ethnic health inequalities. This section now moves on 
to consider another potential explanation – area of residence. This is because, as 
the evidence reviewed here suggests, there are ethnic differences in the areas 
people live in and in the association between area and health, differences that 
could lead to ethnic inequalities in health (303).  
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Ethnic minority populations have been found to be concentrated in deprived 
areas and segregated from other parts of the population (451, 452). This pattern 
of residence occurs in the UK, USA and other countries including New Zealand 
and Holland (451, 453-455). Concentration of ethnic minority groups in deprived 
urban areas in the UK stems from historical migration patterns and 
socioeconomic opportunities (451, 452). Post-war migration from former colonies 
to the UK produced concentrations of ethnic minority groups, driven by 
geographically centered employment opportunities, such as in the textile 
industry in the North of England, alongside limited and discriminatory housing 
choices (452). Movement of white populations to suburbs of cities added to the 
concentration of these communities, although some ethnic minority populations 
have now started to spread into other parts of the country (452, 456). Broadly 
speaking this distribution of population applies to many of the largest ethnic 
minority groups in the UK, although there are ethnic and geographical 
differences in the degree of concentration in deprived areas (308, 309). For 
example, Pakistani and Bangladeshi groups are most concentrated in deprived 
areas (457); the Chinese population is not concentrated into deprived areas in 
the same way as other ethnic minority groups (309); Indian, Pakistani and 
Bangladeshi people have been found to be more concentrated into areas 
populated by people of their own ethnicity compared to black Caribbean and 
Chinese people, who are less concentrated (456, 458); and greater concentration 
of ethnic minority communities is seen in cities in the North West of England 
(179). These ethnic variations in population distribution reflect differences in 
the factors which determine where individuals and communities are located, for 
instance the influence of migration, housing availability, employment 
opportunities, racism, living within a community, religion, and language skills 
(451, 457). It should be noted, however, that in the UK segregation by 
socioeconomic position is greater than segregation by ethnic group (179). 
Segregation of ethnic minority groups is also seen in the USA, to an even greater 
extent than in the UK. Black people in the USA are the most segregated group 
(459, 460), and are concentrated into areas of greater deprivation than white 
individuals (453). Areas populated by the poorest black people are more 
deprived than those populated by the poorest white people (461). Like the UK, 
segregation in the USA is related to discrimination, including in the housing 
system, and socioeconomic differences (318, 459, 462). However, the 
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relationship between socioeconomic position and segregation is not 
straightforward. Segregation does not just affect poorer ethnic minority people 
but is also seen in more affluent groups, although to a lesser extent (459, 462); 
in addition, there are ethnic differences in the relationship between segregation 
and socioeconomic position (462).  
It is possible that the concentration of ethnic minority groups into deprived 
areas or residential segregation of these groups could impact on health. Indeed, 
segregation has been suggested as being a key cause of ethnic inequalities in 
health (460). Health could be affected by differences in the quality of areas that 
different ethnic groups live in, the impact of living in segregated areas on 
socioeconomic position, or through ethnic density effects. 
Area can influence health through the quality of physical environments, i.e. 
contextual effects (see section 2.8.2.2.2). It has been suggested that areas 
populated by high numbers of people from ethnic minority groups may have a 
physical environments that are more detrimental to health. Whilst an 
unhealthier physical environment could also be related to socioeconomic 
deprivation, this may not account for all the differences seen. For instance, 
areas populated by high numbers of black individuals in the USA have higher 
levels of pollution and industry, with low quality housing, fewer services, and 
more fast-food shops than white areas of comparable socioeconomic deprivation 
(459, 460). In the UK, Molaodi et al found that areas with high concentrations of 
ethnic minority populations had more fast food shops (463). However, they also 
found that some of these areas had more supermarkets and facilities for physical 
activity, although this ecological study was not able to look at differences in the 
quality of food or facilities available.  
In addition to being a possible cause of the concentration or segregation of 
ethnic minority groups, socioeconomic position may also be worsened by 
segregation. Areas with high proportions of ethnic minority people have been 
found to be more deprived than areas with low proportions, with lower levels of 
car access, education and central heating (464). Whilst it has been suggested 
that areas with high concentrations of ethnic minority populations may benefit 
socioeconomically, for example because of fewer barriers from discrimination or 
language, there may be detrimental socioeconomic effects (464). Clark and 
Drinkwater found that male unemployment was higher in more ethnically 
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concentrated areas, although they also highlighted that this finding could have 
been affected by bias if employment status influenced a person's decision about 
where to live (464). Income and employment opportunities may be relatively 
worse for ethnic minority individuals living in deprived areas compared to ethnic 
majority groups (451). In addition, segregation in the USA is associated with 
differences in education, employment opportunities and access to good quality 
healthcare, to the detriment of ethnic minority groups living in deprived areas 
(318, 460). 
Whilst areas in which ethnic minority groups are concentrated may have poorer 
physical environment, and living in these areas may exacerbate socioeconomic 
inequalities, it is also possible that living in an area with people of the same 
ethnicity may be beneficial for health - otherwise known as the ethnic density 
effect (461, 465, 466). Evidence on whether such an effect exists is mixed. Some 
studies have found a positive association between ethnic density and improved 
health. For example, Stafford et al found that increased ethnic density was 
significantly associated with lower levels of limiting long-term illness in white 
and Bangladeshi people in the UK (467). Similarly, increased ethnic density has 
been found to be associated with improved self-rated health in Maori individuals 
in New Zealand after adjustment for area and individual deprivation (455). 
Conversely, other studies have found no association between ethnic density and 
health (458, 468). In the UK, analysis of cross-sectional survey data from the 
1990s did not find an association between ethnic density and self-reported 
health in Indian, Pakistani, Bangladeshi or black Caribbean people (468). Indeed, 
there is some evidence from the USA that ethnic density could have a negative 
effect on health, with the finding by Kirby et al that living in an area with a high 
Hispanic population was associated with higher body mass index for Hispanic 
individuals (469). The conclusions of narrative and systematic reviews reflect 
this mixed evidence (461, 466). For instance, Becares et al systematically 
reviewed evidence for an ethnic density effect on physical health, and found 
some evidence that living in an area of high same ethnic density may be 
beneficial for Hispanic people in the USA, although the opposite may be true for 
black people (466); evidence from the UK showed no clear ethnic density effect, 
although small sample sizes in the studies reviewed may have limited these 
findings (466).  
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These results refer to people living in areas with a high proportion of people of 
the same ethnicity but there is also evidence that high ethnic density of one 
group may influence the health of people from other ethnic groups. For 
instance, white individuals living in areas with high density of ethnic minority 
populations have been found to have better general health, and vice versa (468). 
In addition, analysis of the Health Survey for England indicated that living in an 
area with a high density of non-white individuals is associated with lower alcohol 
intake in people from all ethnic groups, including white people (470). It is been 
suggested that religion may play a role in this relationship between ethnicity and 
alcohol consumption, supported by evidence from Holland that the proportion of 
Muslims living in an area can have a small impact on alcohol consumption in 
Dutch individuals (454). 
Ethnic density may affect health because it influences levels of discrimination or 
social capital. Becares et al used cross-sectional data to assess the association 
between racism, ethnic density and health (471). Their findings indicated that 
racism occurred less often in areas with high ethnic density and that ethnic 
density may affect the association between racism and mental health, although 
a lack of statistical power may have limited the strength of their findings (471). 
In the USA, Borrell et al were able to use prospective cohort data to investigate 
the association between discrimination, ethnic density and health behaviours, 
and found that ethnic density did not impact on the relationship between 
discrimination and health behaviour (472). In contrast, another study from the 
USA found that discrimination and neighbourhood stressors were positively 
associated with hypertension, with ethnic minority groups experiencing greater 
levels of stress than white individuals (473). This study did not specifically 
investigate ethnic density but the findings suggest that area characteristics 
related to racism and stress may impact on health. Whilst discrimination may 
have a negative effect on health, it has been suggested that increased social 
support and capital may explain the positive ethnic density effect on health 
(468). Becares and Nazroo investigated this association using mixed methods 
(458). They found a strong association between social capital measured at an 
area level and ethnic density. Their qualitative research also suggested ethnic 
differences in perceived importance and strength of social networks. However, 
their measurement of the association between ethnic density and mental health, 
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with or without adjustment for social capital, was generally non-significant 
across ethnic groups. 
There are methodological challenges that effect the investigation of ethnic 
density effects. These include how ethnic density is measured, such as whether 
it is based on individual perception or quantitative measures (467). Many studies 
in this area are ecological or cross-sectional, leading to difficulty in establishing 
the direction of the association between area characteristics and health (461). 
There is uncertainty as to what defines an area as being ethnically dense, with 
arbitrary thresholds used in some studies (461, 469). Also, as with other studies 
on the relationship between area and health, it is unclear which geographical 
level of analysis is most appropriate to use and whether small areas correspond 
to meaningful neighbourhoods (474). Another complicating factor in 
investigating the association between ethnic density and health is the role of 
socioeconomic position. As described above, socioeconomic position may drive 
ethnic minority concentration and segregation as well as potentially being 
worsened by it. If there were a positive association between ethnic density and 
health, and ethnically dense areas are more deprived, the effect of one may 
cancel out that of the other - i.e. the benefits of ethnic density may be 
cancelled out by the negative impact of socioeconomic deprivation (461, 468). 
This makes disentangling the effects of socioeconomic position and ethnic 
density important but difficult in practice, especially given the limitations of the 
measures available for both of these variables.  
Aside from the impact of ethnic concentration and segregation into deprived 
areas, there may be ethnic differences in the impact that area characteristics 
have on health. Evidence of this comes from Holland, where Agyemang et al 
identified ethnic differences in the association between area characteristics and 
blood pressure (475). Using multilevel modelling they found that the association 
between area characteristics, such as green space and neighbourhood stressors, 
and blood pressure was greater in ethnic minority compared to Dutch 
individuals, although many of the associations observed were not significant. 
Cross-sectional evidence from the UK suggests ethnic differences in the 
association between area deprivation and self-reported health (476). In this 
study the gradient observed between increasing area deprivation and poorer 
self-reported health in ethnic minority groups was notably shallower than the 
gradient for white individuals. However, the authors discuss that the area 
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deprivation measure used (the Index of Multiple Deprivation) may not have 
accurately reflected the greater degree of socioeconomic deprivation seen in 
ethnic minority groups (476). In the USA, Diez Rouz et al found that the 
association between area characteristics and smoking in young adults was not as 
strong in black compared to white individuals, although the diversity of area 
characteristics observed in the black group was limited as they were 
concentrated into deprived areas (477). In contrast, another study from the USA 
found comparable associations between area socioeconomic characteristics and 
IHD in black and white individuals (478). However, the generalisability of these 
findings may be limited because all of the black participants in this study came 
from a single area. 
Clark and Drinkwater suggest that the fact that ethnic minority populations are 
concentrated into deprived areas means that policies which target deprived 
areas could be particularly useful for ethnic minority groups (464). Indeed, by 
targeting programmes at socioeconomically deprived areas in the UK, good 
coverage of ethnic minority populations may have been achieved even though 
they were not specifically targeted (300). In a US context, Williams and Collins 
suggest that policies to tackle racial health inequalities should target segregated 
areas populated by minority populations, given the nature and impact of racial 
segregation (460).  
This evidence suggests that area based interventions may be a useful and 
appropriate way of tackling ethnic health inequalities. However, there are 
practical questions regarding how programmes select areas to target. One 
approach is to use area measures of socioeconomic deprivation, such as the 
Index of Multiple Deprivation, however there are a number of reasons why these 
measures may perform differently across ethnic minority groups. First, if area is 
used as a proxy for individual socioeconomic position it may misclassify people, 
and this misclassification may vary by ethnicity. Diez Roux et al used data from 
three large, American studies to analyse the association between area and 
individual socioeconomic measures (479). They found that misclassification of 
individual socioeconomic position by area varied between black and white 
individuals with black people more likely to live in areas with lower median 
household income irrespective of their individual income. However, odds ratios 
for the association between area and individual measures were similar. Second, 
measures such as the Index of Multiple Deprivation are based on the aggregation 
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and ranking of data from a majority white population (175), and may not fully 
reflect the extent of socioeconomic deprivation within ethnic minority groups. 
As described previously ethnic minority individuals in the same socioeconomic 
grouping, for example occupational class, as white majority individuals may be 
comparatively worse off. This means that these socioeconomic classifications, 
which may be constituent parts of area deprivation measures, may not 
accurately reflect ethnic differences in socioeconomic position (307). This would 
limit the accuracy of area deprivation measures in research involving ethnic 
minority groups (476), and in targeting deprived communities. Third, people 
from ethnic minority groups may choose to remain in deprived areas, where 
their community is established, rather than move to more affluent areas. This 
has been observed to be the case in Leeds, with middle class families from 
ethnic minority groups living in deprived urban areas because of social ties and 
protection from discrimination, rather than moving out to the suburbs as white 
families may do (480). Conversely, it was also observed that less affluent ethnic 
minority individuals were able to move to affluent areas because of resources 
arising from larger extended families (480). Having reasons to live in deprived 
areas that are not related to socioeconomic position could reduce the accuracy 
of area deprivation as a proxy for individual socioeconomic position, and its 
usefulness in targeting deprived ethnic minority individuals. Fourth, the Index of 
Multiple Deprivation has been criticised for potentially underestimating 
socioeconomic deprivation in urban areas (481). One criticism is that it measures 
access to services - this may appear better in urban areas despite other non-
physical barriers that may be especially relevant for ethnic minority groups, such 
as those arising from cultural differences (481). Given that ethnic minority 
populations are concentrated into deprived urban areas (309), this criticism 
could be particularly relevant. Most of these issues relate to individual 
characteristics, and the implications of them will depend on the relative 
importance of area versus individual characteristics for health and 
socioeconomic deprivation.  
3.8.1 Section0summary0
This section highlights that area may cause ethnic differences in health because 
of variations in the areas people live in plus potential ethnic differences in the 
association between area and health. However, it also raises practical issues 
relating to methodological challenges for research and achievement of effective 
  
94 
and accurate targeting of public health interventions for ethnic minority groups; 
in particular, the issue that area based measures of deprivation may not work 
equally well across ethnic groups (307). This latter point is the subject of the 
next chapter.   
3.9 Chapter summary 
This chapter has reviewed evidence relating to ethnicity and CVD, including 
potential causes of ethnic inequalities in CVD. It can be seen that ethnicity is an 
important, though complex, epidemiological variable. With increasing ethnic 
diversity in the UK and well-established ethnic inequalities in health and CVD, it 
is becoming increasingly important to understand the relationship between 
ethnicity and health and to ensure that healthcare interventions promote, and 
do not exacerbate, ethnic health inequalities. Many of the issues raised here, 
and in the previous chapter, are relevant to the rest of this thesis, in particular 
the use of area based measures of deprivation to target public health 
interventions, the performance of cardiovascular risk calculators across ethnic 
groups, and the effectiveness of population approaches.  
3.10 Questions arising from the evidence 
The aim of this thesis is to explore whether there are ethnic differences in the 
potential effectiveness, cost and equity impact of CVD prevention policies 
designed for the general population. From the literature review in this, and the 
previous chapter, two policy choices have been identified for investigation – the 
choice between population and high-risk approaches to CVD prevention, and, 
within the high-risk approach, the choice between mass and targeted screening 
for high cardiovascular risk. Ethnic differences in CVD and its risk factors and 
determinants suggest that there may be ethnic differences in the potential 
impact of these policy options, however it is unclear from the evidence whether 
this is the case.  
Chapter 6 investigates whether there are ethnic differences in the potential 
impact of population and high-risk approaches to CVD prevention in terms of 
prevention of cardiovascular events and changes in ethnic health inequalities. 
Prior to this, Chapter 5 explores whether there are ethnic differences in the 
cost-effectiveness of mass and targeted screening for high cardiovascular risk. 
However, these analyses involve the use of area deprivation measures for 
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targeting deprived individuals. Therefore, given the evidence that suggests that 
area deprivation measures may not be equally applicable across ethnic groups, 
Chapter 4 first investigates whether there are ethnic differences in the utility of 
area deprivation measures to target individual socioeconomic deprivation.
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4 Chapter 4: Cross-sectional study of ethnic differences in the 
utility of area deprivation measures to target 
socioeconomically deprived individuals 
4.1 Introduction 
This chapter forms the first of three sections of analysis in this thesis, each of 
which addresses a separate, though related, research question. The purpose of 
this introduction is to briefly reiterate a number of issues raised in Chapters 2 
and 3 in order to explain why the research question was investigated. 
Socioeconomic position is a well-established determinant of health and health 
inequalities, whereby lower individual socioeconomic position is associated with 
poorer health and, specifically, increased risk of CVD (29, 64, 180, 482). This 
means that targeting public health interventions at socioeconomically deprived 
individuals has the potential to both improve overall health and reduce health 
inequalities. However, it would be resource intensive and rather impractical to 
measure socioeconomic position at an individual level across the whole 
population for this purpose. Therefore, as discussed in Chapter 2, area 
deprivation measures are often used to identify those geographical areas in 
which socioeconomically deprived individuals are more likely to live (181, 182, 
483). These measures have the advantages of being accessible and of including 
multiple aspects of deprivation (182, 484), through the aggregation of a variety 
of indicators from small areas (175). However, they are subject to the 
“ecological fallacy” and may misclassify the socioeconomic position of 
individuals (178, 181). Nonetheless, area deprivation measures may act as an 
effective proxy of individual socioeconomic deprivation and therefore as a useful 
tool for targeting interventions if the proportion of deprived individuals living in 
deprived areas is sufficiently high and the proportion of non-deprived individuals 
living in these areas is sufficiently low.  
Ethnic minority groups in the UK experience higher levels of individual 
socioeconomic deprivation and higher proportions live in deprived areas 
compared to the general population  (238, 303, 308, 451). This coincides with 
higher risk of associated diseases, including CVD, than the white population (8, 
9, 315). Chapter 3 outlined a number of reasons why area deprivation measures, 
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which are derived from a majority white population, may not be equally 
applicable across ethnic minority groups. These included evidence of ethnic 
differences in the misclassification of individual socioeconomic position by area 
deprivation measures (479), the questionable ability of area deprivation 
measures to reflect the extent of socioeconomic deprivation in ethnic minority 
groups (307), and potential ethnic differences in reasons for remaining in or 
moving from deprived areas (480). Given these limitations it is plausible that 
area deprivation measures may not work equally well in ethnic minority groups 
as a tool for targeting socioeconomically deprived individuals. However, there is 
a lack of evidence as to whether this is the case. Previous studies from the UK 
on the effectiveness of area deprivation measures in targeting socioeconomically 
deprived individuals were based on the general population (182, 485), and the 
evidence cited of ethnic differences in misclassification comes from the US 
(479), which is substantially different from the UK in terms of ethnic and 
socioeconomic characteristics. 
This chapter therefore addresses the following research question: 
Are there ethnic differences in the utility of area deprivation measures to 
target socioeconomically deprived individuals? 
This question is divided into three parts. First, are there ethnic differences in 
the extent to which area deprivation measures agree with individual 
socioeconomic measures? Second, are there ethnic differences in the proportion 
of socioeconomically deprived individuals that are correctly identified by area 
deprivation measures? Third, are there ethnic differences in the extent to which 
people without individual socioeconomic deprivation are inappropriately 
included using area deprivation measures? It is worth emphasising that the 
intention of this analysis is to explore the practical use of area deprivation 
measures in the context of interventions aimed at the deprived general 
population rather than in interventions that specifically target ethnic minority 
groups.  
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4.2 Methods 
4.2.1 Data0
Cross-sectional data from the Health Survey for England (HSE) 2004 were used 
(486). The HSE is a large, annual survey that collects data on common health 
conditions and factors that influence health (487). These data are obtained from 
nationally representative samples and allow comparisons between population 
subgroups, monitoring of trends, and calculation of prevalence estimates (487). 
Data from the HSE were used throughout this thesis so will be described in 
further detail here. Subsequent chapters add further information as relevant. 
Both adults and children are included in the HSE but as this thesis only included 
adults aspects of the survey that are only relevant to children are not discussed. 
Unless otherwise specified the information in this sub-section comes from the 
HSE 2004 survey documentation (488, 489). 
A range of alternatives data sources were considered, including the Census and 
surveys such as Understanding Society. The Individual Controlled Access 
Microdata Sample from the 2001 Census includes IMD 2004 data alongside various 
individual socioeconomic measures, excluding income (490). Another potential 
source of data was Understanding Society, otherwise known as the UK Household 
Longitudinal Study (491). Whilst longitudinal data were not required for these 
analyses, this survey also provides socioeconomic data from a boosted sample of 
ethnic minority individuals. However, neither of these datasets contained the 
full range of data that were required for this thesis, in particular measures of 
cardiovascular risk factors, which are included in the HSE. However, carrying out 
similar analyses on these alternatives datasets, in particular on Census data, 
could strengthen the findings of this chapter’s analyses. 
4.2.1.1 Design(of(HSE(2004(
The HSE 2004 is a cross-sectional survey that used a “clustered, stratified multi-
stage sample design” (p34) (489). The HSE 2004 was used in preference to more 
recent years as it contained a boosted sample of people from the largest ethnic 
minority groups in England – black Caribbean, black African, Indian, Pakistani, 
Bangladeshi, Chinese and Irish. It therefore contained much higher numbers of 
participants from ethnic minority groups than are usually present in HSE 
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samples. In addition to the boosted sample data were also collected from a core 
sample of the general population. 
The HSE 2004 received ethical approval from the London Multi-centre Research 
Ethics Committee. 
4.2.1.2 Sampling(
The HSE 2004 used multi-stage stratified probability sampling. For the core 
sample 312 census wards were randomly selected from a list of wards ordered by 
geographical location and an area level measure of socioeconomic position based 
on occupation (proportion of households with a non-manual head of household). 
Each ward was then split into two with one-half randomly selected as the 
primary sampling unit. The Postcode Address File was used as the sampling 
frame to randomly select 21 addresses from each primary sampling unit. This 
meant that 6,552 addresses were selected. In addresses with multiple 
households up to 3 households were selected, and in households with multiple 
residents up to 10 adults and 2 children were randomly selected. 
Broadly speaking the sampling approach for the boost sample was similar, 
although there were differences in how areas were stratified and focused 
enumeration was used in some areas. The boost sample was designed so that 
additional black Caribbean, black African, Indian, Pakistani, Bangladeshi, 
Chinese and Irish participants would be included. Participants of mixed ethnicity 
from these ethnic groups were also included. Census wards were stratified by 
various definitions of ethnic density into 13 groups using 2001 Census estimates. 
408 wards were then selected and divided into primary sampling units as in the 
core sample. Between 40 and 115 addresses were then selected from the 
Postcode Address File for each primary sampling unit depending on its stratum. 
Focused enumeration was used in areas with the lowest density of people from 
Asian and black backgrounds (2-10% of residents) – 80 “seed” addresses were 
selected at which individuals were asked about their own eligibility for inclusion 
(i.e. belonging to a targeted ethnic minority group) and about addresses 
adjacent to their household. This approach was not used to identify Irish 
participants as it relied on visual assessment of ethnicity; Irish participants were 
only sampled from the original “seed” addresses in these areas. Up to 4 adults 
and 3 children from the specified ethnic minority groups were eligible for 
inclusion from each household. Additional sampling was used to obtain Chinese 
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participants. In this case the electoral register was used to identify areas with 
residents with “Chinese sounding” names. 
The design of the HSE is such that only individuals living in private households 
are eligible for inclusion. People living in institutions, such as care homes or 
prisons are excluded. As discussed in the HSE documentation, this may have an 
impact on the assessment of ethnic inequalities in health. This is because ethnic 
minority groups are generally younger and may have different caring 
arrangements for those in need, so excluding people living in institutions may 
have a lower impact on estimates of health in these groups. 
4.2.1.3 Data(collection(
Data were collected in two stages. First, computer-assisted interviews were 
carried out with participants at their home. The interview covered topics such as 
general health, health behaviours, socioeconomic position and ethnicity. Height 
and weight were measured by the interviewer. Participants from ethnic minority 
groups were also asked about CVD. All participants in the ethnic minority groups 
listed above were then invited to participate in a nurse visit. At the nurse visit 
information was collected on prescribed medication, and physical measurements 
were taken such as a blood sample and blood pressure. White participants were 
not asked about CVD nor invited to participate in a nurse visit. 
Steps were taken to ensure that people who did not speak English could take 
part in the survey. Survey materials were available in seven languages (Urdu, 
Punjabi, Gujarati, Hindi, Bengali, Mandarin and Cantonese). Whenever possible, 
interviews and nurse visits were carried out in the participant’s own language. 
4.2.1.4 Survey(response(
Survey response was calculated at both a household and individual level. In 
2004, 72% of households eligible for the core sample participated in the survey, 
compared to 69% of households eligible for the boost sample. In the core sample 
6,704 adults were interviewed. This included 876 adults from ethnic minority 
groups. These individuals were invited for a nurse visit in the same way as 
participants in the boost sample and were combined with the boost sample for 
calculation of response rates. In the boost sample 5,940 adults were interviewed 
but lower numbers agreed to a nurse visit or had a blood sample taken (3,540 
and 2,325 respectively). 
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The HSE calculates individual survey response by estimating the total number of 
adults in eligible households for use as the denominator as no data are available 
on non-responders to the survey interview. Using this approach the individual 
interview response rate for adults was 66% in the general population core sample 
and 63% in the boost sample. However, response rates varied geographically and 
by type of dwelling, and were lower in men and younger adults. Response rates 
also varied by ethnicity (see Table 4-1). 
Table 4-1: Estimated response to HSE 2004 interview by ethnic group and sex 
(489) 
Ethnic minority group Estimated individual response to survey interview (%) 
 Men Women 
Black Caribbean 57 64 
Black African 62 64 
Indian 60 65 
Pakistani 57 63 
Bangladeshi 66 71 
Chinese 55 57 
Irish 64 70 
4.2.1.5 Weights(
Survey weights are used to ensure that samples are representative of their 
intended population by addressing issues such as selection and non-response bias 
that would make the sample unrepresentative (492). The HSE uses weights to 
address differences in the probability of being selected for or of responding to 
the survey. In 2004, slightly different weights were used for the core and boost 
samples, reflecting the differences in sampling between these groups. For the 
core sample, household and individual weights were derived that addressed 
selection and non-response bias. Demographic and geographical information was 
used to calibrate weights for household non-response. In the boost sample 
different weights were used in areas in which focused enumeration was used and 
selection weights were used to account for the fact that probability of selection 
depended on ethnicity. Weighting variables were also calculated to ensure the 
sample was consistent with estimated national populations of each ethnic group. 
This process resulted in three weighting variables that could be applied – an 
interview weight plus nurse visit and blood sample weights. The interview 
weight was applied in this analysis. 
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4.2.2 Participants0
Adults aged 16-64 years old from four ethnic groups (black Caribbean, Indian, 
Pakistani and white) were included in these analyses.  
4.2.3 Variables0
Ethnicity was self-reported, based on questions about cultural background. It is 
recommended that research that includes ethnicity as a variable reports how 
this information was collected and categorised (493). In the HSE participants 
were asked whether they considered themselves to belong to one of the 
following groups – white, mixed, black, black British, Asian, Asian British or 
other (489). Depending on their response they were then asked to further 
specify their cultural background as Caribbean, African, Indian, Pakistani, 
Bangladeshi, Chinese and so on. The exception to this approach was in the 
definition of the Irish group. This was done based on country of birth or parental 
origin (488). The survey design meant that participants reporting mixed ethnicity 
were assigned to an ethnic minority group rather than being classified as having 
mixed ethnicity. The categories used corresponded to those in the 2001 Census 
(see Box 3-1) (488).  
The HSE measures area deprivation using the Index of Multiple Deprivation (IMD) 
2004. The IMD was discussed in Chapters 2 and 3, including some of the 
limitations of its derivation and application, and its use in identifying and 
targeting deprived areas. Briefly, IMD is a composite measure of multiple aspects 
of deprivation in which individual level data on seven domains of deprivation 
(income; employment; health deprivation and disability; education, skills and 
training; barriers to housing and services; crime; and living environment) are 
aggregated for Super Output Areas (small areas of approximately 1,500 
residents) (175). The domains are combined using weights, with the highest 
weights given to the income and employment domains. All Super Output Areas in 
England are then ranked by increasing area deprivation and grouped into 
quintiles. Each household in the HSE 2004 was assigned to an IMD 2004 quintile 
based on its postcode (494). The purpose of the analyses was to assess the utility 
of area deprivation as a tool for targeting interventions. This type of approach 
would require areas to be selected based on a cut-off of area deprivation so the 
IMD 2004 quintiles were then divided into two groups – more deprived (quintile 
5) and less deprived (quintiles 1-4). 
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Individual socioeconomic position was measured using self-reported information 
on education, occupation, car access, income and housing tenure. As there is no 
single gold standard measure of individual socioeconomic position multiple 
measures were selected to represent a range of socioeconomic circumstances. 
Each of these measures has previously been used in the study of the association 
between socioeconomic position and health (28, 29, 180, 326). Education was 
based on highest qualification achieved. Housing tenure was based on the 
circumstances by which the household occupied their current accommodation. 
Occupation was categorised using the UK’s National Statistics Socio-economic 
Classification (NSSEC) for the household reference person (the householder with 
the highest income, or the oldest householder in the case of equal incomes). The 
NSSEC has been recommended as a replacement for older occupational 
classifications, such as social class or socioeconomic group, as it incorporates 
broader aspects of employment status and better reflects women’s employment 
status (495). Education, housing tenure and occupation had multiple categories 
and were dichotomised (see Figure 4-1, which also includes categories used in 
the sensitivity analysis (see section 4.2.4.3)). Car access was based on a yes or 
no response to whether a car or van was normally available for use by the 
respondent or their household. Income was based on equivalised annual income, 
a measure of total household income that accounts for the number of people 
living in the household (488). Income quintiles were calculated based on the 
whole sample, and converted into a binary variable of lower income (quintile 5) 
and higher income (quintiles 1-4).
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Education None Foreign / other NVQ1 
NVQ2 / 
GCSE 
NVQ3 / 
A-level 
Higher 
education Degree 
Narrower 
definition Lower Higher 
Main 
analysis Lower Higher 
Broader 
definition Lower Higher 
   
Occupation 
Never worked 
and long-
term 
unemployed 
Routine Manual Intermediate Managerial and professional 
Narrower 
definition Lower  Higher 
Main 
analysis Lower Higher 
Broader 
definition Lower Higher 
   
Car access No Yes 
Narrower 
definition No further divisions possible 
Main 
analysis Lower Higher 
Broader 
definition No further divisions possible 
  
Income Quintile 5 Quintile 4 Quintile 3 Quintile 2 Quintile 1 
Narrower 
definition Lower Higher 
Main 
analysis Lower Higher 
Broader 
definition Lower Higher 
   
Housing 
tenure Rent free Rented 
Rent and 
mortgage 
(shared 
ownership) 
Own through 
mortgage 
Owned 
outright 
Narrower 
definition No further divisions possible (insufficient numbers) 
Main 
analysis Lower Higher 
Broader 
definition No further divisions possible (insufficient numbers) 
Figure 4-1: Dichotomisation of individual socioeconomic variables in main 
analysis and with narrower and broader definitions 
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4.2.4 Analyses0
4.2.4.1 Descriptive(statistics(
Demographic and socioeconomic characteristics were explored using descriptive 
statistics. Age was the only continuous variable. The mean and standard 
deviation were calculated for each ethnic group and an independent-samples t-
test was used to compare the age of each ethnic minority group with the white 
group. The remaining variables were categorical. Proportions were calculated 
and chi-squared tests used to compare each ethnic minority group with the 
white group. 
4.2.4.2 Agreement,(sensitivity(and(positive(predictive(value(
Ethnic differences in the association between area deprivation and individual 
socioeconomic position were investigated by comparing percentage agreement. 
Percentage agreement signifies the proportion of individuals in whom the 
category of area deprivation and individual socioeconomic position matched (see 
Figure 4-2). Sensitivity and positive predictive value are calculations that are 
commonly used in epidemiological practice to assess the accuracy and efficiency 
of screening tests to identify individuals with disease (496). In this analysis 
sensitivity was used to calculate the proportion of socioeconomically deprived 
individuals correctly identified by the area deprivation measure, a marker of 
accuracy. Positive predictive value was used to investigate the extent to which 
the area deprivation measure inappropriately included people with higher 
socioeconomic position, a marker of efficiency. 
95% confidence intervals for percentage agreement, sensitivity and positive 
predictive value were calculated using the formula for calculating the 
confidence intervals of proportions: 
p± 1.96	
where p is the proportion and n is the sample size. 
Agreement between area deprivation and individual socioeconomic position 
could also have been assessed using alternative statistical techniques, such as 
correlation. However, the approach described above was selected because it 
would provide results consistent with how variables are used for targeting 
interventions, i.e. using thresholds of area deprivation, and because it would 
provide a measure of efficiency.  
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Area deprivation Individual socioeconomic variable  
Lower 
socioeconomic 
position 
Higher 
socioeconomic 
position 
Total 
More deprived a b a + b 
Less deprived c d c + d 
Total a + c b + d a + b + c + d 
    
 Percentage agreement (a + d) / (a + b + c + d) × 100 
 Sensitivity a / (a + c) 
 Positive predictive value a / (a + b) 
Figure 4-2: Calculation of percentage agreement, sensitivity and positive 
predictive value 
4.2.4.3 Sensitivity(analysis(
The effect of using different approaches to dichotimise the measures of 
individual socioeconomic position was investigated in further analyses. Narrower 
and broader definitions of lower individual socioeconomic position were set and 
the analysis repeated using each of these definitions (see Figure 4-1). This 
allowed the robustness of the conclusions from the main analysis to be tested.  
4.2.5 Software0used0
SPSS 19.0 and Microsoft Excel were used for the analyses.  
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4.3 Results 
4.3.1 Demographic0and0socioeconomic0characteristics0
The unweighted sample comprised 7,208 participants, of whom 4,377 (60.7%) 
were white, 1,070 (14.8%) Indian, 874 (12.2%) Pakistani and 887 (12.3%) black 
Caribbean (see Table 4-2). All ethnic minority groups were significantly younger 
than the white group; the lowest mean age was observed in the Pakistani group 
(mean age 34.6 years compared to 39.9 years in the white group). All ethnic 
minority groups had a significantly lower proportion of men than the white 
group, with the lowest proportion in the black Caribbean group.  
The prevalence of area deprivation was significantly higher in all ethnic minority 
groups than in the white group (see Table 4-2). In particular, 52.2% of the 
Pakistani group and 45.1% of the black Caribbean group lived in the more 
deprived quintile compared to 14.9% in the white group. Individual 
socioeconomic position, measured by occupation, car access and income, was 
significantly lower in all ethnic minority groups than in the white group. The 
exceptions to this pattern were housing tenure and education. There was no 
significant difference between the Indian and white group in housing tenure, 
although significantly higher proportions of the Pakistani and black Caribbean 
groups lived in rented or rent free housing. There were no significant differences 
between the Indian or black Caribbean and white groups in education, but a 
significantly higher proportion of the Pakistani group had lower education than 
the white group.  
More deprived areas had higher proportions of individuals with lower 
socioeconomic position (see Table 4-3). This association was observed across all 
ethnic groups and all individual socioeconomic measures. Within less deprived 
areas, the proportion of individuals who had higher socioeconomic position was 
generally greater in the white group and lower in the Pakistani and black 
Caribbean groups. The proportion of individuals with lower socioeconomic 
position who lived in the more deprived areas was more variable and depended 
on the individual socioeconomic measure used. 
4.3.2 Agreement,0sensitivity0and0positive0predictive0value0
Ethnic differences were observed in agreement and sensitivity but not in positive 
predictive value (see Table 4-4). Agreement was generally highest in the white 
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group (ranging from 67.2% to 82.4%), with the exception of education where it 
was highest in the Indian group. In contrast, agreement was lower in the 
Pakistani (50.9% to 63.4%) and black Caribbean (61.0% to 70.1%) groups across all 
individual socioeconomic measures. Intermediate results, closer to the white 
group than the Pakistani and black Caribbean groups, were observed in the 
Indian group. Sensitivity was lowest in the white group and highest in the 
Pakistani and black Caribbean groups across all individual socioeconomic 
measures. Sensitivity ranged from 0.56 to 0.64 in the Pakistani group and from 
0.59 to 0.66 in the black Caribbean group, whereas it ranged from 0.24 to 0.38 
in the white group. Similar to the results for agreement, sensitivity results in the 
Indian group were intermediate and more similar to the white group than to the 
Pakistani and black Caribbean groups. 95% confidence intervals for sensitivity in 
the Pakistani and black Caribbean groups did not overlap with those in the white 
and Indian groups. Positive predictive value was similar across the ethnic groups, 
with no consistent ethnic differences observed. For occupation, positive 
predictive value ranged from 0.60 to 0.64 across the ethnic groups; for car 
access it ranged from 0.22 to 0.56 across the ethnic groups.  
4.3.3 Sensitivity0analysis0
Calculation of agreement, sensitivity and positive predictive value using 
narrower and broader definitions of individual socioeconomic position produced 
results that were generally consistent in direction with the main analysis (see 
Table 4-5). Sensitivity remained lower in the white and Indian groups than in the 
Pakistani and black Caribbean groups using both the narrower and broader 
definitions. Results for positive predictive value were similar across the ethnic 
groups, again with no consistent ethnic differences observed. Agreement was 
higher in the white and Indian groups than in the Pakistani and black Caribbean 
groups using the narrower definition. However, this pattern was less clear using 
the broader definition, where greater similarity in agreement was observed 
across the ethnic groups with relatively lower agreement in the white and Indian 
groups than in the main analysis.
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Table 4-2: Characteristics of participants by ethnic group 
a SD standard deviation; b p Value indicates difference between ethnic minority group 
and white group; c n weighted base; d Quintile 5 for area deprivation represents more 
deprived areas; e NVQ National Vocational Qualification; f Quintile 5 for income 
represents lower income 
 White Indian Pakistani Black Caribbean 
Unweighted base 4,377 1,070 874 887 
Weighted base 64,771 1,784 858 973 
 mean (SD)a 
mean 
(SD) 
p Valueb mean 
(SD) 
p Value mean 
(SD) 
p Value 
Age (years) 39.9 
(13.8) 
38.3 
(12.7) <0.001 
34.6 
(12.2) <0.001 
38.2 
(13.0) <0.001 
 nc (%) n (%)  n (%)  n (%)  
Male 32,513 
(50.2) 
801 
(44.9) <0.001 
386 
(45.0) 0.002 
391 
(40.2) <0.001 
Area deprivation         
Quintiles 1-4 55,138 
(85.1) 
1,428 
(80.0) <0.001 
410 
(47.8) <0.001 
534 
(54.9) <0.001 
Quintile 5d 9,633 
(14.9) 
357 
(20.0)  
448 
(52.2)  
438 
(45.1) 
 
Missing 0 0  0  0  
Education        
NVQe 2 and above 47,092 
(72.9) 
1,331 
(74.9) 0.062 
466 
(54.8) <0.001 
718 
(74.7) 0.221 
NVQ1, other and 
no qualifications 
17,464 
(27.1) 
445 
(25.1)  
385 
(45.2)  
243 
(25.3) 
 
Missing 215 8  7  11  
Occupation        
Managerial, 
professional and 
intermediate  
40,873 
(63.3) 
1,032 
(58.2) <0.001 
394 
(46.8) <0.001 
525 
(54.5) <0.001 
Routine, manual 
and none 
23,688 
(36.7) 
742 
(41.8)  
447 
(53.2)  
438 
(45.5) 
 
Missing 210 10  17  10  
Car access        
Access  57,540 
(88.8) 
1,500 
(84.1) <0.001 
704 
(82.1) <0.001 
591 
(60.7) <0.001 
No access 7,232 
(11.2) 
284 
(15.9)  
154 
(17.9)  
382 
(39.3) 
 
Missing 0 0  0  0  
Income        
Quintiles 1-4 45,650 
(81.7) 
939 
(70.5) <0.001 
264 
(42.0) <0.001 
494 
(63.6) <0.001 
Quintile 5f 10,231 
(18.3) 
393 
(29.5)  
365 
(58.0)  
283 
(36.4) 
 
Missing 8,891 451  229  197  
Housing tenure        
Owner occupier 49,442 
(76.5) 
1,380 
(77.7) 0.233 
593 
(69.7) <0.001 
498 
(51.6) <0.001 
Rent or rent free 15,162 
(23.5) 
395 
(22.3)  
258 
(30.3)  
467 
(48.4) 
 
Missing 168 9  7  8  
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Table 4-3: Individual socioeconomic position for each area deprivation category by ethnic group 
a Quintile 5 for area deprivation represents more deprived areas; b NVQ National Vocational Qualification; c Quintile 5 for income represents 
lowest income
  White Indian Pakistani Black Caribbean 
  Quintile 5a Quintiles 1-4 Quintile 5 Quintiles 1-4 Quintile 5 Quintiles 1-4 Quintile 5 Quintiles 1-4 
  n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%) 
Education NVQ1b, other 
and no 
qualifications 
4,213 (44.0) 13,251 (24.1) 161 (45.4) 284 (20.0) 234 (52.3) 151 (37.4) 150 (34.8) 94 (17.7) 
 NVQ 2 and above 5,356 (56.0) 41,735 (75.9) 194 (54.6) 1,138 (80.0) 213 (47.7) 253 (62.6) 281 (65.2) 437 (82.3) 
Occupation Routine, 
manual and 
none 
6,045 (63.3) 17,643 (32.1) 225 (63.7) 517 (36.4) 267 (60.5) 180 (45.0) 258 (60.0) 179 (33.7) 
 
Managerial, 
professional 
and 
intermediate  
3,505 (36.7) 37,369 (67.9) 128 (36.3) 904 (63.6) 174 (39.5) 220 (55.0) 172 (40.0) 352 (66.3) 
Car access No access 2,738 (28.4) 4,493 (8.1) 124 (34.8) 160 (11.2) 99 (22.1) 55 (13.4) 244 (55.6) 138 (25.8) 
 Access 6,894 (71.6) 50,645 (91.9) 232 (65.2) 1,268 (88.8) 349 (77.9) 355 (86.6) 195 (44.4) 396 (74.2) 
Income Quintile 5c 3,196 (38.0) 7,035 (14.8) 131 (52.2) 262 (24.2) 235 (70.1) 130 (44.2) 168 (49.4) 115 (26.4) 
 Quintiles 1-4 5,219 (62.0) 40,430 (85.2) 120 (47.8) 820 (75.8) 100 (29.9) 164 (55.8) 172 (50.6) 321 (73.6) 
Housing 
tenure 
Rented or 
rent free 4,540 (47.1) 10,622 (19.3) 137 (38.4) 258 (18.2) 144 (32.1) 114 (28.3) 308 (70.5) 159 (30.2) 
 Owner occupier 5,093 (52.9) 44,349 (80.7) 220 (61.6) 1,161 (81.8) 304 (67.9) 289 (71.7) 129 (29.5) 368 (69.8) 
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Table 4-4: Results for agreement, sensitivity and positive predictive value 
calculations for each individual socioeconomic measure by ethnic group 
CI confidence interval 
PPV positive predictive value
   
White 
 
Indian 
 
Pakistani 
 
Black 
Caribbean 
      
 
Education 
 
Agreement (%) 
 
71.2 
 
73.1 
 
57.2 
 
61.0 
 95% CI 70.8-71.5 71.0-75.2 53.9-60.6 57.9-64.1 
 Sensitivity 0.24 0.36 0.61 0.61 
 95% CI 0.23-0.25 0.32-0.41 0.56-0.66 0.55-0.68 
 PPV 0.44 0.45 0.52 0.35 
 95% CI 0.43-0.45 0.40-0.51 0.48-0.57 0.30-0.39 
      
Occupation Agreement (%) 67.2 63.7 57.8 63.4 
 95% CI 66.9-67.6 61.4-65.9 54.6-61.2 60.4-66.5 
 Sensitivity 0.26 0.30 0.60 0.59 
 95% CI 0.25-0.26 0.27-0.34 0.55-0.64 0.54-0.64 
 PPV 0.63 0.64 0.61 0.60 
 95% CI 0.62-0.64 0.59-0.69 0.56-0.65 0.55-0.65 
      
Car access Agreement (%) 82.4 78.0 52.9 65.8 
 95% CI 82.1-82.7 76.1-80.0 49.6-56.3 62.8-68.8 
 Sensitivity 0.38 0.44 0.64 0.64 
 95% CI 0.37-0.39 0.38-0.49 0.57-0.72 0.59-0.69 
 PPV 0.28 0.35 0.22 0.56 
 95% CI 0.28-0.29 0.30-0.40 0.18-0.26 0.51-0.60 
      
Income Agreement (%) 78.1 71.3 63.4 63.0 
 95% CI 77.8-78.4 68.9-73.8 59.7-67.2 59.6-66.4 
 Sensitivity 0.31 0.33 0.64 0.59 
 95% CI 0.30-0.32 0.29-0.38 0.59-0.69 0.54-0.65 
 PPV 0.38 0.52 0.70 0.49 
 95% CI 0.37-0.39 0.46-0.58 0.65-0.75 0.44-0.55 
      
Housing 
tenure 
Agreement (%) 75.7 73.1 50.9 70.1 
95% CI 75.3-76.0 71.0-75.2 47.5-54.2 67.2-73.0 
Sensitivity 0.30 0.35 0.56 0.66 
 95% CI 0.29-0.31 0.30-0.39 0.50-0.62 0.62-0.70 
 PPV 0.47 0.38 0.32 0.70 
 95% CI 0.46-0.48 0.33-0.43 0.28-0.36 0.66-0.75 
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Table 4-5: Results of analyses with narrower and broader definitions of individual socioeconomic position for agreement, sensitivity 
and positive predictive value by ethnic group 
CI confidence interval 
PPV positive predictive value 
Narrower definition of lower socioeconomic position is educational level of no qualifications, occupation of routine or no employment, and income in 
the lowest decile. Broader definition of lower socioeconomic position is educational level of NVQ2 level and below, occupation of intermediate, 
routine, manual or no employment, and income in quintiles 4 and 5. 
 White Indian Pakistani Black Caribbean 
 Narrower 
definition 
Broader 
definition 
Narrower 
definition 
Broader 
definition 
Narrower 
definition 
Broader 
definition 
Narrower 
definition 
Broader 
definition 
Education         
Agreement (%) 75.1 51.4 73.6 61.1 56.6 61.8 60.6 60.5 
95% CI 74.8-75.5 51.0-51.8 71.5-75.6 58.9-63.4 53.3-60.0 58.6-65.1 57.5-63.7 57.4-63.6 
Sensitivity 0.25 0.18 0.35 0.29 0.61 0.62 0.63 0.55 
95% CI 0.24-0.25 0.18-0.19 0.30-0.40 0.26-0.32 0.56-0.67 0.57-0.66 0.57-0.70 0.51-0.59 
PPV 0.33 0.66 0.37 0.64 0.47 0.72 0.29 0.63 
95% CI 0.32-0.34 0.66-0.67 0.32-0.42 0.59-0.69 0.42-0.52 0.68-0.77 0.24-0.33 0.59-0.68 
Occupation         
Agreement (%) 80.1 52.4 74.9 49.7 54.7 57.3 61.9 61.9 
95% CI 79.8-80.4 52.0-52.8 72.8-76.9 47.4-52.0 51.3-58.1 54.0-60.7 58.8-65.0 58.8-65.0 
Sensitivity 0.30 0.21 0.35 0.25 0.62 0.56 0.67 0.55 
95% CI 0.29-0.31 0.20-0.21 0.30-0.40 0.23-0.28 0.56-0.68 0.52-0.60 0.60-0.74 0.51-0.59 
PPV 0.27 0.78 0.30 0.80 0.35 0.88 0.29 0.79 
95% CI 0.26-0.28 0.77-0.79 0.26-0.35 0.76-0.84 0.30-0.39 0.85-0.91 0.25-0.33 0.75-0.83 
Income         
Agreement (%) 82.6 67.0 77.2 55.1 55.5 61.6 61.0 64.9 
95% CI 82.3-82.9 66.6-67.4 74.9-79.5 52.4-57.7 51.6-59.4 57.8-65.4 57.6-64.4 61.6-68.3 
Sensitivity 0.36 0.26 0.38 0.27 0.63 0.59 0.60 0.57 
95% CI 0.35-0.38 0.26-0.27 0.32-0.45 0.24-0.30 0.57-0.70 0.55-0.63 0.53-0.66 0.53-0.62 
PPV 0.21 0.67 0.35 0.82 0.39 0.90 0.35 0.77 
95% CI 0.20-0.22 0.66-0.68 0.29-0.41 0.77-0.86 0.34-0.45 0.87-0.93 0.30-0.40 0.73-0.82 
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4.4 Discussion 
4.4.1 Principal,findings,
These analyses identified ethnic differences in the performance of area 
deprivation as a tool for targeting socioeconomically deprived individuals. 
Despite lower agreement between area and individual measures of 
socioeconomic position in the Pakistani and black Caribbean groups, sensitivity 
was consistently higher compared to the white group. In the Indian group results 
for both agreement and sensitivity were intermediate but most similar to those 
in the white group. There were no consistent ethnic differences in positive 
predictive value and, in particular, positive predictive value was no worse in the 
ethnic minority groups.  
If area deprivation measures were ineffective at identifying deprived individuals 
in ethnic minority groups, then at-risk individuals could be missed and ethnic 
health inequalities could increase. Conversely, if area deprivation measures 
performed more effectively in ethnic minority groups then interventions 
targeted on the basis of area deprivation would tend to reduce ethnic health 
inequalities. If area deprivation measures were inefficient because they 
identified higher numbers of non-deprived individuals in ethnic minority groups 
this would reduce the value for money and increase the opportunity costs of 
interventions targeted at deprived areas. 
In this analysis area deprivation correctly identified higher proportions of 
socioeconomically deprived Pakistani and black Caribbean individuals than white 
or Indian individuals, whilst at the same time performing comparably across the 
ethnic groups at excluding individuals with higher socioeconomic position. 
Compared to the white population, in the context of an area based intervention 
this would lead to increased coverage of deprived Pakistani and black Caribbean 
populations, and comparable coverage of deprived Indian populations, without 
changing the efficiency of the targeted intervention.  
4.4.2 Strengths,and,limitations,
The HSE 2004 provided cross-sectional data from a boosted sample of ethnic 
minority participants. The boosted sample provided sufficient numbers of 
participants from the largest ethnic groups in England. Indeed, the ethnic 
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minority sample sizes in this survey are greater than those in many other general 
population surveys, and certainly in subsequent years of the HSE. Individuals 
from the four largest ethnic groups in England were included in the analyses in 
this chapter and the related publication (497). Extending the analyses to other 
ethnic groups would provide further information to inform the use of area 
deprivation measures for targeting socioeconomically deprived individuals and it 
is possible that the findings may vary in other ethnic groups, for example lower 
levels of socioeconomic deprivation could mean that area deprivation measures 
perform comparably in Chinese and white groups. Survey response rates varied 
by ethnicity and sex leading to a potential for response bias if those who did not 
respond were systematically different from those who did, although a lack of 
information on non-responders makes the extent and direction of this potential 
bias difficult to assess. HSE weighting variables that account for selection and 
non-response bias were applied.  
The HSE had the advantage of including a broad range of individual 
socioeconomic measures, including income, a variable that is not available in 
alternative data sources such as the Census (see section 4.2.1). This enabled the 
performance of the IMD 2004 to be tested against a variety of individual 
socioeconomic measures, thereby strengthening the findings through the 
observation of consistent results across the range of measures. All of the 
individual socioeconomic measures were based on self-reported information, 
raising the possibility of reporting or recall bias. An alternative approach could 
have been for socioeconomic position to be measured using objective 
information, such as tax or housing records. However, this would be impractical 
approach that could potentially put individuals off participating in the survey. 
Bias is arguably most likely to have affected the measurement of income. There 
was a high proportion of missing data on income, which varied between ethnic 
groups (ranging from 13.7% in the white group to 26.7% in the Pakistani group). 
Bias may have been introduced if this non-response was also related to income. 
One option for addressing the missing data would have been to use a statistical 
technique such as multiple imputation. However, given that the results for 
income were consistent with those from the other individual socioeconomic 
measures studied, where levels of missing data were much lower, it was decided 
not to carry out multiple imputation at this stage.  
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Area and individual socio-economic measures were dichotomised. An alternative 
approach to using dichotomised variables could have been to analyse the 
socioeconomic variables using their full range of categories, or continuously in 
the case of income, and to apply different statistical techniques, such as 
correlation. This alternative approach could have added additional information 
on possible gradients in the agreement between individual and area based 
measures of socioeconomic deprivation. Although the conversion into binary 
variables may lose some of this information, it was appropriate for these 
analyses as it reflects the design and practical delivery of many public health 
interventions, where populations are dichotomised into those who are included 
or excluded from the intervention based on a predetermined threshold (e.g. the 
most deprived 20% of areas). However, the cut-offs chosen may be seen as 
somewhat arbitrary and may not reflect an individual’s actual experienced 
socioeconomic position. Indeed, the cut-offs used to define lower individual 
socioeconomic position may not equate to the cut-off used to define greater 
area deprivation. This may be particularly relevant for individuals from ethnic 
minority groups for whom certain categories of socioeconomic position, such as 
having a higher education, may not translate into equally advantageous 
socioeconomic circumstances as in white individuals. A lack of empirical 
evidence quantifying this ethnic inequality meant that it could not be included 
in the analysis. However, the likely impact of considering this inequality would 
have been to increase the number of ethnic minority individuals with lower 
individual socioeconomic position, which would not affect the results for 
sensitivity and could improve them for positive predictive value in these groups. 
Sensitivity analysis was used to explore narrower and broader definitions of 
lower socio-economic position and reassuringly the results were broadly 
consistent with those from the main analysis. 
This study focused on the identification of individual socio-economic 
deprivation. However, as previously discussed in chapter 2, area itself may 
independently influence health, beyond the impact of the characteristics of 
individuals living in an area (177, 178). This could occur through health effects 
of the physical environment or community influence (178). This means that 
targeting public health interventions at deprived areas can potentially address 
two separate risk factors since it identifies individuals subject to both area and 
individual deprivation. However, IMD 2004 is derived from aggregated data on 
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individuals and includes limited measures of area characteristics (air quality is 
an exception to this) (175). Therefore, whilst it will identify areas occupied by 
higher proportions of deprived individuals it may not reflect the full range of 
area characteristics that can influence health. The implications of this for ethnic 
health inequalities are unclear, because whilst addressing area characteristics 
that are detrimental to health will affect all residents regardless of ethnic 
group, there is evidence of ethnic differences in the association between area 
and health (see section 3.8). 
4.4.3 Relations,to,other,studies,
Previous studies have compared the agreement between area and individual 
measures of socioeconomic deprivation. Two studies from Canada found low 
agreement between area and individual measures (190, 191). However, 
methodological differences prevent direct comparisons with this analysis as 
these studies calculated agreement in quintiles or deciles plus with correlation 
coefficients, and did not investigate ethnic differences. In contrast, Diez-Roux 
et al compared the association between area and individual measures in black 
and white individuals in the USA (479). They also found ethnic differences in 
agreement between area and individual measures of income and education, 
accounting for this by the higher proportion of black people living in deprived 
areas irrespective of their socioeconomic position. Despite differences between 
the two countries this may reflect similarities in the relationships between 
ethnicity, socioeconomic deprivation and area of residence in the USA and UK. 
Targeting public health interventions at deprived areas can be an efficient way 
of identifying socioeconomically deprived individuals and focusing limited 
resources on people with the greatest need (181). The geographical clustering of 
socioeconomic deprivation in the UK and availability of area deprivation 
measures make this approach feasible (175, 181). Tunstall and Lupton 
investigated the effectiveness of area deprivation measures in targeting 
deprived individuals in the general population (182). They calculated two 
measures, completeness and efficiency, that correspond with the measures of 
sensitivity and positive predictive value used in this analysis. Their analysis 
included various definitions of areas to be targeted and they found that 
approximately 54-64% of employment benefits claimants would be identified by 
targeting these areas, with 13-17% of adults in these areas being benefits 
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claimants. The former is equivalent to sensitivity in this analysis but the results 
were higher than those observed here for the white group; the latter is 
equivalent to positive predictive value with lower results compared to this 
analysis. These differences could be accounted for by variations in the 
definitions of deprived areas and of individual socioeconomic position between 
the studies. For instance, Tunstall and Lupton used a narrower definition of 
lower individual socioeconomic position (Job Seeker’s Allowance and Income 
Support claimants) compared to this analysis. Results from the narrower 
definition explored here in the sensitivity analysis gave lower positive predictive 
values that correspond more closely with those in Tunstall and Lupton’s analysis. 
In a similar analysis, Batey and Brown noted high levels of inefficiency and 
incompleteness in the area targeting used in the Sure Start programme (485). 
Whilst these studies did not investigate ethnic differences, Tunstall and Lupton 
suggested that spatial patterning of population sub-groups could affect the 
performance of area deprivation measures as tools for targeting deprived 
individuals (182). This conclusion would fit with the findings of this analysis 
given that ethnic minority groups are known to cluster in deprived areas (309, 
451, 452, 464). In fact, geographical clustering of ethnic minority groups into 
deprived areas alongside higher levels of socioeconomic deprivation than in the 
white population are likely to account for the ethnic differences observed in this 
analysis.  
A key criticism of the use of area deprivation measures to target interventions is 
the fact that the majority of deprived people do not live in deprived areas (181, 
190). This example of the ecological fallacy is well established (178), and is 
consistent with findings from this analysis that only 24-38% of deprived white 
individuals lived in deprived areas, although the results indicate that this key 
criticism may not apply to Pakistani and black Caribbean individuals. Despite this 
fundamental drawback and previous conclusions that area deprivation measures 
are unlikely to ever give high completeness and efficiency (182), area based 
initiatives have been widely adopted in the UK. These initiatives include the 
New Deal for Communities initiative and Scotland’s Keep Well CVD prevention 
programme (14, 189). Evidence for the effectiveness of these programmes is 
limited (188), though emerging (498). However, given the drawbacks of area 
deprivation measures, interventions to tackle inequalities may need to adopt 
wider measures beyond targeting areas alone.  
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4.4.4 Implications,
This analysis indicates that area deprivation measures perform relatively well in 
certain ethnic minority groups compared to the white population as a tool for 
targeting deprived individuals, in that higher proportions of deprived individuals 
from ethnic minority groups would be identified without higher inadvertent 
inclusion of non-deprived individuals. This finding is particularly relevant to CVD 
prevention programmes. It has been suggested that targeting CVD prevention 
interventions at deprived areas may be an acceptable and cost-effective 
alternative to mass coverage (192, 443), although this conclusion is based on 
evidence from the general population and it is unclear as yet whether it applies 
to ethnic minority groups (the next chapter addresses this question). Given the 
increased risk of CVD and of socioeconomic deprivation in many ethnic minority 
groups in the UK, it would be particularly important for CVD prevention 
programmes to achieve good coverage of deprived ethnic minority populations in 
such a way that did not waste limited resources. These results therefore provide 
reassuring evidence that the use of area deprivation measures for targeting 
socioeconomically deprived individuals may be appropriate for ethnic minority 
populations, with no evidence to suggest that these groups would be 
systematically disadvantaged. Rather, the evidence suggests systematic 
advantage in these groups with regards to targeting, which could potentially 
reduce ethnic health inequalities. 
These findings may be generalisable to other settings that have ethnic minority 
populations with similar socioeconomic characteristics. However, this would 
need to be done with caution given likely differences in ethnic demographics 
and geographical distribution of socioeconomic deprivation and ethnic minority 
populations.  
4.4.5 Next,steps,
A number of questions regarding the use of area deprivation as a means of 
targeting public health interventions remain unanswered, including whether 
there are ethnic differences in the potential for area deprivation to identify 
individuals at high risk of disease. Therefore, the next stage in this thesis is to 
investigate ethnic differences in the cost-effectiveness of area based targeting 
of cardiovascular risk screening.  
  
119 
5 Chapter 5: Ethnic differences in the cost-effectiveness of 
targeted and mass screening for high cardiovascular risk in 
the UK 
5.1 Introduction 
Having established in the previous chapter that the use of area deprivation 
measures may be appropriate for identifying deprived individuals from ethnic 
minority groups, this chapter builds on that work by investigating ethnic 
differences in the cost-effectiveness of targeted screening for high 
cardiovascular risk in deprived areas. Chapters 2 and 3 described a number of 
key issues that are pertinent to this chapter; these are summarised here in order 
to explain why this particular analysis was carried out.  
Primary prevention, through risk factor modification, is key to successfully 
reducing the burden of CVD, the leading cause of premature mortality in the UK 
(6, 53, 80). Current UK guidance recommends that individuals with an estimated 
cardiovascular risk score ≥20% are offered interventions, such as statins, to 
reduce their risk (although at the time of writing this threshold is set to change 
to ≥10%) (121, 499, 500) . Previously the choice of cardiovascular risk calculator 
was left to the practitioner’s discretion (121), however this looks set to change 
to a recommendation in England to use QRISK2 (501), a calculator that may be 
particularly suitable for ethnic minority populations (121, 438, 444). As 
described in Chapter 2, mass or targeted screening can be used to identify 
individuals with high cardiovascular risk. Whilst mass screening has the potential 
to identify all high-risk individuals in the population, targeting screening at 
deprived areas might be a more cost-effective strategy that identifies the 
majority (192). Current policy varies across the UK, with mass screening through 
NHS Health Checks in England (although local implementation means there is 
variation in programme delivery, including additional targeting of higher risk 
population sub-groups in some areas (502)) and targeted screening of the most 
deprived areas through the Keep Well programme in Scotland (14, 159). 
Public health interventions have the potential to both improve overall health but 
may paradoxically widen health inequalities if people with better baseline 
health benefit more from than the intervention than those with worse health (4, 
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5, 199). The UK’s population is becoming increasingly ethnically diverse (19), 
with many of the largest ethnic minority groups at increased risk of CVD 
compared to the white population (12, 239, 250-252, 259, 260). This means that 
it is particularly important to assess the effectiveness of public health 
interventions, including CVD prevention programmes, in different ethnic groups. 
This is to ensure that these interventions work equally, if not more, effectively 
in these groups, in order to reduce health inequalities as well as improve overall 
health.  
Against a background of limited financial resources and the need to tackle 
health inequalities, the relative merits of mass and targeted CVD prevention 
policies continue to be discussed (159, 169). However, it is unclear what the 
impact of a choice between screening the whole population or focusing on 
deprived communities would be on ethnic minority populations. Ethnic minority 
groups, particularly black Caribbean, Pakistani and Bangladeshi groups, are more 
likely to live in deprived areas than the white population (308, 309, 451, 452, 
457). Therefore, it is likely that there will be ethnic differences in the cost-
effectiveness of targeted screening, and how this compares with mass screening.  
This chapter therefore addresses the following research question: 
Are there ethnic differences in the cost-effectiveness of targeted and 
mass screening for high cardiovascular risk?  
Similar to the previous chapter, the intention of these analyses was to explore 
the potential impact of policies designed for the general population rather than 
to suggest specific screening strategies for different ethnic groups.  
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5.2 Methods 
5.2.1 Data,
This analysis used data from the HSE 2003 and 2004 (486, 503). Details of the 
HSE 2004 were outlined in the previous chapter. The HSE 2004 was used for 
analysis of ethnic minority groups as it contained a boosted sample of the ethnic 
minority population in England. Whilst white individuals were included in the 
core sample of the HSE 2004 the design of the survey meant that only ethnic 
minority participants received a nurse visit at which physical measurements, 
such as cholesterol and blood pressure, were taken. Therefore, the HSE 2003 
was used for analysis of the white group and general population.  
5.2.1.1 HSE(2003((
The HSE 2003 was similar to the 2004 survey in terms of its design, sampling and 
use of weights (504). The focus of the 2003 survey was CVD and cardiovascular 
risk factors in the general population; it did not include a boosted sample of any 
particular population sub-group. The 2003 survey therefore predominantly 
included white participants, although there were small numbers of ethnic 
minority individuals who are included in the general population group. Like the 
2004 survey, ethnicity was self-reported from a question on broad ethnic 
grouping with a follow up question on cultural background. 
In 2003, a similar stratified multistage probability sampling approach was used 
to that in the 2004 core sample. The primary sampling unit was postcode sectors 
of which 720 were selected after stratification by geography and socioeconomic 
position. The Postcode Address File was then used to select 13,680 addresses 
from these postcode sectors. 
Response rates were estimated in a similar way to the 2004 survey. In 2003, 
14,836 adults were interviewed, of whom 11,408 received a nurse visit and 8,552 
gave a blood sample. Using estimated denominators the HSE documentation 
provides the following adult response rates - 66% interviewed, 51% received a 
nurse visit, 50% had blood pressure taken, and 38% gave a blood sample (504). 
The corresponding estimates from the 2004 ethnic boost sample were 63% 
interviewed, 36% received a nurse visit, 32% had blood pressure taken and 21% 
gave a blood sample (489). 
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The HSE 2003 included household and individual nonresponse weights. Logistic 
regression was used to calculate the probability of response for individuals, with 
the model including variables such as age, sex, geography, household type and 
social class. Three individual weights were then calculated to correspond to 
response to the interview, nurse visit or blood sample.  
Ethical approval for the HSE 2003 was obtained from the London Multi-centre 
research ethics committee. 
5.2.1.2 Use(of(the(HSE(2003(and(2004(
The HSE 2003 and 2004 were analysed separately and then the results compared. 
These analyses used data collected from the interview, nurse visit and blood 
sample components of the surveys. Whilst separate weights are available for 
these sections in both 2003 and 2004 the interview weights were applied in 
these analyses.  
5.2.2 Participants,
Adults aged 40-74 years without CVD were included. The ethnic groups included 
were black Caribbean, Indian, Pakistani/Bangladeshi, Irish and white. The 
Pakistani and Bangladeshi groups were initially analysed separately but then 
merged in the final analysis because of small numbers. The black African and 
Chinese groups were excluded because the sample sizes in these groups were 
considered to be too small for the analyses (n = 291 and 313, respectively).  
5.2.3 Variables,
Ethnicity was self-reported and based on 2001 Census categories, as previously 
described (see sections 4.2.3 and 5.2.1.1). CVD was defined as self-reported 
diagnosis of angina, myocardial infarction or stroke. This definition did not 
include conditions such as heart murmur, irregular heart rhythm or high blood 
pressure. Area deprivation was measured using IMD 2004 quintiles (see section 
4.2.3). 
QRISK2-2012 was used to estimate each individual’s cardiovascular risk score. 
QRISK2-2012 was selected as it includes ethnicity and area deprivation as 
independent risk variables and may be more accurate in ethnic minority groups 
in the UK than alternative risk calculators (438, 444). QRISK2-2012 contains a 
broader range of variables than alternative cardiovascular risk calculators such 
as Framingham and Ethrisk (see Table 5-1). HSE variables on age, sex, ethnicity, 
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family history of CVD, systolic blood pressure, total and HDL cholesterol, body 
mass index, treated hypertension, self-reported diabetes and self-reported 
smoking status were used. QRISK2-2012 defines family history of CHD as 
ischaemic heart disease in a first degree relative less than 60 years old, whereas 
the HSE measures it as death of a parent less than 65 years old from CVD, 
hypertension or diabetes. Smoking status was split into five categories in the 
QRISK2-2012 calculation (non-smoker, former smoker, light smoker, moderate 
smoker and heavy smoker) so HSE variables on current smoking and amount 
smoked was recoded to fit these categories. QRISK2-2012 only considers type 2 
diabetes so the small number of individuals with type 1 diabetes were included 
in the same category as non-diabetics. 
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Table 5-1: Summary of variables in QRISK2-2012, Framingham and Ethrisk 
cardiovascular risk calculators 
Variable Cardiovascular risk calculator 
QRISK2-2012 
(438) 
Framingham 
(149) 
Ethrisk (445) 
Age ✓ ✓ ✓ 
Sex ✓ ✓ ✓ 
Ethnicity ✓ ✗ ✓ 
Smoking ✓ ✓ ✓ 
Systolic blood pressure ✓ ✓ ✓ 
Diastolic blood pressure ✗ ✓ ✗ 
Total: HDL cholesterol ratio ✓ ✓ ✓ 
Body mass index ✓ ✗ ✗ 
Family history of CHD ✓ ✗ ✗ 
Socioeconomic deprivation ✓ ✗ ✗ 
Treated hypertension ✓ ✗ ✗ 
Type 2 diabetes ✓ ✓ ✗ 
Atrial fibrillation ✓ ✗ ✗ 
Chronic kidney disease ✓ ✗ ✗ 
Rheumatoid arthritis ✓ ✗ ✗ 
 
5.2.3.1 Estimation.of.variables.for.QRISK2.
5.2.3.1.1 Atrial,fibrillation,,rheumatoid,arthritis,and,chronic,kidney,disease,
The HSE 2003 and 2004 do not include data on atrial fibrillation, rheumatoid 
arthritis and chronic kidney disease. The prevalence of these conditions is 
generally low and previous studies have followed an approach suggested by 
QRISK2 of assuming that these conditions are absent when data are not available 
(437, 505). However, exploratory analysis indicated that these conditions had a 
large effect on the cardiovascular risk score when present. In addition, whilst 
overall prevalence is low it increases with age (e.g. approximately 17% of 
women aged 70-74 have chronic kidney disease). Therefore, a microsimulation 
approach was used to apply prevalence estimates to the HSE samples. These 
variables could not be imputed (see section 5.2.4.2) as they were absent rather 
than containing missing data. Age, sex and IMD 2007 specific prevalence 
estimates for atrial fibrillation and chronic kidney disease were obtained from 
The Health Improvement Network database (THIN), a large primary care 
database that covers 6.2% of the UK population (see Table 5–2 and Table 5-3) 
(506, 507). Similar data were not available for rheumatoid arthritis so age and 
sex specific data from a prevalence survey were used (see Table 5-4) (508). 
These data indicated the important of age in the prevalence of these conditions, 
so although ethnic group specific data were identified these data were not used 
  
125 
as they did not include age (438). A random number simulation approach, based 
on Monte Carlo simulation, was used to apply these prevalence estimates to the 
sample. Stata’s random number function was used to generate random numbers 
between zero and one. On the basis of these numbers individuals were 
designated to a binary variable of presence or absence of each condition 
depending on their age and sex, and also their IMD 2004 quintile for atrial 
fibrillation and chronic kidney disease. The impact of this approach on the 
results was assessed by repeating the analyses (described in section 5.2.5.3) 
with the prevalence of these conditions assumed to be zero. 
Table 5-2: Estimated prevalence (%) of atrial fibrillation by age, sex and IMD 
2007 quintile (507) 
Sex 
Age group 
(years) 
IMD 2007 quintile 
1 – least 
deprived 2 3 4 
5 – most 
deprived 
Men 40-44 0.37 0.34 0.24 0.32 0.25 
 
45-49 0.45 0.52 0.54 0.41 0.36 
 
50-54 0.83 0.76 0.84 0.88 0.77 
 
55-59 1.23 1.42 1.22 1.30 1.46 
 
60-64 2.22 2.50 2.55 2.64 2.52 
 
65-69 4.11 4.25 3.96 3.79 4.24 
 
70-74 6.81 6.55 6.70 6.56 5.94 
       Women 40-44 0.06 0.06 0.12 0.09 0.07 
 
45-49 0.14 0.11 0.13 0.13 0.12 
 
50-54 0.24 0.30 0.29 0.32 0.33 
 
55-59 0.51 0.51 0.58 0.59 0.61 
 
60-64 0.94 1.08 1.09 1.06 1.24 
 
65-69 1.93 1.93 1.94 2.23 2.50 
 
70-74 3.51 4.00 4.34 4.00 4.71 
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Table 5-3: Estimated prevalence (%) of chronic kidney disease by age, sex 
and IMD 2007 quintile (507) 
Sex 
Age group 
(years) 
IMD 2007 quintile 
1 – least 
deprived 2 3 4 
5 – most 
deprived 
Men 40-44 0.20 0.20 0.24 0.33 0.42 
 
45-49 0.40 0.42 0.46 0.46 0.62 
 
50-54 0.73 0.66 0.78 1.11 1.07 
 
55-59 1.56 1.50 1.58 1.84 2.03 
 
60-64 3.03 3.06 3.08 3.65 3.68 
 
65-69 5.67 6.08 6.08 7.22 7.74 
 
70-74 10.77 11.44 11.48 11.76 13.51 
       Women 40-44 0.31 0.28 0.39 0.44 0.47 
 
45-49 0.55 0.55 0.70 0.99 1.07 
 
50-54 1.13 1.23 1.30 1.69 1.83 
 
55-59 2.35 2.35 2.47 3.12 3.24 
 
60-64 4.09 4.54 4.65 5.49 6.58 
 
65-69 7.41 8.13 8.68 9.50 11.06 
 
70-74 12.10 13.40 13.95 15.67 17.35 
Table 5-4: Estimated prevalence (%) of rheumatoid arthritis by age and sex 
(508) 
Sex 
Age group (years) 
16-44 45-64 65-74 
Men 0.02a 0.58 1.14 
Women 0.12 1.67 2.56 
aEstimated by Symmons et al from male:female ratio as this age group was not included 
in the survey 
5.2.3.1.2 Townsend,deprivation,score,
QRISK2-2012 uses Townsend scores, a deprivation index that uses Census data on 
four variables – car access, unemployment, overcrowding and housing tenure 
(60). A positive score indicates greater deprivation, and vice versa (509). 
However, IMD 2004 quintiles rather than Townsend score were available in the 
HSE 2003 and 2004. Therefore, individuals were assigned an estimated Townsend 
score based on their IMD 2004 quintile. Data on Townsend scores for England 
were obtained (510). The Townsend scores were divided into quintiles and the 
mean score calculated in each quintile (see Table 5-5). This mean score was 
then assigned to the corresponding IMD 2004 quintile in the HSE datasets. In 
order to assess the robustness of this approach, the analyses (described in 
section 5.2.5.3) were repeated using the minimum and maximum Townsend 
scores in each quintile, rather than the mean score. 
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Hippesley-Cox et al adopted a similar approach in an analysis of the 
performance of the original QRISK calculator in a dataset that contained 
quintiles of Townsend score rather than individual scores (511). In that study, 
each individual within a given Townsend score quintile was assigned the median 
Townsend score for that quintile. In this analysis, median scores were also 
calculated for each quintile and were found to be similar to the mean score (see 
Table 5-5).  
Table 5-5: Results for calculated mean and median Townsend score by 
quintile 
Townsend score quintile Mean Townsend score Median Townsend score 
1 - least deprived -4.05 -3.95 
2 -2.55 -2.57 
3 -0.79 -0.81 
4 1.70 1.66 
5 - most deprived 5.69 5.34 
5.2.4 Missing,data,
The HSE 2003 and 2004 contain a high proportion of missing data on two 
variables required for the calculation of QRISK2-2012, namely blood pressure and 
cholesterol (39.8% and 44.1%, respectively), with fewer missing data on body 
mass index and family history of CVD (12.1% and 8.0%, respectively). The 
unweighted sample contained 4,051 complete cases (88 black Caribbean, 215 
Indian, 72 Pakistani, 36 Bangladeshi, 228 Irish and 3,412 general population of 
whom 3,180 were white). The presence of missing data is consistent with the 
design of the HSE where body mass index and family history of CVD were 
measured at the interview stage and blood pressure and cholesterol were 
measured at the nurse visit, a component of the survey with a lower response 
rate than the interview stage (see sections 4.2.1.4 and 5.2.1.1). 
5.2.4.1 Options(for(addressing(missing(data(
Missing data may be problematic because it can create unrepresentative samples 
and may lead to biased results (512). A number of approaches for dealing with 
missing data exist, the choice of which depends on why it is missing. Missing 
data have been described as being ignorable or non-ignorable (513), where the 
missingness of ignorable data does not depend on its value whereas it does for 
non-ignorable data (514). Ignorable data can also be classified as missing at 
random or missing completely at random (514). Data that are missing at random 
can be explained by other measured variables (512), in contrast to data that are 
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missing completely at random where chance rather than other variables 
accounts for the missing data. Non-ignorable data can be described as missing 
not at random, where the missing data are dependent on variables that have not 
been measured (512). In practice, it can be difficult to clearly classify missing 
data into one of these categories, and a mixture often occurs (512). In the case 
of the HSE 2003 and 2004, it seems reasonable to assume that the missing data 
are most likely missing at random. The design of the survey where all 
participants were offered a nurse visit but some declined, suggests that data 
collected at the nurse visit would not be entirely randomly missing but could 
depend on other measured characteristics that would determine a person's 
likelihood of participating, such as age and sex. There is little evidence to 
suggest that these missing data fit the definition of being missing not at random. 
Given an understanding of the nature of the missing data, a number of 
approaches for addressing it can be considered. One commonly used approach is 
complete case analysis, where cases with missing data are not included in the 
analysis. This is a simple approach but it can produce biased results if the cases 
with missing data are not representative of the overall sample and the 
unrepresentative variables matter for the analysis (512). Indeed, it has been 
suggested that complete case analysis only gives valid results when the data are 
missing completely at random (513). Alternative approaches for dealing with 
missing data include multiple imputation, mean substitution, regression 
imputation and hot deck substitution (514). The performance of these 
techniques has been found to vary, with evidence of particularly poor 
performance from complete case analysis (514).  
5.2.4.2 Multiple(imputation(
A widely accepted approach for dealing with missing data is multiple imputation 
(515). This approach may be superior to the alternative options, and in the case 
of data that are missing at random has been found to produce unbiased results 
(516). In multiple imputation, missing values are estimated from existing values 
in other variables in the dataset (512). This process is repeated a number of 
times to create multiple imputed datasets that can then be combined for the 
final analysis (515). This approach has the advantage of maintaining variability 
within the data and acknowledging uncertainty in the estimations by repeating 
the process multiple times (512). 
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Given the limitations of complete case analysis and the assumption that the 
missing data were most likely missing at random, multiple imputation was used 
to estimate the missing values for the variables required for calculation of 
QRISK2-2012 and subsequent analyses. A multiple imputation model was built 
using Stata’s Imputation by Chained Equations (ICE) command. The model 
included systolic blood pressure, diastolic blood pressure, total cholesterol 
concentration, HDL cholesterol concentration, body mass index and family 
history of CVD, plus age, sex, ethnicity, IMD 2004, diabetes, smoking status, 
whether taking lipid lowering medication and treated hypertension. The QRISK2 
calculation did not require the lipid lowering medication variable but it was 
added to the imputation model because the cholesterol measurements included 
people taking these medications and were therefore influenced by this variable. 
Prior to running the model, the small number of cases with missing data on 
smoking, diabetes and antihypertensive medication were excluded, along with 
individuals not aged 40-74 years and those with CVD, and survey weights were 
specified. 
Initial analysis of the imputed data indicated that certain values had been 
imputed that would be highly improbable, for example a body mass index of 
nine. Therefore, intervals were set so that imputed values did not fall outside 
the existing ranges of blood pressure, cholesterol or body mass index observed in 
the HSE. This was done by specifying a lower and upper limit for each of these 
variables in the multiple imputation model (517).  
The multiple imputation model was run with 100 imputations. This number was 
determined by calculating the fraction of missing information (γ) for each 
variable to be imputed. The γ values obtained were systolic blood pressure 0.49, 
diastolic blood pressure 0.54, total cholesterol 0.68, HDL cholesterol 0.59, and 
family history of CVD 0.11. On the basis of previous literature this suggested that 
100 imputations would be required (518). 
Descriptive statistics and histograms were used to compare the distribution of 
the original and imputed data (see Table 5-6, Figure 5-1 and Figure 5-2). The 
distributions were generally similar across the continuous imputed variables. 
Histograms for HDL cholesterol concentration and body mass index showed a 
similar picture to those for systolic blood pressure and total cholesterol 
concentration.
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Table 5-6: Mean and standard errors of continuous cardiovascular variables 
from complete cases and imputed data 
  Systolic blood 
pressure 
Total 
cholesterol 
HDL 
cholesterol 
Body mass 
index 
  Mean SE Mean SE Mean SE Mean SE 
Black 
Caribbean 
Complete 
cases 132.74 0.77 5.57 0.05 1.48 0.01 28.94 0.24 
Imputed 
data 131.95 1.18 5.57 0.08 1.44 0.02 28.88 0.26 
Indian Complete 
cases 127.83 0.72 5.55 0.05 1.37 0.02 27.12 0.19 
Imputed 
data 128.21 0.94 5.56 0.06 1.41 0.02 27.21 0.21 
Pakistani / 
Bangladeshi 
Complete 
cases 126.01 0.77 5.52 0.05 1.26 0.01 28.08 0.21 
Imputed 
data 128.13 1.00 5.53 0.07 1.37 0.02 28.01 0.23 
Irish Complete 
cases 129.92 0.75 5.79 0.04 1.58 0.02 27.33 0.21 
Imputed 
data 130.14 0.95 5.82 0.06 1.55 0.02 27.22 0.23 
White Complete 
cases 132.05 0.23 5.98 0.01 1.54 0.00 27.72 0.06 
Imputed 
data 132.01 0.26 5.98 0.02 1.54 0.01 27.75 0.06 
HDL high density lipoprotein, SE standard error 
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Figure 5-1: Histograms comparing original and imputed data on systolic blood 
pressure by ethnic group
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Figure 5-2: Histograms comparing original and imputed data on total 
cholesterol concentration by ethnic group 
 
The QRISK2-2012 calculator, obtained from QRISK open source software (519), 
was then applied to each imputed dataset. The QRISK2-2012 calculator only 
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In addition to the use of imputed data, the analyses described in section 5.2.5.3 
were repeated with complete cases only in order to test the robustness of the 
results from the multiple imputation model. 
Table 5-7: Comparison of QRISK2-2012 scores between complete cases and 
imputed data 
 
Complete cases Imputed data 
 
Mean SD Mean SD 
Black Caribbean 8.60 8.69 10.04 10.03 
Indian 10.63 11.97 11.46 11.69 
Pakistani/Bangladeshi 15.45 13.64 18.14 16.17 
Irish 8.85 8.93 10.70 9.76 
White 10.68 10.09 11.22 10.12 
SD standard deviation 
5.2.4.3 Repeated(analyses(using(Framingham(and(Ethrisk(cardiovascular(risk(
calculators(
The analyses were repeated using the Framingham and Ethrisk cardiovascular 
risk calculators, in order to explore whether the use of different calculators 
influenced the findings. The Framingham cardiovascular risk score was 
calculated using Anderson et al’s approach (149). Adjustments recommended by 
NICE for South Asian males (multiply score by 1.4) and a positive family history 
(multiply score by 1.5) were applied (121). Ethrisk was calculated based on the 
published method, with diabetic individuals excluded as recommended (445). 
5.2.5 Analysis,
5.2.5.1 Demographic(and(cardiovascular(characteristics(
Ethnic differences in demographic and cardiovascular characteristics were 
assessed. The independent samples t-test was used for continuous variables and 
a chi-squared test for categorical variables, with the general population as the 
reference group. 
5.2.5.2 Unit(cost(
The unit cost of a screening appointment was set at £23.70. This was based on a 
previous Department of Health estimation, and included the costs of 
administration, nurse and healthcare assistant time, and blood tests (160). The 
one-off costs of programme start-up, were not included. The costs of subsequent 
investigations and interventions were not included as the aim of this analysis 
was to evaluate the cost-effectiveness of identifying high-risk individuals only.  
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5.2.5.3 Coverage,(effectiveness(and(costLeffectiveness(
A similar analytical approach to that used by Lawson et al for the general 
population was applied (192). The coverage, effectiveness and cost-
effectiveness of targeting screening at the most deprived areas were calculated 
in each ethnic group (see Figure 5-3). This was then compared with mass 
screening using an incremental approach, which assessed the additional costs 
and benefits of extending the targeted programme to the whole population. 
The targeted screening strategy was based on screening the most deprived IMD 
2004 quintile. The overall proportion screened; the proportion of high-risk 
individuals screened (and therefore identified); the proportion screened who 
would be found to be at high-risk and the number needed to screen to identify 
one person at high cardiovascular risk were calculated in each ethnic group. The 
proportion of the high-risk population identified is a measure of how many of the 
high-risk individuals in each ethnic group would be identified by targeting 
screening at the most deprived areas and is therefore a measure of coverage; 
the proportion screened found to be at high-risk demonstrates how many of the 
individuals living in the most deprived areas are found to have high 
cardiovascular risk and is therefore an indicator of the efficiency of the 
screening strategy. This latter value is equivalent to the positive predictive 
value (PPV) and was used to calculate the number needed to screen (NNS) to 
identify one individual at high cardiovascular risk (NNS=1/PPV). The mean cost 
to identify one high-risk individual was calculated by multiplying the number 
needed to screen by the estimated unit cost.  
An incremental analysis was then carried out to assess the additional costs and 
benefits from extending targeted screening to the whole population (mass 
screening). The additional proportion of each ethnic group screened, additional 
proportion of the high-risk population identified, proportion of the additional 
screened population found to be at high-risk and number needed to screen to 
identify one additional person at high cardiovascular risk were calculated for 
each ethnic group. An incremental cost-effectiveness ratio was then calculated 
from the additional number needed to screen multiplied by the estimated unit 
cost. This type of analysis, in which the cost-effectiveness of one intervention is 
compared with another rather than with no intervention, is consistent with the 
approach recommended by NICE (3). 
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Figure 5-3: Values used in targeted screening and incremental analysis 
calculations 
 
5.2.6 Sensitivity,analyses,
Throughout this methods section a number of alternative methodological 
approaches have been described that were used to test the robustness of the 
results. In summary these were: 
• Analysis without simulation of atrial fibrillation, chronic kidney disease and 
rheumatoid arthritis variables (prevalence assumed to be zero) 
• Analysis using minimum and maximum Townsend scores within each quintile, 
rather than mean score 
• Complete case analysis 
• Analysis using Framingham and Ethrisk cardiovascular risk calculators instead 
of QRISK2 
Sensitivity analyses of cost and uptake were also considered. However, varying 
the costs between a minimum and maximum value would not have affected any 
ethnic differences observed because the cost would be varied uniformly across 
the ethnic groups. For instance, although unit costs of £10 or £40 would produce 
different mean costs to identify one high-risk individual, the numbers needed to 
screen, and any ethnic differences in them, would be unchanged. This type of 
analysis would have been appropriate if the costs were to be scaled to a 
population level in order to describe the potential overall costs of a 
cardiovascular risk screening programme, but this was not the aim of this study. 
Likewise, varying uptake uniformly across the ethnic groups would not have 
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Targeted screening Incremental analysis 
Coverage = (a+b)/(a+b+c+d) 
Proportion of high-risk population 
identified = a/(a+c) 
Proportion of screened population at 
high-risk = a/(a+b) 
 
Additional coverage = (c+d)/(a+b+c+d)  
Additional coverage of high-risk 
population = c/(a+c)  
Proportion of additional screened 
population at high-risk = c/(c+d) 
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altered any ethnic differences observed, and evidence for ethnic differences in 
screening uptake is unclear (see section 3.7.7.1).  
5.2.7 Software,used,
All analyses were carried out using Stata V.12 and Microsoft Excel.  
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5.3 Results 
5.3.1 Demographic,and,cardiovascular,characteristics,
The sample comprised 493 black Caribbean, 532 Indian, 516 
Pakistani/Bangladeshi, 617 Irish and 7,249 people from the general population of 
whom 6,633 were white (see Table 5-8). Demographic characteristics varied by 
ethnicity. Compared to the general population, the Indian and 
Pakistani/Bangladeshi groups were significantly younger, there were significantly 
fewer men in the black Caribbean and Irish groups, and significantly higher 
proportions of the black Caribbean, Pakistani/Bangladeshi and Irish groups lived 
in the most deprived quintile. 
Cardiovascular characteristics also varied by ethnicity (see Table 5-8). The 
prevalence of diabetes was significantly higher in the black Caribbean, Indian 
and Pakistani/Bangladeshi groups compared to the general population. The 
prevalence of a family history of CVD was also significantly higher in Indian and 
Pakistani/Bangladeshi groups, although it was significantly lower in the black 
Caribbean group, compared to the general population. In contrast, lower 
proportions of the black Caribbean, Indian and Pakistani/Bangladeshi groups 
were current smokers than the general population. Mean systolic blood pressure 
was significantly lower in the Indian and Pakistani/Bangladeshi groups than in 
the general population, with significantly higher proportions of the black 
Caribbean, Indian and Pakistani/Bangladeshi groups taking antihypertensive 
medication. Total cholesterol was significantly lower in the black Caribbean, 
Indian, Pakistani/Bangladeshi and Irish groups compared to the general 
population, although HDL cholesterol was also significantly lower in the black 
Caribbean, Indian and Pakistani/Bangladeshi groups. Compared to the general 
population, mean body mass index was significantly higher in the black 
Caribbean group but significantly lower in the Indian and Irish groups. 
5.3.2 Targeted,screening,
There were ethnic differences in the effectiveness and cost-effectiveness of 
targeted screening in detecting individuals at high cardiovascular risk.  
Targeted screening of the most deprived quintile would result in higher 
proportions of ethnic minority groups being screened compared to the general 
population and white group (see Table 5-9). Overall, 58.2% of the 
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Pakistani/Bangladeshi group and 44.1% of the black Caribbean group would be 
screened, compared with only 14.1% of the general population. Targeted 
screening would also result in greater coverage of high-risk individuals among 
ethnic minority groups than in the general population or white group; 68.7% of 
high-risk Pakistani/Bangladeshi individuals and 69.8% of high-risk black 
Caribbean individuals would be identified in contrast to only 19.2% of high-risk 
individuals from the general population. Among ethnic minority groups, higher 
proportions of the screened populations would be found to be at high risk 
compared to the general population. For instance, 39.9% of screened 
Pakistani/Bangladeshi individuals and 34.9% of screened Irish individuals would 
be found to be at high risk compared to 24.2% of the general population. This 
would result in a lower number needed to screen to detect one high-risk 
individual in ethnic minority groups than in the general population and white 
group.  The lowest number needed to screen was observed in the 
Pakistani/Bangladeshi group where only 2.5 people would need to be screened 
to detect one person at high cardiovascular risk incurring a cost of £59. In 
comparison, in the general population 4.1 people would need to be screened at 
a cost of £98. 
5.3.3 Comparison,of,mass,and,targeted,screening,
In all ethnic groups, targeted screening was more cost-effective than mass 
screening (see Table 5-9). If targeted screening were expanded to mass 
screening there would be a lower prevalence of high-risk individuals among the 
additional screened population with a higher cost to identify additional high-risk 
individuals. However, the actual figures varied by ethnicity. The proportion of 
the additional screened population found to be at high risk was lowest in the 
black Caribbean and Irish groups, and therefore the number needed to screen to 
identify an additional high-risk individual and the associated cost of doing so was 
highest in these groups (additional numbers needed to screen 11.3 and 6.8 at 
costs of £269 and £161, respectively). In contrast, the additional number needed 
to screen was lowest in the Pakistani/Bangladeshi group (4.0) with a lower 
associated cost (£94). Incremental results for the Indian group were similar to 
the general population and white group. 
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5.3.4 Sensitivity,analyses,
5.3.4.1 Alternative(cardiovascular(risk(calculators(
Repeating the analysis using the Framingham and Ethrisk cardiovascular risk 
calculators produced results that were broadly comparable with the main 
analysis (see Table 5-10 and Table 5-11). With respect to targeted screening, the 
number needed to screen to detect one high-risk individual and the associated 
cost of doing so were lowest in the Pakistani/Bangladeshi and Irish groups with 
both Framingham and Ethrisk. Similar to the main analysis there were ethnic 
differences in the cost-effectiveness of expanding targeted to mass screening, 
and targeted screening was more cost-effective than mass screening in all ethnic 
groups. Whilst, generally speaking, the direction of observed ethnic differences 
was consistent with the main analysis, the size of the differences calculated 
using Framingham and Ethrisk varied. 
5.3.4.2 Complete(case(analysis(
Analysis of complete cases only gave results that were consistent with the main 
analysis (see Table 5-12). For targeted screening, the lowest number needed to 
screen to detect one person at high cardiovascular risk and the cost of doing so 
were lowest in the Indian and Pakistani/Bangladeshi groups. Targeted screening 
was more cost-effective than mass screening across the ethnic groups, although 
it was not possible to calculate this result in the black Caribbean group due to 
limited numbers in the sample. 
5.3.4.3 Estimated(variables(in(QRISK2((
Analyses using alternative estimated Townsend scores, and atrial fibrillation, 
rheumatoid arthritis and chronic kidney disease variables produced results that 
were consistent with the main analysis. Varying the estimated Townsend 
deprivation scores from the minimum to the maximum value within each quintile 
shifted the number needed to screen higher and lower, respectively. The effect 
was consistent across the ethnic groups and reflected lower proportions of the 
population being at high cardiovascular risk using the minimum quintile value, 
which denotes lower socioeconomic deprivation, and vice versa. The effect of 
assuming that the prevalence of atrial fibrillation, rheumatoid arthritis and 
chronic kidney disease was zero was to slightly reduce the proportion of the 
sample at high cardiovascular risk (see Table 5-13). This marginally increased 
the number needed to screen to detect one person at high cardiovascular risk, 
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and the associated cost, for targeted screening and in the incremental analysis. 
This small reduction in number needed to screen occurred across all ethnic 
groups, although it was slightly larger in the black Caribbean group. 
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Table 5-8: Demographic and cardiovascular characteristics by ethnic group 
 
 General population
a Black Caribbean Indian Pakistani / Bangladeshi Irish White
a 
n 7,249 493 532 516 617 6,633 
Age (Mean (SD)) 54.2 (9.6) 53.5 (10.7) 51.7 (8.7) 51.4 (9.3) 54.1 (9.4) 54.4 (9.6) 
p-value  0.150 <0.001 <0.001 0.952 0.174 
Male (%) 48.1 41.5 44.3 47.7 42.3 48.0 
p-value  0.004 0.096 0.855 0.006 0.659 
Most deprived quintile (%) 14.2 44.1 15.5 58.0 18.0 13.0 
p-value  <0.001 0.368 <0.001 0.012 0.053 
Smoking statusb       
Non-smoker (%) 42.3 59.2 76.7 72.4 37.5 40.7 
Ex-smoker (%) 34.9 21.5 10.9 9.4 36.6 36.2 
Light smoker (%) 4.9 10.2 6.4 7.1 5.7 4.6 
Moderate smoker (%) 9.0 6.2 4.8 7.4 9.7 9.1 
Heavy smoker (%) 8.9 2.9 1.2 3.7 10.5 9.4 
p-value  <0.001 <0.001 <0.001 0.177 0.268 
Family history CVD (%) 14.9 11.2 18.6 16.8 12.7 14.9 
p-value  <0.001 <0.001 <0.001 <0.001 0.180 
Taking anti-hypertensive medication (%) 15.9 27.1 21.3 21.7 17.3 15.4 
p-value  <0.001 0.002 0.001 0.331 0.513 
Diabetes (%) 3.9 13.2 11.1 17.8 3.0 3.5 
p-value  <0.001 <0.001 <0.001 0.382 0.244 
Systolic blood pressure (Mean (SE)) 131.8 (0.25) 132.0 (1.18) 128.2 (0.94) 128.1 (1.00) 130.1 (0.95) 132.0 (0.26) 
p-value  0.845 <0.001 <0.001 0.074 0.488 
Total cholesterol (Mean (SE)) 5.9 (0.02) 5.6 (0.08) 5.6 (0.06) 5.5 (0.07) 5.8 (0.06) 6.0 (0.02) 
p-value  <0.001 <0.001 <0.001 0.031 0.153 
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Reference group for p-values is general population. a General population and white data from HSE 2003; b Light smoker is less than 10 cigarettes per day, 
moderate smoker 10-19 cigarettes per day, and heavy smoker 20 or more cigarettes per day. SD standard deviation, CVD cardiovascular disease, SE 
standard error, HDL high-density lipoprotein, BMI body mass index
Table 5-8 continued…       
HDL cholesterol (Mean (SE)) 1.5 (0.01) 1.4 (0.02) 1.4 (0.02) 1.4 (0.02) 1.6 (0.02) 1.5 (0.01) 
p-value  <0.001 <0.001 <0.001 0.411 0.427 
BMI (Mean (SE)) 27.7 (0.06) 28.9 (0.26) 27.2 (0.21) 28.0 (0.23) 27.2 (0.23) 27.7 (0.06) 
p-value  <0.001 0.023 0.226 0.017 0.850 
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Table 5-9: Cost-effectiveness of targeted and mass screening for high cardiovascular risk by ethnic group 
  
General 
populationa 
Black 
Caribbean Indian 
Pakistani / 
Bangladeshi Irish Whitea 
Targeted screening at most deprived quintile       
Proportion of ethnic group screened  14.1% 44.1% 15.5% 58.2% 18.0% 13.0% 
Proportion of high-risk population identified 19.2% 69.8% 23.3% 68.7% 34.2% 17.9% 
Proportion of screened population at high-risk 24.2% 25.9% 30.0% 39.9% 34.9% 24.8% 
NNSb 4.1 3.9 3.3 2.5 2.9 4.0 
Mean cost to detect one person at high cardiovascular risk £98 £92 £79 £59 £68 £96 
Incremental analysis of mass screening       
Additional coverage of ethnic group 85.9% 55.9% 84.5% 41.8% 82.0% 87.0% 
Additional coverage of high-risk population  80.8% 30.2% 76.7% 31.3% 65.8% 82.1% 
Proportion of additional screened population at high-risk 16.8% 8.8% 18.2% 25.3% 14.7% 17.0% 
Additional NNSb 6.0 11.3 5.5 4.0 6.8 5.9 
Mean cost to detect one additional person at high 
cardiovascular riskc £141 £269 £130 £94 £161 £139 
a White and general population data from HSE 2003; b NNS number needed to screen; c This number is also the incremental cost-effectiveness ratio 
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 Table 5-10: Cost-effectiveness of targeted and mass screening for high cardiovascular risk by ethnic group using Framingham 
cardiovascular risk calculator 
 a White and general population data from HSE 2003; b NNS number needed to screen; c Also the incremental cost-effectiveness ratio 
  
General 
populationa 
Black 
Caribbean Indian 
Pakistani / 
Bangladeshi Irish Whitea 
Targeted screening at most deprived quintile       
Proportion of ethnic group screened  14.1% 44.1% 15.5% 58.0% 18.0% 13.0% 
Proportion of high-risk population identified 16.8% 71.3% 16.5% 71.4% 29.0% 15.9% 
Proportion of screened population at high-risk 22.6% 27.3% 23.5% 29.3% 31.6% 23.2% 
NNSb 4.4 3.7 4.2 3.4 3.2 4.3 
Mean cost to detect one person at high cardiovascular risk £105 £87 £101 £81 £75 £102 
Incremental analysis of mass screening       
Additional coverage of ethnic group 85.9% 55.9% 84.5% 42.0% 82.0% 87.0% 
Additional coverage of high-risk population  83.2% 28.7% 83.5% 28.6% 71.0% 84.1% 
Proportion of additional screened population at high-risk 18.4% 8.7% 21.9% 16.3% 16.9% 18.4% 
Additional NNSb 5.4 11.5 4.6 6.2 5.9 5.4 
Mean cost to detect one additional person at high 
cardiovascular riskc £129 £273 £108 £146 £140 £129 
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Table 5-11: Cost-effectiveness of targeted and mass screening for high cardiovascular risk by ethnic group using Ethrisk 
cardiovascular risk calculator 
  
General 
populationa 
Black 
Caribbean Indian 
Pakistani / 
Bangladeshi Irish Whitea 
Targeted screening at most deprived quintile       
Proportion of ethnic group screened  13.9% 42.1% 14.0% 56.3% 17.4% 12.9% 
Proportion of high-risk population identified 16.4% 63.2% 18.3% 65.0% 26.1% 15.8% 
Proportion of screened population at high-risk 20.1% 21.4% 20.7% 21.6% 30.8% 21.1% 
NNSb 5.0 4.7 4.8 4.6 3.2 4.7 
Mean cost to detect one person at high cardiovascular risk £118 £111 £115 £110 £77 £112 
Incremental analysis of mass screening       
Additional coverage of ethnic group 86.1% 57.9% 86.0% 43.7% 82.6% 87.1% 
Additional coverage of high-risk population  83.6% 36.8% 81.7% 35.0% 73.9% 84.2% 
Proportion of additional screened population at high-risk 16.6% 9.0% 15.0% 15.0% 18.4% 16.6% 
Additional NNSb 6.0 11.1 6.7 6.7 5.4 6.0 
Mean cost to detect one additional person at high 
cardiovascular riskc £143 £262 £158 £158 £129 £143 
a White and general population data from HSE 2003 with cardiovascular risk calculated using Framingham risk calculator; b NNS number needed to 
screen; c This number is also the incremental cost-effectiveness ratio 
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Table 5-12: Complete case analysis results for cost-effectiveness of targeted and mass screening for high cardiovascular risk by ethnic 
group 
  
General 
populationa 
Black 
Caribbean Indian 
Pakistani / 
Bangladeshi Irish Whitea 
Targeted screening at most deprived quintile       
Proportion of ethnic group screened  10.9% 48.4% 14.6% 48.9% 13.2% 10.1% 
Proportion of high-risk population identified 16.7% 100.0% 40.6% 57.7% 24.2% 15.9% 
Proportion of screened population at high-risk 23.0% 12.9% 41.5% 32.6% 18.8% 23.9% 
NNSb 4.4 7.8 2.4 3.1 5.3 4.2 
Mean cost to detect one person at high cardiovascular risk £103 £184 £57 £73 £126 £99 
Incremental analysis of mass screening       
Additional coverage of ethnic group 89.1% 51.6% 85.4% 51.1% 86.8% 89.9% 
Additional coverage of high-risk population  83.3% 0.0% 59.4% 42.3% 75.8% 84.1% 
Proportion of additional screened population at high-risk 14.1% 0.0% 10.4% 22.9% 8.9% 14.2% 
Additional NNSb 7.1 § 9.6 4.4 11.2 7.0 
Mean cost to detect one additional person at high 
cardiovascular riskc £169 § £228 £103 £265 £167 
a White and general population data from HSE 2003; b NNS number needed to screen; c This number is also the incremental cost-effectiveness ratio; § 
No value as there were no black Caribbean individuals with high cardiovascular risk in less deprived areas
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Table 5-13: Cost-effectiveness of targeted and mass screening for high cardiovascular risk by ethnic group with prevalence of atrial 
fibrillation, rheumatoid arthritis and chronic kidney disease assumed to be zero 
  
General 
populationa 
Black 
Caribbean Indian 
Pakistani / 
Bangladeshi Irish Whitea 
Targeted screening at most deprived quintile       
Proportion of ethnic group screened  14.1% 44.1% 15.5% 58.2% 18.0% 13.0% 
Proportion of high-risk population identified 19.6% 69.4% 22.1% 68.4% 34.9% 18.1% 
Proportion of screened population at high-risk 22.7% 23.0% 27.2% 38.1% 33.5% 22.9% 
NNSb 4.4 4.3 3.7 2.6 3.0 4.4 
Mean cost to detect one person at high cardiovascular risk £105 £103 £87 £62 £71 £103 
Incremental analysis of mass screening       
Additional coverage of ethnic group 85.9% 55.9% 84.5% 41.8% 82.0% 87.0% 
Additional coverage of high-risk population  80.4% 30.6% 77.9% 31.6% 65.1% 81.9% 
Proportion of additional screened population at high-risk 15.3% 8.0% 17.6% 24.6% 13.7% 15.5% 
Additional NNSb 6.5 12.5 5.7 4.1 7.3 6.5 
Mean cost to detect one additional person at high 
cardiovascular riskc £155 £297 £134 £96 £173 £153 
a White and general population data from HSE 2003; b NNS number needed to screen; c This number is also the incremental cost-effectiveness ratio
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5.4 Discussion 
5.4.1 Principal-findings-
Higher proportions of ethnic minority groups would be screened using a targeted 
screening strategy than in the general population or white group. In particular, 
high proportions of the Pakistani/Bangladeshi and black Caribbean groups would 
be identified by targeted screening of the most deprived areas. Coverage of 
high-risk individuals by targeted screening was good in the general population 
but was higher in ethnic minority groups. Targeted screening was more efficient 
and cost-effective at identifying high-risk individuals in all ethnic minority 
groups than in the general population, especially in the Pakistani/Bangladeshi 
group. Despite similar coverage of high-risk individuals, targeted screening 
performed relatively well in the Indian group where it was more efficient and 
cost-effective than in the general population. 
In comparison with targeted screening, mass screening was less cost-effective in 
all ethnic groups. The cost per additional high-risk individual identified was 
lowest in the Indian and Pakistani/Bangladeshi groups. However, there was a 
greater difference between the Pakistani/Bangladeshi group and the general 
population than between the Indian group and general population. This suggests 
that both strategies would be more cost-effective in South Asian groups, 
particularly for the Pakistani/Bangladeshi group, than in the general population. 
In contrast, the cost per additional high-risk individual identified was highest in 
the black Caribbean group, suggesting that extending targeted screening to the 
whole population would be less cost-effective in this group than in the general 
population. 
5.4.2 Strengths-and-limitations-
This analysis used the QRISK2-2012 cardiovascular risk calculator. QRISK2-2012 
was chosen as it may be a more accurate predictor of cardiovascular risk in the 
UK than the Framingham calculator, and may be particularly relevant for ethnic 
minority and socioeconomically deprived individuals (444, 448). However, the 
use of QRISK2-2012 required estimation of a number of variables that were not 
available in the HSE 2003 and 2004, namely Townsend score, atrial fibrillation, 
chronic kidney disease and rheumatoid arthritis. This may have led to 
inaccuracies in the QRISK2-2012 scores, although sensitivity analyses using 
different estimated Townsend scores and with zero prevalence of atrial 
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fibrillation, chronic kidney disease and rheumatoid arthritis produced results 
that were consistent with the main analysis. In addition, the estimations were 
carried out consistently across all ethnic groups so are unlikely to have 
introduced systematic errors between the groups. This is relevant as the focus of 
this analysis was to investigate ethnic differences rather than produce 
estimations of cost-effectiveness to be used at a population level, for which 
inaccuracies in absolute estimated values would be important. The same 
prevalence estimates for atrial fibrillation, chronic kidney disease and 
rheumatoid arthritis were used across the ethnic groups. Whilst there is 
evidence of ethnic differences in the prevalence of these conditions (520-523), 
ethnic group specific prevalence estimates by age group could not be found. 
QRISK2 provides prevalence estimates by ethnicity but not stratified by age 
(438). Given that the prevalence of these conditions increases markedly with age 
it was decided that age specific estimates were most appropriate. However, 
incorporating ethnic differences in the prevalence of these conditions could 
have strengthened this analysis, and potentially added to the ethnic differences 
observed. Family history was defined differently in the HSE and by QRISK2-2012. 
The use of the HSE definition may have underestimated cardiovascular risk as it 
only included parental mortality rather than morbidity or mortality in any first 
degree relative, although with a higher age threshold and a broader inclusion of 
CVD conditions. Individuals taking lipid-lowering medications were not excluded 
from this analysis. Whilst QRISK2 recommends the exclusion of these individuals 
this was not possible given the design of the survey – there was a high proportion 
of missing data on this variable, which was measured at the nurse visit, meaning 
that it would not be possible to accurately exclude these individuals without 
potentially biasing the results of the multiple imputation model. Including these 
individuals may have led to an underestimation of the cost-effectiveness of both 
targeted and mass screening, as people taking lipid-lowering medication may 
have iatrogenically lowered cholesterol levels that could reduce their QRISK2-
2012 score.  
There was a high proportion of missing data on variables such as cholesterol and 
blood pressure. A widely accepted method of dealing with missing data - 
multiple imputation – was therefore used. Steps were taken to ensure that the 
imputed data were consistent with the original data. The multiple imputation 
model used 100 imputations. Whilst this is a higher number of imputations than 
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has been used in previous studies, this approach was based on literature that 
suggests that high numbers of imputations should be used (518). An alternative 
approach to multiple imputation would have been to analyse complete cases 
only. However, this could have biased the results, especially if the 
representativeness of individuals with complete data varied by ethnicity, and 
would have further limited the sample size. Despite this, sensitivity analysis 
including complete cases only produced results that were broadly consistent 
with the main analysis.  
The survey data used were limited by the age of the data and the sample size. 
These data from 2003 and 2004 will not reflect recent changes in the 
demographic or cardiovascular characteristics of the general population or 
ethnic minority groups. For instance, there is evidence of increasing movement 
of some ethnic minority populations to more affluent areas (524), a change that 
could reduce the cost-effectiveness of targeted screening of the most deprived 
areas. Small sample sizes precluded the inclusion of some ethnic groups in the 
analysis. In particular, the Chinese and black African groups were excluded 
based on a judgement of what sample size was reasonable for inclusion in the 
analysis. The Pakistani and Bangladeshi groups were merged because of small 
numbers; however, separate analyses of these groups produced consistent 
results. The Chinese group may have been an important group to include given 
the relatively low prevalence of CVD among Chinese populations, which may 
have led to contrasting findings compared to the other ethnic groups. Merging 
additional years of the HSE with the 2004 survey, in order to increase the sample 
sizes, was considered but not done as the additional benefit in terms of 
increased numbers of ethnic minority participants was small and differences in 
sampling procedures between the years meant there were technical difficulties 
in accurately weighting the merged sample. Despite these limitations, it was not 
possible to identify an alternative source of more recent data with a sufficiently 
large sample of ethnic minority individuals. The alternative sources discussed in 
the previous chapter (Census data and Understanding Society) would not have 
been appropriate as data on physical measurements, in particular cholesterol 
and blood pressure, were needed. Another option would have been to use UK 
Biobank data (525). At the time of this analysis cholesterol concentrations from 
this large survey were unavailable, however in future UK Biobank will provide a 
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useful source of up-to-date data on sufficiently large numbers of ethnic minority 
individuals.  
This analysis did not consider socioeconomic or ethnic differences in the uptake 
of cardiovascular risk screening. Whilst evidence from the NHS Health Check 
programme suggests that there may be reduced uptake in deprived areas (526), 
there is no consistent evidence on the nature or direction of ethnic differences 
in the uptake of public health interventions (see section 3.7.7.1). Nevertheless, 
differences in uptake would need to be considered in the implementation and 
evaluation of any targeted or mass cardiovascular risk screening programme, as 
they could impact on the effectiveness of screening and on socioeconomic or 
ethnic health inequalities. 
This analysis only considered costs of screening, rather than additional costs of 
subsequent treatment and follow-up. These additional costs would be 
particularly important if the costs were to be scaled to a population level in 
order to provide an estimated total cost for a mass or targeted screening 
programme. However, this was not the aim of this analysis, which was instead 
concerned with investigating relative ethnic differences in the cost-effectiveness 
of identifying high-risk individuals. 
The statistical significance of the observed ethnic differences in cost-
effectiveness was not assessed in this analysis. This means that it is not possible 
to state whether targeted or mass screening would be significantly more or less 
cost-effective in one ethnic group compared to another. It has been argued that 
consideration of uncertainty in economic analysis may be helpful for decision 
makers, particularly if it provides information about whether further data are 
needed to reduce uncertainty (527). However, the approach used in this analysis 
is consistent with other economic theory, whereby Claxton argues that the 
results of statistical tests of significance or precision, such as confidence 
intervals, are not relevant to decision making in health where a choice between 
interventions needs to be made at a particular time (528). This reflects the 
choices that policy makers continue to make between cardiovascular risk 
screening strategies, where one approach must be chosen over another 
regardless of the statistical significance of differences in cost-effectiveness. 
Whilst the decision was made not to include tests of statistical significance in 
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this analysis on this basis, future analyses could benefit from exploration of 
statistical uncertainty.  
5.4.3 Relations-to-other-studies-
Mass screening for high cardiovascular risk has been found to be less cost-
effective than a range of alternative strategies in the general population. 
Lawson et al found that targeted screening based on area deprivation and family 
history was more cost-effective than mass screening in a Scottish population 
(192). Their analysis indicated that targeting deprived areas would identify 25% 
of high-risk individuals with a number needed to screen of 3.0. This contrasts 
with the results from the general population in this analysis, where 19.2% of 
high-risk individuals would be identified with a higher number needed to screen 
of 4.1. These differences could be explained by variations in levels of 
socioeconomic deprivation and cardiovascular risk between England and 
Scotland, alongside the used of different cardiovascular risk calculators in these 
analyses. Chamnan et al and Marshall and Rouse also found that mass screening 
was potentially less cost-effective and efficient that alternative strategies such 
as pre-stratifying individuals by cardiovascular risk (171, 173). However, these 
studies did not investigate the use of targeted screening of deprived areas 
limiting further comparisons that can be made with this analysis. Moreover, this 
analysis differs from this previous evidence as it explores ethnic differences 
rather than studying the general population. 
The ethnic differences observed in deprivation and the prevalence of 
cardiovascular risk factors were broadly consistent with previous studies. The 
significantly higher proportion of the black Caribbean, Pakistani/Bangladeshi and 
Irish groups living in the most deprived areas in this analysis corresponds to 
knowledge of the concentration of these ethnic minority groups into deprived 
areas (308, 309, 452, 457). Similar to this analysis, a range of previous studies 
have demonstrated a higher risk of diabetes mellitus (11, 269, 271), and lower 
prevalence of smoking (271, 272), in South Asian and black Caribbean ethnic 
groups. The lower mean systolic blood pressure in the Indian and 
Pakistani/Bangladeshi groups in this analysis is consistent with previous evidence 
(269, 270), although a significantly higher systolic blood pressure was not 
observed in the black Caribbean group despite evidence of increased blood 
pressure in this ethnic group (270, 275). This discrepancy could be accounted for 
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by differences in the specific populations studied or in the age of the data (Lane 
et al and Whitty et al’s measurements were carried out 20-30 years earlier than 
the HSE 2003 and 2004). Also, compared to White individuals, higher proportions 
of black Caribbean, Indian and Pakistani/Bangladeshi individuals were taking 
anti-hypertensive medication, which may have lowered the observed blood 
pressure values. Evidence of ethnic differences in cholesterol concentrations is 
mixed; the observation in this analysis of lower total cholesterol but lower HDL 
cholesterol in the black Caribbean, Indian and Pakistani/Bangladeshi groups 
partially corresponds with findings by Bhopal et al and Tillin et al (269, 272), but 
contrasts with evidence of there being limited ethnic differences in cholesterol 
concentrations (10, 273). Ethnic differences in mean body mass index in this 
analysis are consistent with previous evidence of a higher prevalence of obesity 
in black Caribbean populations (11), and lower prevalence in South Asian 
populations (271). However, South Asian individuals may also have a higher 
prevalence of central obesity (269, 279), a measurement that was not included 
in this analysis.  
Area deprivation measures may provide an efficient and effective way of 
focusing limited public health resources on at risk populations (181, 182). The 
previous analyses in this thesis found that area deprivation measures are better 
at identifying individual socioeconomic deprivation in ethnic minority groups in 
England. This suggests that area deprivation measures may be a sufficiently 
effective and efficient tool for targeting cardiovascular risk screening at 
deprived ethnic minority populations. The purpose of this would be to identify 
areas in which high concentrations of socioeconomically deprived individuals live 
because socioeconomically deprived individuals are known to be at increased 
risk of CVD, either through the presence of other cardiovascular risk factors or 
because of the independent effect of deprivation itself (see section 2.2) (28, 29, 
31). However, area deprivation measures are subject to the “ecological fallacy” 
(178, 181), meaning that not all individuals screened will be socioeconomically 
deprived, and deprived individuals living outside of the most deprived areas will 
not be offered screening. This could reduce the efficiency of CVD prevention 
programmes targeted at deprived areas, as this is influenced by the 
concentration of risk in the target population, which may not be as high as 
expected. In addition, if socioeconomically deprived individuals living in less 
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deprived areas are systematically excluded, this could decrease the potential for 
the intervention to reduce health inequalities.  
Further to the potential to identify and influence individuals, CVD prevention 
programmes targeted at deprived areas also have the potential to improve 
health through the modification of area characteristics. This is because of the 
independent association between individual and area socioeconomic deprivation 
and CVD (178, 184), and provides another reason for supporting the use of area-
based interventions in CVD prevention. However, promoting healthy 
environments, for example by creating easier access to physical activity, would 
require a different type of intervention to one based on individual cardiovascular 
risk screening, such as that analysed here.  
5.4.4 Implications-
This analysis suggests that both mass and targeted cardiovascular risk screening 
are more efficient and cost-effective in high-risk ethnic minority groups 
compared to the general population. Whilst targeted screening may be more 
efficient and cost-effective than mass screening, especially in ethnic groups with 
high levels of cardiovascular risk and socioeconomic deprivation, mass screening 
may also be a relatively cost-effective option in these groups. This is reassuring 
as it suggests that both approaches have the potential to reduce ethnic health 
inequalities. For decision makers choosing between targeted and mass screening 
for high cardiovascular risk in the population as a whole, this analysis indicates 
that either strategy is likely to work well in ethnic minority groups with little 
evidence that any of the ethnic groups studied here would be systematically 
disadvantaged.  
These findings could potentially be generalisable to ethnic minority groups with 
similar demographic and cardiovascular characteristics in other settings. Ethnic 
minority groups in countries such as the USA and New Zealand are known to be 
at increased risk of CVD and to be concentrated in socioeconomically deprived 
areas (257, 296, 453, 455), characteristics that suggest that cardiovascular 
screening could be useful in these groups, especially if it is targeted at deprived 
areas. However, given international differences in the geographical distribution 
of socioeconomic deprivation and ethnic minority populations any generalisation 
would need to be done with caution.  
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5.4.5 Next-steps-
These analyses focused on ethnic differences in the application of a high-risk 
approach to CVD prevention. However, as discussed in Chapter 2, population 
approaches may offer greater potential to prevent CVD than high-risk 
approaches. Therefore, a further policy choice needs to be considered – the 
choice between population and high-risk approaches. This raises the question of 
whether there are ethnic differences in the potential impact of population and 
high-risk approaches to CVD prevention. The next chapter addresses this 
question. 
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6 Chapter 6: Ethnic differences in the impact of population 
versus high-risk approaches to primary prevention of 
cardiovascular disease 
6.1 Introduction 
The previous chapter explored ethnic differences in the cost-effectiveness of a 
high-risk approach to CVD prevention. This chapter moves on to investigate both 
high-risk and population approaches to CVD prevention, and in particular 
whether there are ethnic differences in the relative effectiveness of these 
approaches. Population and high-risk approaches to CVD prevention were 
introduced and reviewed in Chapter 2, whilst ethnic differences in CVD were 
reviewed in Chapter 3. Relevant points arising from these chapters are 
summarised here. 
A population approach to CVD prevention involves reducing cardiovascular risk 
factors by a small amount across the whole population (91). This could occur by, 
for example, reducing the salt content of processed food to lower blood 
pressure, or by introducing comprehensive tobacco control measures to reduce 
smoking prevalence and exposure. In contrast, the high-risk approach targets 
preventative interventions on individuals deemed to be at high-risk of 
developing CVD (91). Examples of high-risk approaches include cardiovascular 
screening and risk reduction programmes, such as the NHS Health Check 
programme (159). Population approaches may lead to a large reduction in CVD 
at a population level but with small risk reduction for individuals; in contrast 
high-risk approaches may produce a greater risk reduction for individuals but a 
smaller reduction in CVD in the population (91).  
Health policy makers need to decide on the extent to which they invest in 
population or high-risk approaches to primary prevention. Evidence on which 
approach has the greatest potential to prevent CVD at a population level is 
mixed (108, 109, 111), as described in Chapter 2. The general consensus is that a 
combination of both approaches is needed, although the ideal balance is not 
known. Current CVD primary prevention policy includes both approaches, but 
tends to favour high-risk interventions. The NHS Health Check programme, 
estimated by the Department of Health to cost over £200m per year to the NHS 
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(although this may be an underestimate of the cost (529)) (159), demonstrates a 
commitment to a high-risk strategy. Population approaches, such as elimination 
of trans fatty acids from the food chain and minimum pricing for alcohol, have 
also been recommended but not yet acted upon (18, 530).  
Given that public health policies need to both prevent disease and reduce health 
inequalities, it is important that their potential impact on important population 
subgroups, such as ethnic minorities, is considered (4, 5, 199). There are well-
established ethnic differences in CVD and cardiovascular risk factors, as 
described in Chapter 3. For instance, individuals from South Asian groups are 
known to be at increased risk of CVD (239), there are ethnic differences in 
smoking prevalence (11), and blood pressure may be higher in black populations 
(10). This could impact the effectiveness of population and high-risk approaches 
if the prevalence of the risk factor to be reduced varies by ethnicity, or if a 
higher proportion of an ethnic group is categorised as being at high 
cardiovascular risk. However, it is unclear whether the effectiveness of 
population and high-risk approaches to CVD prevention differs across ethnic 
groups.  
This chapter therefore addresses the following research question: 
Are there ethnic differences in the potential impact of population and 
high-risk approaches to CVD prevention? 
In this chapter potential impact is assessed in terms of both effectiveness and 
impact on health inequalities. Similar to the previous two chapters, the 
intention of these analyses was to explore the potential impact of policies 
designed for the population as a whole rather than policies for specific ethnic 
groups.  
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6.2 Methods 
6.2.1 Data-and-participants-
Cross-sectional data from the Health Survey for England (HSE) 2003 and 2004 
were used (486, 503), as described in Chapters 4 and 5. Adults aged 35-74 years 
were included in these analyses. Population approaches to CVD prevention may 
impact on a wider age range than cardiovascular screening programmes so a 
broader age group was selected than in the previous analyses in order to capture 
this. Participants with a self-reported history of CVD (angina, myocardial 
infarction or stroke) were excluded. Black Caribbean, Indian, Pakistani, 
Bangladeshi, Irish and white participants were included. Similar to the previous 
chapter, the Pakistani and Bangladeshi groups were merged because of small 
numbers. The black African and Chinese groups were excluded due to small 
numbers. Interview weights, provided by the HSE, were applied. 
6.2.2 Cardiovascular-risk-calculation-
QRISK2-2012 was used to estimate the 10-year risk of a cardiovascular event 
(angina, myocardial infarction, stroke or transient ischaemic attack) for each 
individual using the same method as the previous chapter (see Chapter 5).  
6.2.3 Missing-data-
The dataset contained large proportions of missing data on variables required for 
the calculation of QRISK2-2012, namely on cholesterol (45.1%) and blood 
pressure (40.6%), with smaller amounts on body mass index (12.1%) and family 
history of CVD (7.5%). Therefore, multiple imputation was used to impute values 
for these missing data in the same way as in the previous chapter (see section 
5.2.4.2). The open source QRISK2-2012 calculator was applied to each imputed 
data set and a mean QRISK2-2012 score calculated for each individual (see 
section 5.2.4.2) (519).  
6.2.4 Population-approach-
Models were developed to simulate the potential risk factor changes that would 
result from a population approach to primary prevention of CVD. These models 
were based on reductions in cholesterol, blood pressure, body mass index and 
smoking. These modifiable risk factors were selected to reflect changes that 
could occur after implementation of national guidelines on population 
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approaches to CVD prevention. For instance, NICE guidance recommends a range 
of interventions aimed at reducing these risk factors through reductions in salt 
intake, saturated and trans fat consumption, and smoking, plus encouragement 
of physical activity (18, 531).  
Plausible reductions in these risk factors were identified from the literature (see 
Table 6-1). A variety of risk factor reductions have been documented, and 
applied in similar modelling studies. Therefore, a range of reductions was 
defined for cholesterol, blood pressure and body mass index, designed to reflect 
increasing levels of impact plus uncertainty in the size of risk factor reductions 
that could be achieved. Initially the impact of separately reducing each risk 
factor was modelled and then the risk factor reductions were applied 
simultaneously in an overall model (see Table 6-2). 
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Table 6-1: Evidence for reductions in cardiovascular risk factors following a 
population approach and reductions applied in models 
Risk factor Possible 
interventions 
Risk factor changes identified in 
literature 
Reduction 
in models 
Total 
cholesterol 
• Elimination of 
trans fatty 
acids from 
food chain. 
• Reduced 
saturated fat 
content in 
processed 
food. 
Reductions of 20% in Finland and 
Sweden following CVD prevention 
programmes and changes in 
dietary fat intake (532, 533). 
15% fall in Mauritius after changes 
in cooking oil (104). 
Reduction of 0.15 mmol/L with 
dietary advice (136). 
Previous modelling studies 
comparing population and high-
risk CVD prevention approaches 
contained reductions ranging from 
1-20% (108, 109, 111). 
0.1, 0.5 
and 1 
mmol/L  
Systolic 
blood 
pressure 
• Reduced salt 
content in 
processed 
food 
6g salt reduction per day led to 
reduction of 5.8mmHg; authors 
recommended aiming for a larger 
reduction in salt intake (427). 
Reduced salt intake led to 
3.39mmHg reduction (130). 
Previous modelling studies 
comparing population and high-
risk CVD prevention approaches 
contained reductions ranging from 
1-20% (108, 109, 534). 
2.5, 5 and 
7.5 mmHg  
Body mass 
index 
• Physical 
environments 
that 
encourage 
physical 
activity 
• Taxation of 
sugar 
sweetened 
drinks  
Prevalence of overweight and 
obesity has increased and needs 
to be reduced (535). 
Recommendation in USA for a 10% 
reduction in proportion of adults 
who are obese, plus a 10% 
increase in proportion with a 
normal weight by 2020 (536). 
Food price changes can affect 
weight (537). 
Evidence of whether physical 
activity by itself can reduce body 
mass index is uncertain (538, 
539). 
0.5, 1.5 
and 2.5 
kg/m2 
 
Smoking 
status 
• Extended 
smoking bans  
• Fiscal 
measures 
English smoking ban decreased 
proportion of heavy smokers 
(540). 
Comprehensive tobacco control 
policies could reduce smoking 
prevalence by 20-40% in next 1-30 
years (541). 
Down 1 
categorya 
a Smoking status reduced by moving each smoker down one smoking category, i.e. heavy 
smokers moved to being moderate smokers, moderate smokers to light smokers, light 
smokers to former smokers, with no change for former and non-smokers. 
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Table 6-2: Combined models of risk factor reductions in population approach 
 Risk factor reductions 
 Model 1 Model 2 Model 3 
Total cholesterol 0.1 mmol/L 0.5 mmol/L 1.0 mmol/L 
Blood pressure 2.5 mmHg 5 mmHg 7.5 mmHg 
Body mass index 0.5 kg/m2 1.5 kg/m2 2.5 kg/m2 
Smoking Down 1 category Down 1 category Down 1 category 
6.2.5 HighFrisk-approach-
Models were developed that simulated the potential impact of targeting those at 
high-risk with nationally recommended risk reducing interventions. Mean total 
cholesterol, systolic blood pressure, and body mass index were calculated for 
each individual from the imputed data sets. Individuals were defined as high-risk 
if they had a QRISK2 score ≥20%, total cholesterol ≥7.5 mmol/L or blood pressure 
≥150/95 mmHg (or isolated systolic hypertension of ≥160 mmHg).  
Results of published studies were used to identify estimates of the relative risk 
of CVD following use of statins and anti-hypertensive medication, and after 
smoking cessation (see Table 6-3). Aspirin was not included in these analyses, as 
it is not currently licensed for primary prevention of CVD in the UK. In 
accordance with national guidelines, it was assumed that hypertension would be 
treated using ACE-inhibitors in non-black Caribbean individuals under 55 years of 
age and calcium channel blockers in the remainder of individuals (122).  
Table 6-3: Relative risks used in model of high-risk approach with sources 
Risk factor Intervention Estimated 
relative risk 
of CVD 
following 
intervention  
Source(s) 
Total cholesterol Statin 
medication 
0.75 Taylor et al. (117) 
Anti-hypertensive 
medication 
  Both from Wright et al. 
(120) (also broadly 
consistent with Law et 
al. (542)) 
Age ≥55 years or 
black Caribbean  
Calcium-
channel blocker 
 
0.71 
 
Age <55 years and 
not black Caribbean 
ACE-inhibitor 0.76 
 
Smoking Smoking 
cessation 
0.50 Derived from various 
sources: Doll et al. (543), 
Kenfield et al. (544), and 
Cao et al. (545) 
ACE-inhibitor Angiotensin converting enzyme inhibitor 
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Risk reductions were applied multiplicatively to each individual’s QRISK2-2012 
score depending on their risk factor status and in accordance with national 
guidelines (see Table 6-4). This multiplicative approach is consistent with similar 
studies (109), plus it would not have been appropriate to sum the risk reductions 
as the total reduction could have exceeded 1. These guidelines recommend that 
individuals with a high cardiovascular risk score (currently ≥20%) are offered 
statins, plus antihypertensive medication if their blood pressure is 135/85mmHg 
or over (121, 122); individuals with blood pressure of 150/95mmHg are offered 
anti-hypertensive medication regardless of their cardiovascular risk score (122). 
In addition, all smokers should be offered individual smoking cessation advice 
and interventions (546). For example, a non-smoker with a high QRISK2 score 
and no hypertension would receive risk reduction from statins only, a black 
Caribbean non-smoker with hypertension and a low QRISK2 score would receive 
risk reduction from a calcium channel blocker only, and an Indian smoker aged 
50 years old with a high QRISK2 score and hypertension would receive risk 
reductions from statins, an ACE inhibitor and smoking cessation. This model 
included individuals who were already taking lipid-lowering medication. They 
received a risk reduction from statins if their total cholesterol was ≥7.5mmol/L, 
with the assumption that they still had the potential to benefit from further 
cholesterol reduction.  
Models were developed with three different uptake levels: model A assumed an 
uptake of 25%, model B 50% and model C 75%. These values were chosen to 
reflect the range of estimates of uptake of high-risk CVD prevention 
programmes. For instance, the Department of Health assumed that 75% of 
people would accept the offer of a cardiovascular screening appointment in 
their modelling for the NHS Health Check programme (159); in contrast, 
evidence from the early stages of the NHS Health Check programme found 
uptake of appointments of approximately 43-45% with a lower proportion taking 
up risk reducing interventions (162, 526).  
Smoking cessation was assumed to be successful in 15% of smokers, meaning that 
only 15% of high-risk smokers received the relative risk reduction from smoking 
cessation. This assumption was based on evidence from NHS smoking cessation 
services, where the 1 year quit rate has been found to be in the region of 13-
23%, with an estimate of 15% based on carbon monoxide measurement (123, 
547).  
  
163 
A microsimulation approach, using random number generation, was used to 
allocate uptake of risk reduction interventions. Stata’s random number function 
was used to generate a random number between 0 and 1. Each individual was 
then allocated to a variable of uptake / no uptake based on this number and the 
relative risk reductions applied accordingly (i.e. if categorised as no uptake then 
no risk reductions were applied). The same method was used to allocate smoking 
cessation success.  
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Table 6-4: Possible combinations of high-risk conditions and corresponding 
risk reducing intervention(s) 
High-risk 
conditions 
Possible combinations of high-risk conditions 
High QRISK2 
score (≥20%) ✓ ✓ ✓ ✓ ✓ ✓      ✓ ✓ ✓ ✓ ✓ ✓      
Hypertension                       
≥135/85mmHg 
(or SBP 
≥160mmHg) 
                      
Age ≥55 years 
or black 
Caribbean 
  ✓ ✓          ✓ ✓        
Age <55 years 
and not black 
Caribbean 
    ✓ ✓          ✓ ✓      
≥150/95mmHg 
(or SBP 
≥160mmHg) 
                      
Age ≥55 years 
or black 
Caribbean 
      ✓  ✓         ✓  ✓   
Age <55 years 
and not black 
Caribbean 
       ✓  ✓         ✓  ✓  
High total 
cholesterol 
(≥7.5mmol/L) 
        ✓ ✓ ✓         ✓ ✓ ✓ 
Smoker and 
successful quit 
attempt 
           ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Eligible for statin ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ ✓  ✓  ✓  ✓ ✓ ✓ ✓ ✓ 
Corresponding risk reducing intervention(s): 
Statin ✓  ✓  ✓    ✓ ✓ ✓ ✓  ✓  ✓    ✓ ✓ ✓ 
Calcium channel 
blocker   ✓ ✓   ✓  ✓     ✓ ✓   ✓  ✓   
ACE-inhibitor     ✓ ✓  ✓  ✓      ✓ ✓  ✓  ✓  
Smoking 
cessation            
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
SBP Systolic blood pressure; ACE-inhibitor Angiotensin converting enzyme inhibitor. 
Note: Relative risk reductions applied multiplicatively; individuals not eligible for statin 
if taking lipid lowering drug and “low” total cholesterol.
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6.2.6 Analyses-
6.2.6.1 Descriptive.statistics.
Ethnic differences in demographic and cardiovascular characteristics were 
assessed using the independent samples t-test for continuous variables and a chi-
squared test for categorical variables. In the previous chapter the general 
population was used as the reference group, but this group was largely made up 
of white people and findings from the two groups were very similar. Therefore, 
in these analyses only the white group was included and was used as the 
reference group.  
Graphs were plotted to allow visual assessment of ethnic differences in the 
distribution of the continuous cardiovascular risk factors. The distribution of 
total cholesterol, systolic blood pressure and body mass index was plotted for 
each ethnic group, and compared to the white group. In addition, graphs were 
produced to compare the distribution of these risk factors in high-risk individuals 
compared to the overall population in each ethnic group. 
6.2.6.2 Impact.of.population.and.high:risk.approaches.
The potential impact of the population and high-risk models described above 
was calculated with the sample divided by ethnic group and sex. Mean QRISK-
2012 score with current risk factors was calculated for each ethnic group and 
sex. The population and high-risk models were then applied in turn and the 
mean QRISK2-2012 score recalculated. For the high-risk model this process was 
repeated 10 times and the results averaged in order to address variability in the 
results arising from the use of random number generation in determining uptake.  
The QRISK2-2012 score was used to estimate the number of cardiovascular 
events that would occur in 10 years, scaled to a population of 100,000. For 
example, a mean QRISK2-2012 score of 12% would equate to 12,000 predicted 
cardiovascular events per 100,000 population in 10 years. This approach of using 
a cardiovascular risk calculator to estimate future cardiovascular events, which 
has been used elsewhere (108), was chosen as it was possible to apply a risk 
calculator to the cross-sectional data in the HSE. An alternative approach could 
have been to use prospective cohort data, like Emberson et al (109). This would 
have allowed specific risk factor coefficients to be calculated from the study 
population using baseline risk factor and cardiovascular incident data, however a 
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suitable study with sufficient numbers of ethnic minority individuals could not be 
identified. 
Comparison of the demographic characteristics of the HSE sample with 2001 
Census data revealed small differences in age distribution. In particular, the 
mean age of HSE participants tended to be lower than the mean age from 2001 
Census data, especially for Pakistani and Bangladeshi males. Unlike the analyses 
in Chapters 4 and 5, these differences were particularly relevant to these 
analyses because they involved scaling the results to a population level to make 
inferences about the number of cardiovascular events that could occur. 
Therefore, direct age standardisation was used to adjust the results. The sample 
was divided into 5-year age categories and the mean QRISK2-2012 score was 
calculated for each age group, ethnic group and sex. 2001 Census data for 
England and Wales, broken down by ethnic group, age and sex (548), was used as 
the reference population. The number of predicted cardiovascular events, 
calculated from the mean QRISK2-2012 scores, was then directly age 
standardised against the reference population (see Figure 6-1).   
Age 
group 
(years) 
Number of predicted 
events per 100,000 
population (A) 
Percentage of reference 
population in age group (B) A × B 
35-39 100 20 2,000 
40-44 1,000 20 20,000 
45-49 2,000 18 36,000 
50-54 3,000 16 48,000 
55-59 4,000 14 56,000 
60-64 5,000 12 60,000 
65-69 6,000 10 60,000 
70-74 7,000 8 56,000 
  Total/100 338,000/100 
  
! Age standardised number of predicted events per 100,000 
population 
3,380 
Figure 6-1: Illustration of method of direct age standardisation (based on 
(549)) 
 
6.2.6.3 Impact.of.population.and.high:risk.approaches.on.health.inequalities.
Changes in absolute inequalities between the ethnic groups following application 
of the population and high-risk models were assessed. The absolute difference in 
the number of predicted cardiovascular events between each ethnic minority 
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group and the white group was calculated at baseline and then following each 
population and high-risk model.  
6.2.7 Statistical-software-
Analyses were carried out using Stata 12.1 and Microsoft Excel.  
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6.3 Results 
6.3.1 Demographic-and-cardiovascular-characteristics-
These analyses were based on 7,929 white, 639 black Caribbean, 659 Indian, 704 
Pakistani/Bangladeshi and 741 Irish individuals (see Table 6-5). Compared with 
the white group, the black Caribbean, Indian and Pakistani/Bangladeshi groups 
were significantly younger and there were significantly fewer men in the black 
Caribbean and Irish groups. Ethnic differences in cardiovascular characteristics 
were similar to those observed in the previous chapter. Compared to the white 
group, systolic blood pressure was significantly lower in the Indian, 
Pakistani/Bangladeshi and Irish groups, total cholesterol was significantly lower 
in all the ethnic minority groups, and body mass index was significantly higher in 
the black Caribbean group but lower in the Indian and Irish groups. Lower 
proportions of the black Caribbean, Indian and Pakistani/Bangladeshi groups 
were current smokers.  
Visual assessment of ethnic differences in the distribution of continuous 
cardiovascular risk factors revealed slight differences. Compared to the white 
group, the distribution of body mass index was shifted slightly to the right in the 
black Caribbean group but was similar in the other ethnic minority groups (see 
Figure 6-2). The distribution of total cholesterol values was shifted slightly 
towards the left in all of the ethnic minority groups compared to the white 
group (see Figure 6-3). The distribution of systolic blood pressure was similar 
between the white and ethnic minority groups. Visual assessment of the data 
from complete cases only produced similar observations to those from the 
imputed data.  
In each ethnic group, the distribution of systolic blood pressure, total 
cholesterol and body mass index values in high-risk individuals was shifted to the 
right in comparison with the overall distribution (Figure 6-4 shows systolic blood 
pressure; similar findings were noted for total cholesterol and body mass index). 
6.3.2 Population-approach-
With current risk factors, the number of predicted cardiovascular events in the 
next 10 years per 100,000 population was highest in Pakistani/Bangladeshi, Irish 
and Indian men (19,939, 14,593 and 14,161 events, respectively) (see Table 6-6). 
Applying each of the population based reductions in cardiovascular risk factors 
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separately prevented varying numbers of cardiovascular events. Reducing total 
cholesterol by 1.0 mmol/L prevented the highest number of events, particularly 
in Pakistani/Bangladeshi, Indian and Irish men. Reducing smoking status by one 
category prevented few cardiovascular events in Indian and 
Pakistani/Bangladeshi women, whilst preventing a higher number of events in 
men from these ethnic groups. In contrast, systolic blood pressure reduction 
prevented similar numbers of events in men and women from all ethnic groups.  
A combined population approach could prevent up to 2,071 events per 100,000 
white men and 1,176 events per 100,000 white women (see Table 6-7). The 
highest number of events could be prevented in the Pakistani/Bangladeshi group 
where up to 3,487 events per 100,000 men and 1,753 events per 100,000 women 
could be prevented. Higher estimated numbers of events prevented were also 
observed for Indian men (up to 2,491 events per 100,000 population) and Irish 
men (up to 2,374 events per 100,000 population). Fewer events would be 
prevented in the black Caribbean group than the white group where up to 1,515 
events per 100,000 men and 1,037 events per 100,000 women could be 
prevented. The lowest number of events prevented was in Indian women (up to 
989 events per 100,000 population). A combined population approach with 
moderate risk factor reductions (model 2) would prevent a similar number of 
events in the Pakistani/Bangladeshi group than an approach with higher risk 
factor reductions (model 3) in the white group. In all ethnic groups, fewer 
events were prevented in women than men. 
6.3.3 HighFrisk-approach-
The high-risk approach was estimated to prevent up to 1,638 events per 100,000 
white men and 751 events per 100,000 white women over ten years (see Table 
6-7). The highest estimated numbers of events prevented were for 
Pakistani/Bangladeshi men (up to 2,698 events per 100,000 population) and Irish 
men (up to 1,979 events per 100,000 population). The lowest number of 
cardiovascular events prevented was observed in the black Caribbean group, 
where up to 935 events per 100,000 men and 469 events per 100,000 women 
could be prevented. A high-risk approach with moderate uptake (model B) would 
prevent a similar number of events in the Pakistani/Bangladeshi group than an 
approach with higher uptake (model C) in the white group. Similar to the 
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population approach, fewer events were prevented in women than men in all 
ethnic groups. 
6.3.4 Population-versus-highFrisk-approaches-
In all ethnic groups, and in both men and women, population approaches 
prevented more events than high-risk approaches (see Table 6-7). The largest 
difference in the number of cardiovascular events that could be prevented by 
the population and high-risk approaches occurred in Pakistani/Bangladeshi 
individuals and Indian men. In women from all ethnic groups and black 
Caribbean men, a high-risk approach with 75% uptake (model C) prevented fewer 
cardiovascular events than a population approach with moderate risk factor 
reductions (model 2). The number of events prevented by a high-risk approach 
with 75% uptake (model C) was intermediate between that prevented by 
population approaches with moderate and high risk factors reductions (models 2 
and 3) in Indian, Pakistani/Bangladeshi, Irish and white men.  
6.3.5 Health-inequalities-
In Indian, Pakistani/Bangladeshi, and Irish men both the population and high-risk 
approaches reduced the absolute difference in the predicted number of events 
per 100,000 population compared to the white group (see Table 6-8 and Figure 
6-5). However, the population approach reduced this difference to a greater 
extent than the high-risk approach in Pakistani/Bangladeshi and Indian men. In 
black Caribbean men the population and high-risk approaches also reduced the 
absolute difference in the predicted number of events per 100,000 population 
compared to the white group, although this occurred in the opposite direction to 
the other ethnic minority groups.  
Reductions in the absolute difference in the predicted number of events 
between the ethnic minority and white group were more modest in women 
compared to men. In Pakistani/Bangladeshi and Irish women both the population 
and high-risk approaches reduced the absolute difference in the predicted 
number of events per 100,000 population compared to the white group, although 
to a slightly greater extent following the population approach. In black 
Caribbean and Indian women the population and high-risk approaches resulted in 
similar, small reductions in the difference in the predicted number of events 
compared to the white group, but in the opposite direction to 
Pakistani/Bangladeshi and Irish women. 
 Table 6-5: Demographic and cardiovascular characteristics by ethnic group 
SE standard error  
Reference group for p-values is white group
  White 
Black 
Caribbean Indian 
Pakistani / 
Bangladeshi Irish 
 n=7,929 n=639 n=659 n=704 n=741 
 
Mean (SE) Mean (SE) Mean (SE) Mean (SE) Mean (SE) 
Age  51.5 (0.1) 49.8 (0.5) 48.7 (0.4) 47.4 (0.4) 51.2 (0.4) 
p-value - <0.001 <0.001 <0.001 0.524 
Systolic blood 
pressure 130.2 (0.2) 129.4 (0.9) 126.4 (0.8) 125.6 (0.9) 128.0 (0.9) 
p-value - 0.364 <0.001 <0.001 0.009 
Total 
cholesterol 5.9 (0.0) 5.4 (0.1) 5.5 (0.1) 5.5 (0.1) 5.7 (0.1) 
p-value - <0.001 <0.001 <0.001 0.001 
Body mass 
index 27.6 (0.1) 28.6 (0.2) 27.1 (0.2) 27.7 (0.2) 27.0 (0.2) 
p-value - <0.001 0.009 0.809 0.002 
      
 n (%) n (%) n (%) n (%) n (%) 
Male 3,806 (48.0) 263 (41.2) 297 (45.1) 342 (48.6) 306 (41.4) 
p-value - 0.001 0.155 0.783 <0.001 
Smoking 
status 
     Non-smoker 3,305 (41.7) 373 (58.4) 507 (77.0) 511 (72.6) 292 (39.4) 
Ex-smoker 2,680 (33.8) 134 (21.0) 70 (10.7) 62 (8.7) 258 (34.9) 
Light smoker 387 (4.9) 72 (11.3) 47 (7.1) 54 (7.6) 47 (6.3) 
Moderate 
smoker  787 (9.9) 45 (7.0) 28 (4.2) 54 (7.7) 75 (10.1) 
Heavy smoker 770 (9.7) 15 (2.3) 7 (1.1) 24 (3.4) 69 (9.3) 
p-value - <0.001 <0.001 <0.001 0.395 
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Figure 6-2: Distribution of body mass index in ethnic minority group compared to white group 
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 Figure 6-3: Distribution of total cholesterol concentration in ethnic minority group compared to white group
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Figure 6-4: Distribution of systolic blood pressure in total population and 
high-risk individuals by ethnic group 
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Table 6-6: Age standardised number of cardiovascular events and events prevented following cholesterol, systolic blood pressure, 
body mass index and smoking reductions 
 
  Black Caribbean Indian 
Pakistani / 
Bangladeshi Irish White 
  Men Women Men Women Men Women Men Women Men Women 
Number of cardiovascular events predicted over 10 years per 100,000 population based on current risk factors 
 
9,280 7,073 14,161 6,832 19,939 12,188 14,593 9,372 12,722 7,948 
          
Number of cardiovascular events prevented over 10 years per 100,000 population 
Cholesterol reduction 
          0.1 mmol/L 81 58 139 58 180 99 140 73 122 61 
0.5 mmol/L 444 291 681 285 907 487 679 361 603 303 
1.0 mmol/L 879 568 1,341 553 1,797 956 1,328 709 1,180 596 
Systolic blood pressure 
reduction           
2.5 mmHg 100 109 169 113 229 202 152 128 141 113 
5.0 mmHg 199 216 335 225 455 399 303 254 280 227 
7.5 mmHg 287 321 500 334 678 594 452 365 418 333 
Body mass index 
reduction           
0.5 kg/m2 42 17 78 20 106 40 63 16 60 17 
1.5 kg/m2 125 52 236 61 317 123 185 48 181 51 
2.5 kg/m2 209 86 391 101 523 205 302 77 301 83 
Smoking reduction           
Decrease of 1 category 229 120 416 48 701 87 416 342 287 230 
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Table 6-7: Age standardised number of cardiovascular events and events prevented following population and high-risk approaches 
Population approach: model 1 applied reductions of 2.5 mmHg systolic blood pressure, 0.1 mmol/L total cholesterol, and 0.5 kg/m2 body mass index; 
model 2 applied reductions of 5.0 mmHg systolic blood pressure, 0.5 mmol/L total cholesterol, and 1.5 kg/m2 body mass index; and model 3 applied 
reductions of 7.5 mmHg systolic blood pressure, 1.0 mmol/L total cholesterol, and 2.5 kg/m2 body mass index. In each model smoking status was also 
reduced by one category. High-risk approach: 25% uptake in model A; 50% uptake in model B; and 75% uptake in model C.
  Black Caribbean Indian 
Pakistani / 
Bangladeshi Irish White 
  Men Women Men Women Men Women Men Women Men Women 
Number of cardiovascular events predicted over 10 years per 100,000 population based on current risk factors 
 
9,280 7,073 14,161 6,832 19,939 12,188 14,593 9,372 12,722 7,948 
          
Number of cardiovascular events prevented over 10 years per 100,000 population 
Population approach 
          Model 1 443 298 786 237 1,193 421 759 550 599 414 
Model 2 958 653 1,600 601 2,284 1,062 1,529 969 1,302 781 
Model 3 1,515 1,037 2,491 989 3,487 1,753 2,374 1,417 2,071 1,176 
           High-risk approach 
          Model A 330 129 658 180 898 275 675 383 553 256 
Model B 662 302 1,295 339 1,766 653 1,291 657 1,085 498 
Model C 935 469 1,802 497 2,698 982 1,979 956 1,638 751 
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Table 6-8: Difference in predicted number of cardiovascular events over 10 years per 100,000 population between ethnic minority 
and white group 
Population approach: model 1 applied reductions of 2.5 mmHg systolic blood pressure, 0.1 mmol/L total cholesterol, and 0.5 kg/m2 body mass index; 
model 2 applied reductions of 5.0 mmHg systolic blood pressure, 0.5 mmol/L total cholesterol, and 1.5 kg/m2 body mass index; and model 3 applied 
reductions of 7.5 mmHg systolic blood pressure, 1.0 mmol/L total cholesterol, and 2.5 kg/m2 body mass index. In each model smoking status was also 
reduced by one category. High-risk approach: 25% uptake in model A; 50% uptake in model B; and 75% uptake in model C.
  Black Caribbean Indian Pakistani / Bangladeshi Irish 
  Men Women Men Women Men Women Men Women 
Current risk factors -3,443 -875 1,438 -1,116 7,217 4,240 1,870 1,424 
         
Population approach 
        Model 1 -3,287 -759 1,251 -939 6,623 4,233 1,711 1,289 
Model 2 -3,099 -747 1,140 -936 6,235 3,959 1,644 1,236 
Model 3 -2,886 -736 1,018 -929 5,801 3,663 1,568 1,183 
         High-risk approach 
        Model A -3,220 -748 1,333 -1,040 6,871 4,221 1,748 1,297 
Model B -3,020 -678 1,228 -957 6,536 4,085 1,665 1,266 
Model C -2,740 -593 1,274 -862 6,157 4,009 1,530 1,219 
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Figure 6-5: Difference in predicted number of cardiovascular events over 10 
years per 100,000 population between ethnic minority and white group 
following population and high-risk approaches 
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6.4 Discussion 
6.4.1 Principal-findings-
Both population and high-risk approaches to primary prevention of CVD were 
found to have the potential to prevent significant numbers of cardiovascular 
events, although there were ethnic differences in the number of cardiovascular 
events that could be prevented. Higher estimated numbers of events could be 
prevented in Pakistani/Bangladeshi individuals, and Indian and Irish men, 
reflecting the higher cardiovascular risk and number of high-risk individuals in 
these groups and, therefore, their higher baseline number of predicted events. 
In ethnic groups with comparatively lower cardiovascular risk, such as the black 
Caribbean group, the population and high-risk approaches prevented fewer 
events than in ethnic groups with higher cardiovascular risk. In 
Pakistani/Bangladeshi individuals, population or high-risk approaches with 
moderate risk factor reduction or moderate uptake could prevent similar 
numbers of events than approaches with high risk factor reduction or high 
uptake in the white group. When population risk factor reductions were 
modelled separately there were ethnic differences in the number of 
cardiovascular events prevented. In particular, compared to white women 
smoking reduction prevented fewer events in Indian and Pakistani/Bangladeshi 
women. This could reflect lower prevalence of smoking in women from these 
ethnic minority groups.  
In all ethnic groups the population approach prevented a larger number of 
events than the high-risk approach, especially in Pakistani/Bangladeshi 
individuals and Indian men. Indeed a population approach that achieved only 
moderate risk factor reduction could prevent a similar number of events as a 
high-risk approach with high uptake in women from all ethnic groups and in 
black Caribbean men.  
Both population and high-risk approaches showed the potential to reduce 
inequalities in the number of cardiovascular events compared to the white 
group, but the results varied by ethnic group and sex. Health inequalities fell 
more noticeably among men than women, particularly following the population 
approach. However, in the black Caribbean group and in Indian women this was 
not in a favourable direction for either approach. This could be explained by the 
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lower baseline cardiovascular risk in these groups compared to the white group, 
in which higher numbers of events would be prevented. Despite this, these 
findings suggest that comprehensive CVD prevention programmes have the 
potential to reduce ethnic health inequalities and the reduction will be greatest 
for population approaches.  
6.4.2 Strengths-and-limitations-
The strengths and limitations related to the use and calculation of QRISK2-2012, 
use of multiple imputation to address missing data, and the sample size and age 
of the HSE data that were discussed in the previous chapter are also relevant to 
these analyses (see Chapter 5). Similar to the previous analyses, it was not 
possible to accurately exclude individuals who were taking lipid-lowering 
medication. Whilst it may have been preferable to exclude these individuals, the 
high-risk model was adapted to apply appropriate risk reductions to this group.  
This modelling study required a number of assumptions to be made that might 
have affected the size of impact estimated. Assumptions were made regarding 
the size of potential risk factor reductions following population approaches, 
relative risk reductions from use of statins, anti-hypertensives and smoking 
cessation, and of uptake in the high-risk approach. Wherever possible these 
assumptions were based on existing evidence. A number of the assumptions, in 
particular the risk reductions that could be achieved by statins and anti-
hypertensive medications or from salt reduction, were based on high quality 
evidence from systematic reviews and meta-analyses (117, 120, 427). However, 
it should be noted that risk reductions from high-risk interventions achieved in 
clinical trial settings might not be achievable in practice. In contrast, evidence 
for the size of population reductions in cholesterol came from real life scenarios 
where population wide changes had been achieved (104, 532, 533). Evidence for 
achievable population changes in body mass index was limited. Body mass index 
differs from the other cardiovascular risk factors modelled in that it is currently 
increasing at a population level – this could explain the relative lack of evidence 
on beneficial population changes in this risk factor and make the reductions 
modelled even more challenging. The risk distribution of body mass index may 
follow a J-shaped curve (550), a difference that may not have been fully 
considered given the way in which the QRISK2-2012 calculator deals with body 
mass index values. In addition, the categorical nature of smoking status limited 
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the changes that could be made to this variable. Nevertheless, the assumptions 
made regarding risk factor changes and risk reductions were consistent with 
those used in comparable modelling studies (108, 109, 111).  
The uncertainty inherent in estimating the size of these risk changes was 
addressed by modelling a range of risk factor reductions for the population 
approach. For the high-risk approach a range of uptake levels was assessed, 
whilst the risk reductions remained constant. These levels were chosen to 
reflect the uncertainty surrounding the uptake that can be achieved in high-risk 
CVD prevention programmes. In this analysis the estimated uptake, e.g. of 25%, 
represented the uptake of screening and interventions but then assumed 100% 
adherence to the risk reducing interventions. Therefore, whilst a 25% uptake 
level may appear low, if considered against less than optimal adherence it may 
reflect a realistic level of take up of risk reducing interventions in high-risk 
individuals. Indeed, Cochrane et al found that 29.8% of individuals invited for an 
NHS Health Check took up risk reducing interventions (526), although this figure 
is based on the performance of the programme in a single area of England and 
estimates of uptake, including by socioeconomic position and ethnic group, 
remain uncertain. Similar to the previous chapter, estimates of uptake and 
assumptions regarding adherence were not varied between ethnic groups, given 
that evidence for ethnic differences in both is mixed (see section 3.7.7.1). 
Uptake (alongside access to healthcare) is an essential component of a high-risk 
approach. If uptake was reduced in ethnic minority groups compared to the 
white group these analyses could have overestimated the potential of high-risk 
approaches to reduce cardiovascular events and health inequalities in these 
groups. However, evidence from the NHS Health Check programme suggests that 
uptake of screening may not be reduced in ethnic minority groups (162), whilst 
other evidence indicates that use of primary care services is not lower in ethnic 
minority groups compared to white individuals (378). Whilst low uptake would 
limit the effectiveness of high-risk interventions, the high-risk approach enables 
programmes to be tailored to the needs of local populations, such as ethnic 
minority communities (551), potentially improving the uptake of appropriately 
designed programmes. It was beyond the scope of these analyses to incorporate 
ethnic differences in the design of the high-risk approaches, and as the aim was 
to model the differential impact of programmes for the general population this 
would not have been relevant.  
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The results of this analysis are presented in terms of absolute changes in 
cardiovascular events and ethnic inequalities. The use of calculations of relative 
changes was considered, for example calculation of percentage reductions in 
events or ratios for changes in ethnic inequalities. However, it was decided to 
focus on absolute changes as these reflect the potential public health impact of 
population and high-risk approaches. Future analyses could benefit from the 
addition of calculations of relative changes.  
Previous analysis of population and high-risk approaches to CVD prevention 
corrected for regression dilution bias, and emphasised the importance of doing 
this so that the impact of the population approach is not underestimated (109). 
Regression dilution bias can occur when single measurements of cardiovascular 
risk factors, such as blood pressure and cholesterol, are used but are affected by 
random measurement error and within-person variability (109, 110, 552). This 
can lead to a reduction in the observed association between exposure and 
outcome, and in Emberson et al’s analysis to an underestimation of the impact 
of population (but not high-risk) approaches (109). Emberson et al were able to 
correct for regression dilution bias using prospective data. However, this was not 
possible in these analyses owing to the use of cross-sectional, i.e. single 
measurement, data. Therefore, it is possible that the potential impact of the 
population approach has been underestimated in these analyses. 
Further underestimation of the impact, particularly of the population approach, 
could have arisen from the age range that was included in this analysis (35-74 
years old). This range was used as it reflects the age range that QRISK2 was 
derived from and can therefore be applied to. However, this means that the 
potential benefits of the population approach in both younger and older ages, 
and the high-risk approach in older ages (it is highly unlikely that younger 
individuals would be classed as high-risk), would have been missed from these 
results.  
6.4.3 Relations-to-other-studies-
These findings are consistent with previous studies, in terms of population 
approaches having the potential to prevent more events than a high-risk strategy 
(108, 109). Evidence suggests that population approaches have the potential to 
prevent large numbers of CVD events and save millions of pounds for the NHS 
(101), whilst high-risk approaches may also have a positive, but smaller, impact 
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on health (105, 106). Modelling studies have sought to directly compare the 
potential for population and high-risk approaches to prevent CVD, using similar 
methods to these analyses. These studies have produced mixed results. On the 
one hand, Emberson et al and Cooney et al both found that population 
approaches could prevent more CVD events than high-risk approaches (108, 109). 
In contrast, studies by Zulman et al and Manuel favoured high-risk approaches 
(111, 112). As discussed in Chapter 2, these discrepancies may be accounted for 
by methodological differences, for instance in the size of the risk reductions 
modelled. Manuel compared a population wide reduction in cholesterol of 2% 
with a high-risk approach with 100% adherence to statins; Emberson et al 
modelled population reductions of 5-15% in cholesterol and blood pressure 
against a high-risk approach using statins, aspirin and anti-hypertensive 
medication. The risk reductions modelled in these analyses are more consistent 
with those used by Emberson et al than by Manuel, perhaps explaining why these 
analyses also found that population approaches had greater potential to prevent 
CVD events than the high-risk approach. However, whilst utilising similar 
methods to these studies, these analyses differed because they explored ethnic 
differences in the potential impact of these programmes.  
There is evidence of a range of ethnic differences (and similarities) in 
cardiovascular risk factors (see section 3.5). The findings of these analyses 
suggest that differences in the prevalence of certain risk factors, in particular 
smoking, may affect the potential impact of population approaches to CVD 
prevention. If it were the case that health policy solely focused on smoking 
cessation, groups such as Pakistani/Bangladeshi women, who are otherwise at 
high cardiovascular risk, may benefit less in terms of overall CVD prevention 
than groups with higher prevalence of smoking. However, in the combined 
population model, the results of which would have reflected ethnic differences 
in smoking status, Pakistani/Bangladeshi women still showed greater potential to 
benefit from a population approach than a high-risk approach. In contrast, the 
models did not incorporate ethnic differences in health behaviours, such as salt 
intake and fat consumption. Evidence suggests that there may be ethnic 
differences in salt intake, with higher consumption of salt from processed food 
among white people (424). In addition, there may be ethnic differences in blood 
pressure response to salt reduction, with evidence of larger falls in black 
compared to white people (131). A population wide policy of reducing hidden 
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salt in processed food could therefore have a differential effect across ethnic 
groups, for example by lowering blood pressure more in black individuals 
through increased physiological response or in white individuals who consume 
more processed food. Likewise, ethnic differences in the consumption of 
industrially produced trans fatty acids could lead to differences in the impact of 
eliminating them from the food chain, with potentially greater benefit for ethnic 
minority groups who consume them more (425). Despite this evidence, it was 
difficult to quantify these ethnic differences to the extent that they could be 
incorporated into these analyses. However, it is possible that population policies 
could lead to additional ethnic differences in impact beyond those considered 
here.  
Ethnic minority groups in the UK experience higher levels of socioeconomic 
deprivation than the majority white population (308, 309). Socioeconomic 
position is a risk factor for CVD and is incorporated into the QRISK2-2012 
calculator, so some of these socioeconomic differences will be reflected in the 
results. In addition, however, it has been suggested that high-risk approaches 
may systematically disadvantage socioeconomically deprived populations and 
may lead to an increase in inequalities (4, 5), perhaps because of lower access 
to or uptake of high-risk interventions in socioeconomically deprived populations 
(206, 208). Population strategies have been favoured from an equity perspective 
(5), although the type of population intervention adopted could affect its impact 
on health inequalities (204). Given higher levels of socioeconomic deprivation, 
the impact of population and high-risk approaches on socioeconomic health 
inequalities is likely to be particularly applicable to ethnic minority populations. 
The complex relationships that determine the impact of a particular population 
or high-risk intervention on socioeconomic health inequalities will not have been 
fully considered in these analyses and it remains possible that both approaches 
may have additional impacts on health inequalities; in particular, the benefits of 
the population approach on health inequalities may have been underestimated 
in this study.  
6.4.4 Implications-
Deciding on the optimum balance between population and high-risk approaches 
to primary prevention of CVD continues to be challenging for academics, policy 
makers and politicians. Despite evidence that both of these approaches are 
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needed, and that the population approach may be a particularly effective way of 
preventing disease, recent policy has favoured the high-risk approach. These 
findings reinforce the need to supplement high-risk CVD prevention with 
comprehensive and effective population approaches, such as salt reduction 
legislation. Although this may be a difficult political choice, this approach has 
the potential to prevent significant numbers of cardiovascular events and to 
reduce ethnic inequalities in health.  
These results may be partially generalisable to ethnic minority populations in 
other settings, if they have comparable cardiovascular characteristics. The 
finding that comprehensive population and high-risk approaches to CVD 
prevention can prevent significant amounts of CVD and reduce health 
inequalities, particularly in ethnic groups at high risk of CVD, is applicable to 
many populations. However, the absolute benefits of these approaches will 
depend on the population’s baseline risk. Further, alternative cardiovascular risk 
calculators will need to be used in other populations because of differences in 
baseline risk of CVD.  
6.4.5 Next-steps-
The need to tackle health inequalities means that it is essential that the impact 
of public health interventions on high-risk sections of the population be 
considered. These analyses investigated ethnic differences in the potential 
impact of population and high-risk approaches to disease prevention, but the 
impact may also vary across other axes of inequality, particularly socioeconomic 
position.  
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7 Chapter 7: General discussion 
7.1 Overview 
This thesis explored ethnic differences in two CVD prevention policy choices – 
the choice between mass and targeted screening for high cardiovascular risk, 
including the use of area deprivation measures to target screening, and the 
choice between population and high-risk approaches. The findings suggest that 
area deprivation measures may be both effective and efficient at identifying 
individual deprivation in ethnic minority groups, and cardiovascular screening 
programmes targeted at deprived areas may be particularly cost-effective in 
ethnic minority groups that have a high risk of CVD. In addition, both population 
and high-risk approaches to CVD prevention, especially the population approach, 
were found to have significant potential to prevent CVD and reduce ethnic 
health inequalities, particularly in ethnic groups at high risk of CVD. 
These findings could be explained by ethnic differences in individual and area 
deprivation, alongside differences in CVD and cardiovascular risk factors. For 
instance, the black Caribbean population in the UK experiences relatively high 
levels of individual socioeconomic deprivation, and is concentrated into 
socioeconomically deprived areas but has a lower overall risk of CVD than the 
white population, despite an increased risk of stroke (250, 259, 308, 309, 438). 
This accounts for why area deprivation measures performed effectively at 
identifying individual deprivation in the black Caribbean group, but targeting 
cardiovascular risk screening at socioeconomically deprived areas was no more 
cost-effective than in the general population whilst mass screening was less 
cost-effective. In contrast, in the Indian group levels of individual and area 
socioeconomic deprivation are more comparable to the white population, but 
overall risk of CVD is higher (12, 309, 310, 438). For the Indian group this 
explains why the performance of area deprivation measures in identifying 
individual socioeconomic deprivation was similar to the white group, but both 
mass and targeted screening for high cardiovascular risk were more cost-
effective. Ethnic differences in the impact of population and high-risk 
approaches to CVD prevention, and in the cost-effectiveness of mass and 
targeted screening, could be explained by ethnic differences in baseline 
  
188 
cardiovascular risk, with greater impact and cost-effectiveness seen in the 
higher risk ethnic groups.  
Chapters 4, 5 and 6 contained discussion sections that outlined the principal 
findings, and strengths and limitations of each analysis, alongside discussion of 
how the findings related to other relevant studies. Briefly, key strengths related 
to the use of survey data with a boosted sample of ethnic minority participants, 
use of QRISK2 as arguably the most appropriate cardiovascular risk calculator 
available at present and the use of evidence in informing modelling assumptions. 
Limitations arose from the age and sample size of the data used, estimations 
required for the calculation of QRISK2, the presence of missing data and steps 
required to address this, and the potential for the impact of the population 
approach to have been underestimated. This chapter builds on these previous 
discussion sections by examining issues and implications related to three core 
themes of this thesis, namely cardiovascular risk calculation, the use of ethnicity 
as a variable in research and health service planning, and CVD prevention policy. 
This is followed by conclusions and recommendations. 
7.2 Cardiovascular risk calculation 
Cardiovascular risk calculation was used in two ways in this thesis. First, it was 
used to designate individuals as being at high or low cardiovascular risk (see 
Chapter 5). This application reflects the use of cardiovascular risk calculators in 
clinical practice and in cardiovascular risk screening programmes, where risk 
estimations are used to categorise individuals according to predetermined 
thresholds and to guide future interventions or advice. This use would be the 
same whether a mass or targeted screening programme was adopted. Indeed, 
cardiovascular risk calculators are integral to high-risk approaches to CVD 
prevention, and are a cornerstone of current national guidelines and screening 
programmes for primary prevention of CVD (13, 121). They can improve the 
accuracy of predictions of future risk beyond consideration of single risk factors, 
increasing the chances of risk reduction interventions being targeted at 
appropriate individuals (150, 151). 
Despite the advantages and widespread use of cardiovascular risk calculation, it 
is important to recognise that they are imperfect tools that are often inaccurate 
predictors of risk. For instance, Jackson et al highlighted that in one study only 
30% of cardiovascular events happened in individuals identified as being high-risk 
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by QRISK (a predecessor to QRISK2) (553). This misclassification of individuals 
as high or low risk could reduce the effectiveness and efficiency of even the best 
designed and implemented cardiovascular screening programme, as individuals 
who are subsequently going to have a cardiovascular event will not be correctly 
identified and therefore not offered risk reducing interventions, which instead 
may be given to people who would not have gone on to develop CVD. This 
limitation would have impacted the findings of the mass and targeted screening 
analysis in this thesis, and could mean that the cost to identify one high-risk 
individual may not be equivalent to the cost to detect one person who will 
actually develop CVD. Furthermore, the performance of cardiovascular risk 
calculators is known to vary by ethnicity (266, 434). Indeed, whilst the correct 
prediction of future events by cardiovascular risk calculators is far from perfect, 
it may be even lower in ethnic minority groups (450). This could further reduce 
the effectiveness and efficiency of cardiovascular screening in ethnic minority 
groups beyond the measures considered in these analyses and could adversely 
impact ethnic health inequalities. Further prospective analyses, based on 
sufficient numbers of ethnic minority individuals, could help to establish the 
significance of this issue and further improve the accuracy of cardiovascular risk 
prediction across ethnic groups. Whilst it may not be possible for cardiovascular 
risk calculators to ever accurately predict all cardiovascular events, it may at 
least be possible to predict them with similar accuracy across population 
subgroups. 
In addition, there is limited evidence that the use of cardiovascular risk 
calculators has a positive impact on health outcomes (152, 554). Whilst short-
term measures of the success of cardiovascular screening programmes, such as 
uptake or the measures of screening programme performance used in this thesis, 
may appear favourable, they do not provide evidence for positive clinical 
outcomes. Further evidence is needed to determine the long-term impact of 
cardiovascular risk calculation in cardiovascular risk screening programmes 
(152). Evidence from the NHS Health Check programme has the potential to 
inform this question, although it may be difficult to differentiate the effects of 
risk estimation from other aspects of the programme.  
The second use of cardiovascular risk calculation in this thesis was in the 
estimation of average cardiovascular risk in population subgroups before and 
after implementation of population and high-risk interventions (see Chapter 6). 
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This illustrates a research application of cardiovascular risk calculators, 
similar to that adopted elsewhere (108, 534), where risk estimation is used to 
model future cardiovascular events. Whilst this use would not be subject to the 
misclassification that can arise when categorising individuals as high or low risk, 
limitations of cardiovascular risk estimation could mean that estimates of future 
cardiovascular events made using this method will be subject to inaccuracies, 
although the direction of these inaccuracies is unclear. From a policy 
perspective, although Manuel et al suggested that risk prediction algorithms 
could also be useful for planning and prioritising population interventions (114), 
population interventions would not rely on the use of cardiovascular risk 
calculators or be subject to their limitations. 
A number of changes to the current definition of high cardiovascular risk and the 
tools used to predict cardiovascular risk have been suggested. These changes 
have the potential to alter how high-risk CVD prevention is delivered, by 
expanding the number of people eligible for individual risk reducing 
interventions or by altering the types of interventions offered. For instance, 
simpler methods of determining high cardiovascular risk have been suggested, 
such as using age alone (555), whilst NICE has recently proposed that the 
threshold for defining high cardiovascular risk be lowered from ≥20% to ≥10% 
(500). This latter change could result in higher numbers of cardiovascular events 
being prevented in all ethnic groups, as the number of people who are classified 
as being at high cardiovascular risk, and therefore offered individual risk 
reducing interventions would increase across the population. However, this 
would also increase both the financial and opportunity costs of this high-risk CVD 
prevention approach. In contrast, new guidelines recommend the use of lifetime 
risk prediction (556, 557), an approach that provides an estimate of an 
individual’s risk of developing CVD during the rest of their life, rather than in 
just the next 10 years (558). This change is said to better reflect the progressive 
course of atherosclerosis and improve the identification of high cardiovascular 
risk in younger and ethnic minority individuals (556, 557). For ethnic minority 
groups in which CVD develops at younger ages lifetime risk prediction may be 
particularly beneficial (254, 556). This change has the potential to alter how 
CVD is prevented in the future as lifestyle rather than pharmaceutical 
interventions are likely to be more appropriate for younger people who are 
found to be at high lifetime, but low 10 year, cardiovascular risk (557). 
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However, further evidence is needed to establish the usefulness of lifetime 
risk measures, the effectiveness of long-term risk reduction interventions, and 
whether a threshold of high or low lifetime cardiovascular risk can be set (559).  
Despite developments in cardiovascular risk prediction, such as new calculators 
adapted to specific populations and the addition of new variables, improvements 
in the accuracy of risk estimation have been incremental and small. Whilst 
evidence for the association between cardiovascular risk factors and the 
development of CVD is substantial, the fact the these risk factors do not predict 
higher proportions of cardiovascular events indicates complexity in the pathway 
to developing CVD that has not been accounted for or that may not be fully 
understood. Ethnic differences in cardiovascular risk factors, and potential 
differences in the association between these risk factors and disease, may add 
further complexity when considering the application of cardiovascular risk 
calculators across ethnic groups. New approaches to cardiovascular risk 
prediction continue to be developed and widely applied, however, unless the 
accuracy of cardiovascular risk estimation significantly improves the 
effectiveness of these tools in preventing CVD will continue to be limited. 
Perhaps the addition of epigenetic information could improve accuracy of risk 
assessment for individuals or, alternatively, these limitations could be minimised 
through greater use of population approaches to CVD prevention. 
7.3 Ethnicity 
This thesis used ethnicity data to explore population subgroup differences in the 
impact of CVD prevention policies designed for the general population. A one-off 
self-reported measure of ethnicity, based on standard Census categories, was 
used. This approach is comparable to how ethnicity has been measured and used 
in other research and health service planning in the UK, and is perhaps the best 
method that is currently available. However, there are a number of issues to 
consider when interpreting evidence of ethnic differences in health or health 
policy performance.  
Ethnicity is a multifaceted and complex variable (219-222), which is measured 
for a number of reasons, including for epidemiological, political and legal 
purposes. From an epidemiological point of view, ethnicity data can help 
develop understanding of patterns of disease between populations, provide 
appropriate and effective health care services, and tackle inequalities in health 
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(220, 222, 224). However, its complex meaning must also be considered. For 
instance, it is important to recognise the heterogeneity that exists within ethnic 
groups. There is likely to be important heterogeneity within the ethnic groups 
studied in this thesis, particularly if there are differences in other determinants 
of health such as migration status, socioeconomic position or cultural 
background within these groups. Indeed, whilst inequalities in socioeconomic 
position within ethnic groups were considered in these analyses, differences in 
migration status were not. A specific criticism of the use of ethnicity data is the 
aggregation of South Asian ethnic groups, often for reasons of sample size (222). 
Whilst the Indian group was analysed separately from the Pakistani and 
Bangladeshi groups in this thesis, and indeed the findings differed between these 
groups, again limited sample sizes meant that the groups could not be fully 
separated. Heterogeneity will also exist within categories of other commonly 
used epidemiological variables, such as socioeconomic position, and full 
consideration of heterogeneity within ethnic groups would be difficult using 
currently available ethnicity data. However, heterogeneity has implications for 
the development of health policy because, whilst evidence may suggest that a 
policy may be effective in a particular ethnic group, these findings may not 
apply equally to all individuals within that group. This limitation could be 
addressed by ensuring that ethnicity is not considered or analysed in isolation, 
but alongside other related variables such as socioeconomic position, migration 
status, experience of racism, and so on. In the context of secondary data 
analysis, this would require availability of data with sufficiently large sample 
sizes by ethnic group and other relevant variables, so that valid sub-group 
analyses could be performed. In a related issue, it is important to ensure that 
health policy decisions are not based on stereotypical perceptions of different 
ethnic groups, for instance on assumptions of the health behaviours of people 
with certain cultural or religious backgrounds. Indeed, it has been suggested 
that stereotypical assumptions made by health care professionals could lead to 
bias in the provision of healthcare and exacerbate ethnic inequalities in health 
(350).  
Senior and Bhopal highlighted the issue of ethnocentricity that can arise when 
ethnicity is used in epidemiological research, whereby there is a tendency for 
researchers to compare minority groups with the majority leading to limited set 
of interpretations and conclusions about the nature of ethnic differences in 
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health (222). However, the implications of ethnocentricity for health policy 
development may differ. For decision makers developing CVD prevention policy 
for the population as a whole, comparisons against the ethnic majority may be 
necessary and may allow appropriate adaptations to population wide policy 
decisions. For instance, if the health needs of one ethnic minority group are 
found to be relatively high compared to the majority population, for whom the 
policy is being principally developed, a potential source of inequalities could be 
identified and the policy adapted as appropriate.  
Ethnic inequalities in CVD and cardiovascular risk factors were evident in this 
thesis, consistent with existing evidence (see sections 3.4 and 3.5). Given the 
range of possible causes of ethnic inequalities in CVD (see section 3.7), a tension 
arises in how to interpret or tackle these differences. At one extreme, it is 
possible that some ethnic inequalities in CVD are unavoidable, arising from 
biological or genetic differences. In the way that differences in risk of CVD 
between men and women seem to have been accepted as inevitable, perhaps 
this is also true for some ethnic inequalities in CVD. In contrast, ethnic 
inequalities in CVD could be due to deeply embedded and troubling social issues 
such as racism and institutional discrimination. These starkly contrasting 
explanations of ethnic health inequalities would need to be addressed using very 
different actions. For example, the biological explanation of ethnic inequalities 
in CVD may suggest that steps are needed to optimise the effectiveness of 
pharmacological interventions in different ethnic groups or that knowledge of 
biological differences should be used to set ethnic specific thresholds of risk. 
Alternatively, racism and discrimination would need to be tackled through 
structural, legal and social changes. Biology and racism were selected, and 
separated, here to illustrate the contrast between explanations of ethnic 
inequalities in CVD. However, explanations of ethnic inequalities in health and 
CVD are not independent of each other but are likely linked through complex 
mechanisms. Indeed, some explanations may lie on the causal pathway between 
ethnicity and CVD, mediating this association. For instance, being a member of 
an ethnic minority group could lead to poorer socioeconomic position because of 
the negative impact of discrimination, resulting in increased risk of CVD; this 
pathway would suggest that a policy to reduce socioeconomic deprivation across 
the whole population could also improve ethnic inequalities in CVD. Therefore, 
whilst this complexity further increases the difficulties of choosing appropriate 
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and effective measures to reduce ethnic inequalities in health, 
understanding these associations is important because they may influence the 
choice and effectiveness of policies to improve health and reduce ethnic health 
inequalities.   
Changes in the ethnic composition of populations present a further challenge for 
research and health service development in this area. As previously highlighted, 
the UK is becoming more ethnically diverse (19). Migration to the UK, key to the 
formation of ethnic minority groups, is increasing, and the countries that people 
migrate from have changed in recent years, particularly following the expansion 
of the European Union (560). At the same time, the experience of populations 
who migrated to the UK in previous decades will be developing as communities 
become established, future generations grow and socioeconomic circumstances 
change. For instance, UK projections suggest that higher proportions of ethnic 
minority populations will move to more affluent areas and become less 
segregated over forthcoming decades (561). Changing ethnic minority and 
migrant populations have implications for determining the health needs of 
populations and providing appropriate services (one high profile example of this 
is the impact of immigration on maternity services in the UK (562)). Therefore, 
public health professionals and researchers working in this area need to find 
ways to adapt to changes in populations.  
A challenge in carrying out the analyses in this thesis was finding suitable and 
recent data with sufficient numbers of ethnic minority individuals. The data that 
were used are now 10 years old and may not reflect recent demographic and 
socioeconomic changes in ethnic minority populations. In particular, movement 
of ethnic minority populations out of deprived areas may make targeted 
screening for high cardiovascular risk based on area deprivation relatively less 
cost-effective in these groups. The data were further limited by incomplete 
response rates that also varied by ethnicity. This raises the possibility that the 
samples studied may not be representative of the intended populations. Whilst 
survey weights were used to account for non-response, it is possible that some 
response bias may remain. Given that the analyses in this thesis focused on 
investigating ethnic differences, this bias would be particularly important if it 
also varied by ethnic group – i.e. if the populations that responded varied by 
ethnicity. Whilst this limitation must be considered when interpreting the 
results, its scale and direction are unclear. 
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The routine collection of ethnicity data is improving (563), and data linkage 
may further increase the availability of large scale datasets that include 
ethnicity (251, 252, 261, 564), as well as economic and migration data. The 
availability of these new data will be helpful for both research and health 
service planning. These issues will also be relevant to other countries that are 
also experiencing changes in the ethnic composition of their populations (565). 
7.4 Implications for CVD prevention policy 
Current UK CVD prevention policy appears to favour high-risk approaches, based 
on cardiovascular risk screening. English policy makers have opted for a mass 
screening strategy in the NHS Health Check programme, a programme that 
comes with significant financial and opportunity cost. This is despite unclear 
evidence for the effectiveness of health checks on clinical outcomes (although 
the NHS Health Check programme has the potential to add to the evidence base 
in this area) (155, 566-569), alongside evidence that population approaches may 
be a more effective and equitable way of preventing CVD (5, 108, 109), and 
targeted screening may be a more cost-effective alternative to mass screening 
(171, 192). This thesis further adds to these findings by indicating that 
population approaches may be particularly effective in ethnic groups at high-risk 
of CVD, and targeted screening may be particularly cost-effective in these 
groups. Given existing ethnic health inequalities and the fact that health policy 
needs to reduce inequalities as well as improve overall health, these findings 
lend further support to the use of population rather than high-risk approaches, 
and to a strategy of targeted rather than mass screening in the prevention of 
CVD in the general population.  
Despite evidence on effectiveness, cost and the equity impact of these CVD 
prevention polices, there are other factors that will influence the policy choices 
that are made. These factors include questions of politics and economics, and 
may explain the current direction of CVD prevention policy. For instance, 
population approaches have been criticised because they involve changes that 
affect the whole population, arguably infringing individual’s rights to determine 
their own health choices (94). Whether this is seen as a reason for avoiding 
population approaches may depend on political viewpoint. Development of the 
NHS health check programme may reflect a political preference for a high-
profile programme that is seen to be available for the whole population and that 
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encourages individual behaviour change. Furthermore, population 
approaches may also involve compulsory regulation of products produced by 
private industries, such as the food industry (18). However, these industries may 
prefer the choice of voluntary regulation or a focus on individual lifestyle 
change, which may influence the policy choices that are made.  
This thesis focused on the choices between population and high-risk approaches, 
and between mass and targeted screening for high cardiovascular risk. However, 
there are other policy options available that may provide further opportunities 
for CVD prevention. First, an area-based approach could be taken to prevent 
CVD. This thesis explored the use of area deprivation measures as a means of 
targeting socio-economically deprived individuals, and subsequently as a tool for 
targeting cardiovascular risk screening programmes. However, this was an 
approach based on individuals and not area itself. Physical and social 
environments can influence health and CVD (177, 178, 184), an association that 
may be particularly relevant to ethnic minority groups owing to issues of 
segregation, and concentration in socioeconomically deprived areas and areas 
with unhealthy environmental characteristics (see section 3.8). Therefore, in 
addition to using area as a means of targeting at risk individuals, interventions 
could be developed which make areas themselves better for cardiovascular 
health, for example through urban design enabling easier access to active travel 
or green space to increase levels of physical activity and reduce stress (570, 
571). This type of intervention could potentially lead to lasting improvements in 
upstream determinants and causes of CVD, with the co-benefit of improving 
health outcomes for other chronic diseases. If the purpose of an intervention 
were to prevent CVD by improving area characteristics, this would raise the 
question of which areas would be selected – socioeconomic deprivation and the 
ethnic make-up of the population may be factors that would influence this 
decision. Second, whilst this thesis considered primary prevention of CVD, health 
policy could be based on achieving primordial prevention - that is prevention of 
cardiovascular risk factors before they occur rather than reduction in existing 
risk factors (572). This is perhaps an idealistic scenario, which is most likely to 
be achieved in populations that currently have a low baseline risk using 
comprehensive population interventions and environmental change (79), 
reflecting our understanding of the development of cardiovascular risk factors 
over the lifecourse (573). However, it holds significant potential to improve 
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population health across all ethnic groups (572, 574). Indeed, one approach 
could be to achieve primordial prevention of CVD by stopping the development 
of cardiovascular risk factors in children through the kind of upstream area 
intervention described above. Third, another, quite different, option is the 
widespread use of a pill that contains a combination of medications known to 
reduce cardiovascular risk, i.e. the “polypill” (148). This could be a relatively 
simple approach to deliver, although evidence of its effectiveness is mixed (148, 
575). Furthermore, its effectiveness in different ethnic groups would need to be 
assessed, as it is possible that the same combination of medications may not be 
equally effective across ethnic groups. 
Whilst the changing ethnic composition of populations has implications for 
research and service provision, the evolving CVD epidemic will also influence 
which CVD prevention policy options are most appropriate. The burden of CVD is 
declining in the UK and other developed countries, however, prevalence of 
obesity and diabetes are increasing (39, 41, 57). These risk factors are 
particularly important in many ethnic minority groups in the UK, and increases in 
them may further increase ethnic inequalities in health (576). Therefore, CVD 
prevention policy will need to increasingly focus on the prevention of obesity 
and diabetes, including in high-risk ethnic minority groups. 
7.5 Conclusions and recommendations 
7.5.1 For-policy-makers-
The findings of this thesis lead to four conclusions. First, area deprivation 
measures work relatively effectively and efficiently at identifying individual 
socioeconomic deprivation in the largest ethnic minority groups in England, with 
reassurance that these groups would not be systematically disadvantaged by the 
use of these measures. This finding is of relevance to policy makers seeking to 
use area deprivation measures to target public health interventions at 
socioeconomically deprived individuals but needing to ensure that population 
subgroups would also be appropriately targeted. Whilst the findings support the 
use of area deprivation measures for this purpose from an ethnicity perspective, 
the age of the data analysed and potential changes in the geographical 
distribution of ethnic minority populations are important caveats to this 
conclusion. In addition, further evidence would be needed to extend this 
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conclusion and recommendation to other population subgroups and smaller or 
new ethnic minority groups.  
Second, cardiovascular risk screening programmes are a relatively cost-effective 
option in ethnic groups that have a high risk of CVD, and screening programmes 
targeted at deprived areas could be a particularly cost-effective option in these 
groups. Given limited health care resources and the need to use existing 
resources efficiently, this further supports the use of area based targeted 
cardiovascular risk screening programmes in the general population. Although 
the cardiovascular risk screening strategies adopted in the UK may be unlikely to 
change in the near future, this finding may be of relevance to health 
professionals delivering programmes locally and could be relevant to discussions 
about the relative merits of the existing approaches.  
Third, comprehensive population and high-risk approaches have the potential to 
prevent a significant amount of CVD across all ethnic groups, with population 
approaches being particularly effective and equitable in ethnic groups at high-
risk of CVD. Indeed, the potential impact of population approaches may be 
greater than estimated in this thesis. The relative merits of population and high-
risk approaches to CVD prevention have been debated for many years, with a 
general consensus that a balance of both approaches is needed. However, 
current CVD prevention policy in the UK tends to favour high-risk rather than 
population approaches, despite the existence of feasible and successful 
population policies (for example, salt reduction programmes and smoke free 
legislation). Therefore, current high-risk policies should be supplemented with 
further population policies in order to maximize the health gain arising from CVD 
prevention, narrow health inequalities and create a more sustainable health 
service in the long-term. 
Finally, the fact that this thesis found ethnic differences in the potential 
effectiveness, costs and equity impact of various CVD prevention policies, 
highlights the importance of assessing the impact of public health interventions 
in subgroups of the population. This should be done for both new and existing 
policies and interventions. Modelling can be used to predict the potential cost-
effectiveness and impact on health inequalities of new policies within population 
subgroups, whilst monitoring and evaluation can be used for existing policies. 
This thesis considered ethnicity, but other important groupings would be those 
based on socioeconomic position, sex, age and geographical area of residence, 
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including urban or rural location. Although this would be a significant 
undertaking, and some of this work is already undertaken (e.g. in health 
inequalities impact assessments), a more systematic approach across a wide 
range of population subgroups could help to maximize the ability of public 
health interventions to improve health and reduce health inequalities.  
7.5.2 For-researchers-
The conclusions and recommendations described above will also be of relevance 
to researchers. In particular, researchers will need to continue to be involved in 
assessing the impact of public health interventions in population subgroups and 
in further investigation of the utility of area deprivation measures to target 
socioeconomically deprived individuals in other population subgroups. The 
availability of appropriate and sufficiently large datasets is key to achieving 
these recommendations and informing the implementation of effective and 
equitable public health policies. Whilst no secondary data sources are perfect, a 
number of data limitations were encountered in this thesis. This highlights the 
need for researchers in this field to continue to expand the data available. 
Datasets should contain ethnicity data alongside other relevant social and 
economic measures that are relevant to health and to the pathway between 
ethnicity and health. Increasing the recording of ethnicity data in routine health 
datasets alongside data linkage are two key approaches that can provide large, 
flexible datasets that could be adapted to the changing demographics of the 
population. 
Considered together these conclusions provide reassurance that ethnic minority 
groups in the UK are unlikely to be systematically disadvantaged by CVD 
prevention policies that have been suggested, and implemented, for the general 
population. Furthermore, ethnic minority groups at high risk of CVD may benefit 
more from these CVD prevention policies, leading to a reduction in ethnic health 
inequalities. General speaking, this lends further support to the argument in 
favour of the implementation of and investment in comprehensive CVD 
prevention policies in the UK, using a range of approaches. 
7.6 Reflections on this and future research  
Reflecting on my experience of carrying out this research has allowed me to 
consider alternative approaches for addressing similar research questions in the 
future. At various points in this thesis the potential for using alternative data 
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sources was considered. If I were to start this research again I would look 
again to see what new data sets were available, in particular exploring the 
potential for data linkage between Census and primary care data as this would 
provide the information required for these analyses. Another alternative 
approach, which was considered at the outset of this research, would be the use 
of microsimulation to create a large, ethnically diverse hypothetical population. 
This approach could have allowed the inclusion of additional ethnic groups, for 
example individuals from Eastern Europe, and could have led to the production 
of a model that could be applied to alternative research questions in the future, 
although its development would still have had to rely on existing lifestyle and 
health data from across ethnic groups. 
Moving forward from the analyses in this thesis, it would be useful to investigate 
ethnic differences in the potential impact of specific population CVD prevention 
policies. For example, whether there would be ethnic differences in the impact 
of eliminating trans fatty acids from the food chain in the UK. An analysis of this 
type would require ethnic group specific data on trans fatty acid intake. 
Furthermore, it would be interesting to look again at the relationship between 
area, health and ethnicity and consider the use of population wide, area-based 
interventions that could prevent CVD or reduce health inequalities through 
systematic changes in areas themselves. 
  
201 
8 References 
1. NHS England. The NHS belongs to the people: a call to action. 2013. 
2. Oliver D, Foot C, Humphries R. Making our health and care systems fit for 
an ageing population. London: The King's Fund, 2014. 
3. Wonderling D, Sawyer L, Fenu E, Lovibond K, Laramee P. National Clinical 
Guideline Centre cost-effectiveness assessment for the National Institute for 
Health and Clinical Excellence. Annals of Internal Medicine. 2011;154:758-65. 
4. White M, Adams J, Heywood P. How and why do interventions that 
increase health overall widen inequalities within populations? In: Babones SJ, 
editor. Social Inequality and Public Health. Bristol: The Policy Press; 2009. 
5. Capewell S, Graham H. Will cardiovascular disease prevention widen 
health inequalities? PLoS Medicine. 2010;7(8):e1000320. 
6. Murray CJL, Richards MA, Newton JN, Fenton KA, Anderson HR, Atkinson 
C, et al. UK health performance: findings of the Global Burden of Disease Study 
2010. Lancet. 2013;381(9871):997-1020. 
7. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of 
potentially modifiable risk factors associated with myocardial infarction in 52 
countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-52. 
8. Bhopal R, Hayes L, White M, Unwin N, Harland J, Ayis S, et al. Ethnic and 
socio-economic inequalities in coronary heart disease, diabetes and risk factors 
in Europeans and South Asians. Journal of Public Health Medicine. 2002;24(2):95-
105. 
9. Davey Smith G, Chaturvedi N, Harding S, Nazroo J, Williams R. Ethnic 
inequalities in health: a review of UK epidemiological evidence. Critical Public 
Health. 2000;10(4):375-408. 
10. Kurian AK, Cardarelli KM. Racial and ethnic differences in cardiovascular 
disease risk factors: a systematic review. Ethnicity and Disease. 2007;17:143-52. 
11. Zaninotto P, Mindell J, Hirani V. Prevalence of cardiovascular risk factors 
among ethnic groups: results from the Health Surveys for England. 
Atherosclerosis. 2007;195:e48-e57. 
12. Forouhi NG, Sattar N, Tillin T, McKeigue PM, Chaturvedi N. Do known risk 
factors explain the higher coronary heart disease mortality in South Asian 
compared with European men? Prospective follow-up of the Southall and Brent 
studies, UK. Diabetologia. 2006;49:2580-8. 
  
202 
13. Vascular programme. Putting prevention first. Vascular checks: risk 
assessment and management. London: Department of Health, 2008. 
14. Mackenzie M, O'Donnell C, Reid M, Turner F, Wang Y, Clark J, et al. 
National evaluation of Keep Well. Final report: summary of findings and 
implications for policy and practice. NHS Health Scotland, 2011. 
15. Faculty of Public Health. FPH withdraws from responsibility deals. 2013 
[cited 2014 10th September]; Available from: 
http://www.fph.org.uk/fph_withdraws_from_responsibility_deals. 
16. Department of Health. The public health responsibilty deal. London: COI; 
2011. 
17. Petticrew M, Eastmure E, Mays N, Knai C, Durand MA, Nolte E. The Public 
Health Responsibility Deal: how should such a complex public health policy be 
evaluated? Journal of Public Health. 2013;35(4):495-501. 
18. National Institute for Health and Clinical Excellence. Prevention of 
cardiovascular disease at population level. London: NICE, 2010. 
19. Office for National Statistics. Ethnicity and national identity in England 
and Wales 2011. London: Office for National Statistics, 2012. 
20. British Heart Foundation. Cardiovascular disease.  [cited 2014 4th 
September]; Available from: http://www.bhf.org.uk/heart-
health/conditions/cardiovascular-disease.aspx. 
21. Capewell S, Allender S, Critchley J, Lloyd-Williams F, O'Flaherty M, 
Rayner M, et al. Modelling the UK burden of Cardiovascular Disease to 2020. 
London: Cardio and Vascular Coalition and the British Heart Foundation, 2008. 
22. British Heart Foundation. Stroke and your heart.  [cited 2014 4th 
September]; Available from: http://www.bhf.org.uk/heart-
health/conditions/stroke.aspx. 
23. Levy D, Kannel WB. Cardiovascular risks: new insights from Framingham. 
American Heart Journal. 1988;116:266-72. 
24. Reddy KS, Satija A. The Framingham Heart Study: impact on the 
prevention and control of cardiovascular diseases in India. Progress in 
cardiovascular diseases. 2010;53:21-7. 
25. van den Hoogen PCW, Feskens EJM, Nagelkerke NJD, Menotti A, Nissinen 
A, Kromhout D. The relation between blood pressure and mortality due to 
coronary heart disease among men in different parts of the world. New England 
Journal of Medicine. 2000;342:1-8. 
  
203 
26. Rockhill B, Newman B, Weinberg C. Use and misuse of population 
attributable fractions. American Journal of Public Health. 1998;88(1):15-9. 
27. Smulders YM, Thijs A, Twisk JW. New cardiovascular risk determinants do 
exist and are clinically useful. European heart journal. 2008;29:436-40. 
28. Mackenbach JP, Cavelaars AEJM, Kunst AE, Groenhof F. Socioeconomic 
inequalities in cardiovascular disease mortality: an international study. European 
heart journal. 2000;21:1141-51. 
29. Marmot MG, Davey Smith G, Stansfeld S, Patel C, North F, Head J, et al. 
Health inequalities among British civil servants: the Whitehall II study. Lancet. 
1991;337:1387-93. 
30. Lynch J, Kaplan G. Socioeconomic position. In: Berkman LF, Kawachi I, 
editors. Social Epidemiology. New York: Oxford University Press; 2000. p. 13-35. 
31. Davey Smith G, Hart C, Watt G, Hole D, Hawthorne V. Individual social 
class, area-based deprivation, cardiovascular disease risk factors, and mortality: 
the Renfrew and Paisley study. Journal of Epidemiology and Community Health. 
1998;52:399-405. 
32. Singh-Manoux A, Nabi H, Shipley M, Gueguen A, Sabia S, Dugravot A, et al. 
The role of conventional risk factors in explaining social inequalities in coronary 
heart disease: the relative and absolute approaches to risk. Epidemiology. 
2008;19:599-605. 
33. Dahlgren G, Whitehead M. Policies and strategies to promote social equity 
in health. Stockholm: Institute for Future Studies, 1991. 
34. Institute of Health Metrics and Evaluation. The global burden of disease: 
generating evidence, guiding policy. Seattle, WA: IHME, 2013. 
35. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. 
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 
1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. 
Lancet. 2012;380:2163-96. 
36. Luengo-Fernández R, Leal J, Gray A, Petersen S, Rayner M. Cost of 
cardiovascular diseases in the United Kingdom. Heart. 2006;92:1384-9. 
37. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular 
diseases: Part I: General considerations, the epidemiologic transition, risk 
factors, and impact of urbanization. Circulation. 2001;104:2746-53. 
  
204 
38. Ergin A, Muntner P, Sherwin R, He J. Secular trends in cardiovascular 
disease mortality, incidence, and case fatality rates in adults in the United 
States. American Journal of Medicine. 2004;117:219-27. 
39. Smolina K, Wright FL, Rayner M, Goldacre MJ. Determinants of the decline 
in mortality from acute myocardial infarction in England between 2002 and 
2010: linked national database study. BMJ. 2012;344:d8059. 
40. Vaartjes I, O'Flaherty M, Capewell S, Kappelle J, Bots M. Remarkable 
decline in ischemic stroke mortality is not matched by changes in incidence. 
Stroke. 2013;44:591-7. 
41. Nichols M, Townsend N, Scarborough P, Rayner M. Trends in age-specific 
coronary heart disease mortality in the European Union over three decades: 
1980–2009. European heart journal. 2013;34:3017-27. 
42. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, 
Amouyel P. Contribution of trends in survival and coronary-event rates to 
changes in coronary heart disease mortality: 10-year results from 37 WHO 
MONICA project populations. Lancet. 1999;353:1547-57. 
43. Capewell S, Hayes DK, Ford ES, Critchley JA, Croft JB, Greenlund KJ, et 
al. Life-years gained among US adults from modern treatments and changes in 
the prevalence of 6 coronary heart disease risk factors between 1980 and 2000. 
American journal of epidemiology. 2009;170(2):229-36. 
44. Goldman L, Phillips KA, Coxson P, Goldman PA, Williams L, Hunink MGM, 
et al. The effect of risk factor reductions between 1981 and 1990 on coronary 
heart disease incidence, prevalence, mortality and cost. Journal of the American 
College of Cardiology. 2001;38(4):1012-7. 
45. Tunstall-Pedoe H, Connaghan J, Woodward M, Tolonen H, Kuulasmaa K. 
Pattern of declining blood pressure across replicate population surveys of the 
WHO MONICA project, mid-1980s to mid-1990s, and the role of medication. BMJ. 
2006;332:629. 
46. Critchley JA, Capewell S. Substantial potential for reductions in coronary 
heart disease mortality in the UK through changes in risk factor levels. Journal 
of Epidemiology and Community Health. 2003;57:243-7. 
47. Bajekal M, Scholes S, Love H, Hawkins N, O'Flaherty M, Raine R, et al. 
Analysing recent socioeconomic trends in coronary heart disease mortality in 
England, 2000-2007: a population modelling study. PLoS Med. 
2012;9(6):e1001237. 
  
205 
48. Bandosz P, O'Flaherty M, Drygas W, Rutkowski M, Koziarek J, 
Wyrzykowski B, et al. Decline in mortality from coronary heart disease in Poland 
after socioeconomic transformation: modelling study. BMJ. 2012;344:d8136. 
49. Bennett K, Kabir Z, Unal B, Shelley E, Critchley J, Perry I, et al. 
Explaining the recent decrease in coronary heart disease mortality rates in 
Ireland, 1985-2000. Journal of Epidemiology and Community Health. 
2006;60:322-7. 
50. Bjorck L, Rosengren A, Bennett K, Lappas G, Capewell S. Modelling the 
decreasing coronary heart disease mortality in Sweden between 1986 and 2002. 
European heart journal. 2009;30:1046-56. 
51. Capewell S, Morrison CE, McMurray JJ. Contribution of modern 
cardiovascular treatment and risk factor changes to the decline in coronary 
heart disease mortality in Scotland between 1975 and 1994. Heart. 1999;81:380-
6. 
52. Young F, Capewell S, Ford ES, Critchley JA. Coronary mortality declines in 
the US between 1980 and 2000: quantifying the contributions from primary and 
secondary prevention. American Journal of Preventive Medicine. 2010;39(3):228-
34. 
53. Hardoon SL, Whincup PH, Lennon LT, Wannamethee SG, Capewell S, 
Morris RW. How much of the recent decline in the incidence of myocardial 
infarction in British men can be explained by changes in cardiovascular risk 
factors? : Evidence from a prospective population-based study. Circulation. 
2008;117:598-604. 
54. Capewell S, Ford ES, Croft JB, Critchley JA, Greenlund KJ, Labarthe DR. 
Cardiovascular risk factor trends and potential for reducing coronary heart 
disease mortality in the United States of America. Bulletin of the World Health 
Organization. 2010;88:120-30. 
55. Kramarow E, Lubitz J, Francis Jr R. Trends in the coronary heart disease 
risk profile of middle-aged adults. Annals of Epidemiology. 2013;23:31-4. 
56. Raum E, Rothenbacher D, Low M, Stegmaier C, Ziegler H, Brenner H. 
Changes of cardiovascular risk factors and their implications in subsequent birth 
cohorts of older adults in Germany: a life course approach. European Journal of 
Cardiovascular Prevention and Rehabilitation. 2007;14:809-14. 
  
206 
57. Ford ES, Capewell S. Coronary heart disease mortality among young 
adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. 
Journal of the American College of Cardiology. 2007;50(22):2128-32. 
58. Kawachi I, Subramanian SV, Almeida-Filho N. A glossary for health 
inequalities. Journal of Epidemiology and Community Health. 2002;56:647-52. 
59. Braveman P, Gruskin S. Defining equity in health. Journal of Epidemiology 
and Community Health. 2003;57:254-8. 
60. Carr-Hill R, Chalmers-Dixon P. The public health observatory handbook of 
health inequalities measurement. Oxford: South East Public Health Observatory, 
2005. 
61. Asaria P, Fortunato L, Fecht D, Tzoulaki I, Abellan JJ, Hambly P, et al. 
Trends and inequalities in cardiovascular disease mortality across 7932 English 
electoral wards, 1982–2006: Bayesian spatial analysis. International Journal of 
Epidemiology. 2012;41:1737-49. 
62. Chaturvedi N. Ethnic differences in cardiovascular disease. Heart. 
2003;89:681-6. 
63. Law MR, Morris JK. Why is mortality higher in poorer areas and in more 
northern areas of England and Wales? Journal of Epidemiology and Community 
Health. 1998;52(344-52). 
64. Ferrie JE, Shipley MJ, Davey Smith G, Stansfeld SA, Marmot MG. Change in 
health inequalities among British civil servants: the Whitehall II study. Journal of 
Epidemiology and Community Health. 2002;56:922-6. 
65. O'Flaherty M, Bishop J, Redpath A, McLaughlin T, Murphy D, Chalmers J, 
et al. Coronary heart disease mortality among young adults in Scotland in 
relation to social inequalities: time trend study. BMJ. 2009;339:b2613. 
66. Scholes S, Bajekal M, Love H, Hawkins N, Raine R, O'Flaherty M, et al. 
Persistent socioeconomic inequalities in cardiovascular risk factors in England 
over 1994-2008: a time-trend analysis of repeated cross-sectional data. BMC 
Public Health. 2012;12:129. 
67. Capewell S, Lloyd-Jones DM. Optimal cardiovascular prevention strategies 
for the 21st century. JAMA. 2010;304(18):2057-8. 
68. Pearson TA. The prevention of cardiovascular disease: have we really 
made progress? Health Affairs. 2007;26(1):49-60. 
  
207 
69. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren WMM, 
et al. European Guidelines on cardiovascular disease prevention in clinical 
practice (version 2012). European heart journal. 2012;33:1635-701. 
70. Kahn R, Robertson RM, Smith R, Eddy D. The impact of prevention on 
reducing the burden of cardiovascular disease. Circulation. 2008;118:576-85. 
71. Qureshi AI, Suri MFK, Kirmani JF, Divani AA. The relative impact of 
inadequate primary and secondary prevention on cardiovascular mortality in the 
United States. Stroke. 2004;35:2346-50. 
72. Vartiainen E. A lot more can be done to prevent cardiovascular diseases. 
European heart journal. 2004;25:457-8. 
73. Cupples ME, Smith SM, Murphy AW. How effective is prevention in 
coronary heart disease? Heart. 2008;94:1370-1. 
74. Nieuwlaat R, Schwalm J-D, Khatib R, Yusuf S. Why are we failing to 
implement effective therapies in cardiovascular disease? European heart journal. 
2013;34:1262-9. 
75. Gervas J, Starfield B, Heath I. Is clinical prevention better than cure? 
Lancet. 2008;372:1997-99. 
76. Starfield B, Hyde J, Gervas J, Heath I. The concept of prevention: a good 
idea gone astray? Journal of Epidemiology and Community Health. 2008;62:580-
3. 
77. Olsen J, Chongsuvivatwong V, Beaglehole R. Prevention and control of 
chronic, non-communicable diseases. In: Detels R, Beaglehole R, Lansang MA, 
Gulliford M, editors. Oxford Textbook of Public Health. Oxford: Oxford University 
Press; 2009. p. 1592-601. 
78. van Venrooij FV, Stolk RP, Banga JD, Erkelens DW, Grobbee DE. Primary 
and secondary prevention in cardiovascular disease: an old-fashioned concept? 
Journal of Internal Medicine. 2002;251:301-6. 
79. Foraker RE, Olivo-Marston SE, Allen NB. Lifestyle and primordial 
prevention of cardiovascular disease: challenges and opportunities. Current 
Cardiovascular Risk Reports. 2012;6:520-7. 
80. Lowther M, Mordue A. Primary prevention of cardiovascular disease in 
Scotland: we must go further. Glasgow: Health Scotland, 2006. 
81. Kabir Z, Bennett K, Shelley E, Unal B, Critchley JA, Capewell S. 
Comparing primary prevention with secondary prevention to explain decreasing 
  
208 
Coronary Heart Disease death rates in Ireland, 1985-2000. BMC Public Health. 
2007;7:117. 
82. Unal B, Critchley JA, Capewell S. Modelling the decline in coronary heart 
disease deaths in England and Wales, 1981-2000: comparing contributions from 
primary prevention and secondary prevention. BMJ. 2005;331(7517):614. 
83. Gemmell I, Heller RF, Payne K, Edwards R, Roland M, Durrington P. 
Potential population impact of the UK government strategy for reducing the 
burden of coronary heart disease in England: comparing primary and secondary 
prevention strategies. Quality and Safety in Health Care. 2006;15:339-43. 
84. Rosamond WD, Chambless LE, Folsom AR, Cooper LS, Conwill DE, Clegg L, 
et al. Trends in the incidence of myocardial infarction and in mortality due to 
coronary heart disease, 1987 to 1994. New England Journal of Medicine. 
1998;339(13):861-7. 
85. Yeh RW, Go AS. Rethinking the epidemiology of acute myocardial 
infarction: challenges and opportunities. Archives of Internal Medicine. 
2010;170(9):759-64. 
86. Hobbs FDR. Cardiovascular disease: different strategies for primary and 
secondary prevention? Heart. 2004;90:1217-23. 
87. Banegas JR, Lopez-Garcia E, Dallongeville J, Guallar E, Halcox JP, Borghi 
C, et al. Achievement of treatment goals for primary prevention of 
cardiovascular disease in clinical practice across Europe: the EURIKA study. 
European heart journal. 2011;32:2143-52. 
88. Laverty AA, Bottle A, Majeed A, Millett C. Blood pressure monitoring and 
control by cardiovascular disease status in UK primary care: 10 year 
retrospective cohort study 1998-2007. Journal of Public Health. 2011;33(2):302-
9. 
89. Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent 
cardiovascular disease: meta-analysis on 376,162 patients. The American journal 
of medicine. 2012;125:882-7. 
90. DeWilde S, Carey IM, Richards N, Whincup PH, Cook DG. Trends in 
secondary prevention of ischaemic heart disease in the UK 1994-2005: use of 
individual and combination treatment. Heart. 2008;94:83-8. 
91. Rose G. Rose's Strategy of Preventive Medicine. Oxford: Oxford University 
Press; 2008. 
  
209 
92. Rose G. Sick individuals and sick populations. International Journal of 
Epidemiology. 2001;30:427-32. 
93. Di Castelnuovo A, Costanzo S, Bagnardi V, Donati MB, Iacoviello L, de 
Gaetano G. Alcohol dosing and total mortality in men and women: an updated 
meta-analysis of 34 prospective studies. Archives of Internal Medicine. 
2006;166:2437-45. 
94. Charlton BG. A critique of Geoffrey Rose's 'population strategy' for 
preventive medicine. Journal of the Royal Society of Medicine. 1995;88:607-10. 
95. Burton H, Sagoo GS, Pharoah P, Zimmern RL. Time to revisit Geoffrey 
Rose: strategies for prevention in the genomic era? Italian Journal of Public 
Health. 2012;9(4):e8665. 
96. Hingorani A, Hemingway H. How should we balance individual and 
population benefits of statins for preventing cardiovascular disease? BMJ. 
2011;342:c6244. 
97. Jackson R, Lynch J, Harper S. Preventing coronary heart disease. BMJ. 
2006;332:617-8. 
98. Cobiac LJ, Magnus A, Lim S, Barendregt JJ, Carter R, Vos T. Which 
interventions offer best value for money in primary prevention of cardiovascular 
disease? PLoS ONE. 2012;7(7):e41842. 
99. Jorgensen T, Capewell S, Prescott E, Allender S, Sans S, Zdrojewski T, et 
al. Population-level changes to promote cardiovascular health. European journal 
of preventive cardiology. 2012. 
100. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular 
diseases: Part II: Variations in cardiovascular disease by specific ethnic groups 
and geographic regions and prevention strategies. Circulation. 2001;104:2855-
64. 
101. Barton P, Andronis L, Briggs A, McPherson K, Capewell S. Effectiveness 
and cost effectiveness of cardiovascular disease prevention in whole 
populations: modelling study. BMJ. 2011;343:d4044. 
102. Kabir Z, Bennett K, Critchley JA, Capewell S. Can small changes in 
cardiovascular risk factors predict large future reductions in coronary heart 
disease mortality in Ireland? European Journal of Epidemiology. 2007;22:83-9. 
103. Jousilahti P, Vartiainen E, Pekkanen J, Tuomilehto J, Sundvall J, Puska P. 
Serum cholesterol distribution and coronary heart disease risk: observations and 
  
210 
predictions among middle-aged population in eastern Finland. Circulation. 
1998;97:1087-94. 
104. Dowse GK, Gareeboo H, Alberti KGMM, Zimmet P, Tuomilehto J, Purran A, 
et al. Changes in population cholesterol concentrations and other cardiovascular 
risk factor levels after five years of the non-communicable disease intervention 
programme in Mauritius. BMJ. 1995;311:1255-9. 
105. McCluskey S, Baker D, Percy D, Lewis P, Middleton E. Reductions in 
cardiovascular risk in association with population screening: a 10-year 
longitudinal study. Journal of Public Health. 2007;29(4):379-87. 
106. Rasmussen SR, Thomsen JL, Kilsmark J, Hvenegaard A, Engberg M, 
Lauritzen T, et al. Preventive health screenings and health consultations in 
primary care increase life expectancy without increasing costs. Scandinavian 
journal of public health. 2007;35:365-72. 
107. Murray CJL, Lauer JA, Hutubessy RCW, Niessen L, Tomijima N, Rodgers A, 
et al. Effectiveness and costs of interventions to lower systolic blood pressure 
and cholesterol: a global and regional analysis on reduction of cardiovascular-
disease risk. Lancet. 2003;361:717-25. 
108. Cooney M-T, Dudina A, Whincup P, Capewell S, Menotti A, Jousilahti P, et 
al. Re-evaluating the Rose approach: comparative benefits of the population and 
high-risk preventive strategies. European Journal of Cardiovascular Prevention & 
Rehabilitation. 2009;16:541-9. 
109. Emberson J, Whincup P, Morris R, Walker M, Ebrahim S. Evaluating the 
impact of population and high-risk strategies for the primary prevention of 
cardiovascular disease. European heart journal. 2004;25:484-91. 
110. Strachan D, Rose G. Strategies of prevention revisited: effects of 
imprecise measurement of risk factors on the evaluation of “high-risk” and 
“population-based” approaches to prevention of cardiovascular disease. Journal 
of Clinical Epidemiology. 1991;44(11):1187-96. 
111. Manuel DG, Lim J, Tanuseputro P, Anderson GM, Alter DA, Laupacis A, et 
al. Revisiting Rose: strategies for reducing coronary heart disease. BMJ. 
2006;332:659-62. 
112. Zulman DM, Vijan S, Omenn GS, Hayward RA. The relative merits of 
population-based and targeted prevention strategies. The Milbank Quarterly. 
2008;86(4):557-80. 
  
211 
113. Whincup P, Emberson J, Morris R. Response to "Revisiting Rose: 
strategies for reducing coronary heart disease": Impact of population strategy 
greatly underestimated. BMJ. 2006;332:659. 
114. Manuel DG, Rosella LC, Hennessy D, Sanmartin C, Wilson K. Predictive risk 
algorithms in a population setting: an overview. Journal of Epidemiology and 
Community Health. 2012;66:859-65. 
115. Brugts JJ, Yetgin T, Hoeks SE, Gotto AM, Shepherd J, Westendorp RGJ, et 
al. The benefits of statins in people without established cardiovascular disease 
but with cardiovascular risk factors: meta-analysis of randomised controlled 
trials. BMJ. 2009;338:b2376. 
116. Ray KK, Seshasai SRK, Erqou S, Sever P, Jukema JW, Ford I, et al. Statins 
and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 
randomized controlled trials involving 65 229 participants. Archives of Internal 
Medicine. 2010;170(12):1024-31. 
117. Taylor F, Huffman MD, Macedo AF, Moore THM, Burke M, Davey Smith G, 
et al. Statins for the primary prevention of cardiovascular disease. Cochrane 
Database of Systematic Reviews. 2013;DOI: 10.1002/14651858.CD004816.pub5. 
118. Capewell S, Ford ES. Why have total cholesterol levels declined in most 
developed countries? BMC Public Health. 2011;11:641. 
119. Ellis JJ, Erickson SR, Stevenson JG, Bernstein SJ, Stiles RA, Fendrick AM. 
Suboptimal statin adherence and discontinuation in primary and secondary 
prevention populations. Journal of General Internal Medicine. 2004;19:638-45. 
120. Wright JM, Musini VM. First-line drugs for hypertension. Cochrane 
Database of Systematic Reviews. 2009;DOI: 10.1002/14651858.CD001841.pub2. 
121. National Institute for Health and Clinical Excellence. Lipid modification: 
cardiovascular risk assessment and the modification of blood lipids for the 
primary and secondary prevention of cardiovascular disease. London: NICE, 2008 
(reissued 2010). 
122. National Institute for Health and Clinical Excellence. Hypertension: the 
clinical management of primary hypertension in adults. London: National Clinical 
Guideline Centre, 2011. 
123. Bauld L, Bell K, McCullough L, Richardson L, Greaves L. The effectiveness 
of NHS smoking cessation services: a systematic review. Journal of Public 
Health. 2010;32(1):71-82. 
  
212 
124. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, et 
al. Nicotine replacement therapy for smoking cessation. Cochrane Database of 
Systematic Reviews. 2012;DOI: 10.1002/14651858.CD000146.pub4. 
125. West R, May S, West M, Croghan E, McEwen A. Performance of English 
stop smoking services in first 10 years: analysis of service monitoring data. BMJ. 
2013;347:f4921. 
126. Callinan JE, Clarke A, Doherty K, Kelleher C. Legislative smoking bans for 
reducing secondhand smoke exposure, smoking prevalence and tobacco 
consumption. Cochrane Database of Systematic Reviews. 2010;DOI: 
10.1002/14651858.CD005992.pub2. 
127. Meyers DG, Neuberger JS, He J. Cardiovascular effect of bans on smoking 
in public places: a systematic review and meta-analysis. Journal of the American 
College of Cardiology. 2009;54(14):1249-55. 
128. Frieden TR, Mostashari F, Kerker BD, Miller N, Hajat A, Frankel M. Adult 
tobacco use levels after intensive tobacco control measures: New York City, 
2002-2003. American Journal of Public Health. 2005;95:1016-23. 
129. Wilson LM, Avila Tang E, Chander G, Hutton HE, Odelola OA, Elf JL, et al. 
Impact of tobacco control interventions on smoking initiation, cessation, and 
prevalence: a systematic review. Journal Of Environmental and Public Health. 
2012;doi: 10.1155/2012/961724. 
130. Aburto NJ, Ziolkovska A, Hooper L, Elliott P, Cappuccio FP, Meerpohl JJ. 
Effect of lower sodium intake on health: systematic review and meta-analyses. 
BMJ. 2013;346:f1326. 
131. Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, 
Pletcher MJ, et al. Projected effect of dietary salt reductions on future 
cardiovascular disease. New England Journal of Medicine. 2010;362:590-9. 
132. Sadler K, Nicholson S, Steer T, Gill V, Bates B, Tipping S, et al. National 
Diet and Nutrition Survey - Assessment of dietary sodium in adults (aged 19 to 64 
years) in England, 2011. London: Department of Health, 2012. 
133. MacGregor GA, He FJ, Pombo-Rodrigues S. Food and the responsibility 
deal: how the salt reduction strategy was derailed. BMJ. 2015;350:h1936. 
134. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans 
fatty acids and cardiovascular disease. New England Journal of Medicine. 
2006;354:1601-13. 
135. Coombes R. Trans fats: chasing a global ban. BMJ. 2011;343:d5567. 
  
213 
136. Rees K, Dyakova M, Ward K, Thorogood M, Brunner E. Dietary advice 
for reducing cardiovascular risk. Cochrane Database of Systematic Reviews. 
2013;DOI: 10.1002/14651858.CD002128.pub4. 
137. Hartley L, Igbinedion E, Holmes J, Flowers N, Thorogood M, Clarke A, et 
al. Increased consumption of fruit and vegetables for the primary prevention of 
cardiovascular diseases. Cochrane Database of Systematic Reviews. 2013;DOI: 
10.1002/14651858.CD009874.pub2. 
138. Hooper L, Bartlett C, Davey Smith G, Ebrahim S. Advice to reduce dietary 
salt for prevention of cardiovascular disease. Cochrane Database of Systematic 
Reviews. 2004;DOI: 10.1002/14651858.CD003656.pub2. 
139. Estruch R, Ros E, Salas-Salvado J, Covas MI, Pharm D, Corella D, et al. 
Primary prevention of cardiovascular disease with a mediterranean diet. New 
England Journal of Medicine. 2013;368(14):1279-90. 
140. Baker PRA, Francis DP, Soares J, Weightman AL, Foster C. Community 
wide interventions for increasing physical activity. Cochrane Database of 
Systematic Reviews. 2011;DOI: 10.1002/14651858.CD008366.pub2. 
141. Foster C, Hillsdon M, Thorogood M, Kaur A, Wedatilake T. Interventions 
for promoting physical activity. Cochrane Database of Systematic Reviews. 
2005;DOI: 10.1002/14651858.CD003180.pub2. 
142. Antithrombotic Trialists’ (ATT) Collaboration. Aspirin in the primary and 
secondary prevention of vascular disease: collaborative meta-analysis of 
individual participant data from randomised trials. Lancet. 2009;373:1849-60. 
143. Barnett H, Burrill P, Iheanacho I. Don’t use aspirin for primary prevention 
of cardiovascular disease. BMJ. 2010;340:c1805. 
144. British Cardiac Society, British Hypertension Society, Diabetes UK, HEART 
UK, Primary Care Cardiovascular Society, The Stroke Association. JBS 2: Joint 
British Societies' guidelines on prevention of cardiovascular disease in clinical 
practice. Heart. 2005;91(Suppl V):v1-v52. 
145. Stampfer M, Hu FB, Manson JE, Rimm EB, Willett WC. Primary prevention 
of coronary heart disease in women through diet and lifestyle. New England 
Journal of Medicine. 2000;343:16-22. 
146. Ebrahim S, Taylor F, Ward K, Beswick A, Burke M, Davey Smith G. Multiple 
risk factor interventions for primary prevention of coronary heart disease. 
Cochrane Database of Systematic Reviews. 2011;DOI: 
10.1002/14651858.CD001561.pub3. 
  
214 
147. de Cates AN, Farr MRB, Wright N, Jarvis MC, Rees K, Ebrahim S, et al. 
Fixed-dose combination therapy for the prevention of cardiovascular disease. 
Cochrane Database of Systematic Reviews. 2014;DOI: 
10.1002/14651858.CD009868.pub2. 
148. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more 
than 80%. BMJ. 2003;326:1419-23. 
149. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease 
risk profiles. Am Heart J. 1990;121:293-8. 
150. Cooney MT, Cooney HC, Dudina A, Graham IM. Assessment of 
cardiovascular risk. Current hypertension reports. 2010;12:384-93. 
151. Dent THS. Predicting the risk of coronary heart disease I. The use of 
conventional risk markers. Atherosclerosis. 2010;213:345-51. 
152. Sheridan SL, Crespo E. Does the routine use of global coronary heart 
disease risk scores translate into clinical benefits or harms? A systematic review 
of the literature. BMC health services research. 2008;8:60. 
153. Cooney MT, Dudina A, D'Agostino R, Graham IM. Cardiovascular risk-
estimation systems in primary prevention: Do they differ? Do they make a 
difference? Can we see the future? Circulation. 2010;122:300-10. 
154. Krogsbøll LT, Jørgensen KJ, Grønhøj Larsen C, Gøtzsche PC. General 
health checks in adults for reducing morbidity and mortality from disease. 
Cochrane Database of Systematic Reviews. 2012;DOI: 
10.1002/14651858.CD009009.pub2. 
155. Jorgensen T, Jacobsen RK, Toft U, Aadahl M, Glumer C, Pisinger C. Effect 
of screening and lifestyle counselling on incidence of ischaemic heart disease in 
general population: Inter99 randomised trial. BMJ. 2014;348:g3617. 
156. Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, Sargeant LA, Williams KM, 
Prevost AT, et al. Screening for type 2 diabetes and population mortality over 10 
years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet. 
2012;380:1741-8. 
157. Schuetz CA, Alperin P, Guda S, van Herick A, Carlou B, Eddy D, et al. A 
standardized vascular disease health check in Europe: a cost-effectiveness 
analysis. PLoS ONE. 2013;8(7):e66454. 
158. NHS Health Check eBulletin. NHS Health Check - response to the Cochrane 
review.  [cited 2014 17th February]; Available from: 
  
215 
http://www.nhshealthcheck.nhs.uk/Default.aspx?iID=11&aID=66&st=cochran
e review. 
159. Department of Health. Impact assessment of vascular checks programme. 
London: COI; 2008. 
160. Department of Health. Economic modelling for vascular checks. London: 
2008. 
161. Artac M, Dalton ARH, Babu H, Bates S, Millett C, Majeed A. Primary care 
and population factors associated with NHS Health Check coverage: a national 
cross-sectional study. Journal of Public Health. 2013;35(3):431-9. 
162. Dalton ARH, Bottle A, Okoro C, Majeed A, Millett C. Uptake of the NHS 
Health Checks programme in a deprived, culturally diverse setting: cross-
sectional study. Journal of Public Health. 2011;33(3):422-9. 
163. Artac M, Dalton ARH, Majeed A, Car J, Huckvale K, Millett C. Uptake of 
the NHS Health Check programme in an urban setting. Family Practice. 
2013;30(4):426-35. 
164. Nicholas JM, Burgess C, Dodhia H, Miller J, Fuller F, Cajeat E, et al. 
Variations in the organization and delivery of the 'NHS health check' in primary 
care. Journal of Public Health. 2012;35(1):85-91. 
165. Diabetes UK. The NHS Health Check programme: Let's get it right. London: 
2012. 
166. Cochrane T, Davey R, Iqbal Z, Gidlow C, Kumar J, Chambers R, et al. NHS 
health checks through general practice: randomised trial of population 
cardiovascular risk reduction. BMC Public Health. 2012;12:944. 
167. Artac M, Dalton ARH, Majeed A, Car J, Millett C. Effectiveness of a 
national cardiovascular disease risk assessment program (NHS Health Check): 
Results after one year. Preventive Medicine. 2013;57:129-34. 
168. Khunti K, Walker N, Sattar N, Davies M. Unanswered questions over NHS 
health checks. BMJ. 2011;342:c6312. 
169. Goodyear-Smith F. Government’s plans for universal health checks for 
people aged 40-75. BMJ. 2013;347:f4788. 
170. Reckless JPD. Primary prevention of cardiovascular disease. BMJ. 
2011;342:d201. 
171. Chamnan P, Simmons RK, Khaw K-T, Wareham NJ, Griffin SJ. Estimating 
the population impact of screening strategies for identifying and treating people 
at high risk of cardiovascular disease: modelling study. BMJ. 2010;340:c1693. 
  
216 
172. Harding AH, Griffin SJ, Wareham NJ. Population impact of strategies 
for identifying groups at high risk of type 2 diabetes. Preventive Medicine. 
2006;42:364-8. 
173. Marshall T, Rouse A. Resource implications and health benefits of primary 
prevention strategies for cardiovascular disease in people aged 30 to 74: 
mathematical modelling study. BMJ. 2002;325:197. 
174. Townsend P. Poverty in the United Kingdom: a survey of household 
resources and standards of living. Middlesex: Penguin; 1979. 
175. Noble M, Wright G, Dibben C, Smith GAN, McLennan D, Anttila C, et al. 
The English Indices of Deprivation 2004 (revised). London: Office of the Deputy 
Prime Minister, 2004. 
176. Geronimus AT, Bound J. Use of census-based aggregate variables to proxy 
for socioeconomic group: evidence from national samples. American journal of 
epidemiology. 1998;148(5):475-86. 
177. Macintyre S, Maciver S, Sooman A. Area, class and health: should we be 
focusing on places or people? Journal of Social Policy. 1993;22:213-34. 
178. Macintyre S, Ellaway A, Cummins S. Place effects on health: how can we 
conceptualise, operationalise and measure them? Social Science & Medicine. 
2002;55:125-39. 
179. Parkinson M, Champion T, Evans R, Simmie J, Turok I, Crookston M, et al. 
State of the English cities: volume 1. London: Office of the Deputy Prime 
Minister, 2006. 
180. Macintyre S, Ellaway A, Der G, Ford G, Hunt K. Do housing tenure and car 
access predict health because they are simply markers of income or self esteem? 
A Scottish study. Journal of Epidemiology and Community Health. 1998;52:657-
64. 
181. Smith GR. Area-based initiatives: the rationale and options for area 
targeting. London: Centre for Analysis of Social Exclusion, 1999. 
182. Tunstall R, Lupton R. Is targeting deprived areas an effective means to 
reach poor people? An assessment of one rationale for area-based funding 
programmes. London: Centre for Analysis of Social Exclusion, 2003. 
183. Diez Roux AV, Mair C. Neighborhoods and health. Annals of the New York 
Academy of Sciences. 2010;1186:125-45. 
  
217 
184. Leyland AH. Socioeconomic gradients in the prevalence of 
cardiovascular disease in Scotland: the roles of composition and context. Journal 
of Epidemiology and Community Health. 2005;59:799-803. 
185. Pickett KE, Pearl M. Multilevel analyses of neighbourhood socioeconomic 
context and health outcomes: a critical review. Journal of Epidemiology and 
Community Health. 2001;55:111-22. 
186. Stafford M, Bartley M, Mitchell R, Marmot M. Characteristics of individuals 
and characteristics of areas: investigating their influence on health in the 
Whitehall II study. Health and Place. 2001;7:117-29. 
187. Barker DJP. The origins of the developmental origins theory. Journal of 
Internal Medicine. 2007;261:412-7. 
188. Judge K, Bauld L. Learning from policy failure? Health Action Zones in 
England. European journal of public health. 2006;16(4):341-4. 
189. Stafford M, Nazroo J, Popay JM, Whitehead M. Tackling inequalities in 
health: evaluating the New Deal for Communities initiative. Journal of 
Epidemiology and Community Health. 2008;62:298-304. 
190. Demissie K, Hanley J, Menzies D, Joseph L, Ernst P. Agreement in 
measuring socio-economic status: Area-based versus individual measures. 
Chronic Diseases in Canada. 2000;21(1):1-7. 
191. Hanley GE, Morgan S. On the validity of area-based income measures to 
proxy household income. BMC health services research. 2008;8:79. 
192. Lawson KD, Fenwick EAL, Pell ACH, Pell JP. Comparison of mass and 
targeted screening strategies for cardiovascular risk: simulation of the 
effectiveness, cost-effectiveness and coverage using a cross-sectional survey of 
3921 people. Heart. 2010;96:208-12. 
193. Marshall T. Targeted case finding for cardiovascular prevention. BMJ. 
2010;340:c1376. 
194. Care Quality Commission. Closing the gap: Tackling cardiovascular disease 
and health inequalities by prescribing statins and stop smoking services. London: 
2009. 
195. National Institute for Health and Clinical Excellence. Identifying and 
supporting people most at risk of dying prematurely. London: NICE, 2008. 
196. National Institute for Health and Clinical Excellence. Prevention of 
cardiovascular disease: costing report. London: NICE, 2010. 
  
218 
197. Macintyre S. Prevention and the reduction of health inequalities. BMJ. 
2000;320:1399-400. 
198. Tugwell P, de Savigny D, Hawker G, Robinson V. Applying clinical 
epidemiological methods to health equity: the equity effectiveness loop. BMJ. 
2006;332:358-61. 
199. Victora CG, Vaughan JP, Barros FC, Silva AC, Tomasi E. Explaining trends 
in inequities: evidence from Brazilian child health studies. Lancet. 
2000;356:1093-8. 
200. Kivimaki M, Shipley MJ, Ferrie JE, Singh-Manoux A, Batty GD, Chandola T, 
et al. Best-practice interventions to reduce socioeconomic inequalities of 
coronary heart disease mortality in UK: a prospective occupational cohort study. 
Lancet. 2008;372:1648-54. 
201. Frohlich KL, Potvin L. The inequality paradox: the population approach 
and vulnerable populations. American Journal of Public Health. 2008;98:216-21. 
202. Ji C, Kandala N-B, Cappuccio FP. Spatial variation of salt intake in Britain 
and association with socioeconomic status. BMJ open. 2013;3:e002246. 
203. Pechey R, Jebb SA, Kelly MP, Almiron-Roig E, Conde S, Nakamura R, et al. 
Socioeconomic differences in purchases of more vs. less healthy foods and 
beverages: analysis of over 25,000 British households in 2010. Social Science and 
Medicine. 2013;92:22-6. 
204. Lorenc T, Petticrew M, Welch V, Tugwell P. What types of interventions 
generate inequalities? Evidence from systematic reviews. Journal of 
Epidemiology and Community Health. 2013;67:190-3. 
205. Thomas S, Fayter D, Misso K, Ogilvie D, Petticrew M, Sowden A, et al. 
Population tobacco control interventions and their effects on social inequalities 
in smoking: systematic review. Tobacco Control. 2008;17:230-7. 
206. Macintyre S. Inequalities in health in Scotland: what are they and what 
can we do about them? Glasgow: MRC Social and Public Health Sciences Unit, 
2007. 
207. McLaren L, McIntyre L, Kirkpatrick S. Rose's population strategy of 
prevention need not increase social inequalities in health. International Journal 
of Epidemiology. 2010;39:372-7. 
208. Dryden R, Williams B, McCowan C, Themessl-Huber M. What do we know 
about who does and does not attend general health checks? Findings from a 
narrative scoping review. BMC Public Health. 2012;12:723. 
  
219 
209. Hippisley-Cox J, Pringle M, Cater R, Coupland C, Meal A. Coronary 
heart disease prevention and age inequalities: the first year of the National 
Service Framework for CHD. British Journal of General Practice. 2005;55:369-75. 
210. Rodin D, Stirbu I, Ekholm O, Dzurova D, Costa G, Mackenbach JP, et al. 
Educational inequalities in blood pressure and cholesterol screening in nine 
European countries. Journal of Epidemiology and Community Health. 
2012;66:1050-55. 
211. Wallach-Kildemoes H, Diderichsen F, Krasnik A, Lange T, Andersen M. Is 
the high-risk strategy to prevent cardiovascular disease equitable? A 
pharmacoepidemiological cohort study. BMC Public Health. 2012;12:610. 
212. Hiscock R, Bauld L. Stop Smoking Services and Health Inequalities. 
London: National Centre for Smoking Cessation and Training, 2013. 
213. Ashworth M, Medina J, Morgan M. Effect of social deprivation on blood 
pressure monitoring and control in England: a survey of data from the quality 
and outcomes framework. BMJ. 2008;337:a2030. 
214. Bauld L, Judge K, Platt S. Assessing the impact of smoking cessation 
services on reducing health inequalities in England: observational study. Tobacco 
Control. 2007;16:400-4. 
215. Lorenc T, Oliver K. Adverse effects of public health interventions: a 
conceptual framework. Journal of Epidemiology and Community Health. 
2014;68:288-90. 
216. Beauchamp A, Peeters A, Tonkin A, Turrell G. Best practice for prevention 
and treatment of cardiovascular disease through an equity lens: a review. 
European Journal of Cardiovascular Prevention & Rehabilitation. 2010;17:599-
606. 
217. Heart UK. Bridging the gaps: Tackling inequalities in cardiovascular 
disease. Berkshire: 2013. 
218. Whaley AL. Ethnicity/race, ethics, and epidemiology. Journal of the 
National Medical Association. 2003;95(8):736-42. 
219. Aspinall PJ. The conceptual basis of ethnic group terminology and 
classifications. Social Science and Medicine. 1997;45(5):689-98. 
220. Bhopal R. Is research into ethnicity and health racist, unsound, or 
important science? BMJ. 1997;314:1751-6. 
  
220 
221. Bhopal R. Race and ethnicity: responsible use from epidemiological 
and public health perspectives. Journal of Law, Medicine and Ethics. 
2006;34(3):500-7. 
222. Senior PA, Bhopal R. Ethnicity as a variable in epidemiologic research. 
BMJ. 1994;309:327-30. 
223. Ford CL, Harawa NT. A new conceptualization of ethnicity for social 
epidemiologic and health equity research. Social Science and Medicine. 
2010;71(2):251-8. 
224. Anand SS. Using ethnicity as a classification variable in health research: 
perpetuating the myth of biological determinism, serving socio-political 
agendas, or making valuable contributions to medical sciences? Ethnicity and 
Health. 1999;4(4):241-4. 
225. Karlsen S. 'Black like Beckham'? Moving beyond definitions of ethnicity 
based on skin colour and ancestry. Ethnicity and Health. 2004;9(2):107-37. 
226. Witzig R. The medicalization of race: scientific legitimization of a flawed 
social construct. Annals of Internal Medicine. 1996;125:675-9. 
227. Winker MA. Race and ethnicity in medical research: requirements meet 
reality. Journal of Law, Medicine and Ethics. 2006;34(3):520-5. 
228. U.S. Census Bureau Population Division. Annual estimates of the resident 
population by sex, race, and hispanic origin for the United States, states, and 
counties: April 1, 2010 to July 1, 2012 2013 [cited 2014 2nd June]; Available 
from: http://factfinder2.census.gov/faces/nav/jsf/pages/index.xhtml. 
229. Platt L, Simpson L, Akinwale B. Stability and change in ethnic groups in 
England and Wales. London: Office for National Statistics, 2005. 
230. Aspinall PJ. The new 2001 Census question set on cultural characteristics: 
is it useful for the monitoring of the health status of people from ethnic groups 
in Britain? Ethnicity and Health. 2000;5(1):33-40. 
231. Aspinall PJ. The utility and validity for public health of ethnicity 
categorization in the 1991, 2001 and 2011 British Censuses. Public Health. 
2011;125:680-7. 
232. Iqbal G, Johnson MR, Szczepura A, Wilson S, Gumber A, Dunn JA. UK 
ethnicity data collection for healthcare statistics: the South Asian perspective. 
BMC Public Health. 2012;12:243. 
233. Office for National Statistics. A guide to comparing 1991 and 2001 Census 
ethnic group data. London: Office for National Statistics, 2006. 
  
221 
234. Mir G, Salway S, Kai J, Karlsen S, Bhopal R, Ellison GTH, et al. 
Principles for research on ethnicity and health: the Leeds Consensus Statement. 
European journal of public health. 2012;23(3):504-10. 
235. Rees P, Wohland P, Norman P, Boden P. Ethnic population projections for 
the UK, 2001-2051. Journal of Population Research. 2012;29:45-89. 
236. Coleman D. Projections of the ethnic minority populations of the United 
Kingdom 2006-2056. Population and Development Review. 2010;36(3):441-86. 
237. Statistics Netherlands. Population; key figures. 2013 [cited 2014 2nd 
June]; Available from: 
http://statline.cbs.nl/StatWeb/publication/?VW=T&DM=SLEN&PA=37296eng&D1
=a&D2=0,10,20,30,40,58-59&HD=090302-1045&LA=EN&HDR=G1&STB=T. 
238. Smaje C. Health, 'race' and ethnicity: making sense of the evidence. 
London: King's Fund Institute; 1995. 
239. Wild S, Mckeigue P. Cross sectional analysis of mortality by country of 
birth in England and Wales, 1970-92. BMJ. 1997;314:705. 
240. Harding S, Maxwell R. Differences in mortality of migrants. In: Drever F, 
Whitehead M, editors. Health inequalities: decennial supplement. London: The 
Stationery Office; 1997. p. 108-21. 
241. Marmot MG, Adelstein AM, Bulusu L. Lessons from the study of immigrant 
mortality. Lancet. 1984;323(8392):1455-7. 
242. Harding S, Balarajan R. Limiting long-term illness among black 
Caribbeans, black Africans, Indians, Pakistanis, Bangladeshis and Chinese born in 
the UK. Ethnicity and Health. 2000;5(1):41-6. 
243. Becares L. Which ethnic groups have the poorest health? Ethnic health 
inequalities 1991 to 2011. Manchester: Centre on Dynamics of Ethnicity, 2013. 
244. Cooper H. Investigating socio-economic explanations for gender and 
ethnic inequalities in health. Social Science and Medicine. 2002;54:693-706. 
245. National Cancer Intelligence Network and Cancer Research UK. Cancer 
incidence and survival by major ethnic group, England, 2002 - 2006. 2009. 
246. Braveman P. Health inequalities by class and race in the US: what can we 
learn from the patterns? Social Science and Medicine. 2012;74:665-7. 
247. Nielsen SS, Krasnik A. Poorer self-perceived health among migrants and 
ethnic minorities versus the majority population in Europe: a systematic review. 
International journal of public health. 2010;55:357-71. 
  
222 
248. Bos V, Kunst AE, Keij-Deerenberg IM, Garssen J, Mackenbach JP. 
Ethnic inequalities in age- and cause-specific mortality in The Netherlands. 
International Journal of Epidemiology. 2004;33:1112-9. 
249. Blakely T, Tobias M, Atkinson J, Yeh L-C, Huang K. Tracking disparity: 
trends in ethnic and socioeconomic inequalities in mortality, 1981–2004. 
Wellington: Ministry of Health, 2007. 
250. Wild SH, Fischbacher C, Brock A, Griffiths C, Bhopal R. Mortality from all 
causes and circulatory disease by country of birth in England and Wales 2001-
2003. Journal of Public Health. 2007;29(2):191-8. 
251. Fischbacher CM, Bhopal R, Povey C, Steiner M, Chalmers J, Mueller G, et 
al. Record linked retrospective cohort study of 4.6 million people exploring 
ethnic variations in disease: myocardial infarction in South Asians. BMC Public 
Health. 2007;7:142. 
252. Bhopal RS, Bansal N, Fischbacher C, Brown H, Capewell S, on behalf of 
the Scottish Health and Ethnicity Linkage Study. Ethnic variations in chest pain 
and angina in men and women: Scottish Ethnicity and Health Linkage Study of 
4.65 million people. European journal of preventive cardiology. 2012;19(6):1250-
7. 
253. Teoh M, Lalondrelle S, Roughton M, Grocott-Mason R, Dubrey SW. Acute 
coronary syndromes and their presentation in Asian and Caucasian patients in 
Britain. Heart. 2007;93:183-8. 
254. Joshi P, Islam S, Pais P, Reddy S, Dorairaj P, Kazmi K, et al. Risk factors 
for early myocardial infarction in South Asians compared with individuals in 
other countries. JAMA. 2007;297(3):286-94. 
255. Zaman MJS, Philipson P, Chen R, Farag A, Shipley M, Marmot MG, et al. 
South Asians and coronary disease: is there discordance between effects on 
incidence and prognosis? Heart. 2013;99:729-36. 
256. Scarborough P, Bhatnagar P, Kaur A, Smolina K, Wickramasinghe K, Rayner 
M. Ethnic differences in cardiovascular disease. Oxford: British Heart Foundation 
Health Promotion Research Group, 2010. 
257. Mensah GA, Mokdad AH, Ford ES, Greenlund KJ, Croft JB. State of 
disparities in cardiovascular health in the United States. Circulation. 
2005;111:1233-41. 
258. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, et al. 
Differences in risk factors, atherosclerosis, and cardiovascular disease between 
  
223 
ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic 
groups (SHARE). Lancet. 2000;356:279-84. 
259. Smeeton NC, Heuschmann PU, Rudd AG, McEvoy AW, Kitchen ND, Sarker 
SJ, et al. Incidence of hemorrhagic stroke in black Caribbean, black African, and 
white populations: the South London Stroke Register, 1995-2004. Stroke. 
2007;38:3133-8. 
260. Heuschmann PU, Grieve AP, Toschke AM, Rudd AG, Wolfe CDA. Ethnic 
group disparities in 10-year trends in stroke incidence and vascular risk factors: 
the South London Stroke Register (SLSR). Stroke. 2008;39:2204-10. 
261. Bhopal RS, Bansal N, Fischbacher CM, Brown H, Capewell S, on behalf of 
the Scottish Health and Ethnic Linkage Study. Ethnic variations in the incidence 
and mortality of stroke in the Scottish Health and Ethnicity Linkage Study of 4.65 
million people. European journal of preventive cardiology. 2012;19(6):1503-8. 
262. Stansbury JP, Jia H, Williams LS, Vogel WB, Duncan PW. Ethnic disparities 
in stroke: epidemiology, acute care, and postacute outcomes. Stroke. 
2005;36:374-87. 
263. Markus HS, Khan U, Birns J, Evans A, Kalra L, Rudd AG, et al. Differences 
in stroke subtypes between black and white patients with stroke: the South 
London Ethnicity and Stroke Study. Circulation. 2007;116:2157-64. 
264. Wang Y, Rudd AG, Wolfe CDA. Trends and survival between ethnic groups 
after stroke: the South London Stroke Register. Stroke. 2013;44:380-7. 
265. Hurley LP, Dickinson LM, Estacio RO, Steiner JF, Havranek EP. Prediction 
of cardiovascular death in racial/ethnic minorities using Framingham risk 
factors. Circulation: Cardiovascular Quality and Outcomes. 2010;3(2):181-7. 
266. Quirke TP, Gill PS, Mant JW, Allan TF. The applicability of the 
Framingham coronary heart disease prediction function to black and minority 
ethnic groups in the UK. Heart. 2003;89(7):785-6. 
267. Cappuccio FP, Barbato A, Kerry SM. Hypertension, diabetes and 
cardiovascular risk in ethnic minorities in the UK. British Journal of Diabetes and 
Vascular Disease. 2003;3:286-93. 
268. Forouhi NG, Sattar N. CVD risk factors and ethnicity - a homogeneous 
relationship? Atherosclerosis Supplements. 2006;7:11-9. 
269. Bhopal R, Unwin N, White M, Yallop J, Walker L, Alberti KGMM, et al. 
Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, 
  
224 
Bangladeshi, and European origin populations: cross sectional study. BMJ. 
1999;319:215-20. 
270. Whitty CJM, Brunner EJ, Shipley MJ, Hemingway H, Marmot MG. 
Differences in biological risk factors for cardiovascular disease between three 
ethnic groups in the Whitehall II study. Atherosclerosis. 1999;142:279-86. 
271. Cappuccio FP, Cook DG, Atkinson RW, Strazzullo P. Prevalence, detection, 
and management of cardiovascular risk factors in different ethnic groups in 
south London. Heart. 1997;78:555-63. 
272. Tillin T, Forouhi NG, McKeigue PM, Chaturvedi N. The role of diabetes and 
components of the metabolic syndrome in stroke and coronary heart disease 
mortality in U.K. white and African-Caribbean populations. Diabetes Care. 
2006;29(9):2127-9. 
273. Abbotts J, Harding S, Cruickshank K. Cardiovascular risk profiles in UK-
born Caribbeans and Irish living in England and Wales. Atherosclerosis. 
2004;175:295-303. 
274. Lawes CMM, Hoorn SV, Rodgers A. Global burden of blood-pressure-related 
disease, 2001. Lancet. 2008;371:1513-8. 
275. Lane D, Beevers DG, Lip GYH. Ethnic differences in blood pressure and the 
prevalence of hypertension in England. Journal of Human Hypertension. 
2002;16:267-73. 
276. Yoon SSS, Ostchega Y, Louis T. Recent trends in the prevalence of high 
blood pressure and its treatment and control, 1999-2008. Hyattsville, MD: 
National Center for Health Statistics, 2010. 
277. Kramer H, Han C, Post W, Goff D, Diez-Roux A, Cooper R, et al. 
Racial/ethnic differences in hypertension and hypertension treatment and 
control in the Multi-Ethnic Study of Atherosclerosis (MESA). American Journal of 
Hypertension. 2004;17:963-70. 
278. Lyratzopoulos G, McElduff P, Heller RF, Hanily M, Lewis PS. Comparative 
levels and time trends in blood pressure, total cholesterol, body mass index and 
smoking among Caucasian and South-Asian participants of a UK primary-care 
based cardiovascular risk factor screening programme. BMC Public Health. 
2005;5:125. 
279. Tillin T, Hughes AD, Mayet J, Whincup P, Sattar N, Forouhi NG, et al. The 
relationship between metabolic risk factors and incident cardiovascular disease 
in Europeans, South Asians, and African Caribbeans: SABRE (Southall and Brent 
  
225 
Revisited) - a prospective population-based study. Journal of the American 
College of Cardiology. 2013;61(17):1777-86. 
280. Karlsen S, Millward D, Sandford A. Investigating ethnic differences in 
current cigarette smoking over time using the health surveys for England. 
European journal of public health. 2012;22(2):254-6. 
281. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A 
comparative risk assessment of burden of disease and injury attributable to 67 
risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic 
analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224-60. 
282. Williams ED, Stamatakis E, Chandola T, Hamer M. Physical activity 
behaviour and coronary heart disease mortality among South Asian people in the 
UK: an observational longitudinal study. Heart. 2011;97:655-9. 
283. Clark LT. Primary prevention of cardiovascular disease in high-risk 
patients: physiologic and demographic risk factor differences between African 
American and white American populations. American Journal of Medicine. 
1999;107(2A):22-4S. 
284. Howard G, Cushman M, Kissela BM, Kleindorfer DO, McClure LA, Safford 
MM, et al. Traditional risk factors as the underlying cause of racial disparities in 
stroke: lessons from the half-full (empty?) glass. Stroke. 2011;42:3369-75. 
285. Lane DA, Lip GYH, Beevers DG. Ethnic differences in cardiovascular and 
all-cause mortality in Birmingham, England: The Birmingham Factory Screening 
Project. Journal of Hypertension. 2005;23:1347-53. 
286. Jolly K, Gill P. Ethnicity and cardiovascular disease prevention: practical 
clinical considerations. Current opinion in cardiology. 2008;23:465-70. 
287. Sharma S, Malarcher AM, Giles WH, Myers G. Racial, ethnic and 
socioeconomic disparities in the clustering of cardiovascular disease risk factors. 
Ethnicity and Disease. 2004;14:43-8. 
288. Prescott E, Osler M, Andersen PK, Hein HO, Borch-Johnsen K, Lange P, et 
al. Mortality in women and men in relation to smoking. International Journal of 
Epidemiology. 1998;27(1):27-32. 
289. Marang-van de Mheen PJ, Davey Smith G, Hart CL. The health impact of 
smoking in manual and non-manual social class men and women: a test of the 
Blaxter hypothesis. Social Science and Medicine. 1999;48:1851-6. 
290. Bellary S, O'Hare JP, Raymond NT, Mughal S, Hanif WM, Jones A, et al. 
Premature cardiovascular events and mortality in south Asians with type 2 
  
226 
diabetes in the United Kingdom Asian Diabetes Study - effect of ethnicity on 
risk. Current Medical Research and Opinion. 2010;26(8):1873-9. 
291. Howard G, Lackland DT, Kleindorfer DO, Kissela BM, Moy CS, Judd SE, et 
al. Racial differences in the impact of elevated systolic blood pressure on stroke 
risk. JAMA Internal Medicine. 2013;173(1):46-51. 
292. Patel KCR, Shah AM, editors. Prevention, treatment and rehabilitation of 
cardiovascular disease in South Asians. London: The Stationery Office; 2005. 
293. National Institute for Health and Care Excellence. Assessing body mass 
index and waist circumference thresholds for intervening to prevent ill health 
and premature death among adults from black, Asian and other minority ethnic 
groups in the UK. Manchester: NICE, 2013. 
294. Ntuk UE, Gill JM, Mackay DF, Sattar N, Pell JP. Ethnic-specific obesity 
cutoffs for diabetes risk: cross-sectional study of 490,288 UK Biobank 
participants. Diabetes Care. 2014;37(9):2500-7. 
295. Menotti A, Keys A, Blackburn H, Kromhout D, Karvonen M, Nissinen A, et 
al. Comparison of multivariate predictive power of major risk factors for 
coronary heart diseases in different countries: results from eight nations of the 
Seven Countries Study, 25-year follow-up. Journal of Cardiovascular Risk. 
1996;3:69-75. 
296. Blakely T, Tobias M, Robson B, Ajwani S, Bonne M, Woodward A. Widening 
ethnic mortality disparities in New Zealand 1981-99. Social Science and 
Medicine. 2005;61:2233-51. 
297. Barnett E, Armstrong DL, Casper ML. Evidence of increasing coronary 
heart disease mortality among black men of lower social class. Annals of 
Epidemiology. 1999;9(8):464-71. 
298. Bleich SN, Jarlenski MP, Bell CN, LaVeist TA. Health inequalities: trends, 
progress, and policy. Annual Review of Public Health. 2012;33:7-40. 
299. Gunarathne A, Patel JV, Potluri R, Gill PS, Hughes EA, Lip GYH. Secular 
trends in the cardiovascular risk profile and mortality of stroke admissions in an 
inner city, multiethnic population in the United Kingdom (1997-2005). Journal of 
Human Hypertension. 2008;22:18-23. 
300. Parliamentary Office of Science and Technology. Ethnicity and health. 
London: 2007. 
301. Acheson D. Independent Inquiry into Inequalities in Health Report. 
London: The Stationary Office, 1998. 
  
227 
302. Salway S, Nazroo JY, Mir G, Craig G, Johnson M, Gerrish K. Fair 
society, healthy lives: a missed opportunity to address ethnic inequalities in 
health. BMJ. 2010;340:c684. 
303. Nazroo JY. Genetic, cultural or socio-economic vulnerability? Explaining 
ethnic inequalities in health. Sociology of Health and Illness. 1998;20(5):710-30. 
304. Williams R, Wright W, Hunt K. Social class and health: the puzzling 
counter-example of British South Asians. Social Science and Medicine. 
1998;47(9):1277-88. 
305. Nazroo JY, Karlsen S. Ethnic inequalities in health: social class, racism 
and identity. Lancaster: Lancaster University, 2001. 
306. Glasgow Centre for Population Health. Understanding Glasgow: The 
Glasgow Indicators Project. Glasgow [cited 2015 19th June]; Available from: 
http://www.understandingglasgow.com/. 
307. Davey Smith G. Learning to live with complexity: ethnicity, socioeconomic 
position, and health in Britain and the United States. American Journal of Public 
Health. 2000;90:1694-8. 
308. Barnard H, Turner C. Poverty and ethnicity: a review of evidence. York: 
Joseph Rowntree Foundation, 2011. 
309. Tinsley J, Jacobs M. Deprivation and ethnicity in England: a regional 
perspective. London: Office for National Statistics, 2006. 
310. Hills J, Brewer M, Jenkins S, Lister R, Lupton R, Machin S, et al. An 
anatomy of economic inequality in the UK: report of the National Equality Panel. 
London: Government Equalities Office and Centre for Analysis of Social 
Exclusion, 2010. 
311. Netto G, Sosenko F, Bramley G. Poverty and ethnicity in Scotland: review 
of the literature and datasets. York: Joseph Rowntree Foundation, 2011. 
312. Platt L. Inequality within ethnic groups. York: Joseph Rowntree 
Foundation, 2011. 
313. Armstrong DL, Strogatz D, Barnett E, Wang R. Joint effects of social class 
and community occupational structure on coronary mortality among black men 
and white men, upstate New York, 1988-92. Journal of Epidemiology and 
Community Health. 2003;57:373-8. 
314. LaVeist TA. Disentangling race and socioeconomic status: a key to 
understanding health inequalities. Journal of Urban Health. 2005;82(2 Suppl 
3):iii26-iii34. 
  
228 
315. Nazroo JY. The structuring of ethnic inequalities in health: economic 
position, racial discrimination, and racism. American Journal of Public Health. 
2003;93(2):277-84. 
316. Chandola T. Ethnic and class differences in health in relation to British 
South Asians: using the new National Statistics Socio-Economic Classification. 
Social Science and Medicine. 2001;52:1285-96. 
317. Harding S, Balarajan R. Longitudinal study of socio-economic differences 
in mortality among South Asian and West Indian migrants. Ethnicity and Health. 
2001;6(2):121-8. 
318. Williams DR. Race, socioeconomic status, and health. The added effects 
of racism and discrimination. Annals New York Academy of Sciences. 
1999;896:173-88. 
319. Bos V, Kunst AE, Garssen J, Mackenbach JP. Socioeconomic inequalities in 
mortality within ethnic groups in the Netherlands, 1995-2000. Journal of 
Epidemiology and Community Health. 2005;59:329-35. 
320. Fischbacher CM, Cezard G, Bhopal RS, Pearce J, Bansal N. Measures of 
socioeconomic position are not consistently associated with ethnic differences in 
cardiovascular disease in Scotland: methods from the Scottish Health and 
Ethnicity Linkage Study (SHELS). International Journal of Epidemiology. 
2014;43:129-39. 
321. Harding S. Examining the contribution of social class to high 
cardiovascular mortality among Indian, Pakistani and Bangladeshi male migrants 
living in England and Wales. London: Office for National Statistics, 2000. 
322. Agyemang C, van Oeffelen AAM, Bots ML, Stronks K, Vaartjes I. 
Socioeconomic inequalities in acute myocardial infarction incidence in migrant 
groups: has the epidemic arrived? Analysis of nation-wide data. Heart. 
2014;100(3):239-46. 
323. Karlamangla AS, Merkin SS, Crimmins EM, Seeman TE. Socioeconomic and 
ethnic disparities in cardiovascular risk in the United States, 2001-2006. Annals 
of Epidemiology. 2010;20(8):617-28. 
324. Reddy KS, Prabhakaran D, Jeemon P, Thankappan KR, Joshi P, Chaturvedi 
V, et al. Educational status and cardiovascular risk profile in Indians. 
Proceedings of the National Academy of Sciences. 2007;104(41):16263-8. 
  
229 
325. Scott AP, Timaeus IM. Mortality differentials 1991-2005 by self-
reported ethnicity: findings from the ONS Longitudinal Study. Journal of 
Epidemiology and Community Health. 2013;67:743-50. 
326. Davey Smith G, Neaton JD, Wentworth D, Stamler R, Stamler J. Mortality 
differences between black and white men in the USA: contribution of income 
and other risk factors among men screened for the MRFIT. Lancet. 1998;351:934-
9. 
327. Thomas AJ, Eberly LE, Davey Smith G, Neaton JD, Stamler J. 
Race/ethnicity, income, major risk factors, and cardiovascular disease 
mortality. American Journal of Public Health. 2005;95(8):1417-23. 
328. Krieger N, Chen JT, Waterman PD, Soobader M-J, Subramanian SV, Carson 
R. Geocoding and monitoring of US socioeconomic inequalities in mortality and 
cancer incidence: does the choice of area-based measure and geographic level 
matter? The Public Health Disparities Geocoding Project. American journal of 
epidemiology. 2002;156(5):471-82. 
329. Geyer S, Hemstrom O, Peter R, Vagero D. Education, income, and 
occupational class cannot be used interchangeably in social epidemiology. 
Empirical evidence against a common practice. Journal of Epidemiology and 
Community Health. 2006;60:804-10. 
330. Kelaher M, Paul S, Lambert H, Ahmad W, Smith GD. The impact of 
different measures of socioeconomic position on the relationship between 
ethnicity and health. Annals of Epidemiology. 2008;18:351-6. 
331. Brancati FL, Whelton PK, Kuller LH, Klag MJ. Diabetes mellitus, race, and 
socioeconomic status: a population-based study. Annals of Epidemiology. 
1996;6:67-73. 
332. Jones-Webb R, Yu X, O'Brien J, Hannan P, Wall M, Oswald J. Does 
socioeconomic position moderate the effects of race on cardiovascular disease 
mortality? Ethnicity and Disease. 2004;14:489-96. 
333. Huxley RR, Bell EJ, Lutsey PL, Bushnell C, Shahar E, Rosamond W, et al. A 
comparative analysis of risk factors for stroke in blacks and whites: the 
Atherosclerosis Risk in Communities study. Ethnicity and Health. 2014;19(6):601-
16. 
334. Glymour MM, Avendano M, Haas S, Berkman LF. Lifecourse social 
conditions and racial disparities in incidence of first stroke. Annals of 
Epidemiology. 2008;18:904-12. 
  
230 
335. Tillin T, Chaturvedi N, Forouhi NG, Smith GD, McKeigue PM. 
Cardiovascular disease mortality in relation to childhood and adulthood 
socioeconomic markers in British South Asian men. Heart. 2008;94:476-81. 
336. Gunarathne A, Patel JV, Gammon B, Gill PS, Hughes EA, Lip GYH. 
Ischemic stroke in South Asians: a review of the epidemiology, pathophysiology, 
and ethnicity-related clinical features. Stroke. 2009;40:e415-23. 
337. Gray L, Harding S, Reid A. Evidence of divergence with duration of 
residence in circulatory disease mortality in migrants to Australia. European 
journal of public health. 2007;17(6):550-4. 
338. Saposnik G, Redelmeier DA, Lu H, Lonn E, Fuller-Thomson E, Ray JG. Risk 
of premature stroke in recent immigrants (PRESARIO): population-based matched 
cohort study. Neurology. 2010;74:451-7. 
339. Cangiano A. The impact of migration on UK population growth. Oxford: 
The Migration Observatory, 2012. 
340. Rafnsson SB, Bhopal RS, Agyemang C, Fagot-Campagna A, Harding S, 
Hammar N, et al. Sizable variations in circulatory disease mortality by region 
and country of birth in six European countries. European journal of public 
health. 2013;23(4):594-605. 
341. Harding S. Mortality of migrants from the Indian subcontinent to England 
and Wales: effect of duration of residence. Epidemiology. 2003;14:287-92. 
342. Harding S. Mortality of migrants from the Caribbean to England and 
Wales: effect of duration of residence. International Journal of Epidemiology. 
2004;33(2):382-6. 
343. Moran A, Diez Roux AV, Jackson SA, Kramer H, Manolio TA, Shrager S, et 
al. Acculturation is associated with hypertension in a multiethnic sample. 
American Journal of Hypertension. 2007;20:354-63. 
344. Smith NR, Kelly YJ, Nazroo JY. The effects of acculturation on obesity 
rates in ethnic minorities in England: evidence from the Health Survey for 
England. European journal of public health. 2012;22(4):508-13. 
345. Smeeton NC, Corbin DOC, Hennis AJ, Hambleton IR, Fraser HS, Wolfe CDA, 
et al. Differences in risk factors between black Caribbean patients with stroke in 
Barbados and South london. Stroke. 2009;40:640-3. 
346. Patel JV, Vyas A, Cruickshank JK, Prabhakaran D, Hughes E, Reddy KS, et 
al. Impact of migration on coronary heart disease risk factors: comparison of 
  
231 
Gujaratis in Britain and their contemporaries in villages of origin in India. 
Atherosclerosis. 2006;185:297-306. 
347. Harding S, Rosato M, Teyhan A. Trends for coronary heart disease and 
stroke mortality among migrants in England and Wales, 1979-2003: slow declines 
notable for some groups. Heart. 2008;94:463-70. 
348. Barker DJP. Fetal origins of coronary heart disease. BMJ. 1995;311:171-4. 
349. Karlsen S, Nazroo JY. Agency and structure: the impact of ethnic identity 
and racism on the health of ethnic minority people. Sociology of Health and 
Illness. 2002;24(1):1-20. 
350. van Ryn M, Fu SS. Paved with good intentions: do public health and human 
service providers contribute to racial/ethnic disparities in health? American 
Journal of Public Health. 2003;93(2):248-55. 
351. Becares L, Stafford M, Nazroo J. Fear of racism, employment and 
expected organizational racism: their association with health. European journal 
of public health. 2009;19(5):504-10. 
352. Astell-Burt T, Maynard MJ, Lenguerrand E, Harding S. Racism, ethnic 
density and psychological well-being through adolescence: evidence from the 
Determinants of Adolescent Social well-being and Health longitudinal study. 
Ethnicity and Health. 2012;17(1-2):71-87. 
353. Cozier YC, Yu J, Coogan PF, Bethea TN, Rosenberg L, Palmer JR. Racism, 
segregation, and risk of obesity in the Black Women's Health Study. American 
journal of epidemiology. 2014;179(7):875-83. 
354. Williams ED, Steptoe A, Chambers JC, Kooner JS. Ethnic and gender 
differences in the relationship between hostility and metabolic and autonomic 
risk factors for coronary heart disease. Psychosomatic Medicine. 2011;73:53-8. 
355. Gebreab SY, Diez-Roux AV, Hickson DA, Boykin S, Sims M, Sarpong DF, et 
al. The contribution of stress to the social patterning of clinical and subclinical 
CVD risk factors in African Americans: the Jackson Heart Study. Social Science 
and Medicine. 2012;75:1697-707. 
356. Netto G, McCloughan L, Bhatnagar A. Effective heart disease prevention: 
lessons from a qualitative study of user perspectives in Bangladeshi, Indian and 
Pakistani communities. Public Health. 2007;121:177-86. 
357. Cruickshank JK, Mbanya JC, Wilks R, Balkau B, McFarlane-Anderson N, 
Forrester T. Sick genes, sick individuals or sick populations with chronic disease? 
  
232 
The emergence of diabetes and high blood pressure in African-origin 
populations. International Journal of Epidemiology. 2001;30:111-7. 
358. Carulli L, Rondinella S, Lombardini S, Canedi I, Loria P, Carulli N. Review 
article: diabetes, genetics and ethnicity. Alimentary Pharmacology and 
Therapeutics. 2005;22(Suppl. 2):16-9. 
359. Osei K. Metabolic consequences of the West African diaspora: lessons from 
the thrifty gene. Journal of Laboratory and Clinical Medicine. 1999;133:98-111. 
360. Zaman J, Brunner E. Social inequalities and cardiovascular disease in 
South Asians. Heart. 2008;94(4):406-7. 
361. Budoff MJ, Yang TP, Shavelle RM, Lamont DH, Brundage BH. Ethnic 
differences in coronary atherosclerosis. Journal of the American College of 
Cardiology. 2002;39(3):408-12. 
362. Bennett PC, Silverman S, Gill PS, Lip GYH. Ethnicity and peripheral artery 
disease. QJM. 2009;102:3-16. 
363. Chaturvedi N, Coady E, Mayet J, Wright AR, Shore AC, Byrd S, et al. Indian 
Asian men have less peripheral arterial disease than European men for 
equivalent levels of coronary disease. Atherosclerosis. 2007;193:204-12. 
364. Brown MJ. Hypertension and ethnic group. BMJ. 2006;332:833-6. 
365. Eapen D, Kalra GL, Merchant N, Arora A, Khan BV. Metabolic syndrome 
and cardiovascular disease in South Asians. Vascular Health and Risk 
Management. 2009;5:731-43. 
366. Barnett AH, Dixon AN, Bellary S, Hanif MW, O'Hare JP, Raymond NT, et al. 
Type 2 diabetes and cardiovascular risk in the UK south Asian community. 
Diabetologia. 2006;49:2234-46. 
367. West J, Lawlor DA, Fairley L, Bhopal R, Cameron N, McKinney PA, et al. 
UK-born Pakistani-origin infants are relatively more adipose than White British 
infants: findings from 8704 mother-offspring pairs in the Born-in-Bradford 
prospective birth cohort. Journal of Epidemiology and Community Health. 
2013;67(7):544-51. 
368. Lear SA, Humphries KH, Kohli S, Chockalingam A, Frohlich JJ, Birmingham 
CL. Visceral adipose tissue accumulation differs according to ethnic background: 
results of the Multicultural Community Health Assessment Trial (M-CHAT). 
American Journal of Clinical Nutrition. 2007;86:353-9. 
  
233 
369. Gulliford M, Figueroa-Munoz J, Morgan M, Hughes D, Gibson B, Beech 
R, et al. What does 'access to health care' mean? Journal of Health Services 
Research and Policy. 2002;7(3):186-8. 
370. Szczepura A. Access to health care for ethnic minority populations. 
Postgraduate medical journal. 2005;81:141-7. 
371. Bansal N, Bhopal RS, Steiner MFC, Brewster DH. Major ethnic group 
differences in breast cancer screening uptake in Scotland are not extinguished 
by adjustment for indices of geographical residence, area deprivation, long-term 
illness and education. British Journal of Cancer. 2012;106:1361-6. 
372. Hawker JI, Olowokure B, Wood AL, Wilson RC, Johnson R. Widening 
inequalities in MMR vaccine uptake rates among ethnic groups in an urban area 
of the UK during a period of vaccine controversy (1994-2000). Vaccine. 
2007;25:7516-9. 
373. Blanchard J, Lurie N. Preventive care in the United States: are blacks 
finally catching up? Ethnicity and Disease. 2005;15:498-504. 
374. Millward D, Karlsen S. Tobacco use among minority ethnic populations and 
cessation interventions. London: Race Equality Foundation, 2011. 
375. Horgan JMP, Blenkinsopp A, McManus RJ. Evaluation of a cardiovascular 
disease opportunistic risk assessment pilot ('Heart MOT' service) in community 
pharmacies. Journal of Public Health. 2010;32(1):110-6. 
376. Lambert AM, Burden AC, Chambers J, Marshall T. Cardiovascular screening 
for men at high risk in Heart of Birmingham Teaching Primary Care Trust: the 
'Deadly Trio' programme. Journal of Public Health. 2012;34(1):73-82. 
377. Brown DW, Giles WH, Greenlund KJ, Croft JB. Disparities in cholesterol 
screening: falling short of a national health objective. Preventive Medicine. 
2001;33:517-22. 
378. Nazroo JY, Falaschetti E, Pierce M, Primatesta P. Ethnic inequalities in 
access to and outcomes of healthcare: analysis of the Health Survey for England. 
Journal of Epidemiology and Community Health. 2009;63:1022-7. 
379. Britton A, Shipley M, Marmot M, Hemingway H. Does access to cardiac 
investigation and treatment contribute to social and ethnic differences in 
coronary heart disease? Whitehall II prospective cohort study. BMJ. 
2004;329:318. 
  
234 
380. Ben-Shlomo Y, Naqvi H, Baker I. Ethnic differences in healthcare-
seeking behaviour and management for acute chest pain: secondary analysis of 
the MINAP dataset 2002-2003. Heart. 2008;94:354-9. 
381. Patel MG, Wright DJ, Gill PS, Jerwood D, Silcock J, Chrystyn H. 
Prescribing of lipid lowering drugs to South Asian patients: ecological study. 
BMJ. 2002;325:25-6. 
382. Ashworth M, Lloyd D, Smith RS, Wagner A, Rowlands G. Social deprivation 
and statin prescribing: a cross-sectional analysis using data from the new UK 
general practitioner 'Quality and Outcomes Framework'. Journal of Public 
Health. 2007;29(1):40-7. 
383. Brown DW, Shepard D, Giles WH, Greenlund KJ, Croft JB. Racial 
differences in the use of aspirin: an important tool for preventing heart disease 
and stroke. Ethnicity and Disease. 2005;15:620-6. 
384. Lewey J, Shrank WH, Bowry ADK, Kilabuk E, Brennan TA, Choudhry NK. 
Gender and racial disparities in adherence to statin therapy: a meta-analysis. 
American Heart Journal. 2013;165:665-78. 
385. Aarabi M, Skinner J, Price CE, Jackson PR. Patients' acceptance of 
antihypertensive therapy to prevent cardiovascular disease: a comparison 
between South Asians and Caucasians in the United Kingdom. European Journal 
of Cardiovascular Prevention & Rehabilitation. 2008;15:59-66. 
386. Forde I, Chandola T, Raine R, Marmot MG, Kivimaki M. Socioeconomic and 
ethnic differences in use of lipid-lowering drugs after deregulation of 
simvastatin in the UK: the Whitehall II prospective cohort study. Atherosclerosis. 
2011;215:223-8. 
387. Mathur R, Badrick E, Boomla K, Bremner S, Hull S, Robson J. Prescribing in 
general practice for people with coronary heart disease; equity by age, sex, 
ethnic group and deprivation. Ethnicity and Health. 2011;16(2):107-23. 
388. Hippisley-Cox J, O'Hanlon S, Coupland C. Association of deprivation, 
ethnicity, and sex with quality indicators for diabetes: population based survey 
of 53 000 patients in primary care. BMJ. 2004;329:1267-70. 
389. Giles T, Aranda JM, Jr., Suh D-C, Choi I-S, Preblick R, Rocha R, et al. 
Ethnic/racial variations in blood pressure awareness, treatment, and control. 
Journal of Clinical Hypertension. 2007;9(5):345-54. 
390. Zweifler RM, McClure LA, Howard VJ, Cushman M, Hovater MK, Safford 
MM, et al. Racial and geographic differences in prevalence, awareness, 
  
235 
treatment and control of dyslipidemia: the Reasons for Geographic and 
Racial Differences in Stroke (REGARDS) study. Neuroepidemiology. 2011;37:39-
44. 
391. Horne M, Skelton DA, Speed S, Todd C. Perceived barriers to initiating and 
maintaining physical activity among South Asian and white British adults in their 
60s living in the United Kingdom: a qualitative study. Ethnicity and Health. 
2013;18(6):626-45. 
392. Grace C, Begum R, Subhani S, Kopelman P, Greenhalgh T. Prevention of 
type 2 diabetes in British Bangladeshis: qualitative study of community, 
religious, and professional perspectives. BMJ. 2008;337:a1931. 
393. Chauhan U, Baker D, Lester H, Edwards R. Exploring uptake of cardiac 
rehabilitation in a minority ethnic population in England: a qualitative study. 
European Journal of Cardiovascular Nursing. 2010;9:68-74. 
394. Johnson JA. Ethnic differences in cardiovascular drug response: potential 
contribution of pharmacogenetics. Circulation. 2008;118:1383-93. 
395. Ong HT. Evidence-based prescribing of statins: a developing world 
perspective. PLoS Medicine. 2006;3(3):e50. 
396. Park IU, Taylor AL. Race and ethnicity in trials of antihypertensive 
therapy to prevent cardiovascular outcomes: a systematic review. Annals of 
Family Medicine. 2007;5:444-52. 
397. Brewster LM, van Montfrans GA, Kleijnen J. Systematic review: 
antihypertensive drug therapy in black patients. Annals of Internal Medicine. 
2004;141:614-27. 
398. Gupta AK, Poulter NR, Dobson J, Eldridge S, Cappuccio FP, Caulfield M, et 
al. Ethnic differences in blood pressure response to first and second-line 
antihypertensive therapies in patients randomized in the ASCOT Trial. American 
Journal of Hypertension. 2010;23(9):1023-30. 
399. Leenen FHH, Nwachuku CE, Black HR, Cushman WC, Davis BR, Simpson 
LM, et al. Clinical events in high-risk hypertensive patients randomly assigned to 
calcium channel blocker versus angiotensin-converting enzyme inhibitor in the 
antihypertensive and lipid-lowering treatment to prevent heart attack trial. 
Hypertension. 2006;48:374-84. 
400. Sehgal AR. Overlap between whites and blacks in response to 
antihypertensive drugs. Hypertension. 2004;43:566-72. 
  
236 
401. Quan AP, Kerlikowske K, Gueyffier F, Boissel JP, INDANA Investigators. 
Pharmacotherapy for hypertension in women of different races. Cochrane 
Database of Systematic Reviews. 2000;DOI: 10.1002/14651858.CD002146. 
402. Khan JM, Beevers DG. Management of hypertension in ethnic minorities. 
Heart. 2005;91:1105-9. 
403. Arima H, Anderson C, Omae T, Liu L, Tzourio C, Woodward M, et al. 
Perindopril-based blood pressure lowering reduces major vascular events in 
Asian and Western participants with cerebrovascular disease: the PROGRESS 
trial. Journal of Hypertension. 2010;28:395-400. 
404. Albert MA, Glynn RJ, Fonseca FAH, Lorenzatti AJ, Ferdinand KC, 
MacFadyen JG, et al. Race, ethnicity, and the efficacy of rosuvastatin in primary 
prevention: the Justification for the Use of Statins in Prevention: an Intervention 
Trial Evaluating Rosuvastatin (JUPITER) trial. American Heart Journal. 
2011;162(1):106-14.e2. 
405. Chapman N, Chang CL, Caulfield M, Dahlof B, Feder G, Sever PS, et al. 
Ethnic Variations in Lipid-lowering in Response to a Statin (EVIREST): a substudy 
of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Ethnicity and 
Disease. 2011;21(2):150-7. 
406. Brunner NW, Ramanathan K, Wang H, Quan H, Khan NA. Effectiveness of 
statin prescribing on reducing mortality in South Asian, Chinese, and white 
patients with diabetes. Canadian Journal of Cardiology. 2013;29:920-6. 
407. Liao JK. Safety and efficacy of statins in Asians. American Journal of 
Cardiology. 2007;99(3):410-4. 
408. Matsuzawa Y, Kita T, Mabuchi H, Matsuzaki M, Nakaya N, Oikawa S, et al. 
Sustained reduction of serum cholesterol in low-dose 6-year simvastatin 
treatment with minimum side effects in 51,321 Japanese hypercholesterolemic 
patients. Circulation Journal. 2003;67:287-94. 
409. Muck W, Unger S, Kawano K, Ahr G. Inter-ethnic comparisons of the 
pharmacokinetics of the HMG-CoA reductase inhibitor cerivastatin. British 
Journal of Clinical Pharmacology. 1998;45:583-90. 
410. Rahemtulla T, Bhopal R. Pharmacogenetics and ethnically targeted 
therapies. BMJ. 2005;330:1036-7. 
411. Millett C, Gray J, Bottle A, Majeed A. Ethnic disparities in blood pressure 
management in patients with hypertension after the introduction of pay for 
performance. Annals of Family Medicine. 2008;6:490-6. 
  
237 
412. Millett C, Gray J, Wall M, Majeed A. Ethnic disparities in coronary 
heart disease management and pay for performance in the UK. Journal of 
General Internal Medicine. 2009;24(1):8-13. 
413. Schofield P, Saka O, Ashworth M. Ethnic differences in blood pressure 
monitoring and control in south east London. British Journal of General Practice. 
2011;61(585):190-6. 
414. Huxley RR, Yatsuya H, Lutsey PL, Woodward M, Alonso A, Folsom AR. 
Impact of age at smoking initiation, dosage, and time since quitting on 
cardiovascular disease in African Americans and whites: the Atherosclerosis Risk 
in Communities study. American journal of epidemiology. 2012;175(8):816-26. 
415. Health and Social Care Information Centre. NHS Stop Smoking Services: 
England, April 2012 to December 2012 (Q3 quarterly report). Leeds: 2013. 
416. Cantrell J, Vallone DM, Thrasher JF, Nagler RH, Feirman SP, Muenz LR, et 
al. Impact of tobacco-related health warning labels across socioeconomic, race 
and ethnic groups: results from a randomized web-based experiment. PLoS ONE. 
2013;8(1):e52206. 
417. Liu JJ, Wabnitz C, Davidson E, Bhopal RS, White M, Johnson MR, et al. 
Smoking cessation interventions for ethnic minority groups - a systematic review 
of adapted interventions. Preventive Medicine. 2013;57:765-75. 
418. He FJ, Markandu ND, Sagnella GA, MacGregor GA. Importance of the renin 
system in determining blood pressure fall with salt restriction in black and white 
hypertensives. Hypertension. 1998;32:820-4. 
419. He FJ, Marciniak M, Visagie E, Markandu ND, Anand V, Dalton RN, et al. 
Effect of modest salt reduction on blood pressure, urinary albumin, and pulse 
wave velocity in white, black, and Asian mild hypertensives. Hypertension. 
2009;54:482-8. 
420. Juhaeri, Stevens J, Chambless LE, Nieto FJ, Jones D, Schreiner P, et al. 
Associations of weight loss and changes in fat distribution with the remission of 
hypertension in a bi-ethnic cohort: the Atherosclerosis Risk in Communities 
Study. Preventive Medicine. 2003;36:330-9. 
421. Dowd JB, Aiello AE. Did national folic acid fortification reduce 
socioeconomic and racial disparities in folate status in the US? International 
Journal of Epidemiology. 2008;37:1059-66. 
  
238 
422. Sumar N, McLaren L. Impact on social inequalities of population 
strategies of prevention for folate intake in women of childbearing age. 
American Journal of Public Health. 2011;101:1218-24. 
423. Millett C, Laverty AA, Stylianou N, Bibbins-Domingo K, Pape UJ. Impacts 
of a national strategy to reduce population salt intake in England: serial cross 
sectional study. PLoS ONE. 2012;7(1):e29836. 
424. Consensus Action on Salt and Health. Salt and ethnic minorities. London: 
University of London;  [cited 2014 29th September]; Available from: 
http://www.actiononsalt.org.uk/salthealth/ethnic/index.html. 
425. O'Flaherty M, Flores-Mateo G, Nnoaham K, Lloyd-Williams F, Capewell S. 
Potential cardiovascular mortality reductions with stricter food policies in the 
United Kingdom of Great Britain and Northern Ireland. Bulletin of the World 
Health Organization. 2012;90:522-31. 
426. Appel LJ. At the tipping point: accomplishing population-wide sodium 
reduction in the United States. Journal of Clinical Hypertension. 2008;10(1):7-
11. 
427. He FJ, Li J, MacGregor GA. Effect of longer term modest salt reduction on 
blood pressure: Cochrane systematic review and meta-analysis of randomised 
trials. BMJ. 2013;346:f1325. 
428. Hahn EJ. Smokefree legislation: a review of health and economic 
outcomes research. American Journal of Preventive Medicine. 2010;39(6S1):S66-
S76. 
429. Pickett MS, Schober SE, Brody DJ, Curtin LR, Giovino GA. Smoke-free laws 
and secondhand smoke exposure in US non-smoking adults, 1999-2002. Tobacco 
Control. 2006;15:302-7. 
430. Lock K, Adams E, Pilkington P, Duckett K, Gilmore A, Marston C. 
Evaluating social and behavioural impacts of English smoke-free legislation in 
different ethnic and age groups: implications for reducing smoking-related 
health inequalities. Tobacco Control. 2010;19:391-7. 
431. Highet G, Ritchie D, Platt S, Amos A, Hargreaves K, Martin C, et al. The 
re-shaping of the life-world: male British Bangladeshi smokers and the English 
smoke-free legislation. Ethnicity and Health. 2011;16(6):519-33. 
432. Asia Pacific Cohort Studies Collaboration, Barzi F, Patel A, Gu D, Sritara P, 
Lam TH, et al. Cardiovascular risk prediction tools for populations in Asia. 
Journal of Epidemiology and Community Health. 2007;61:115-21. 
  
239 
433. Bhopal R, Fischbacher C, Vartiainen E, Unwin N, White M, Alberti G. 
Predicted and observed cardiovascular disease in South Asians: application of 
FINRISK, Framingham and SCORE models to Newcastle Heart Project data. 
Journal of Public Health. 2005;27(1):93-100. 
434. D'Agostino RB, Grundy S, Sullivan LM, Wilson P. Validation of the 
Framingham coronary heart disease prediction scores: results of a multiple 
ethnic groups investigation. JAMA. 2001;286:180-7. 
435. Riddell T, Wells S, Jackson R, Lee A-W, Crengle S, Bramley D, et al. 
Performance of Framingham cardiovascular risk scores by ethnic groups in New 
Zealand: PREDICT CVD–10. New Zealand Medical Journal. 2010;123(1309):50-61. 
436. Wang Z, Hoy WE. Is the Framingham coronary heart disease absolute risk 
function applicable to Aboriginal people? MJA. 2005;182(2):66-9. 
437. Dalton ARH, Bottle A, Soljak M, Majeed A, Millett C. Ethnic group 
differences in cardiovascular risk assessment scores: national cross-sectional 
study. Ethnicity and Health. 2014;19(4):367-84. 
438. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh 
A, et al. Predicting cardiovascular risk in England and Wales: prospective 
derivation and validation of QRISK2. BMJ. 2008;336:a332. 
439. Davies M, Khunti K, Webb D, Mostafa S, Gholap N, Crasto W, et al. 
Updated: the handbook for vascular risk assessment, risk reduction and risk 
management. Leicester: University of Leicester and the UK National Screening 
Committee, 2012. 
440. Brindle PM, McConnachie A, Upton MN, Hart CL, Davey Smith G, Watt 
GCM. The accuracy of the Framingham risk-score in different socioeconomic 
groups: a prospective study. British Journal of General Practice. 2005;55:838-45. 
441. Ramsay SE, Morris RW, Whincup PH, Papacosta AO, Thomas MC, 
Wannamethee SG. Prediction of coronary heart disease risk by Framingham and 
SCORE risk assessments varies by socioeconomic position: results from a study in 
British men. European Journal of Cardiovascular Prevention and Rehabilitation. 
2011;18(2):186-93. 
442. Tunstall-Pedoe H, Woodward M. By neglecting deprivation, cardiovascular 
risk scoring will exacerbate social gradients in disease. Heart. 2006;92:307-10. 
443. Woodward M, Brindle P, Tunstall-Pedoe H. Adding social deprivation and 
family history to cardiovascular risk assessment: the ASSIGN score from the 
Scottish Heart Health Extended Cohort (SHHEC). Heart. 2007;93:172-6. 
  
240 
444. Schofield P, Chen R, Crichton N. Methods for assessing cardiovascular 
disease risk in a UK black population. Heart. 2012;98(18):1373-7. 
445. Brindle P, May M, Gill P, Cappuccio F, D'Agostino R, Sr., Fischbacher C, et 
al. Primary prevention of cardiovascular disease: a web-based risk score for 
seven British black and minority ethnic groups. Heart. 2006;92:1595-602. 
446. Aarabi M, Jackson PR. Predicting coronary risk in UK South Asians: an 
adjustment method for Framingham-based tools. European Journal of 
Cardiovascular Prevention & Rehabilitation. 2005;12:46-51. 
447. Cappuccio FP, Oakeshott P, Strazzullo P, Kerry SM. Application of 
Framingham risk estimates to ethnic minorities in United Kingdom and 
implications for primary prevention of heart disease in general practice: cross 
sectional population based study. BMJ. 2002;325:1271. 
448. Collins GS, Altman DG. An independent and external validation of QRISK2 
cardiovascular disease risk score: a prospective open cohort study. BMJ. 
2010;340:c2442. 
449. Collins GS, Altman DG. Predicting the 10 year risk of cardiovascular 
disease in the United Kingdom: independent and external validation of an 
updated version of QRISK2. BMJ. 2012;344:e4181. 
450. Tillin T, Hughes AD, Whincup P, Mayet J, Sattar N, McKeigue PM, et al. 
Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and 
Framingham scores in a UK tri-ethnic prospective cohort study (SABRE—Southall 
And Brent REvisited). Heart. 2014;100(1):60-7. 
451. Garner S, Bhattacharyya G. Poverty, ethnicity and place. York: Joseph 
Rowntree Foundation, 2011. 
452. Phillips D. Black minority ethnic concentration, segregation and dispersal 
in Britain. Urban Studies. 1998;35(10):1681-702. 
453. Braveman PA, Cubbin C, Egerter S, Chideya S, Marchi KS, Metzler M, et al. 
Socioeconomic status in health research: one size does not fit all. JAMA. 
2005;294:2879-88. 
454. Kuipers MAG, Jongeneel-Grimen B, Droomers M, Wingen M, Stronks K, 
Kunst AE. Why residents of Dutch deprived neighbourhoods are less likely to be 
heavy drinkers: the role of individual and contextual characteristics. Journal of 
Epidemiology and Community Health. 2013;67(7):587-94. 
  
241 
455. Becares L, Cormack D, Harris R. Ethnic density and area deprivation: 
neighbourhood effects on Maori health and racial discrimination in 
Aotearoa/New Zealand. Social Science and Medicine. 2013;88:76-82. 
456. Becares L, Finney N, Nazroo J. Diversity or deprivation – what’s the issue? 
Manchester: University of Manchester, 2013. 
457. Joseph Rowntree Foundation. Ethnic minorities in the inner city. York: 
1998. 
458. Becares L, Nazroo J. Social capital, ethnic density and mental health 
among ethnic minority people in England: a mixed-methods study. Ethnicity and 
Health. 2013;18(6):544-62. 
459. Landrine H, Corral I. Separate and unequal: residential segregation and 
black health disparities. Ethnicity and Disease. 2009;19:179-84. 
460. Williams DR, Collins C. Racial residential segregation: a fundamental 
cause of racial disparities in health. Public Health Reports. 2001;116:404-16. 
461. Pickett KE, Wilkinson RG. People like us: ethnic group density effects on 
health. Ethnicity and Health. 2008;13(4):321-34. 
462. Iceland J, Wilkes R. Does socioeconomic status matter? Race, class, and 
residential segregation. Social Problems. 2006;53(2):248-73. 
463. Molaodi OR, Leyland AH, Ellaway A, Kearns A, Harding S. Neighbourhood 
food and physical activity environments in England, UK: does ethnic density 
matter? International Journal of Behavioral Nutrition and Physical Activity. 
2012;9:75. 
464. Clark K, Drinkwater S. Enclaves, neighbourhood effects and employment 
outcomes: ethnic minorities in England and Wales. Journal of Population 
Economics. 2002;15:5-29. 
465. Halpern D. Minorities and mental health. Social Science and Medicine. 
1993;36(5):597-607. 
466. Becares L, Shaw R, Nazroo J, Stafford M, Albor C, Atkin K, et al. Ethnic 
density effects on physical morbidity, mortality, and health behaviors: a 
systematic review of the literature. American Journal of Public Health. 
2012;102:e33-66. 
467. Stafford M, Becares L, Nazroo J. Objective and perceived ethnic density 
and health: findings from a United Kingdom general population survey. American 
journal of epidemiology. 2009;170(4):484-93. 
  
242 
468. Karlsen S, Nazroo JY, Stephenson R. Ethnicity, environment and 
health: putting ethnic inequalities in health in their place. Social Science and 
Medicine. 2002;55:1647-61. 
469. Kirby JB, Liang L, Chen H-J, Wang Y. Race, place, and obesity: the 
complex relationships among community racial/ethnic composition, individual 
race/ethnicity, and obesity in the United States. American Journal of Public 
Health. 2012;102:1572-8. 
470. Becares L, Nazroo J, Stafford M. The ethnic density effect on alcohol use 
among ethnic minority people in the UK. Journal of Epidemiology and 
Community Health. 2011;65:20-5. 
471. Becares L, Nazroo J, Stafford M. The buffering effects of ethnic density on 
experienced racism and health. Health and Place. 2009;15:700-8. 
472. Borrell LN, Kiefe CI, Diez-Roux AV, Williams DR, Gordon-Larsen P. Racial 
discrimination, racial/ethnic segregation, and health behaviors in the CARDIA 
study. Ethnicity and Health. 2013;18(3):227-43. 
473. Mujahid MS, Diez Roux AV, Cooper RC, Shea S, Williams DR. Neighborhood 
stressors and race/ethnic differences in hypertension prevalence (the Multi-
Ethnic Study of Atherosclerosis). American Journal of Hypertension. 
2011;24(2):187-93. 
474. Diez Roux AV. Neighborhoods and health: where are we and where do we 
go from here? Revue d'Epidémiologie et de Santé Publique. 2007;55(1):13-21. 
475. Agyemang C, van Hooijdonk C, Wendel-Vos W, Ujcic-Voortman JK, 
Lindeman E, Stronks K, et al. Ethnic differences in the effect of environmental 
stressors on blood pressure and hypertension in the Netherlands. BMC Public 
Health. 2007;7:118. 
476. Becares L, Nazroo J, Albor C, Chandola T, Stafford M. Examining the 
differential association between self-rated health and area deprivation among 
white British and ethnic minority people in England. Social Science and 
Medicine. 2012;74:616-24. 
477. Diez Roux AV, Merkin SS, Hannan P, Jacobs DR, Kiefe CI. Area 
characteristics, individual-level socioeconomic indicators, and smoking in young 
adults: the Coronary Artery Disease Risk Development in Young Adults Study. 
American journal of epidemiology. 2003;157(4):315-26. 
  
243 
478. Diez-Roux AV, Merkin SS, Arnett DK, Chambless L, Massing M, Nieto FJ, 
et al. Neighborhood of residence and incidence of coronary heart disease. New 
England Journal of Medicine. 2001;345:99-106. 
479. Diez Roux AV, Kiefe CI, Jacobs DR, Haan M, Jackson SA, Nieto FJ, et al. 
Area characteristics and individual-level socioeconomic position indicators in 
three population-based epidemiologic studies. Annals of Epidemiology. 
2001;11:395-405. 
480. Stillwell J, Phillips D. Diversity and change: understanding the ethnic 
geographies of Leeds. Journal of Ethnic and Migration Studies. 2006;32(7):1131-
52. 
481. Deas I, Robson B, Wong C, Bradford M. Measuring neighbourhood 
deprivation: a critique of the Index of Multiple Deprivation. Environment and 
Planning C: Government and Policy. 2003;21:883-903. 
482. Marmot M. Social determinants of health inequalities. Lancet. 
2005;365:1099-104. 
483. Geronimus AT, Bound J, Neidert LJ. On the validity of using census 
geocode characteristics to proxy individual socioeconomic characteristics. 
Journal of the American Statistical Association. 1996;91(434):529-37. 
484. Galobardes B, Shaw M, Lawlor DA, Lynch JW, Davey Smith G. Indicators of 
socioeconomic position (part 2). Journal of Epidemiology and Community Health. 
2006;60:95-101. 
485. Batey P, Brown P. The spatial targeting of urban policy initiatives: a 
geodemographic assessment tool. Environment and Planning A. 2007;39:2774-93. 
486. National Centre for Social Research, University College London. Health 
Survey for England, 2004 [computer file]. Colchester, Essex: UK Data Archive, 
2010. 
487. Mindell J, Biddulph JP, Hirani V, Stamatakis E, Craig R, Nunn S, et al. 
Cohort profile: the Health Survey for England. International Journal of 
Epidemiology. 2012;41:1585-93. 
488. Sproston K, Mindell J, editors. Health Survey for England 2004: volume 1 - 
the health of minority ethnic groups. Leeds: The Information Centre; 2006. 
489. Sproston K, Mindell J, editors. Health Survey for England 2004: volume 2 - 
methodology and documentation. Leeds: The Information Centre; 2006. 
  
244 
490. UK Data Service. Census microdata guide.  [cited 2014 24th 
September]; Available from: http://census.ukdataservice.ac.uk/use-
data/guides/microdata.aspx. 
491. Understanding Society. About Understanding Society. 2014 [cited 2014 
18th June]; Available from: 
https://http://www.understandingsociety.ac.uk/about. 
492. Buckley J, King-Hele S. What is weighting? Univerisity of Essex and 
University of Manchester: UK Data Service, 2014. 
493. British Medical Journal. Defining ethnicity.  [cited 2014 20th June]; 
Available from: http://www.bmj.com/about-bmj/resources-authors/house-
style/defining-ethnicity. 
494. Joint Health Surveys Unit. Health Survey for England. The health of ethnic 
groups 2004: list of variables. London: University College London, 2004. 
495. Rose D, Pevalin DJ, O'Reilly K. The National Statistics Socio-economic 
Classification: origins, development and use. London: Office for National 
Statistics, 2005. 
496. Streetly A, Holland WW. Population screening and public health. In: 
Detels R, Beaglehole R, Lansang MA, Gulliford M, editors. Oxford Textbook of 
Public Health. Oxford: Oxford University Press; 2009. p. 1623-38. 
497. Baker J, Mitchell R, Pell J. Cross-sectional study of ethnic differences in 
the utility of area deprivation measures to target socioeconomically deprived 
individuals. Social Science and Medicine. 2013;85:27-31. 
498. Stafford M, Badland H, Nazroo J, Halliday E, Walthery P, Povall S, et al. 
Evaluating the health inequalities impact of area-based initiatives across the 
socioeconomic spectrum: a controlled intervention study of the New Deal for 
Communities, 2002-2008. Journal of Epidemiology and Community Health. 
2014;68(10):979-86. 
499. Scottish Intercollegiate Guidelines Network. Risk estimation and the 
prevention of cardiovascular disease: a national clinical guideline. Edinburgh: 
2007. 
500. National Institute for Health and Care Excellence. Wider use of statins 
could cut deaths from heart disease. 2014 [cited 2014 13th August]; Available 
from: http://www.nice.org.uk/News/Article/wider-use-of-statins-could-cut-
deaths-from-heart-disease. 
  
245 
501. National Institute for Health and Care Excellence. Lipid modification: 
Cardiovascular risk assessment and the modification of blood lipids for the 
primary and secondary prevention of cardiovascular disease, draft for 
consultation. London: National Clinical Guideline Centre, 2014. 
502. Diabetes UK. NHS Health Checks in Local Authorities: the story so far. 
London: Diabetes UK, 2014. 
503. National Centre for Social Research, University College London. Health 
Survey for England, 2003 [computer file]. Colchester, Essex: UK Data Archive, 
2010. 
504. Sproston K, Primatesta P, editors. Health Survey for England 2003: volume 
3 - methodology and documentation. London: The Stationery Office; 2004. 
505. Dalton AR, Soljak M, Samarasundera E, Millett C, Majeed A. Prevalence of 
cardiovascular disease risk amongst the population eligible for the NHS Health 
Check Programme. European Journal of Cardiovascular Prevention and 
Rehabilitation. 2013;20(1):142-50. 
506. The Health Improvement Network (THIN) research team. THIN database. 
University College London; 2013 [cited 2014 1st July]; Available from: 
http://www.ucl.ac.uk/pcph/research-groups-themes/thin-pub/database. 
507. Eastern Region Public Health Observatory. Chronic disease prevalence by 
age and sex for 2008 in England by IMD 2007 quintile. 2009 [cited 2013 15th 
Jan]; Available from: http://www.erpho.org.uk/ViewResource.aspx?id=20575. 
508. Symmons D, Turner G, Webb R, Asten P, Barrett E, Lunt M, et al. The 
prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a 
new century. Rheumatology. 2002;41:793-800. 
509. University of Southampton. Geographical Referencing Learning Resources: 
Townsend deprivation index. 2008 [cited 2013 19th March]; Available from: 
http://www.geog.soton.ac.uk/geo-refer/go3_142_c15p19819999snsw.html. 
510. Gartner A. 2001 LSOA Townsend scores from unadjusted Census data 
England. Association of Public Health Observatories; 2007 [cited 2014 1st July]; 
Available from: http://www.apho.org.uk/resource/item.aspx?RID=47506. 
511. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Brindle P. 
Performance of the QRISK cardiovascular risk prediction algorithm in an 
independent UK sample of patients from general practice: a validation study. 
Heart. 2008;94:34-9. 
  
246 
512. Wayman J. Multiple imputation for missing data: what is it and how 
can I use it?  Annual Meeting of the American Educational Research Association; 
Chicago, IL2003. 
513. Schafer JL. Multiple imputation: a primer. Statistical Methods in Medical 
Research. 1999;8:3-15. 
514. Hawthorne G, Elliott P. Imputing cross-sectional missing data: comparison 
of common techniques. Australian and New Zealand Journal of Psychiatry. 
2005;39:583-90. 
515. Rubin DB. Multiple imputation for nonresponse in surveys. New Jersey: 
John Wiley & Sons, Inc.; 2004. 
516. Donders ART, van der Heijden GJMG, Stijnen T, Moons KGM. Review: a 
gentle introduction to imputation of missing values. Journal of Clinical 
Epidemiology. 2006;59:1087-91. 
517. Royston P. Multiple imputation of missing values: further update of ice, 
with an emphasis on interval censoring. The Stata Journal. 2007;7(4):445-64. 
518. Graham JW, Olchowski AE, Gilreath TD. How many imputations are really 
needed? Some practical clarifications of multiple imputation theory. Prevention 
Science. 2007;8:206-13. 
519. ClinRisk Ltd. QRISK2. 2012 [cited 2013 15th Jan]; Available from: 
http://www.qrisk.org/index.php. 
520. Dreyer G, Hull S, Aitken Z, Chesser A, Yaqoob MM. The effect of ethnicity 
on the prevalence of diabetes and associated chronic kidney disease. QJM. 
2009;102:261-9. 
521. Hameed K, Gibson T. A comparison of the prevalence of rheumatoid 
arthritis and other rheumatic diseases amongst Pakistanis living in England and 
Pakistan. British Journal of Rheumatology. 1997;36:781-5. 
522. Lip GYH, Bawden L, Hodson R, Rutland E, Snatchfold J, Beevers DG. Atrial 
fibrillation amongst the Indo-Asian general practice population: the West 
Birmingham Atrial Fibrillation Project. International Journal of Cardiology. 
1998;65:187-92. 
523. Marcus GM, Olgin JE, Whooley M, Vittinghoff E, Stone KL, Mehra R, et al. 
Racial differences in atrial fibrillation prevalence and left atrial size. American 
Journal of Medicine. 2010;123(4):375.e1-.e7. 
524. The Economist. Suburban dreams. London: The Economist Newspaper 
Limited; 2013 [cited 2014 23rd September]; Available from: 
  
247 
http://www.economist.com/news/britain/21578703-sometimes-explicitly-
indians-are-following-jews-out-london-suburban-dreams. 
525. UK Biobank Coordinating Centre. UK Biobank: protocol for a large-scale 
prospective epidemiological resource. Stockport: 2007. 
526. Cochrane T, Gidlow CJ, Kumar J, Mawby Y, Iqbal Z, Chambers RM. Cross-
sectional review of the response and treatment uptake from the NHS Health 
Checks programme in Stoke on Trent. Journal of Public Health 2012;35(1):92-8. 
527. Briggs AH, Gray AM. Handling uncertainty in economic evaluations of 
healthcare interventions. BMJ. 1999;319:635-8. 
528. Claxton K. The irrelevance of inference: a decision-making approach to 
the stochastic evaluation of health care technologies. Journal of Health 
Economics. 1999;18:341-64. 
529. Bostock N. RCGP warns NHS health checks are 'waste of money'. GP; 2013 
[cited 2015 8th May]; Available from: http://www.gponline.com/rcgp-warns-
nhs-health-checks-waste-money/article/1208028. 
530. O'Dowd A. Government drops plans for minimum alcohol pricing in 
England and Wales. BMJ. 2013;347:f4622. 
531. National Institute for Health and Care Excellence. School-based 
interventions to prevent smoking. Manchester: NICE, 2010. 
532. Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell 
S. Explaining the decline in coronary heart disease mortality in Finland between 
1982 and 1997. American journal of epidemiology. 2005;162(8):764-73. 
533. Lindholm L, Rosen M, Weinehall L, Asplund K. Cost effectiveness and 
equity of a community based cardiovascular disease prevention programme in 
Norsjo, Sweden. Journal of Epidemiology and Community Health. 1996;50:190-5. 
534. Qin X, Jackson R, Marshall R, Lee L, Cao W, Zhan S, et al. Modelling the 
potential impact of population-wide and targeted high-risk blood pressure-
lowering strategies on cardiovascular disease in China. European Journal of 
Cardiovascular Prevention and Rehabilitation. 2009;16:96-101. 
535. Department of Health. Healthy lives, healthy people: a call to action on 
obesity in England. London: 2011. 
536. Healthy People 2020. Nutriton and weight status. Washington, DC: US 
Department of Health and Human Services; 2014 [cited 2014 28th July]; 
Available from: 
  
248 
http://www.healthypeople.gov/2020/topicsobjectives2020/overview.aspx?to
picId=29. 
537. Powell LM, Chriqui JF, Khan T, Wada R, Chaloupka FJ. Assessing the 
potential effectiveness of food and beverage taxes and subsidies for improving 
public health: a systematic review of prices, demand and body weight outcomes. 
Obesity Reviews. 2013;14:110-28. 
538. Church TS, Earnest CP, Skinner JS, Blair SN. Effects of different doses of 
physical activity on cardiorespiratory fitness among sedentary, overweight or 
obese postmenopausal women with elevated blood pressure: a randomized 
controlled trial. JAMA. 2007;297:2081-91. 
539. Shaw KA, Gennat HC, O'Rourke P, Del Mar C. Exercise for overweight or 
obesity. Cochrane Database of Systematic Reviews. 2006;DOI: 
10.1002/14651858.CD003817.pub3. 
540. Elton PJ, Campbell P. Smoking prevalence in a north-west town following 
the introduction of Smoke-free England. Journal of Public Health. 
2008;30(4):415-20. 
541. Nagelhout GE, Levy DT, Blackman K, Currie L, Clancy L, Willemsen MC. 
The effect of tobacco control policies on smoking prevalence and smoking-
attributable deaths. Findings from the Netherlands SimSmoke Tobacco Control 
Policy Simulation Model. Addiction. 2012;107:407-16. 
542. Law M, Wald N, Morris J. Lowering blood pressure to prevent myocardial 
infarction and stroke: a new preventive strategy. Health Technology Assessment. 
2003;7(31). 
543. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 
50 years' observations on male British doctors. BMJ. 2004;328:1519. 
544. Kenfield SA, Wei EK, Rosner BA, Glynn RJ, Stampfer MJ, Colditz GA. 
Burden of smoking on cause-specific mortality: application to the Nurses' Health 
Study. Tobacco Control. 2010;19:248-54. 
545. Cao Y, Kenfield S, Song Y, Rosner B, Qiu W, Sesso HD, et al. Cigarette 
smoking cessation and total and cause-specific mortality: a 22-year follow-up 
study in US male physicians. Archives of Internal Medicine. 2011;171(21):1956-9. 
546. National Institute for Health and Clinical Excellence. Brief interventions 
and referral for smoking cessation. Manchester: NICE, 2006. 
547. Bell K, McCullough L, Greaves L, Mulryne R, Jategaonkar N, DeVries K. 
The effectiveness of National Health Service intensive treatments for smoking 
  
249 
cessation in England. London: National Institute for Health and Care 
Excellence, 2006. 
548. Office for National Statistics. Census 2001 national report for England and 
Wales. London: The Stationary Office, 2004. 
549. Coggon D, Rose G, Barker D. Epidemiology for the Uninitiated. Wiley; 
2009 [cited 2014 29th September]; Available from: http://www.bmj.com/about-
bmj/resources-readers/publications/epidemiology-uninitiated. 
550. Thorogood M, Appleby PN, Key TJ, Mann J. Relation between body mass 
index and mortality in an unusually slim cohort. Journal of Epidemiology and 
Community Health. 2003;57:130-3. 
551. Patel JV, Gunarathne A, Lane D, Lim HS, Tracey I, Panja NC, et al. 
Widening access to cardiovascular healthcare: community screening among 
ethnic minorities in inner-city Britain - the Healthy Hearts Project. BMC health 
services research. 2007;7:192. 
552. Hutcheon JA, Chiolero A, Hanley JA. Random measurement error and 
regression dilution bias. BMJ. 2010;340:c2289. 
553. Jackson R, Marshall R, Kerr A, Riddell T, Wells S. QRISK or Framingham for 
predicting cardiovascular risk? BMJ. 2009;339:b2673. 
554. Brindle P, Beswick A, Fahey T, Ebrahim S. Accuracy and impact of risk 
assessment in the primary prevention of cardiovascular disease: a systematic 
review. Heart. 2006;92:1752-9. 
555. Wald NJ, Simmonds M, Morris JK. Screening for future cardiovascular 
disease using age alone compared with multiple risk factors and age. PLoS ONE. 
2011;6(5):e18742. 
556. Hippisley-Cox J, Coupland C, Robson J, Brindle P. Derivation, validation, 
and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular 
disease: cohort study using QResearch database. BMJ. 2010;341:c6624. 
557. JBS3 Board. Joint British Societies' consensus recommendations for the 
prevention of cardiovascular disease (JBS3). Heart. 2014;100:ii1-ii67. 
558. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing 
coronary heart disease. Lancet. 1999;353:89-92. 
559. Sniderman AD, Toth PP, Thanassoulis G, Pencina MJ, Furberg CD. Taking a 
longer term view of cardiovascular risk: the causal exposure paradigm. BMJ. 
2014;348:g3047. 
  
250 
560. Rienzo C, Vargas-Silva C. Migrants in the UK: an overview. Oxford: The 
Migration Observatory, 2012. 
561. Wohland P, Rees P, Norman P, Boden P, Jasinska M. Ethnic population 
projections for the UK and local areas, 2001-2051: working paper 10/02. Leeds: 
University of Leeds, 2010. 
562. Easton M. NHS 'not ready for immigration'. London2008 [cited 2014 14th 
August]; Available from: http://news.bbc.co.uk/1/hi/health/7215624.stm. 
563. Mathur R, Bhaskaran K, Chaturvedi N, Leon DA, vanStaa T, Grundy E, et 
al. Completeness and usability of ethnicity data in UK-based primary care and 
hospital databases. Journal of Public Health. 2013. 
564. Bhopal R. Chronic diseases in Europe's migrant and ethnic minorities: 
challenges, solutions and a vision. European journal of public health. 
2009;19(2):140-3. 
565. Agyemang C, de-Graft Aikins A, Bhopal R. Ethnicity and cardiovascular 
health research: pushing the boundaries by including comparison populations in 
the countries of origin. Ethnicity and Health. 2012;17(6):579-96. 
566. Gotzsche PC, Jorgensen KJ, Krogsboll LT. General health checks don't 
work. BMJ. 2014;348:g3680. 
567. Gotzsche PC, Jorgensen KJ, Krogsboll LT. Authors' reply to Lauritzen and 
colleagues, Newton and colleagues, and Mangin. BMJ. 2014;349:g4790. 
568. Lauritzen T, Sandbaek A, Borch-Johnsen K. General health checks may 
work. BMJ. 2014;349:g4697. 
569. Si S, Moss JR, Sullivan TR, Newton SS, Stocks NP. Effectiveness of general 
practice-based health checks: a systematic review and meta-analysis. British 
Journal of General Practice. 2014;64(618):e47-53. 
570. Richardson EA, Pearce J, Mitchell R, Kingham S. Role of physical activity 
in the relationship between urban green space and health. Public Health. 
2013;127(4):318-24. 
571. Pretty J, Peacock J, Sellens M, Griffin M. The mental and physical health 
outcomes of green exercise. International journal of environmental health 
research. 2005;15(5):319-37. 
572. Reddy KS. Primordial prevention of coronary heart disease in India: 
challenges and opportunities. Preventive Medicine. 1999;29:S119-23. 
  
251 
573. Davey Smith G, Hart C. Life-course socioeconomic and behavioral 
influences on cardiovascular disease mortality: the collaborative study. 
American Journal of Public Health. 2002;92:1295-8. 
574. James SA. Primordial prevention of cardiovascular disease among African-
Americans: a social epidemiological perspective. Preventive Medicine. 
1999;29:S84-9. 
575. Selak V, Elley CR, Bullen C, Crengle S, Wadham A, Rafter N, et al. Effect 
of fixed dose combination treatment on adherence and risk factor control among 
patients at high risk of cardiovascular disease: randomised controlled trial in 
primary care. BMJ. 2014;348:g3318. 
576. Ikram UZ, Kunst AE, Lamkaddem M, Stronks K. The disease burden across 
different ethnic groups in Amsterdam, the Netherlands, 2011-2030. European 
journal of public health. 2014;24(4):600-5. 
 
 
